Therapeutic Goods Administration

 

 

 

POISONS STANDARD 2015

 

 

I, ANTHONY GILL, a delegate of the Secretary to the Department of Health for the purposes of paragraph 52D(2)(b) of the Therapeutic Goods Act 1989 (the Act) and acting in accordance with the Secretary’s power under that paragraph of the Act, prepare this new Poisons Standard, in substitution for the current Poisons Standard.

 

 

(Signed by)

 

 

ANTHONY GILL

Delegate of the Secretary to the Department of Health

 

 

Dated this 5 February 2015


  1. Citation

 

This instrument is the Poisons Standard 2015.

 

 

2.              The New Poisons Standard

 

The Poisons Standard 2015 consists of the Standard for the Uniform Scheduling of Medicines and Poisons No. 6 (the SUSMP6) as set out in Schedule 1.

 

 

3.              Commencement

 

The Poisons Standard 2015 commences on the day after registration.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule 1-Standard for the Uniform Scheduling of Medicines and Poisons No. 6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

STANDARD FOR THE UNIFORM SCHEDULING OF

MEDICINES AND POISONS

No. 6

 

February 2015

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reasons for scheduling delegates final decisions can be accessed from the TGA website, at https://www.tga.gov.au/reasons-scheduling-delegates-final-decisions

 

Futher inquiries in relation to this document should be directed to:

 

The Secretary

Chemicals Scheduling Secretariat (MDP88)

Office of Chemical Safety

Department of Health

GPO Box 9848

CANBERRA  ACT  2601

 

or by email to Chemicals.Scheduling@health.gov.au

 

The Secretary

Medicines Scheduling Secretariat (MD122)
Communications and Secretariat
Therapeutic Goods Administration
PO Box 100
WODEN ACT 2606

 

or by email to Medicines.Scheduling@tga.gov.au

 

 

Media Liaison Unit

Australian Government Department of Health

 

 

 

 

Contents

INTRODUCTION

CLASSIFICATION

PRINCIPLES OF SCHEDULING

READING THE SCHEDULES

PART 1

INTERPRETATION

PART 2

CONTROL ON MEDICINES AND POISONS

SECTION ONE   LABELS

SECTION TWO   CONTAINERS

PART 3

MISCELLANEOUS REGULATIONS

SECTION ONE  ADVERTISING

SECTION TWO  SALE OR SUPPLY

SECTION 3 STORAGE

PART 4

THE SCHEDULES

SCHEDULE 1

SCHEDULE 2

SCHEDULE 3

SCHEDULE 4

SCHEDULE 5

SCHEDULE 6

SCHEDULE 7

SCHEDULE 8

SCHEDULE 9

SCHEDULE 10

PART 5

THE APPENDICES

APPENDIX A

APPENDIX B

APPENDIX C (see SCHEDULE 10)

APPENDIX D

APPENDIX E

APPENDIX F

APPENDIX G

APPENDIX H

APPENDIX I

APPENDIX J

APPENDIX K

APPENDIX L

INTRODUCTION

 

The Poisons Standard 2015, which, under section 2 above consists of the Standard for the Uniform Scheduling of Medicines and Poisons (the Standard, or the SUSMP), is made under paragraph 52D(2)(b) of the Therapeutic Goods Act 1989, and is a compilation of the decisions made under section 52D of the same Act.  The SUSMP should be read in conjunction with the Scheduling Policy Framework (SPF) of the Australian Health Ministers' Advisory Council.  Further information on the scheduling amendments and the SPF can be accessed at www.tga.gov.au.  Refer to Part 1, Interpretation, on page 2 below for definitions of specific terms used in this document including “medicine” and “poison” (noting that the definition of poison includes medicine).

 

The SUSMP serves two key purposes.

 

Firstly, the SUSMP contains the decisions of the Secretary of the Department of Health or the Secretary's delegates regarding the classification of poisons into Schedules, as recommendations to Australian States and Territories.  The scheduling classification sets the level of control on the availability of poisons.  The scheduling of poisons is implemented through relevant State and Territory legislation.  Certain advertising, labelling and packaging requirements may also be a consequence of scheduling, but are the subject of other Commonwealth registration schemes.

 

Secondly, the SUSMP includes model provisions for labelling, containers, storage and possession of poisons in general, which are intended to be adopted for use in each jurisdiction of Australia, according to local requirements and local law.  Other government agencies may also impose controls on certain products, for example cosmetics.

 

The requirements for labelling and containers in the SUSMP are intended to integrate with existing legislative instruments for labelling and containers.  Advertising, labelling and packaging of therapeutic goods and agricultural and veterinary chemicals are also dealt with through the respective product registration schemes provided for in Commonwealth legislation. 

 

Poisons which are packed and sold solely for industrial, manufacturing, laboratory or dispensary use are exempt from all labelling requirements included in the SUSMP as they are covered by Safe Work Australia's National Code of Practice for the Labelling of Workplace Substances [NOHSC: 2012(1994)].  Note, however that this exemption does not extend to controls on supply of these poisons.

 

The SUSMP is presented with a view to promoting uniform:

 

The various Commonwealth Acts, legislative instruments and other documents which integrate with the SUSMP include:

 

 

 

Poisons are classified according to the Schedules in which they are included.  The following is a general description of the Schedules.  For the legal definitions, however, it is necessary to check with each relevant State or Territory authority.

 

Schedule 1. This Schedule is intentionally blank.

 

Schedule 2. Pharmacy Medicine – Substances, the safe use of which may require advice from a pharmacist and which should be available from a pharmacy or, where a pharmacy service is not available, from a licensed person.

 

Schedule 3.   Pharmacist Only Medicine – Substances, the safe use of which requires professional advice but which should be available to the public from a pharmacist without a prescription.

 

Schedule 4. Prescription Only Medicine, or Prescription Animal Remedy – Substances, the use or supply of which should be by or on the order of persons permitted by State or Territory legislation to prescribe and should be available from a pharmacist on prescription.

 

Schedule 5. Caution – Substances with a low potential for causing harm, the extent of which can be reduced through the use of appropriate packaging with simple warnings and safety directions on the label.

 

Schedule 6. Poison – Substances with a moderate potential for causing harm, the extent of which can be reduced through the use of distinctive packaging with strong warnings and safety directions on the label.

 

Schedule 7. Dangerous Poison – Substances with a high potential for causing harm at low exposure and which require special precautions during manufacture, handling or use.  These poisons should be available only to specialised or authorised users who have the skills necessary to handle them safely.  Special regulations restricting their availability, possession, storage or use may apply.

 

Schedule 8. Controlled Drug – Substances which should be available for use but require restriction of manufacture, supply, distribution, possession and use to reduce abuse, misuse and physical or psychological dependence.

 

Schedule 9.   Prohibited Substance – Substances which may be abused or misused, the manufacture, possession, sale or use of which should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with approval of Commonwealth and/or State or Territory Health Authorities.

 

Schedule 10/

Appendix C. Substances of such danger to health as to warrant prohibition of sale, supply and use - Substances which are prohibited for the purpose or purposes listed for each poison.

 

 

Poisons are not scheduled on the basis of a universal scale of toxicity.  Although toxicity is one of the factors considered, and is itself a complex of factors, the decision to include a substance in a particular Schedule also takes into account many other criteria such as the purpose of use, potential for abuse, safety in use and the need for the substance.

 

This Standard lists poisons in nine Schedules according to the degree of control recommended to be exercised over their availability to the public.

 

Poisons for therapeutic use (medicines) are mostly included in Schedules 2, 3, 4 and 8 with progression through these Schedules signifying increasingly restrictive regulatory controls.

 

For some medicines and agricultural, domestic and industrial poisons, Schedules 5, 6 and 7 represent increasingly stricter container and labelling requirements with special regulatory controls over the availability of the poisons listed in Schedule 7.  Products for domestic use must not include poisons listed in Schedule 7.

 

Schedule 9 contains substances that should be available only for teaching, training, medical or scientific research including clinical trials conducted with the approval of Commonwealth and/or State and Territory health authorities.  Although appearing as a Schedule in this Standard, the method by which it is implemented in the States and Territories may vary.

 

Schedule 10/Appendix C contains a list of substances or preparations, the sale, supply or use of which should be prohibited because of their known dangerous properties. 

 

Substances in products which have been considered for scheduling, but have been exempted from this Standard, may be listed in either Appendix A (general exemptions) or Appendix B (substances considered not to require control by scheduling).

 

 

Schedule entries have been designed to be as simple as possible while retaining readability, legal integrity and as much freedom from ambiguity and contradiction as possible.  As a result, they are expressed in a number of ways, though this number has been kept to a minimum.  It is necessary to keep this variety of expression in mind when searching or interpreting Schedule entries.

 

Firstly, poisons are scheduled individually using their approved names wherever practicable although exceptions are necessary in some cases.  Some of those are mentioned overleaf.  Older group entries are revised and replaced by individual entries as time permits, although in some of these cases a group term has also been retained to deal with any members of the group or class that may have escaped attention but should be scheduled.

 

Secondly, Schedule entries have been expressed in either positive or negative terms and care must be taken to distinguish between the two different forms of expression. Thus, selenium is in Schedule 6 only when one of the clauses in this Schedule entry applies, while fluorides are in Schedule 6 unless one of the exempting clauses applies.

 

Where exceptions are included in an entry, these have been emphasised by printing the word “except” in bold type.

 

Where the Schedule entries for a poison make a specific exclusion or exemption, the requirements of this Standard do not apply to that poison within the constraints of that exclusion or exemption although controls under other legislation, such as pesticide registration, may apply.

 

Where a Schedule entry for a poison requires a specific statement to be included on a label as a condition for a product to qualify for an exemption (‘reverse scheduling’), then in cases where it is impracticable for a supplier to use the exact wording of such a statement, its wording may be varied provided that the full intent and meaning of the statement is not changed.

 

Where a poison has been included in more than one Schedule, the principal entry, where practicable, has been included in the most restrictive Schedule with references to the other Schedule(s) involved.

 

It is important to remember that a Schedule entry includes preparations containing the poison in any concentration and all salts and derivatives of the poison unless it specifically states otherwise. (See Part 1, Interpretation, subparagraph 1(2).

 

It is important to note that a substance is not classed as a derivative on the basis of a single, prescriptive set of criteria.  Classification of a substance as a derivative of a scheduled poison relies on a balanced consideration of factors to decide if a substance has a similar nature (e.g. structurally, pharmacologically, toxicologically) to a scheduled poison or is readily converted (either physically or chemically) to a scheduled poison.  However, a substance is only considered a derivative of a scheduled poison if it is not individually listed elsewhere in the Schedules, or captured by a more restrictive group or class entry.  Additionally, some entries specifically exclude derivatives.  Once a substance is determined to be a derivative of a scheduled poison, the same scheduling requirements as the scheduled poison, including limits on access, supply and availability, will apply.

 

 

 

Finally, when using this Standard to determine the scheduling status of a poison, it may be necessary to search each relevant Schedule as well as Appendices A and B, the Index and the Cross Reference Index.  In this process, if the poison is not found under its “approved name” it may be shown under a group term such as:

 

Group     Example

 

the parent acid of salts   “oxalic acid” to find sodium oxalate

 

the radical of a salt   “chromates” to find potassium

  chromate

 

the element   “arsenic” to find arsenic trioxide

 

a chemical group with similar   “hydrocarbons, liquid” to find

toxicological or pharmacological  kerosene

activity 

 

a pharmacological group  “anabolic steroidal agents” to find

  “androsterone”

 

 

The purpose of classification is to group substances into Schedules that require similar regulatory controls over their availability.

 

These Schedules have been developed over a long period and contain poisons that may be obsolete for various reasons.  Also, as part of the move to harmonise the Australian and New Zealand classifications, many substances have been added to the Schedules for that purpose, irrespective of their availability in either country.

 

Inclusion of a poison in a Schedule indicates the degree of control required if it is marketed.  It does not indicate:

 

 

If a preparation contains two or more poisons, the provisions relating to each of the Schedules in which those poisons are included apply.

 

Where it is not possible to comply both with a provision relating to one of those Schedules and with a provision relating to another of those Schedules, the provision of the more restrictive Schedule applies, unless a contrary intention is indicated in the Schedules or relevant legislation.

 

The Schedules listed in order of greatest to least restriction on access and availability are 9, 10, 8, 4, 7, 3, 2, 6, 5.


Schedule 1 is not currently in use.

 


Some substances in certain circumstances are also subject to exemptions or additional restrictions as described in the Appendices of this Standard.  The table below summarises the purpose of each of the Appendices and the controls imposed on substances included in them.

 

Appendix

Title

Purpose/ controls imposed

Appendix A

General exemptions

List of classes of products or uses exempted from this Standard.

Appendix B

Substances considered not to require control by scheduling

List of poisons exempted from scheduling.

Appendix C

Appendix is intentionally left blank

 

Appendix D

Additional controls on possession or supply of poisons included in Schedule 4 or 8

List of poisons included in Schedule 4 or 8 where additional specified controls apply on possession or supply.

Appendix E

First aid instructions for poisons

First aid instructions for poisons (other than agricultural and veterinary chemicals and chemicals packed and sold solely for industrial, dispensary, manufacturing or laboratory use).

Appendix F

Warning statements and general safety directions for poisons

Warning statements and general safety directions for poisons (other than human medicines, agricultural and veterinary chemicals and chemicals packed and sold solely for industrial, dispensary, manufacturing or laboratory use).

Appendix G

Dilute preparations

Concentration cut-offs for specified poisons, below which the requirements of the Standard do not apply

Appendix H

Schedule 3 medicines permitted to be advertised

List of medicines included in Schedule 3 that are permitted to be advertised to the public.

Appendix I

Appendix is intentionally left blank

 

Appendix J

Conditions for availability and use of Schedule 7 poisons

List of poisons included in Schedule 7 where additional specified conditions apply to their availability and use.

Appendix K

Human medicines required to be labelled with a sedation warning

List of human medicines required to be labelled with a warning regarding their sedation potential.

Appendix L

 

Requirements for dispensing labels for medicines

Requirements applying to labels attached to medicines at the time of dispensing.

 

This page is intentionally blank.

PART 1

 

INTERPRETATION

 

1. (1) In this Standard, unless the contrary intention appears —

 

  Agricultural chemical” means a substance that is represented, imported, manufactured, supplied or used as a means of directly or indirectly:

 

   (a) destroying, stupefying, repelling, inhibiting the feeding of, or preventing infestation by or attacks of, any pest in relation to a plant, a place or a thing;

 

   (b) destroying a plant;

 

   (c) modifying the physiology of a plant or pest so as to alter its natural development, productivity, quality or reproductive capacity;

 

   (d) modifying an effect of another agricultural chemical;

 

   (e) attracting a pest for the purpose of destroying it; or

 

   (f) any active ingredient included in a product declared by regulation under the Agricultural and Veterinary Chemicals Code Act 1994 to be an agricultural chemical product;

 

   but does not include:

 

   (g) a veterinary chemical.

 

  Agricultural chemical product” has the meaning defined in the Agricultural and Veterinary Chemicals Code Act 1994.

 

  Animal” means any animal (other than a human being), whether vertebrate or not, and whether a food producing species or not, and includes mammals, birds, bees, reptiles, amphibians, fish, crustaceans and molluscs.

 

  “Animal feed premix” means a concentrated preparation, containing one or more poisons, for mixing with food ingredients to produce a bulk feed for a group of animals (including fish or birds), but does not include a preparation for mixing with an individual animal’s food.

 

  Appropriate authority” means:

 

   (a) in the Australian Capital Territory, ACT Government Health Directorate;

 

   (b) for the purpose of providing an exemption from all or part of paragraphs 2 to 12 in Part 2 of this Standard by the Australian Pesticides and Veterinary Medicines Authority, the Chief Executive Officer or their delegate;

 

   (c) in New South Wales, the Director-General of the NSW Ministry of Health;

 

   (d) in the Northern Territory, the Chief Health Officer of the Department of Health;

 

   (e) in Queensland, the Chief Executive of Queensland Health;

 

   (f) in South Australia, the Chief Executive of the Department for Health and Ageing;

 

   (g) in Tasmania, the Secretary of the Department of Health and Human Services;

 

   (h) for the purpose of providing an exemption from all or part of Section 1.1 to Section 1.5.3 of this Standard  by the Therapeutic Goods Administration, the National Manager or their delegate;

 

   (i) in Victoria, the Secretary to the Department of Health;

 

   (j) in Western Australia, the Chief Executive Officer of the Department of Health.

  

  “Approved name” means:

 

   (a) in relation to a poison that is for human therapeutic use, the name approved for use by the Therapeutic Goods Administration; 

 

   (b) in relation to a poison that is for animal or agricultural use, the name approved for use by the Australian Pesticides and Veterinary Medicines Authority;

 

   (c) in relation to all other poisons:

 

    (i) the name used in an entry in these Schedules; or, if no such name is given,

 

    (ii) the English name recommended by Standards Australia as the common name for the poison; or, if no such name is given,

 

    (iii) the English name given to the poison by the International Organization for Standardization; or, if no such name is given,

 

    (iv) the English name given to the poison by the British Standards Institution; or, if no such name is given,

 

    (v) the name that would comply with the requirements of part (a) or (b) of this definition, or, if no such name is given,

 

    (vi) the English name given to the poison by the European Committee for Standardization (CEN); or, if no such name is given,

 

    (vii) the international non-proprietary name recommended for the poison by the World Health Organization; or, if no such name is given,

 

    (viii) the International Nomenclature Cosmetic Ingredient name for the poison listed in the International Cosmetic Ingredient Dictionary & Handbook published by the Personal Care Products Council of America; or, if no such name is given,

 

    (ix) the accepted scientific name or the name descriptive of the true nature and origin of the poison.

 

  “Australian Code for the Transport of Dangerous Goods by Road and Rail” means the seventh edition of the document of that name.

 

  Authorised prescriber” means a registered medical, dental or veterinary practitioner or such other person authorised by the appropriate authority.

 

  “Blood” means whole blood extracted from human donors.

 

  Blood components” means therapeutic components that have been manufactured from blood (including red cells, white cells, stem cells, platelets and plasma), except for products derived through fractionation of plasma.

 

  “Child-resistant closure” means:

 

   (a) a closure that complies with the requirements for a child-resistant closure in the Australian Standard AS 1928-2007 entitled Child-resistant packaging – Requirements and testing procedures for reclosable packages (ISO 8317:2003, MOD);

 

   (b) a closure approved by an order made under subsection 10(3) of the Commonwealth Therapeutic Goods Act 1989; or

 

   (c) in the case of a can fitted with a press-on lid, a lid of the design known as “double tight” or “triple tight”.

 

   See also "Non-access packaging.

 

   “Child-resistant packaging” means packaging that:

 

   (a) complies with the requirements of the Australian Standard AS 1928-2007 entitled

    Child resistant packaging – Requirements and testing procedures for reclosable packages (ISO 8317:2003, MOD);

 

   (b) is reclosable and complies with the requirements of at least one of the following Standards:

 

    (i) the International Organization for Standardization Standard ISO 8317:2003 entitled Child-resistant packaging – Requirements and testing procedures for reclosable packages;

 

    (ii) the British Standards Institution Standard BS EN ISO 8317:2004 entitled

     Child-resistant packaging.  Requirements and testing procedures for reclosable packages;

 

    (iii) the Canadian Standards Association Standard CSA Z76.1-06 entitled Reclosable Child-Resistant Packages;

 

    (iv) the United States Code of Federal Regulations, Title 16, Section 1700.15, entitled Poison prevention packaging standards and Section 1700.20, entitled Testing procedure for special packaging;

 

   (c) is approved as child-resistant by any order made under subsection 10(3) of the Commonwealth Therapeutic Goods Act 1989; or

 

   (d) is in the form of blister or strip packaging in which a unit of use is individually protected until the time of release and that complies with Section 3 (Requirements for non-reclosable packages) of Australian Standard AS 1928-2001 entitled Child-resistant packages.

 

  See also "Non-access packaging".

 

  “Compounded” in relation to a substance means combined with one or more other therapeutically active substances in such a way that it cannot be separated from them by simple dissolution or other simple physical means.

 

  Cosmetic means:

(a) a substance or preparation intended for placement in contact with any external part of the human body, including:

   (i) the mucous membranes of the oral cavity; and

   (ii) the teeth;

       with a view to:

   (iii) altering the odours of the body; or

   (iv) changing its appearance; or

 (v) cleansing it; or

 (vi) maintaining it in good condition; or

 (vii) perfuming it; or

 (viii) protecting it.

 

  Debitterised neem seed oil” means highly purified oil from the neem seed containing only fatty acids and glycerides of fatty acids.

  

  “Dermal use” means application to the skin primarily for localised effect.

 

  “Designated solvent” means the following:

   acetone

   dimethylformamide

   N-(N-dodecyl)-2-pyrrolidone

   hydrocarbons, liquid

   methanol when included in Schedule 5

   methyl ethyl ketone

   methyl isoamyl ketone

   methyl isobutyl ketone

   N-methyl-2-pyrrolidone

   N-(N-octyl)-2- pyrrolidone

   phenyl methyl ketone

   styrene

   tetrachloroethylene

   1,1,1-trichloroethane

 

  “Dispensing label” means the label attached to the immediate container of a substance for therapeutic use at the time of dispensing.

 

  “Distributor” means a person who imports, sells or otherwise supplies a poison.

 

  “Divided preparation” means a preparation manufactured and packed as discrete pre-measured dosage units prior to sale or supply, and includes tablets, capsules, cachets, single dose powders or single dose sachets of powders or granules.

 

  “Dosage unit” means an individual dose of a poison for therapeutic use and includes a tablet, capsule, cachet, single dose powder or single dose sachet of powders or granules.

 

  “Drug” means a poison intended for human or animal therapeutic use.

 

  “Essential oils” means products obtained from natural raw materials either by distillation with water or steam or from the epicarp of citrus fruits by a mechanical process, or by dry distillation.  For scheduling purposes it also means:

 

   (a) oils of equivalent composition derived through synthetic means; or

 

   (b) prepared mixtures of oils of equivalent composition comprising a mixture of synthetic and natural components.

 

  “External” in relation to the use of a poison means application in the ears, eyes or nose or to a body surface other than in the mouth, rectum, vagina, urethra or other body orifice.

 

  “First Schedule Paint” means a paint containing the specified proportion of any substance in the First Group to Part 2 of this Standard.

 

  “Free formaldehyde” includes all hydrated and non-hydrated formaldehyde present in aqueous solution, including methylene glycol.

 

  “Graphic material” means the material which is to be deposited on another material by a graphic instrument during writing, drawing or marking and includes cores of pencils, school pastels or crayons, blackboard chalks, finger or showcard colours, poster paints and watercolour blocks.

 

  “Height” in relation to letters used for words, expressions or statements on labels means the height of capital letters or lower case letters having an ascender or a descender.

 

  “Hemp seed oil” means the oil obtained by cold expression from the ripened fruits (seeds) of Cannabis sativa.

 

  “Immediate container” includes all forms of containers in which a poison is directly packed but does not include any such container intended for consumption or any immediate wrapper.

 

  “Immediate wrapper” means metal foil, plastic foil, waxed paper, or any other such material not intended for consumption, when used as the first wrapper for a dosage unit or dressing.

 

  “Internal use” means administration:

 

   (a) orally, except for topical effect in the mouth; or

 

   (b) for absorption and the production of a systemic effect;

    (i) by way of a body orifice other than the mouth; or

    (ii)  parenterally, other than by application to unbroken skin.

 

  “Label” means:

 

   (a) a written statement on a container of a poison; and

 

   (b) in relation to a therapeutic good, includes a display of printed information about the product:

    (i)  on, or attached to, the good;

    (ii) on, or attached to, a container or primary pack in which the good is supplied; or

    (iii) supplied with such a container or pack.

 

  “Main label” means, where there are two or more labels on a container or a label is divided into two or more portions:

 

   (a) the part of a label that is most likely to be displayed, presented, shown, or examined under ordinary or customary conditions of display; and

 

   (b) where there are two or more labels or two or more portions of a single label – that label or portion of the label where the product name is more or most conspicuously shown; or

 

   (c) where the product name is equally conspicuous on two or more labels or portions of a label – each such label or portion.

 

  “Manufacturer” means a person who manufactures, produces, or packs a poison.

 

  “Measure pack” means a sealed container which contains a measured quantity of poison for use on one occasion as a pesticide or domestic product and one or more of which is enclosed in a primary pack.

 

  “Medicine” means any poison for therapeutic use.

   Note: To be preceded by “human” or “veterinary” where restriction of the “medicine” to human or animal use is intended.

 

  “Name and address” means the name and address, in Australia, of the manufacturer or distributor of a poison but does not include a post office, cable, telegraphic or code address.  Where such manufacturer or distributor is a company incorporated in accordance with the appropriate law of any State or Territory of the Commonwealth of Australia or a firm registered under the Business Names Act of any State or Territory, the inclusion in the label of the registered name of the corporation or firm or its branch or its division and the city or town in which a registered office is situated shall be deemed to comply with the requirements.

 

  “Non-access packaging” is packaging that complies with the requirements of Australian Standard AS4710-2001 entitled Packages for chemicals not intended for access or contact with their contents by humans, in relation to products that are not intended for human therapeutic use.

 

   See also "Child-resistant closure" and "Child-resistant packaging”..

 

  “Non-volatile content” in relation to a paint or tinter means that portion of a paint or tinter determined to be the non-volatile content by Method 301.1 of Australian Standard AS 1580-301.1-2005 entitled Paints and related materials – Methods of test – Non-volatile content by mass.

 

  Oromucosal use” means administration to the oral mucosa, specifically the oral cavity and/or the pharynx.

 

  “Paint”, without limiting the ordinary meaning, includes any substance used or intended to be used for application as a colouring or protective coating to any surface but does not include graphic material or paints for therapeutic use.

 

  “Pesticide” means any substance or mixture of substances used or intended to be used:

 

   (a) for preventing, destroying, repelling, attracting, inhibiting or controlling any insects, rodents, birds, nematodes, bacteria, fungi, weeds or other forms of plant or animal life or viruses, which are pests; or

 

   (b) as a plant regulator, promoter, defoliant or desiccant for food storage, household, industrial, commercial, agricultural and non-agricultural application, but does not include veterinary drugs, stock medicines, stock feeds, stock feed additives, drugs for human use, food additives or fertilisers.

 

  “Poison” means any substance or preparation included in a Schedule to this Standard.

 

  “Primary pack” means the pack in which a poison and its immediate container or immediate wrapper or measure pack are presented for sale or supply.

 

  “Required Advisory Statements for Medicine Labels” means the document made under subsection 3(5A) of the Therapeutic Goods Act 1989 by the Therapeutic Goods Administration.

 

  “Restricted flow insert” means a restriction fitted, or moulded, in the neck of a container which:

 

   (a) cannot readily be removed from the container by manual force; and

 

   (b) limits the delivery of the contents to drops each of which is not more than 200 microlitres.

 

  “Second Schedule Paint means a paint containing the specified proportion of any substance in the Second Group to Part 2 Section 7 of this Standard.

 

  “Selected container” means:

 

   (a) an injection vial having a nominal capacity of ten millilitres or less;

 

   (b) a single use syringe; or

 

   (c) any other container for substances for therapeutic use having a nominal capacity of ten millilitres or less.

 

  “Solid” is considered to include “powder” for the purposes of scheduling.

  

  “Therapeutic good” has the meaning defined in the Commonwealth Therapeutic Goods Act 1989.

 

  

 

 

“Therapeutic use” means use in or in connection with:

 

   (a) preventing, diagnosing, curing or alleviating a disease, ailment, defect or injury in human beings or animals;

 

   (b) influencing, inhibiting or modifying a physiological process in human beings or animals;

 

   (c) testing the susceptibility of human beings or animals to a disease or ailment;

 

   (d) influencing, controlling or preventing conception in persons or animals;

 

   (e) testing for pregnancy in persons or animals; or

 

   (f) the replacement or modification of parts of the anatomy in persons or animals.

 

  “Tinter” means any pigment or admixture of pigment with other substances, in powder, semi-solid or liquid form, sold or supplied for the purpose of adding to paint in order to change the colour of the paint.

 

  “Topical use” means application of a poison for the purpose of producing a localised effect on the surface of the organ or within the tissue to which it is applied.

 

  “Toy” means an object or number of objects manufactured, designed, labelled or marketed as a plaything for a child or children up to the age of fourteen years.

 

  “Transdermal use” means application to the skin primarily for systemic effect.

 

  “Veterinary chemical” means a substance that is represented as being suitable for, or is manufactured, supplied or used for, administration or application to an animal by any means, or consumption by an animal, as a way of directly or indirectly:

 

(a) preventing, diagnosing, curing or alleviating a disease or condition in the animal or an infestation of the animal by a pest;

 

(b) curing or alleviating an injury suffered by the animal;

 

(c) modifying the physiology of the animal:

 

(i) so as to alter its natural development, productivity, quality or reproductive capacity; or

 

(ii) so as to make it more manageable;

 

(d) modifying the effect of another veterinary chemical

 

(e) any vitamin, mineral substance, or additive, if, and only if, the vitamin, substance or additive is used for a purpose mentioned in paragraph (a), (b), (c) or (d); or

 

(f) any active ingredient included in a product declared by regulation under the Agricultural and Veterinary Chemicals Code Act 1994 to be an veterinary chemical product;

 

   but does not include:

 

   (g) an agricultural chemical.

 

“Veterinary chemical product” has the meaning defined in the Agricultural and Veterinary Chemicals Code Act 1994.

 

  “Writing” includes the visible representation or reproduction of words or figures in any form, and “to write” and “written” have corresponding meanings.

 

 

 (2) Unless the contrary intention appears a reference to a substance in a Schedule or an Appendix to this Standard includes:

 

  (a) that substance prepared from natural sources or artificially; and

 

  (b) where the substance is a plant (other than a plant included in Schedule 8 or 9), that plant or any part of that plant when packed or prepared for therapeutic use; and

 

  (c) every salt, active principle or derivative of the substance, including esters and ethers, and every salt of such an active principle or derivative; and

 

  (d) every alkaloid of the substance and every salt of such an alkaloid; and

 

  (e) every stereoisomer of the substance and every salt of such a stereoisomer; and

 

  (f) every recombinant form of the substance; and 

 

  (g) a preparation or admixture containing any proportion of the substance,

 

  but does not include:

 

  (h) a preparation or product included in Appendix A, or a substance and the reason for its entry in Appendix B; or

 

  (i) a substance included in Appendix G at a concentration not exceeding the concentration specified in column 2 of that Appendix in respect of that substance; or

 

  (j) any other substance included in Schedules 1 to 6, at a concentration not exceeding 10 mg per litre or 10 mg per kilogram, unless that substance is also included in Schedule 7 or 8; or

 

  (k) any substance present as an impurity in a pesticide, at a concentration at or below the maximum content for that substance, specified for the pesticide in the Standards for Active Constituents, as published by the Australian Pesticides and Veterinary Medicines Authority.

 

 (3) Unless the contrary intention appears where a concentration, strength or quantity is specified in a Schedule or an Appendix to this Standard in respect of a substance:

 

  (a) if the substance is present as a salt, active principle or derivative (including an ester or ether), the concentration, strength or quantity is calculated as the equivalent amount of the substance that is listed in the Schedule or Appendix; and

 

  (b) the expression “one per cent” means:

 

   (i) in the case of a liquid preparation, 1 gram of the substance per 100 millilitres of the preparation; or

 

   (ii) in the case of a solid, semi-solid or pressurised spray aerosol preparation, 1 gram of the substance per 100 grams of the preparation; and

 

   (iii) any expression of greater or lesser percentages shall have a corresponding meaning; and

 

  (c) in the case of codeine, such concentration, strength or quantity is calculated as anhydrous codeine.

 

 (4) A reference to a boiling or distillation temperature in the Schedules means that temperature at an atmospheric pressure of 101.325 kPa (760 millimetres of mercury).

PART 2

 

CONTROL ON MEDICINES AND POISONS

 

 

 

 (1) A person must not sell or supply a poison unless it is labelled in accordance with Part 2 Section 1 of this Standard              .

 

 (2) Any word, expression or statement required by this Standard to be written on a label or container must be written:

 

  (a) on the outside face of the label or container; and

 

  (b) in the English language; and

 

  (c) in durable characters; and

 

  (d) in a colour or colours to provide a distinct contrast to the background colour; and

 

  (e) in letters at least 1.5 millimetres in height.

 

 (3) Section 1.1(2)(e) does not apply to a word, expression or statement on a container which has a capacity of 20 millilitres or less, or on the label of such a container if:

 

  (a) an appropriate authority approves the use of smaller letters; and

 

  (b) the letters are at least 1 millimetre in height.

 

 (4) The label must be printed on, or securely attached to:

 

  (a) the outside of the immediate container; and

 

  (b) if the immediate container is enclosed in a primary pack, the outside of that primary pack.

 

 

 (1) A poison enclosed in an immediate wrapper must be contained in a primary pack labelled in accordance with Section 1.3 of this Standard; and

 

 (2) the immediate wrapper must be conspicuously labelled with:

 

  (a) the name of the manufacturer or distributor or the brand name or trade name used exclusively by the manufacturer or distributor for that poison; and

 

  (b) the approved name of the poison; and

 

 

  (c) a statement of the quantity or strength of the poison in accordance with
Section 1.4 of this Standard.

 

 

 (1) The primary pack and immediate container of a poison must be labelled as follows:

 

(a)    with the signal word or words relating to the Schedule in which the poison is included and the purpose for which it is to be used, as shown in the following table:

 

 

 Schedule Purpose Signal words required

 

 2 for any purpose PHARMACY MEDICINE

 

 3 for any purpose PHARMACIST ONLY MEDICINE

 

 4 for human use PRESCRIPTION ONLY MEDICINE

 

 4 for animal use PRESCRIPTION ANIMAL REMEDY

 

 5 for any purpose CAUTION

 

 6 for any purpose POISON

 

 7 for any purpose DANGEROUS POISON

 

 8 for any purpose CONTROLLED DRUG

 

   written:

 

   (i) on the first line or lines of the main label; and

 

   (ii) in bold-face sans serif capital letters of uniform thickness; and

 

   (iii) in letters at least half the height of the largest letter or numeral on the label but need not be larger than:

 

    (A) 6 millimetres on labels for packages having a nominal capacity of
2 litres or less; or

 

    (B) 15 millimetres on labels for packages having a nominal capacity of more than 2 litres; and 

 

   (iv) if the poison:

 

    (A) is a Schedule 5 poison, with nothing, other than a Class label as specified in the Australian Code for the Transport of Dangerous Goods by Road and Rail or a statement of the principal hazard of the poison, written on that line; or

 

    (B) is not a Schedule 5 poison, with nothing, other than a Class label as specified in the Australian Code for the Transport of Dangerous Goods by Road and Rail, written on that line;

 

  (b) if the poison is a Schedule 8 poison, with the cautionary statement –

 

POSSESSION WITHOUT AUTHORITY ILLEGAL

 

   written:

 

   (i) on a separate line or lines immediately below the signal words required by  Section1.3(1)(a); and

 

   (ii) in bold-face sans serif capital letters of uniform thickness; and

 

   (iii) in letters at least four-tenths the height of the letters used for the signal words; and

 

   (iv) with no other statement written on the same line;

 

  (c) with the cautionary statement –

 

 

KEEP OUT OF REACH OF CHILDREN

 

   written:

 

   (i) on a separate line or lines:

 

    (A) immediately below the signal word or words required by Section 1.3(1)(a); or

 

    (B) where the cautionary statement “POSSESSION WITHOUT AUTHORITY ILLEGAL” is required by Section 1.3(1)(b), on the line immediately below that statement; and

 

   (ii) in bold-face sans serif capital letters of uniform thickness; and

 

   (iii) in letters at least four-tenths the height of the letters used for the signal word or words; and

 

   (iv) with nothing, other than a Class label as specified in the Australian Code for the Transport of Dangerous Goods by Road and Rail, written on the same line;

 

  (d) if the poison is a dry chlorinating compound containing more than 10 per cent of available chlorine, except for preparations certified by a relevant State or Territory authority as not being a Dangerous Good of Class 5, Division 5.1: Oxidising substances, as specified in the Australian Code for the Transport of Dangerous Goods by Road and Rail, with the cautionary statement –

 

FIRE AND EXPLOSION HAZARD

 

   written:

 

   (i) on a separate line or lines immediately below the cautionary statement “KEEP OUT OF REACH OF CHILDREN” as required by Section 1.3(1)(c); and

 

   (ii) in bold-face sans serif capital letters of uniform thickness; and

 

   (iii) in letters at least four-tenths the height of the letters used for the signal word or words; and

 

   (iv) with nothing, other than a Class label as specified in the Australian Code for the Transport of Dangerous Goods by Road and Rail, written on the same line;

 

  (e) if the poison is an alkaline salt in a dishwashing machine product, with the cautionary statement –

 

BURNS SKIN AND THROAT

 

   written:

 

   (i) on a separate line or lines immediately below the cautionary statement “KEEP OUT OF REACH OF CHILDREN” as required by Section 1.3(1)(c); and

 

   (ii) in bold-face sans serif capital letters of uniform thickness; and

 

   (iii) in letters at least four-tenths the height of the letters used for the signal word; and

 

   (iv) with nothing, other than a Class label as specified in the Australian Code for the Transport of Dangerous Goods by Road and Rail, written on the same line of the main label;
 

(f) if the poison is an aqueous solution of paraquat, with the cautionary statements –

 

CAN KILL IF SWALLOWED

DO NOT PUT IN DRINK BOTTLES

KEEP LOCKED UP

 

   

   written:

 

   (i) on separate lines immediately below the cautionary statement “KEEP OUT OF REACH OF CHILDREN” as required by Section1.3(1)(c); and

 

   (ii) in bold-face sans serif capital letters of uniform thickness; and

 

   (iii) in letters at least four-tenths the height of the letters used for the signal words; and

 

   (iv) with nothing, other than a Class label as specified in the Australian Code for the Transport of Dangerous Goods by Road and Rail, written on the same lines of the main label;

 

  (g) for any poison other than a poison for human therapeutic use labelled in accordance with the Required Advisory Statements for Medicine Labels, if safety directions are required on the label by Section 1.3(1)(n), with the cautionary statement –

 

 

READ SAFETY DIRECTIONS BEFORE OPENING

OR USING

 

   or with the cautionary statement –

 

READ SAFETY DIRECTIONS

 

   written:

 

   (i) on a separate line or lines;

 

    (A) immediately below the cautionary statement “KEEP OUT OF REACH OF CHILDREN” as required by Section (1)(c); or

 

    (B) if one or more other cautionary statements is required to be on the line immediately below “KEEP OUT OF REACH OF CHILDREN”, immediately below that statement or those statements; and

 

   (ii) in bold-face sans serif capital letters of uniform thickness; and

 

   (iii) in letters at least four-tenths the height of the letters used for the signal word or words; and

 

   (iv) with nothing, other than a Class label as specified in the Australian Code for the Transport of Dangerous Goods by Road and Rail, written on the same line;

 

  (h) if the poison meets the criteria for a ‘flammable liquid’ in the Australian Code for the Transport of Dangerous Goods by Road and Rail, with the cautionary statement –

 

FLAMMABLE

 

   written on the main label in bold-face sans serif capital letters of uniform thickness, unless already present in accordance with the requirements of the Australian Code for the Transport of Dangerous Goods by Road and Rail;

(i) if the poison is for the treatment of animals, with the cautionary statement –

 

FOR ANIMAL TREATMENT ONLY

 

   written on the main label in bold-face sans serif capital letters of uniform thickness;

 

  (j) if the poison is a Schedule 5 poison intended for any purpose other than internal or pesticidal use, with the cautionary statement –

 

DO NOT SWALLOW

 

   written in sans serif capital letters on the main label or as part of the directions for use;

 

  (k) with the approved name of the poison and a statement of the quantity, proportion or strength of the poison in accordance with Section 1.4:

 

   (i) if the poison is for human therapeutic use, written in accordance with orders made under subsection 10(3) of the Commonwealth Therapeutic Goods Act, 1989; or

 

   (ii) if the poison is not for human therapeutic use, written in bold-face sans serif capital letters on the main label, unless:

 

    (A) a list of approved names is required; and

 

    (B) it is impractical to include the list on the main label; and

 

    (C) an appropriate authority has authorised its inclusion on another part of the label; or

 

   (iii) if the poison is a Schedule 5 poison referred to in column 1 of the following table the appropriate name opposite thereto in column 2 may be used as the approved name:

 

TABLE

 

    Column 1 Column 2

 

    Alkaline salts Alkaline salts

 

     Amines for use as curing Aliphatic amines or

      agents for epoxy resins aromatic amines

      (unless separately specified

      in the Schedules) 

 

      Epoxy resins, liquid Liquid epoxy resins

 

      Hydrocarbons, liquid Liquid hydrocarbons

 

      Quaternary ammonium Quaternary ammonium

      compounds compound(s)

 

   (iv) if a poison contains a mixture of designated solvents in excess of 25 per cent of the total volume of the poison but the proportion of one or more individual designated solvents in the mixture is equal to or less than 25 per cent, the approved names of those solvents may be expressed as follows:

 

    (A) where the designated solvent is a liquid hydrocarbon as “liquid hydrocarbons”; or

 

    (B) where the designated solvent is a ketone as “ketones”; or

 

    (C) in any other case as “solvents” or “other solvents”;

 

  (l) if the poison is an organophosphorus compound or carbamate for pesticidal use or for the treatment of animals, with the following expression written immediately below the approved name or the list of declared contents –

 

AN ANTICHOLINESTERASE COMPOUND

 

   (i) the requirements of Section 1.3(1)(l) do not apply to:

 

    (A) dazomet, mancozeb, metiram, propineb, thiram, tri-allate, zineb or ziram; or

 

    (B) an organophosphorus compound or carbamate contained in impregnated plastic resin strips, medallions or granules; or

 

    (C) an organophosphorus compound or carbamate contained in a

     pressurised spray pack for household use;

 

  (m) for any poison other than a poison for human therapeutic use labelled in accordance with Therapeutic Goods Order 69 General requirements for labels for medicines or in an agricultural or veterinary chemical product labelled in compliance with the Agricultural and Veterinary Chemicals Code Act 1994, if the poison is prepared, packed or sold for a specific purpose, with clear and adequate directions for use unless:

 

   (i) the poison is included in Schedule 4 or Schedule 8; or

 

   (ii) it is impractical to include such directions on the label and:

 

    (A) the primary pack and the immediate container are labelled with the statement “DIRECTIONS FOR USE: See package insert”; and

 

    (B) an appropriate authority has authorised the directions for use to be written on a package insert instead of the label; and

 

    (C) the insert is enclosed in the primary pack;

 

  (n) for any poison other than a poison for human therapeutic use labelled in accordance with the Required Advisory Statements for Medicine Labels, if use of the poison may be harmful to the user, with appropriate safety directions (see Appendix F), grouped together as a distinct section of the label and prefaced by the words –

 

SAFETY DIRECTIONS

 

   written in bold-face capital letters;

 

  (o) for any poison other than a poison for human therapeutic use labelled in accordance with the Required Advisory Statements for Medicine Labels, if any warning statement or statements are required for the poison (see Appendix F), with that warning statement or those statements grouped together:

 

   (i) if safety directions are included on the label, immediately after the words “SAFETY DIRECTIONS”; or

 

   (ii) if there are no safety directions, immediately preceding the directions for use;

 

  (p) if the poison is not for human internal use and is not a Schedule 3, Schedule 4 or Schedule 8 poison, with appropriate first aid instructions (see Appendix E):
 

   (i) grouped together and prefaced by the words –

 

FIRST AID

 

    written in bold-face capital letters; or

 

   (ii) if a primary pack contains two or more immediate containers of poisons each requiring different first aid instructions:

 

    (A) written on each immediate container as specified in Section 1.3(1)(p)(i); and

 

    (B) replaced on the primary pack with the statement –

 

FIRST AID: See inner packs;

 

  (q) with the name and address of the manufacturer or distributor.

 

 (2) For the purposes of Section 1.3(1)(a)(iii) the term “largest letter or numeral” does not include:

 

  (a) a single letter or numeral which is larger than other lettering on the label; or

 

  (b) an affix forming part of the trade name; or

 

  (c) in the case of a poison for therapeutic use, numerals used to distinguish the strength of a preparation from the strengths of other preparations of the same poison.

 

 

(1)  The statement of the quantity, proportion or strength of a poison must be expressed in the most appropriate of the following forms:

 

 (a) if the poison is for human therapeutic use, in the manner prescribed by orders made under subsection 10(3) of the Commonwealth Therapeutic Goods Act 1989;

 

 (b) if the poison is for a purpose or purposes other than human therapeutic use and:

 

  (i) if the poison is in a pressurised spray aerosol preparation, as the mass of the poison per stated mass of the preparation;

 

  (ii) if the poison is a liquid in a liquid preparation, as the mass or volume of the poison per stated volume of the preparation;

 

  (iii) if the poison is a liquid in a solid or semi-solid preparation, as the mass or volume of the poison per stated mass of the preparation;

 

  (iv) if the poison is a solid or semi-solid in a liquid preparation, as the mass of the poison per stated volume of the preparation;

 

  (v) if the poison is a solid or semi-solid in a solid or semi-solid preparation, as the mass of the poison per stated mass of the preparation;

 

  (vi) if the poison is a gas in a liquid preparation, as the mass of the poison per stated volume of the preparation;

 

  (vii) if the poison is a gas in a solid or semi-solid preparation, as the mass of the poison per stated mass of the preparation;

 

  (viii) if the poison is a gas in a gaseous preparation, as the mass of the poison per stated mass of the preparation;

 

 (c) if the poison is a solution of a mineral acid, the proportion of the acid (un-neutralised by any bases present in the preparation) in a preparation may be expressed as the un-neutralised mass of the acid per stated mass of the preparation;

 

 (d) if the poison is an inorganic pigment, the proportion may be expressed as a percentage of the metal present using one of the following expressions as appropriate:

 

   contains not more than 10 per cent of (insert name of the metal); or

 

   contains not more than 30 per cent of (insert name of the metal); or

 

   contains more than 30 per cent of (insert name of the metal);

 

 (e) if the poison is included in a paint, other than a paint for therapeutic or cosmetic use, the proportion may be expressed as a range provided that the limits of the range do not differ by more than 5 per cent of the product;

 

 (f) if the poison is a lead-based pigment included in automotive paint, the proportion may be expressed as the maximum content of the lead that may be present in the non-volatile content of the paint;

 

 (g) if a preparation contains more than one derivative of a poison, the quantity or proportion of the poison may be expressed as the equivalent quantity or proportion of one of the derivatives present which it would contain if all of the derivatives were that derivative.

 

 (h) For the purposes of Section 1.4(1)(g) “derivative” includes alkaloid.

 

 

 

(1)  The requirements of Section 1.3 do not apply to an immediate container that is a measure pack or a selected container (other than an ampoule, a pre-filled syringe or an injection vial to which Section 1.5.2 (1) and  (2) apply) when:

 

 (a) the immediate container is for a therapeutic good and is labelled in the manner prescribed by orders made under subsection 10(3) of the Commonwealth Therapeutic Goods Act 1989; or

 

 (b) the immediate container is:

 

   (i) packed in a primary pack labelled in accordance with Section 1.3; and

 

   (ii) labelled with:

 

    (A) the signal word or words relating to the Schedule in which the poison is included and the purpose for which it is to be used, as shown in the table to Section 1.3(1)(a); and

 

    (B) the approved name of the poison and the quantity, proportion or strength of the poison in accordance with Section 1.4; and

 

    (C) the name of the manufacturer or distributor or the brand name or trade name used exclusively by the manufacturer or distributor for the poison; and

 

    (D) if the poison is for the treatment of animals, with the cautionary statement –

 

FOR ANIMAL TREATMENT ONLY

 

      written in sans serif capital letters.

 

 

(1) The requirements of Section 1.3 do not apply to a selected container, or an ampoule (other than an ampoule to which Section 1.5.2(2) applies) when:

 

 (a) the selected container or ampoule is for a therapeutic good and is labelled in the manner prescribed by orders made under subsection 10(3) of the Commonwealth Therapeutic Goods Act 1989; or

 

 (b) the selected container or ampoule is:

 

  (i) packed in a primary pack labelled in accordance with Section 1.3; and

 

  (ii) labelled with:

 

   (A) the approved name of the poison and the quantity, proportion or strength of the poison in accordance with Section 1.4; and

 

   (B) with the name of the manufacturer or distributor or the brand name or trade name used exclusively by the manufacturer or distributor for the poison; and
 

 

   (C) if the poison is for the treatment of animals, with the cautionary statement –

 

FOR ANIMAL TREATMENT ONLY

 

     written in sans serif capital letters.

 

(2) The requirements of Section 1.3  do not apply to a selected container that is a plastic ampoule that is continuous with a strip of the same material and opens as it is detached from the strip when:

 

 (a) the selected container is a plastic ampoule that is continuous with a strip of the same material and opens as it is detached from the strip, is for a therapeutic good and is labelled in the manner prescribed by orders made under subsection 10(3) of the Commonwealth Therapeutic Goods Act 1989; or

 

 (b) the selected container is a plastic ampoule that is continuous with a strip of the same material and opens as it is detached from the strip, is:             

 

  (i) packed in a primary pack labelled in accordance with Section 1.3; and

 

  (ii) the strip is labelled in accordance with Section 1.5.2; and

 

  (iii) the ampoule is labelled with:

 

   (A) the approved name of the poison or the trade name of the product; and

 

   (B) the quantity, proportion or strength of the poison in accordance with Section 1.4.

 

 

(1) The labelling requirements of this Standard do not apply to a transparent cover, or to any wrapper, hamper, packing case, crate or other cover used solely for the purposes of transport or delivery.

 

 

(1) The labelling requirements of this Standard do not apply to a poison that:

 

  (a) is packed and sold solely for dispensary, industrial, laboratory or manufacturing purposes; and

 

  (b) is labelled in accordance with Safe Work Australia's National Code of Practice for the Labelling of Workplace Substances [NOHSC: 2012(1994)].

 

 

 (1) The labelling requirements of Sections 1.3 to 1.5.3  do not apply to a poison where an appropriate authority has granted a labelling exemption in whole or in part for these sections for a specified product; and

 

 (2) the labelling exemption from an appropriate authority referred to in Section 1.5.5(1) is limited to no more than 12 months from the effective date of the decision for retail supply of the product; and

 

 (3) for the avoidance of doubt this paragraph does not apply to exemptions issued under Section 1.3(1)(m)(ii)(B) of this Standard.

 

 

(1)  Unless otherwise specified by regulation:

 

 (a) The labelling requirements of this Standard do not apply to a medicine that:

 

  (i) is supplied by an authorised prescriber or other person authorised to supply and is labelled in accordance with the requirements of Appendix L Part 1 of this Standard; or

 

  (ii) is supplied on and in accordance with a prescription written by an authorised prescriber and is labelled in accordance with the requirements of Appendix L Part 1 of this Standard; or

 

  (iii) is prepared and supplied by a pharmacist for an individual patient and is labelled in accordance with the requirements of Appendix L Part 1 of this Standard.

 

 (b) A person must not supply a dispensed medicine for human use containing:

 

(i)     a poison listed in column 1 of the table at Appendix L Part 2 of this Standard unless it is clearly labelled with the warning statement(s) specified in column 2 of that table; or

 

  (ii) a poison listed in Appendix K unless it is clearly labelled with a sedation warning (being statement 39, 40 or 90 as specified in Appendix F Part 1 of this Standard).

 

 

(1) The requirements of Sections 1.3(1)(a)(iv), 1.3(1)(c)(iv), and 1.3(1)(g)(iv) do not apply to a cylinder containing a poison that is a compressed gas.

 

 

(1) The requirements of Section 1.3 do not apply to:

 

 (a) paint (other than a paint for therapeutic or cosmetic use) which:

 

  (i) contains only Schedule 5 poisons; or

 

  (ii) is a First Group or Second Group paint that is labelled with:

 

   (A) the word “WARNING”, written in bold-face sans serif capital letters, the height of which is not less than 5 mm, on the first line of the main label with no other words written on that line;  and

 

   (B) the expression “KEEP OUT OF REACH OF CHILDREN”, written in bold-face sans serif capital letters, the height of which is not less than 2.5 mm, on a separate line immediately below the word “WARNING”; and

 

   (C) the appropriate warnings specified for the paint in Appendix F, written immediately below the expression “KEEP OUT OF REACH OF CHILDREN”; and

 

   (D) the name and proportion of the First Group or Second Group poisons it contains, provided that where the substance is a metal or metal salt the proportion is expressed as the metallic element present “calculated on the non-volatile content” or “in the dried film” of the paint; or

 

 (b) a tinter which contains:

 

  (a) only Schedule 5 poisons; or

 

  (b) a poison included in the First Group or Second Group in Part 2 Section 7, provided that it is labelled with the name and proportion of that poison, and where the poison is a metal or metal salt, the proportion is expressed as the metallic element present as “calculated on the non-volatile content” or “in the dried film”.

 

 

(1) The labelling requirements of Section1.1(2)(d) and Section 1.3 do not apply to a device that contains camphor or naphthalene in block, ball, disc, pellet or flake form if the device:

 

 (1) complies with Section 2.7; and

 

 (2) is sold or supplied in a primary pack labelled in accordance with Section 1.1 and Section 1.3.

 

 

(1) A label used in connection with any poison must not include:

 

 (a) any reference to this Standard, or any comment on, reference to, or explanation of any expression required by this Standard that directly or by implication contradicts, qualifies or modifies such expression; or

 

 (b) any expression or device suggesting or implying that the poison is safe, harmless, non-toxic, non-poisonous, or is recommended or approved by the Government or any government authority unless required by legislation; or

 

 (c) any expression or device which is false or misleading in any particular concerning the safety of the poison or any of its ingredients; or

 

 (d) any trade name or description that:

 

  (i) represents any single constituent of a compound preparation; or

 

  (ii) misrepresents the composition or any property or quality of the poison; or

 

  (iii) gives any false or misleading indication of origin or place of manufacture of the poison.

 

(2) A label must not be attached to the immediate container or primary pack used in connection with any poison in such a manner as to obscure:

 

 (a) any expression required by this Standard to be written or embossed on the container or pack; or

 

 (b) any of the ribs or embossed or printed words required by paragraph 21, 22 or 23 as appropriate.

 

 

 

2.1 Containers for poisons other than Schedule 5 poisons

 

(1) A person must not sell or supply a poison unless the immediate container complies with the requirements of Sections 2.1 and 2.3 to 2.7  of this Standard.

 

(2) If a poison, other than a Schedule 5 poison, is sold or supplied in a container with a nominal capacity of 2 litres or less, the container must comply with Australian Standard AS 2216-1997, entitled Packaging for poisonous substances.

 

(3) Notwithstanding Section 2.1(2), a poison which is in Schedule 6 and is an essential oil may be packed in an amber glass container which does not comply with the tactile identification requirements of Australian Standard AS 2216-1997, entitled Packaging for poisonous substances, if:

 

 (a) the other safety factors are not diminished; and

 

 (b) the container has a restricted flow insert and a child-resistant closure.

 

(4) If a poison, other than a Schedule 5 poison, is sold or supplied in a container with a nominal capacity of more than 2 litres, the container must:

 

 (a) comply with subsection 1.4 (General Requirements) of Australian Standard AS 2216-1997 entitled Packaging for poisonous substances; and

 

 (b) have the word “POISON”:

 

  (ia) in sans serif capital letters the height of which is at least one thirty second part of the length, height or width of the container, whichever is the greatest:

 

   (A) embossed; or

 

   (B) indelibly written in a colour in distinct contrast to the background colour;

 

  (ii) on the side or shoulder of the container.

 

 

 (1) The container in which any Schedule 5 poison is sold or supplied must:

 

  (a) comply with the container requirements of Sections 2.1(2) or 2.1(4); or

 

  (b) be readily distinguishable from a container in which food, wine or other beverage is sold; and

 

   (i) comply with subsection 1.4 (General Requirements) of Australian Standard AS 2216-1997 entitled Packaging for poisonous substances, excluding paragraph 1.4.3;

 

   (ii) be securely closed and, except when containing a preparation for use on one occasion only, be capable of being re-closed to prevent spillage of its contents; and

 

   (iii) have the expression “POISON”, “NOT TO BE TAKEN” or “NOT TO BE USED AS A FOOD CONTAINER” embossed or indelibly written thereon, or printed on a permanent adhesive label designed to adhere to a substrate without lifting and which cannot be removed without damaging either the label or the substrate.

 

 (2) Notwithstanding Section 2.2(1),  the following Schedule 5 poisons namely:

 

  (a) methylated spirit(s);

 

  (b) liquid hydrocarbons when packed as kerosene, lamp oil, mineral turpentine, thinners, reducers, white petroleum spirit or dry cleaning fluid;

 

  (c) petrol;

 

  (d) toluene; or

 

  (e) xylene,

 

  must not be sold or supplied in a bottle or jar having a nominal capacity of 2 litres or less, unless the immediate container complies with the container requirements specified in Section 2.1(2).

 

 

(1)  Notwithstanding subparagraphs 21, 22 and 23 a poison may be packed in a container that does not comply with the tactile identification requirements of Australian Standard AS2216-1997 entitled Packaging for poisonous substances or the requirements of Section 2.1(4)(b) or Section 2.2(1)(b)(iii) if:

 

 (a) the other safety factors are not diminished;

 

 (b) the container is for a specific purpose; and

 

 (c) an appropriate authority has approved the use of the container for that purpose.

 

 

(1) If a poison, other than a poison included in a therapeutic good packaged in a manner compliant with orders made under subsection 10(3) of the Commonwealth Therapeutic Goods Act 1989, listed in column 1 of the following table is sold or supplied in a container having a nominal capacity specified for that poison in column 2, it must be closed with a child-resistant closure.

 

  Alkaline salts included  in Schedule 5,   All sizes
when packed and labelled as dishwashing

  machine tablets.

 

  Alkaline salts included in Schedule 5,   5 litres /kilograms or less
when packed and labelled as dishwashing

  machine liquids, solids or gels.

 

  Alkaline salts included in Schedule 5, when   2.5 litres or less

  packed and labelled as a food additive.

 

  Anise oil when included in Schedule 5.   200 millilitres or less

 

  Basil oil when included in Schedule 5.   200 millilitres or less

 

  Bay oil when included in Schedule 6.   200 millilitres or less

 

  Cajuput oil when included in Schedule 6.   200 millilitres or less

 

  Cassia oil when included in Schedule 5.   200 millilitres or less

 

  Cineole when included in Schedule 6.   2 litres or less

 

  Cinnamon bark oil when included   200 millilitres or less

  in Schedule 5.

 

  Cinnamon leaf oil when included in Schedule 6.  200 millilitres or less

  

  Clove oil when included in Schedule 6.   200 millilitres or less

 

  Essential oils when included in Schedule 6   200 millilitres or less

  because of their natural camphor component.

 

  Ethylene glycol when included in Schedule 6.   5 litres or less

  

  Ethylene glycol when included in    5 litres or less

  Schedule 5 in preparations containing

  more than 50 per cent of ethylene glycol.

 

  Eucalyptus oil when included in Schedule 6.   2 litres or less

  

  Eugenol when included in Schedule 6.   200 millilitres or less

 

  Hydrocarbons, liquid, when packed     5 litres or less

  as kerosene, lamp oil, mineral turpentine,

  thinners, reducers, white petroleum spirit

  or dry cleaning fluid.

 

  Hydrochloric acid when included in Schedule 6.  5 litres or less  

  

  Leptospermum scoparium oil (manuka oil)   200 millilitres or less

  when included in Schedule 6

  

  Marjoram oil when included in Schedule 5.   200 millilitres or less

 

  

Melaleuca oil (tea-tree oil) when included   200 millilitres or less

  in Schedule 6.

 

  Methylated spirit excluding preparations or   5 litres or less  

  admixtures.

 

  Methyl salicylate and preparations containing   200 millilitres or less

  more than 50 per cent of methyl salicylate.

 

  Nutmeg oil when included in Schedule 5.   200 millilitres or less

 

  Oil of turpentine.   5 litres or less

 

  Pennyroyal oil when included in Schedule 6.   200 millilitres or less

  

  Potassium hydroxide as such.   2.5 litres or less

 

  Potassium hydroxide in oven, hot plate or   5 litres or less

  drain cleaners when included in Schedule 6

  except when in pressurised spray packs.

 

  d-Pulegone when included in Schedule 6.   200 millilitres or less

  

  Sage oil (Dalmatian) when included   200 millilitres or less

  in Schedule 6.

 

  Sodium hydroxide as such.   2.5 litres or less

 

  Sodium hydroxide in oven, hot plate or    5 litres or less

  drain cleaners when included in Schedule 6

  except when in pressurised spray packs.

 

  Thujone when included in Schedule 6.   200 millilitres or less

  

  Thyme oil when included in Schedule 5.   200 millilitres or less

 

 (2) The manufacturer or packer of a poison must ensure that the child-resistant closure is appropriate for the container and the poison and that it retains its child-resistant properties for the expected life of the poison.

 

 

 (1) A person who supplies any Schedule 8 poison must ensure that the Schedule 8 poison is packaged in such a way that its primary pack is so sealed that, when the seal is broken, it is readily distinguishable from other sealed primary packs.

 

 (2) This paragraph does not apply to the supply of a Schedule 8 poison by an:

 

  (a) authorised prescriber or other authorised supplier;

 

  (b) pharmacist on the prescription of an authorised prescriber;

 

  (c) pharmacist employed at a hospital, on the written requisition of a medical practitioner, a dentist or the nurse or midwife in charge of the ward in which the Schedule 8 poison is to be used or stored; or

 

  (d) nurse or midwife on the direction in writing of an authorised prescriber.

 

 

 (1) Section 2.1(2), Section 2.1(4) and Section 2.2  do not apply to the immediate container of a poison prepared, packed and sold:

 

  (a) for human internal or animal internal use; or

 

  (b) as a solid or semi-solid preparation for human external or animal external use; or

 

  (c) as a paint, other than a paint for therapeutic or cosmetic use; or

 

  (d) in containers having a nominal capacity of 15 millilitres or less; or

 

  (e) for use in automatic photographic or photocopy processing machines if the container is specifically designed to fit into the machines; or

 

  (f) solely for dispensary, industrial, laboratory or manufacturing purposes.

 

  (2)   Section 2.4  does not apply to a poison prepared, packed and sold solely for dispensary, industrial, laboratory or manufacturing purposes.

 

  (3)     The tactile identification or embossing required by Section 2.1(2), Section 2.1(4) and Section (2.2) of this Standard or Australian Standard AS 2216-1997 entitled Packaging for poisonous substances do not apply to a container that is an aerosol container, a collapsible tube, or a measure pack which is a flexible sachet.

 

 

(1) The container requirements of Section 2.1(2)  do not apply to a device that contains only camphor or naphthalene in block, ball, disc, pellet or flake form for domestic use, if the device:

 

 (a) in normal use, prevents removal or ingestion of its contents; and

 

 (b) is incapable of reacting with the poison; and

 

 (c) is sufficiently strong to withstand the ordinary risks of handling, storage or transport; and

 

 (d) has the word “POISON” and the approved name of the poison embossed or indelibly printed on it.

 

(2) A person must not sell or supply camphor or naphthalene in ball, block, disc, pellet or flake form for domestic use unless the balls, blocks, discs, pellets or flakes are enclosed in a device which prevents removal or ingestion of its contents.

 

 

(1) A person must not sell or supply a poison in a container which has the name of another poison embossed or indelibly marked thereon.

 

(2) A person must not sell any poison which is for internal use or any food, drink or condiment in a container prescribed by Sections 2.1(2), 2.1(4) and Section 2.2 of this Standard.

 

(3)  A person must not sell any poison in a container that is not readily distinguishable from a container in which food, alcohol, other beverage or condiment is sold..

 

 

 

 

 

SECTION THREE STORAGE 

 

3.1 General requirements

 

(1)       A person who sells or supplies Schedule 6 poisons by way of retail sale must keep those poisons in such a way as to prevent access by children.

 

(2)       A  person who sells or supplies Schedule 7 poisons must not keep those poisons  for retail sale in any areas or in any area or in any manner that allows physical access by any person unless they are:

 

(a)       the owner of the retail establishment; or

(b)       an employee of the owner; or

(c)       legally permitted to purchase the substance and are under the supervision of the owner or an employee  of the owner.

(3) Controls on storage of Schedule 2, 3, 4 and 8 poisons require referral to Part 3 of this Standard and relevant legislation.

 

 

SECTION FOUR  DISPOSAL

 

4.1 General requirements 

 

(1)    A person must not dispose of or cause to be disposed of a Schedule 5, Schedule 6 or Schedule 7 poison in any place or manner that constitutes or is likely to constitute a risk to public health or safety.

 

(2)    Controls on disposal of Schedule 2, 3, 4 and 8 poisons require referral to relevant legislation.

 

 

SECTION FIVE  RECORD KEEPING  

 

5.1 General Requirements

 

(1)        A person who sells or supplies Schedule 7 poisons must keep a record of:

 

 (a) Name and address of seller or supplier and purchaser; and

 (b) Date of order and supply; and

 (c) Approved name or trade name that identifies the poison to be  supplied or sold; and

 (d) Quantity supplied or sold; and

 (e) Proof of purchaser authorisation must be recorded in jurisdictions where an authorisation is required for purchase.

(2)        Records for sale or supply of Schedule 7 poisons must be kept for a minimum period of five years.

 

(3)       Controls on record keeping for sale or supply of Schedule 2, 3, 4 and 8 poisons require referral to relevant legislation.

 

 

SECTION SIX  SALE,  SUPPLY, POSSESSION, or USE

 

6.1 General Requirements for Schedule 5 and Schedule 6 Product samples

 

(1)       A person must not sell or supply or distribute free a product sample containing a Schedule 5 or Schedule 6 poison in any manner unless the recipient has the opportunity to refuse  at the time of sale or supply.

 

(2)       A person must not sell or supply or distribute free a product sample containing a Schedule 5 or Schedule 6 poison in an unsolicited manner for example via the post / mailbox or attached to any other product.

 

(3)       A person must not sell or supply a Schedule 5 or Schedule 6 poison product sample in a manner that does not promote  disposal in accordance with section four.

 

6.2    Schedule 7 Poisons

 

(1)        A person must not possess or use a Schedule 7 poison for domestic or domestic garden purposes.

 

(2)        A person must not sell or supply:

 

  (a) a Schedule 7 poison for domestic or domestic garden purposes; or

 

 (b) a Schedule 7 poison being a liquid preparation containing paraquat unless it is coloured blue or green     and contains sufficient stenching agent to produce an offensive smell; or

 

(c) a Schedule 7 poison for which an authorisation to purchase, possess or use is required by the appropriate authority unless the purchaser produces his or her authorisation. 

 

(3)       A person must not sell, supply or distribute free product samples containing Schedule 7 poisons.

 

6.3 Schedule 10/Appendix C poisons

 

(1)       A person must not knowingly have in his or her possession or sell, supply or use a poison listed in Schedule 10/Appendix C of this Standard for the purpose or purposes indicated in relation to that poison in Schedule 10/Appendix C;

 

 

6.4 Hawking

 

(1)       A person must not sell by way of hawking a Schedule 7 poison.

 

(2)       Controls on sale or supply or sale by way of hawking of Schedule 2, 3, 4 and 8 poisons require referral to Part 3 of this Standard and relevant legislation.

 

SECTION SEVEN/Appendix I PAINT OR TINTERS

 

7.1 General Requirements

 

(1) A person must not manufacture, sell, supply or use a First Group Paint for application to:

 (a) a roof or any surface to be used for the collection or storage of potable water; or

 (b) furniture; or

 (c) any fence, wall, post, gate or building (interior or exterior) other than a building which is used exclusively for industrial purposes or mining or any oil terminal; or

 (d) any premises used for the manufacture, processing, preparation, packing or serving of products intended for human or animal consumption.

 

(2)      A person must not manufacture, sell, supply or use a  paint or tinter containing more than 0.1% Lead (the proportion of Lead for the purposes of this section is calculated as a percentage of the element present in the non-volatile content of the paint).

 (3) A person must not manufacture, sell, supply or use a paint for application to toys unless the paint complies with the specification for coating materials contained in Australian/New Zealand Standard AS/NZS ISO 8124.3:2012 entitled Safety of toys Part 3: Migration of certain elements (ISO 8124-03:2010, MOD).

 

(4) A person must not manufacture, sell, supply, or use a paint or tinter containing a pesticide except a fungicide, algicide, bactericide or antifouling agent.

 

The First Group

The proportion of a substance for the purposes of this Group is calculated as a percentage of the element present in the non-volatile content of the paint.

Substance Proportion

ANTIMONY or antimony compounds other than  more than 5 per cent

antimony titanate pigments

BARIUM salts except barium sulfate or barium metaborate more than 5 per cent

CADMIUM or cadmium compounds more than 0.1 per cent

CHROMIUM as chromates of ammonia, barium, potassium more than 5 per cent

sodium, strontium or zinc

SELENIUM or selenium compounds more than 0.1 per cent

 

The Second Group

Substance Proportion

DICHLOROMETHANE (methylene chloride) more than 5 per cent by wt

ETHYLENE GLYCOL MONOALKYL ETHERS and their acetates more than 10 per cent by vol

TOLUENE more than 50 per cent by vol

XYLENE more than 50 per cent by vol

PART 3

 

MISCELLANEOUS REGULATIONS

 

(It is recommended that the States and Territories implement regulations which
provide controls similar to those included in this Part of the Standard.)

 

 

3.1  General requirements

 

(1)  A person must not include any reference to a poison included in:

 

  (a) Schedule 3 unless included in Appendix H; or

 

  (b)  Schedule 4 or Schedule 8,

 

 of this Standard in any advertisement except in genuine professional or trade journals or other publications intended for circulation only within the medical, nursing, veterinary, dental or pharmaceutical professions or the wholesale drug industry.

 

(2) A person must not include any reference to a poison included in Schedule 9 or Schedule 10/Appendix C of this Standard in any advertisement.

 

 

 

(1)  A person, other than a pharmacist (or an assistant under the direction of a pharmacist) or a medical, dental or veterinary practitioner in the lawful practice of their professions, must not sell or supply a Schedule 2 poison unless licensed to do so.

 

(2) A person is not eligible to be granted a licence to sell a Schedule 2 poison by way of retail sale unless:

 

  (a) he or she is carrying on the business of selling goods by retail; and

 

  (b) the premises from which the poison will be sold is more than 25 kilometres by the shortest practical route from the nearest pharmacy;  and

 

  (c he or she produces such evidence, as may be required, that he or she is a fit and proper person to be so licensed.

 

 

(1) A person, other than a pharmacist, or a medical, dental or veterinary practitioner, in the lawful practice of his or her profession, must not sell or supply a Schedule 3 poison.

 

(2) The person who sells or supplies a Schedule 3 poison must:

 

 (a) provide adequate instructions for use, either written or verbal, at the time of supply or sale; and

 

 (b) label the container with his or her name or the name of the pharmacy and the address from which it was sold or supplied; and

 

 (c) if required by regulation, make a record of the transaction in a prescription book or other approved recording system.

 


 

(1) A person, other than a medical, dental or veterinary practitioner in the ordinary course of their professions or a pharmacist dispensing a legal prescription must not sell or supply a Schedule 4 poison.

 

(2) Section 3.4(1) does not apply to a pharmacist who sells or supplies a Schedule 4 poison, other than a poison excepted by regulation from this provision, without a prescription if:

 

 (a) the patient is under medical treatment with the poison and continuation of medication is essential;  and

 

 (b) the quantity sold or supplied does not exceed 3 days' medication; and

 

 (c) the pharmacist is satisfied that an emergency exists.

 

(3) Section 3.2(1), Sections 3.3(1) and (2) and Section 3.4(1) do not apply to sale by way of wholesale dealing to a pharmacist, medical practitioner, veterinary practitioner, dentist or a person licensed or otherwise authorised to possess, sell or supply such poisons.

 

 

 

(1) A person must not:

 

 (a) sell or supply, other than by way of wholesale dealing, or prescribe a poison listed in Appendix D paragraphs 1, 2, 3 or 4 except in accordance with the provisions indicated for that poison in Appendix D; or

 

 (b) knowingly have in his or her possession a poison listed in Appendix D paragraph 5 without authority.

 

 

3.6 A person who sells or supplies Schedule 2 poisons must keep those poisons in such a way that public access to advice from a pharmacist is available if required.

 

3.7 A person who sells or supplies Schedule 3 or Schedule 4  poisons must keep those poisons in a part of the premises to which the public does not have access.

This page is intentionally blank.

 


PART 4

 

THE SCHEDULES

 

This Schedule is intentionally blank.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Substances marked  are listed in Appendix C)

 

ACETIC ACID (excluding its salts and derivatives) and preparations containing  more than 80 per cent of acetic acid (CH3COOH) for therapeutic use. 

 

ACETYLCYSTEINE in preparations for oral use except when labelled with a recommended daily dose of 1 g or less of acetylcysteine.

 

ACONITUM spp. for therapeutic use in adults:

 

 (a) in preparations for oral use in packs each containing 0.2 mg or less of total alkaloids except in packs containing 0.02 mg or less of total alkaloids; or

 

 (b) in preparations for dermal use containing 0.02 per cent or less of total alkaloids, in packs each containing 0.2 mg or less of total alkaloids except in packs containing 0.02 mg or less of total alkaloids.

 

ALOXIPRIN.

 

AMETHOCAINE in preparations for topical use other than eye drops, containing 10 per cent or less of total local anaesthetic substances except in dermal preparations containing 2 per cent or less of total local anaesthetic substances.

 

AMOROLFINE in preparations for topical use except in preparations for the treatment of tinea pedis.

 

ANTAZOLINE in eye drops.

 

ASPIRIN except:

 

 (a) when included in Schedule 4, 5 or 6;

 

 (b) in individually wrapped powders or sachets of granules each containing 650 mg or less of aspirin as the only therapeutically active constituent other than an effervescent agent when:

 

   (i) enclosed in a primary pack that contains 12 or less such powders or sachets of granules; and

 

   (ii) compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (c) in tablets or capsules each containing no other therapeutically active constituent other than an effervescent agent when:

 

   (i) packed in blister or strip packaging or in a container with a child-resistant closure;

 

   (ii) in a primary pack of not more than 25 tablets or capsules, each containing 325  mg or less of aspirin, or in a primary pack of not more than 16 tablets or capsules, each containing 500 mg or less of aspirin; and

 

   (iii) compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (d) in tablets or capsules each containing no other therapeutically active constituent other than an effervescent agent when:

 

   (i)  packed in blister or strip packaging or in a container with a child-resistant

 

    closure;

 

   (ii) in a primary pack containing 100 or less tablets or capsules, each containing 100 mg  or less of aspirin when packed and labelled for the prevention of cardiovascular disease or for the inhibition of platelet aggregation; and

 

   (iii) compliant with the requirements of the Required Advisory Statements for Medicine Labels.

 

ATROPA BELLADONNA (belladonna):

 

 (a) for external use in preparations containing 0.03 per cent or less of total solanaceous alkaloids; or

 

 (b) for oral use:

 

   (i) in undivided preparations containing 0.03 per cent or less of total solanaceous alkaloids when labelled with a dose of 0.3 mg or less of total solanaceous alkaloids and a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids; or

 

   (ii) in divided preparations containing 0.3 mg or less of total solanaceous alkaloids per dosage unit, when labelled with a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids.

 

ATROPINE (excluding atropine methonitrate) for oral use:

 

 (a) in undivided preparations containing 0.03 per cent or less of total solanaceous alkaloids when labelled with a dose of 0.3 mg or less of total solanaceous alkaloids and a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids; or

 

 (b) in divided preparations containing 0.3 mg or less of total solanaceous alkaloids per dosage unit when labelled with a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids.

 

AZELAIC ACID in dermal preparations.

 

AZELASTINE:

 

 (a) in preparations for nasal use; or

 

 (b) in topical eye preparations containing 0.05 per cent or less of azelastine.

 

BECLOMETHASONE in aqueous nasal sprays delivering 50 micrograms or less of beclomethasone per actuation when the maximum recommended daily dose is no greater than 400 micrograms and when packed in a primary pack containing 200 actuations or less, for the prophylaxis or treatment of allergic rhinitis for up to 6 months in adults and children 12 years of age and over.

 

BENZOCAINE in preparations for topical use other than eye drops:

 

 (a) containing 10 per cent or less of total local anaesthetic substances, except in dermal preparations containing 2 per cent or less of total local anaesthetic substances; or

 

 (b) in divided preparations containing 200 mg or less of total local anaesthetic substances per dosage unit, except in lozenges containing 30 mg or less of total local anaesthetic substances per dosage unit.

 

BENZOYL PEROXIDE in preparations for human external therapeutic use containing 10 per cent or less of benzoyl peroxide except in preparations containing 5 per cent or less of benzoyl peroxide.

 

BENZYDAMINE in preparations for topical use, except in preparations for dermal use.

 

BEPHENIUM SALTS.

 

BIFONAZOLE in preparations for dermal use except:

 

 (a) in preparations containing 1 per cent or less of bifonazole for the treatment of the scalp; or

 

 (b) in preparations for the treatment of tinea pedis.

 

BROMHEXINE.

 

BROMPHENIRAMINE when combined with one or more other therapeutically active substances in oral preparations when:

 

 (a) at least one of the other therapeutically active substances is a sympathomimetic decongestant; or

 

 (b) in a day-night pack containing brompheniramine in the bed-time dose where the day and night doses are in the same immediate container or immediate wrapper,

 

 except in preparations for the treatment of children under 2 years of age.

 

BUDESONIDE in aqueous nasal sprays delivering 50 micrograms or less of budesonide per actuation when the maximum recommended daily dose is no greater than 400 micrograms and when packed in a primary pack containing 200 actuations or less, for the prophylaxis or treatment of allergic rhinitis for up to 6 months in adults and children 12 years of age and over.

 

CARBETAPENTANE except in preparations containing 0.5 per cent or less of carbetapentane.

 

CARBOCISTEINE.

 

CETIRIZINE in preparations for oral use except in divided preparations for the treatment of seasonal allergic rhinitis in adults and children 12 years of age and over when:

 

(a)                 in a primary pack containing not more than 5 days’ supply; and

 

(b)                labelled with a recommended daily dose not exceeding 10 mg of cetirizine.

 

CHLOPHEDIANOL.

 

CHLORBUTOL for human use in topical preparations containing 5 per cent or less of chlorbutol except in preparations containing 0.5 per cent or less of chlorbutol.

 

CHLOROFORM in preparations for therapeutic use except:

 

 (a) when included in Schedule 4; or

 

 (b) in preparations containing 0.5 per cent or less of chloroform.

 

CHLORPHENIRAMINE when combined with one or more other therapeutically active substances in oral preparations when:

 

 (a) at least one of the other therapeutically active substances is a sympathomimetic decongestant; or

 

 (b) in a day-night pack containing chlorpheniramine in the bed-time dose where the day and night doses are in the same immediate container or immediate wrapper,

 

 except in preparations for the treatment of children under 2 years of age.

 

CICLOPIROX:

 

(a)            in preparations for dermal use containing 2 per cent or less of ciclopirox except in preparations for the treatment of tinea pedis; or

 

(b)            in preparations for application to the nails containing 8 per cent or less of ciclopirox.

 

CINCHOCAINE in preparations for topical use other than eye drops, containing 0.5 per cent or less of total local anaesthetic substances.

 

CINNAMEDRINE.

 

CLOTRIMAZOLE for human use in dermal preparations and for application to the nails except in preparations for the treatment of tinea pedis.

 

CODEINE in preparations for the treatment of coughs and colds when:

(a)          not combined with any other opiate substance;

 

(b)         compounded with one or more other therapeutically active substances, of which at least one is phenylephrine and not more than one is an analgesic substance:

 

(i)          in divided preparations containing 10 mg or less of codeine per dosage unit; or

 

  (ii) in undivided preparations containing 0.25 per cent or less of codeine;

 

(c)          labelled with a recommended daily dose not exceeding 60 mg of codeine; and

 

 (d) in packs containing not more than 6 days' supply at the maximum dose recommended on the label.

 

CREOSOTE derived from wood other than beechwood for human therapeutic use, except in preparations containing 10 per cent or less of creosote derived from wood other than beechwood.

 

DATURA spp. for oral use:

 

 (a) in undivided preparations containing 0.03 per cent or less of total solanaceous alkaloids when labelled with a dose of 0.3 mg or less of total solanaceous alkaloids and a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids, or

 

 (b) in divided preparations containing 0.3 mg or less of total solanaceous alkaloids per dosage unit when labelled with a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids,

 

 except when separately specified in these Schedules.

 

DATURA STRAMONIUM (stramonium) for oral use when:

 

 (a) in undivided preparations containing 0.03 per cent or less of total solanaceous alkaloids when labelled with a dose of 0.3 mg or less of total solanaceous alkaloids and a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids; or

 

 (b) in divided preparations containing 0.3 mg or less of total solanaceous alkaloids per dosage unit when labelled with a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids,

 

 except for smoking or burning.

 

DATURA TATULA (stramonium) for oral use:

 

 (a) in undivided preparations containing 0.03 per cent or less of total solanaceous alkaloids when labelled with a dose of  0.3 mg or less of total solanaceous alkaloids and a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids; or

 

 (b) in divided preparations containing 0.3 mg or less of total solanaceous alkaloids per dosage unit when labelled with a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids,

 

except for smoking or burning.

 

DELPHINIUM STAPHISAGRIA except in preparations containing 0.2 per cent or less of Delphinium staphisagria.

 

DESLORATADINE in preparations for oral use.

 

DEXCHLORPHENIRAMINE when combined with one or more other therapeutically active substances in oral preparations when:

 

 (a) at least one of the other therapeutically active substances is a sympathomimetic decongestant; or

 

 (b) in a day-night pack containing dexchlorpheniramine in the bed-time dose where the day and night doses are in the same immediate container or immediate wrapper,

 

 except in preparations for the treatment of children under 2 years of age.

 

DEXTROMETHORPHAN (excluding its stereoisomers) when supplied in a pack containing 600 mg or less of dextromethorphan and with a recommended daily dose of 120 mg or less of dextromethorphan.

 

DIBROMOPROPAMIDINE for ophthalmic use.

 

DICLOFENAC when:

 

(a)                 in divided preparations for oral use containing 12.5 mg or less of diclofenac per dosage unit in a pack containing 20 or less dosage units and labelled with a recommended daily dose of 75 mg or less of diclofenac;

 

(b)                 in preparations for dermal use containing 4 per cent or less of diclofenac except in preparations for dermal use containing 1 per cent or less of diclofenac or for the treatment of solar keratosis; or

 

(c)                 in transdermal preparations for topical use containing 140 mg or less of diclofenac.

 

DIHYDROCODEINE when compounded with aspirin and no other therapeutically active substance in divided preparations:

 

 (a) containing 5 mg or less of dihydrocodeine per dosage unit;

 

 (b) packed in blister or strip packaging or in a container with a child-resistant closure;

 

 (c) enclosed in primary packs containing 25 or less dosage units; and

 

 (d) labelled with a recommended dose not exceeding 10 mg of dihydrocodeine.

 

DIMENHYDRINATE in primary packs of 10 doses or less for the prevention or treatment of motion sickness, except in preparations for the treatment of children under 2 years of age.

 

DIPHENHYDRAMINE in oral preparations:

 

 (a) in a primary pack containing 10 dosage units or less for the prevention or treatment of motion sickness; or

 

 (b) when combined with one or more other therapeutically active substances when:

   (i) at least one of the other therapeutically active substances is a sympathomimetic decongestant; or

   (ii) in a day-night pack containing diphenhydramine in the bed-time dose where the day and night doses are in the same immediate container or immediate wrapper,

 

 except in preparations for the treatment of children under 2 years of age.

 

DOXYLAMINE when combined with one or more other therapeutically active substances in oral preparations when:

 

 (a) at least one of the other therapeutically active substances is a sympathomimetic decongestant; or

 

 (b) in a day-night pack containing doxylamine in the bed-time dose where the day and night doses are in the same immediate container or immediate wrapper,              

 

 except in preparations for the treatment of children under 2 years of age.

 

DUBOISIA LEICHHARDTII for oral use:

 

 (a) in undivided preparations containing 0.03 per cent or less of total solanaceous alkaloids when labelled with a dose of 0.3 mg or less of total solanaceous alkaloids and a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids; or

 

 (b) in divided preparations containing 0.3 mg or less of total solanaceous alkaloids per dosage unit when labelled with a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids.

 

DUBOISIA MYOPOROIDES for oral use:

 

 (a) in undivided preparations containing 0.03 per cent or less of total solanaceous alkaloids when labelled with a dose of 0.3 mg or less of total solanaceous alkaloids and a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids; or

 

 (b) in divided preparations containing 0.3 mg or less of total solanaceous alkaloids per dosage unit when labelled with a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids.

 

ECONAZOLE for human use in dermal preparations except in preparations for the treatment of tinea pedis.

 

ETAFEDRINE.

 

ETHER for therapeutic use except:

 

 (a) when included in Schedule 4; or

 

 (b) in preparations containing 10 per cent or less of ether.

 

ETHYLMORPHINE when:

 

 (a) compounded with one or more other therapeutically active substances:

 

   (i) in divided preparations containing 10 mg or less of ethylmorphine per dosage unit; or

 

   (ii) in undivided preparations containing 0.25 per cent or less of ethylmorphine;

  

 (b) labelled with a recommended dose not exceeding 15 mg of ethylmorphine.

 

ETOFENAMATE in preparations for external use.

 

FAMOTIDINE when sold in the manufacturer’s original pack containing not more than 14 days' supply.

 

FELBINAC in preparations for external use.

 

FEXOFENADINE in preparations for oral use except in divided preparations for the treatment of seasonal allergic rhinitis in adults and children 12 years of age and over when:

 

(a)                 in a primary pack containing 10 dosage units or less and not more than 5 days’ supply; and

 

(b)                 labelled with a recommended daily dose not exceeding 120 mg of fexofenadine.

 

FLUORIDES for human use:

 

 (a)  in preparations for ingestion containing 0.5 mg or less of fluoride ion per dosage unit; or

 

 (b)  in liquid preparations for topical use containing 1000 mg/kg or less of fluoride ion, in a container with a child-resistant closure:

 

   (i) for therapeutic use when compliant with the requirements of the Required Advisory Statements for Medicine Labels except in preparations containing 220 mg/kg or less of fluoride ion, in packs containing not more than 120 mg total fluoride when fitted with a child-resistant closure and compliant with the requirements of Required Advisory Statements for Medicine Labels; or

 

   (ii) for non-therapeutic use when labelled with warnings to the following effect:

 

    (A) Do not swallow; and

 

    (B) Do not use [this product/name of product] in children six years of age or less,

 

    except in preparations containing 220 mg/kg or less of fluoride ion, in packs containing not more than 120 mg total fluoride, when fitted with a child-resistant closure and labelled with warnings to the following effect:

 

    (A) Do not swallow; and

 

    (B) Do not use [this product/name of product] in children six years of age or less,

 except in preparations containing 15 mg/kg or less of fluoride ion or preparations for supply to registered dental professionals or by approval of an appropriate authority.

 

FLURBIPROFEN in preparations for topical oral use when:

 (a)  in divided preparations containing 10 mg or less of flurbiprofen per dosage unit; or

 

 (b) in undivided preparations containing 0.25 per cent or less, or 10 mg or less per dose, of flurbiprofen.

 

FLUTICASONE in aqueous nasal sprays delivering 50 micrograms or less of fluticasone per actuation when the maximum recommended daily dose is no greater than 400 micrograms and when packed in a primary pack containing 200 actuations or less, for the prophylaxis or treatment of allergic rhinitis for up to 6 months in adults and children 12 years of age and over.

 

FOLIC ACID for human therapeutic use except:

 

 (a) when included in Schedule 4; or

 

 (b) in preparations containing 500 micrograms or less of folic acid per recommended daily dose.

 

FOLINIC ACID for human therapeutic use except:

 

 (a) when included in Schedule 4; or

 

 (b) in preparations containing 500 micrograms or less of folinic acid per recommended daily dose.

 

 FORMALDEHYDE (excluding its derivatives) for human therapeutic use except:

 

 (a) in oral hygiene preparations containing 0.1 per cent or less of free formaldehyde; or

 

 (b) in other preparations containing 0.2 per cent or less of free formaldehyde.

 

GUAIPHENESIN in a modified release dosage form of 1200 mg or less of guaiphenesin with a recommended daily dose of 2400 mg or less when not labelled  for the treatment of children under 12 years of age.

 

GELSEMIUM SEMPERVIRENS.

 

GLUTARALDEHYDE for human therapeutic use.

 

HEXACHLOROPHANE in preparations for human use containing 3 per cent or less of hexachlorophane except:

 

 (a) in preparations containing 0.75 per cent or less of hexachlorophane; or

 

 (b) in preparations for use on infants, as specified in Schedule 4.

 

HYDROCORTISONE and HYDROCORTISONE ACETATE, but excluding other salts and derivatives, in preparations for human therapeutic use containing 0.5 per cent or less of hydrocortisone:

 

 (a) for dermal use, in packs containing 30 g or less of such preparations, containing no other therapeutically active constituent other than an antifungal substance; or

 

 (b) for rectal use when combined with a local anaesthetic substance but no other therapeutically active constituent except unscheduled astringents:

 

   (i) in undivided preparations in packs of 35 g or less; or

 

   (ii) in packs containing 12 or less suppositories.

 

HYDROQUINONE (excluding monobenzone and alkyl ethers of hydroquinone included in Schedule 4) in preparations for human external therapeutic or cosmetic use containing 2 per cent or less of hydroquinone except:

 

(a)     in hair preparations containing 0.3 per cent or less of hydroquinone; or

 

(b)    in cosmetic nail preparations containing 0.02 per cent or less of hydroquinone.

 

8-HYDROXYQUINOLINE and its non-halogenated derivatives for human therapeutic use, except in preparations for external use containing 1 per cent or less of such substances.

 

HYOSCINE (excluding hyoscine butylbromide):

 

 (a) for transdermal use in preparations containing 2 mg or less of total solanaceous alkaloids per dosage unit; or

 

 (b) for oral use:

  

   (i) in undivided preparations containing 0.03 per cent or less of total solanaceous alkaloids, when labelled with a dose of 0.3 mg or less of total solanaceous alkaloids and a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids; or

 

    (ii) in divided preparations containing 0.3 mg or less of total solanaceous alkaloids per dosage unit when labelled with a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids.

 

HYOSCINE BUTYLBROMIDE as the only therapeutically active substance, in divided preparations for oral use, containing 20 mg or less of hyoscine butylbromide per dosage unit in a pack containing 200 mg or less of hyoscine butylbromide.

 

HYOSCYAMINE:

 

 (a) for external use in preparations containing 0.03 per cent or less of total solanaceous alkaloids; or

 

 (b) for oral use:

 

   (i) in undivided preparations containing 0.03 per cent or less of total solanaceous alkaloids, when labelled with a dose of 0.3 mg or less of total solanaceous alkaloids and a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids; or

 

   (ii) in divided preparations containing 0.3 mg or less of total solanaceous alkaloids per dosage unit when labelled with a recommended daily dose of 1.2  mg or less total solanaceous alkaloids.

 

HYOSCYAMUS NIGER for oral use:

 

 (a) in undivided preparations containing 0.03 per cent or less of total solanaceous alkaloids when labelled with a dose of 0.3 mg or less of total solanaceous alkaloids and a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids; or

 

 (b) in divided preparations containing 0.3 mg of total solanaceous alkaloids or less per dosage unit when labelled with a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids,

 

 except in a pack containing 0.03 mg or less of total solanaceous alkaloids.

 

IBUPROFEN in preparations for oral use when labelled with a recommended daily dose of 1200 mg or less of ibuprofen:

 

 (a) in liquid preparations when sold in the manufacturer’s original pack containing 8 grams or less of ibuprofen; or

 

 (b) in divided preparations, each containing 200 mg or less of ibuprofen, in packs of not more than 100 dosage units except when:

 

  (i) as the only therapeutically active constituent (other than phenylephrine or when combined with an effervescent agent);

 

  (ii) packed in blister or strip packaging or in a container with a child-resistant closure;

 

  (iii) in a primary pack containing not more than 25 dosage units;

 

  (iv) compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

  (v) not labelled for the treatment of children 6 years of age or less; and

 

  (vi) not labelled for the treatment of children under 12 years of age when combined with phenylephrine.

 

INDANAZOLINE.

 

INDOMETHACIN in preparations for external use containing 1 per cent or less of indomethacin.

 

IODINE:

 

 (a) in preparations for human internal therapeutic use containing 300 micrograms or more of iodine per recommended daily dose; or

 

 (b) in preparations for human external therapeutic use containing more than 2.5 per cent of available iodine (excluding salts, derivatives or iodophors),

 

 except in oral preparations for use in prophylaxis and treatment in the event of radioactive iodine exposure under an emergency plan approved by an appropriate authority.

 

IPRATROPIUM in preparations for nasal use.

 

IRON COMPOUNDS (excluding iron oxides when present as an excipient, in divided preparations containing 10 mg or less of total iron oxides per dosage unit or in undivided preparations containing 1 per cent or less of total iron oxides) for human internal use except:

 

 (a) when included in Schedule 4; or

 

 (b)  when labelled with a recommended daily dose of 24 mg or less of iron:

 

   (i)  in undivided preparations supplied in packs each containing 750 mg or less of iron; or

 

   (ii)  in divided preparations:

 

    (A)  containing more than 5 mg of iron per dosage unit in packs each containing 750 mg or less of iron; or

 

    (B) containing 5 mg or less of iron per dosage unit.

 

ISOCONAZOLE for human use in dermal preparations.

 

ISOPROPAMIDE in preparations for dermal use containing 2 per cent or less of isopropamide.

 

KETOCONAZOLE in preparations for dermal use except:

 

 (a) in preparations containing 1 per cent or less of ketoconazole for the treatment of the

  scalp; or

 

 (b) in preparations for the treatment of tinea pedis.

 

KETOTIFEN for ophthalmic use in preparations containing 0.025 per cent or less of ketotifen.

 

LEVOCABASTINE in topical eye or nasal preparations.

 

LIGNOCAINE in preparations for topical use other than eye drops:

 

 (a) containing 10 per cent or less of total local anaesthetic substances, except in dermal preparations containing 2 per cent or less of total local anaesthetic substances; or

 

 (b) in divided preparations containing 200 mg or less of total local anaesthetic substances per dosage unit, except in lozenges containing 30 mg or less of total local anaesthetic substances per dosage unit.

 

LINDANE in preparations for human external therapeutic use containing 2 per cent or less of lindane.

 

LITHIUM in preparations for dermal use containing 1 per cent or less of lithium except:

 

 (a) when present as an excipient at 0.25 per cent or less of lithium; or

 

 (b) in preparations containing 0.01 per cent or less of lithium.

 

LOBELIA INFLATA except for smoking or burning.

 

LOBELINE except in preparations for smoking or burning.

 

LODOXAMIDE in preparations for ophthalmic use.

 

LOPERAMIDE in divided preparations for oral use in packs of 20 dosage units or less except in preparations containing 2 mg or less of loperamide per dosage unit, in a primary pack containing 8 dosage units or less.

 

LORATADINE in preparations for oral use except in divided preparations for the treatment of seasonal allergic rhinitis in adults and children 12 years of age and over when:

 

 (a) in a primary pack containing 5 dosage units or less; and

 

 (b) labelled with a recommended daily dose not exceeding 10 mg of loratadine.

 

MACROGOLS in preparations for oral use as a liquid concentrate for laxative use.

 

MEBENDAZOLE for human therapeutic use.

 

MECLOZINE in primary packs containing 12 or less tablets or capsules of meclozine for the prevention or treatment of motion sickness, except in preparations for the treatment of children under 2 years of age.

 

MEFENAMIC ACID in divided preparations for oral use in packs of 30 or less dosage units for the treatment of dysmenorrhoea.

 

MEPYRAMINE for dermal use.

 

MERCUROCHROME in preparations for external use containing 2 per cent or less of mercurochrome except when included in Schedule 6.

 

MERCURY for external use in preparations containing 0.5 per cent or less of mercury.

 

METHOXAMINE in preparations for external use except in preparations containing 1 per cent or less of methoxamine.

 

METHOXYPHENAMINE.

 

METHYLEPHEDRINE.

 

MICONAZOLE for human use in dermal preparations and for application to the nails except in preparations for the treatment of tinea pedis.

 

MINOXIDIL in preparations for dermal use containing 5 per cent or less of minoxidil.

 

MOMETASONE in aqueous nasal sprays delivering 50 micrograms or less of mometasone per actuation when the maximum recommended daily dose is no greater than 200 micrograms for the prophylaxis or treatment of allergic rhinitis for up to six months in adults and children 12 years of age and over.

 

NAPHAZOLINE.

 

NAPROXEN in divided preparations containing 250 mg or less of naproxen per dosage unit in packs of 30 or less dosage units.

 

NICLOSAMIDE for human therapeutic use.

 

NIZATIDINE when sold in the manufacturer’s original pack containing not more than 14 days' supply.

 

NOSCAPINE.

 

NYSTATIN in dermal preparations.

 

OXETACAINE (oxethazaine) in preparations for internal use.

 

OXICONAZOLE for dermal use except in preparations for the treatment of tinea pedis.

 

OXYMETAZOLINE.

 

PAPAVERINE except when included in Schedule 4.

 

PARACETAMOL for therapeutic use except:

 

(a)  when included in Schedule 4;

 

(b)  in individually wrapped powders or sachets of granules each containing 1000 mg or less of paracetamol as the only therapeutically active constituent (other than phenylephrine and/or guaiphenesinor when combined with effervescent agents) when:

 

(i)                   enclosed in a primary pack that contains not more than 10 such powders or sachets of granules;

(ii)                compliant with the requirements of the Required Advisory Statements  for Medicine Labels;

(iii)              not labelled for the treatment of children 6 years of age or less; and

(iv)              not labelled for the treatment  of children under 12 years of age when  combined with phenylephrine and/or guaiphenesin; or

 (c) in tablets or capsules each containing 500 mg or less of paracetamol as the only therapeutically active constituent (other than phenylephrine and/or guaiphenesin or when combined with effervescent agents) when:

 

(i)                   packed in blister or strip packaging or in a container with a child-resistant closure;

(ii)                in a primary pack containing not more than 20 tablets or capsules;

(iii)              compliant with the requirements of the Required Advisory Statements for Medicine Labels;

(iv)              not labelled for the treatment of children 6 years of age or less; and

(v)                not labelled for the treatment of children under 12 years of age when combined with phenylephrine and/or guaiphenesin.

 

 PARAFORMALDEHYDE (excluding its derivatives) for human therapeutic use except:

 

 (a) in oral hygiene preparations containing 0.1 per cent or less of free formaldehyde; or

 

 (b) in other preparations containing 0.2 per cent or less of free formaldehyde.

 

PENCICLOVIR for external use for the treatment of herpes labialis.

 

PHEDRAZINE.

 

PHENAZONE for human external use.

 

PHENIRAMINE:

 

 (a) in eye drops; or

 

 (b) when combined with one or more other therapeutically active substances in oral preparations when:

 

   (i) at least one of the other therapeutically active substances is a sympathomimetic decongestant; or

 

   (ii) in a day-night pack containing pheniramine in the bed-time dose where the day and night doses are in the same immediate container or immediate wrapper,

 

 except in preparations for the treatment of children under 2 years of age.

 

PHENOL, or any homologue boiling below 220°C, for human therapeutic use except:

 

 (a) when included in Schedule 4; or

 

 (b) in preparations for external use containing 3 per cent or less of such substances.

 

PHENYLEPHRINE except:

 

 (a) when included in Schedule 4;

 

 (b) in oral preparations containing 50 mg or less of phenylephrine per recommended daily dose in packs containing 250 mg or less of phenylephrine; or

 

 (c)  in topical eye or nasal preparations containing 1 per cent or less of phenylephrine.

 

PHOLCODINE:

 

 (a) in liquid preparations containing 0.5 per cent or less of pholcodine and with a recommended dose not exceeding 25 mg of pholcodine; or

 

 (b) when compounded with one or more other therapeutically active substances in divided preparations containing 10 mg or less of pholcodine per dosage unit and with a               recommended dose not exceeding 25 mg of pholcodine.

 

PIPERAZINE for human therapeutic use.

 

PODOPHYLLOTOXIN in preparations containing 0.5 per cent or less of podophyllotoxin for human use for the treatment of warts other than anogenital warts.

 

PODOPHYLLUM EMODI (podophyllin) in preparations containing 10 per cent or less of podophyllin for human use for the treatment of warts other than anogenital warts.

 

PODOPHYLLUM PELTATUM (podophyllin) in preparations containing 10 per cent or less of podophyllin for human use for the treatment of warts other than anogenital warts.

 

POTASSIUM CHLORATE for therapeutic use except in preparations containing 10 per cent or less of potassium chlorate.

 

PRILOCAINE in preparations for dermal use containing 10 per cent or less of total local anaesthetic substances.

 

PROCYCLIDINE in preparations containing 5 per cent or less of procyclidine for dermal use.

 

PROMETHAZINE in oral preparations:

 

 (a) in a primary pack containing 10 dosage units or less for the prevention or treatment of motion sickness; or

 

 (b) when combined with one or more other therapeutically active substances when:

   (i) at least one of the other therapeutically active substances is a sympathomimetic decongestant; or

   (ii) in a day-night pack containing promethazine in the bed-time dose where the day and night doses are in the same immediate container or immediate wrapper,

 

 except in preparations for the treatment of children under 2 years of age.

 

PROPAMIDINE for ophthalmic use.

 

PYRANTEL for human therapeutic use.

 

PYRETHRINS, naturally occurring, being pyrethrolone, cinerolone or jasmolone esters of chrysanthemic or pyrethric acids, for human therapeutic use in preparations containing more than 10 per cent of such substances.

 

PYRITHIONE ZINC for human therapeutic use, except in preparations for the treatment of the scalp containing 2 per cent or less of pyrithione zinc when compliant with the requirements of the Required Advisory Statements for Medicine Labels.

 

RANITIDINE in preparations supplied in the manufacturer’s original pack containing not more than 14 days' supply except in divided preparations for oral use containing 150 mg or less of ranitidine per dosage unit in the manufacturer’s original pack containing not more than 14 dosage units.

 

SALICYLAMIDE except when included in Schedule 4.

 

SELENIUM in preparations for human therapeutic use except:

 

(a) for topical use containing 3.5 per cent or less of selenium sulfide;

 

 (b) when included in Schedule 4; or

 

 (c) for oral use with a recommended daily dose of 150 micrograms or less.

 

SILVER for therapeutic use except:

 

 (a) in solutions for human oral use containing 0.3 per cent or less of silver when compliant with the requirements of the Required Advisory Statements for Medicine Labels; or

 

 (b) in other preparations containing 1 per cent or less of silver.

 

SODIUM CROMOGLYCATE in preparations for nasal or ophthalmic use.

 

SODIUM NITRITE for therapeutic use (excluding when present as an excipient).

 

SQUILL except in preparations containing 1 per cent or less of squill.

 

SULCONAZOLE in preparations for dermal use.

 

TERBINAFINE for dermal use except in preparations for the treatment of tinea pedis.

 

TETRACHLOROETHYLENE for human therapeutic use.

 

TETRAHYDROZOLINE.

 

THIABENDAZOLE for human therapeutic use.

 

TIOCONAZOLE in preparations for dermal use except in preparations for the treatment of tinea pedis.

 

TRAMAZOLINE.

 

TRIAMCINOLONE in aqueous nasal sprays delivering 55 micrograms or less of triamcinolone per actuation when the maximum recommended daily dose is no greater than 220 micrograms, for prophylaxis or treatment of allergic rhinitis for up to 6 months in adults and children 12 years of age and over.

 

TRIMEPRAZINE when combined with one or more other therapeutically active substances in solid oral preparations when:

 

 (a) at least one of the other therapeutically active substances is a sympathomimetic decongestant; or

 

 (b) in a day-night pack containing trimeprazine in the bed-time dose where the day and night doses

  are in the same immediate container or immediate wrapper,

 

 except in preparations for the treatment of children under 2 years of age.

 

TRIPROLIDINE when combined with one or more other therapeutically active substances in oral preparations when:

 

 (a) at least one of the other therapeutically active substances is a sympathomimetic decongestant; or

 

 (b) in a day-night pack containing triprolidine in the bed-time dose where the day and night

  doses are in the same immediate container or immediate wrapper,

 

 except in preparations for the treatment of children under 2 years of age.

 

TUAMINOHEPTANE.

 

TYMAZOLINE.

 

XYLOMETAZOLINE.

 

ZINC CHLORIDE for human dermal use except in preparations containing 5 per cent or less of zinc chloride.

 

ADRENALINE in preparations containing 1 per cent or less of adrenaline except in preparations containing 0.02 per cent or less of adrenaline unless packed and labelled for injection.

 

ALCLOMETASONE as the only therapeutically active substance in preparations for dermal use containing               0.05 per cent or less of alclometasone in packs containing 30 g or less of the preparation.

 

AMINOPHYLLINE in liquid oral preparations containing 2 per cent or less of aminophylline.

 

AZATADINE in oral preparations.

 

BROMPHENIRAMINE in oral preparations except:

 

 (a) when included in Schedule 2; or

 

 (b) for the treatment of children under 2 years of age.

 

BUCLIZINE in oral preparations.

 

BUTOCONAZOLE in preparations for vaginal use.

 

CHLORAMPHENICOL for ophthalmic use only.

 

CHLORBUTOL in preparations for human use except:

 

 (a) when included in Schedule 2; or

 

 (b) in preparations containing 0.5 per cent or less of chlorbutol.

 

CHLORPHENIRAMINE in oral preparations except:

 

 (a) when included in Schedule 2; or

 

 (b) for the treatment of children under 2 years of age.

 

CICLOPIROX in preparations for dermal use and for application to the nails except:

 

 (a) when included in Schedule 2; or

 

 (b) in preparations for the treatment of tinea pedis.

 

CIMETIDINE in a primary pack containing not more than 14 days' supply.

 

CLEMASTINE in preparations for oral use.

 

CLOBETASONE (clobetasone-17-butyrate) as the only therapeutically active substance in preparations for dermal use containing 0.05 per cent or less of clobetasone in packs containing 30 g or less of the preparation.

 

CLOTRIMAZOLE in preparations for vaginal use.

 

CODEINE when:

 

 (a) not combined with any other opiate substance;

 

 (b) compounded with one or more other therapeutically active substances, of which not more than one is an analgesic substance:

 

  (i) in divided preparations containing 12 mg or less of codeine per dosage unit; or

 

  (ii) in undivided preparations containing 0.25 per cent or less of codeine;

 

  (c) labelled with a recommended daily dose not exceeding 100 mg of codeine; and

 

 (d) in packs containing not more than 5 days' of supply at the maximum dose recommended on the label,

 

 except when included in Schedule 2.

 

CYCLIZINE in preparations for oral use.

 

CYPROHEPTADINE in oral preparations.

 

DEXCHLORPHENIRAMINE in oral preparations except:

 

 (a) when included in Schedule 2; or

 

 (b) for the treatment of children under 2 years of age.

 

DICLOFENAC in divided preparations for oral use containing 25 mg or less of diclofenac per dosage unit in a pack containing 30 or less dosage units except when included in Schedule 2.

 

DIHYDROCODEINE when compounded with one or more other therapeutically active substances:

 

 (a) in divided preparations containing 10 mg or less per dosage unit and with a recommended dose not exceeding 15 mg of dihydrocodeine; or

 

 (b) in undivided preparations containing 0.25 per cent or less of dihydrocodeine with a recommended dose not exceeding 15 mg of dihydrocodeine,

 

 except when included in Schedule 2.

 

DI-IODOHYDROXYQUINOLINE (iodoquinol) for vaginal use.

 

DIMENHYDRINATE in oral preparations except when included in Schedule 2.

 

DIMETHINDENE in oral preparations.

 

DIPHENHYDRAMINE in oral preparations except:

 

 (a) when included in Schedule 2; or

 

 (b) for the treatment of children under 2 years of age.

 

DIPHENOXYLATE in packs of 8 or less dosage units, each dosage unit containing 2.5 mg or less of diphenoxylate and a quantity of atropine sulfate equivalent to at least 1 per cent of the dose of diphenoxylate.

 

DITHRANOL for therapeutic use.

 

DOXYLAMINE in oral preparations except:

 

 (a) when included in Schedule 2; or

 

 (b) for the treatment of children under 2 years of age.

 

ECONAZOLE in preparations for vaginal use.

 

ERYTHRITYL TETRANITRATE for therapeutic use.

 

ESOMEPRAZOLE in oral preparations containing 20 mg or less per dosage unit for the relief of heartburn and other symptoms of gastro-oesophageal reflux disease, in packs containing not more than 14 days supply.

 

FAMCICLOVIR for oral use, in divided preparations containing a total dose of 1500 mg or less of famciclovir for the treatment of herpes labialis (cold sores).

 

FLAVOXATE.

 

FLUCONAZOLE in single-dose oral preparations containing 150 mg or less of fluconazole for the treatment of vaginal candidiasis.

 

FLUORIDES for human topical use:

 

 (a) in liquid preparations containing 5500 mg/kg or less of fluoride ion, in a container with a child-resistant closure except when included in or expressly excluded from Schedule 2; or

 

 (b) in non-liquid preparations containing 5500 mg/kg or less of fluoride ion except:

 

   (i) in preparations for therapeutic use containing 1500 mg/kg or less of fluoride ion and, when containing more than 1000 mg/kg fluoride ion, compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

   (ii) in preparations for non-therapeutic use containing 1500 mg/kg or less of fluoride ion and, when containing more than 1000 mg/kg fluoride ion, labelled with warnings to the following effect:

 

    (A) Do not swallow; and

 

    (B) Do not use [this product/name of product] in children six years of age or less; or

 

   (iii) in preparations for supply to registered dental professionals or by approval of an appropriate authority.

 

GLUCAGON.

 

GLYCERYL TRINITRATE:

 

 (a) in preparations for oral use; or

 

 (b) in preparations for rectal use.

 

GLYCOPYRRONIUM except when included in Schedule 4.

 

HYDROCORTISONE and HYDROCORTISONE ACETATE, but excluding other salts and derivatives, in preparations for human therapeutic use containing 1 per cent or less of hydrocortisone:

 

 (a) for dermal use, in packs containing 30 g or less of such preparations, containing no other therapeutically active constituent other than an antifungal substance; or

 

 (b) for rectal use when combined with a local anaesthetic substance but no other therapeutically active constituent except unscheduled astringents:

 

   (i) in undivided preparations, in packs of 35 g or less; or

 

   (ii) in packs containing 12 or less suppositories,

 

 except when included in Schedule 2.

 

IBUPROFEN in divided preparations, each containing 400 mg or less of ibuprofen in a primary pack containing not more than 50 dosage units when labelled:

 

 (a) with a recommended daily dose of 1200 mg or less of ibuprofen; and

 

 (b) not for the treatment of children under 12 years of age,

 

 except when included in or expressly excluded from Schedule 2.

 

INOSITOL NICOTINATE.

 

ISOCONAZOLE in preparations for vaginal use.

 

ISOSORBIDE DINITRATE in oral preparations containing 10 mg or less of isosorbide dinitrate per dosage unit.

 

KETOPROFEN in divided preparations for oral use containing 25 mg or less of ketoprofen per dosage unit in a pack containing 30 or less dosage units.

 

LANSOPRAZOLE in oral preparations containing 15 mg or less of lansoprazole per dosage unit for the relief of heartburn and other symptoms of gastro-oesophageal reflux disease, in packs containing not more than 14 days' supply.

 

LEVONORGESTREL for emergency post-coital contraception.

 

MACROGOLS in preparations for oral use for bowel cleansing prior to diagnostic, medical or surgical procedures.

 

MAGNESIUM SULFATE for human therapeutic use in divided oral preparations except when containing 1.5 g or less of magnesium sulfate per recommended daily dose.

 

Malathion in preparations for human external use except in preparations containing 2 per cent or less of malathion.

 

MANNITYL HEXANITRATE for therapeutic use.

 

MEPYRAMINE in oral preparations.

 

METHDILAZINE in oral preparations.

 

METOCLOPRAMIDE when combined with paracetamol in divided preparations, packed and labelled only for the treatment of nausea associated with migraine, in packs containing not more than 10 dosage units.

 

MICONAZOLE for human use in topical preparations:

 

 (a) for the treatment of oral candidiasis; or

 

 (b) for vaginal use.

 

NAPROXEN in a modified release dosage form of 600 mg or less of naproxen per dosage unit in packs of 16 or less dosage units when labelled not for the treatment of children under 12 years of age.

 

NICOTINIC ACID for human therapeutic use in divided preparations containing 250 mg or less of nicotinic acid per dosage unit except:

 

 (a) in preparations containing 100 mg or less of nicotinic acid per dosage unit; or

 

 (b) nicotinamide.

 

NICOTINYL ALCOHOL except in preparations containing 100 mg or less of nicotinyl alcohol per dosage unit.

 

NYSTATIN in preparations for topical use except when included in Schedule 2.

 

OMEPRAZOLE in oral preparations containing 20 mg or less of omeprazole per dosage unit for the relief of heartburn and other gastro-oesophageal reflux disease, in packs containing not more than 14 days' supply.

 

ORLISTAT in oral preparations for weight-control purposes containing 120 mg or less of orlistat per dosage unit.

 

OXICONAZOLE in preparations for vaginal use.

 

PANTOPRAZOLE in oral preparations containing 20 mg or less of pantoprazole per dosage unit for the relief of heartburn and other symptoms of gastro-oesophageal reflux disease, in packs containing not more than 14 days' supply.

 

PARACETAMOL when combined with ibuprofen in a primary pack containing 30 dosage units or less.

 

PHENIRAMINE in oral preparations except:

 

 (a) when included in Schedule 2; or

 

 (b) for the treatment of children under 2 years of age.

 

PODOPHYLLOTOXIN in preparations containing 1 per cent or less of podophyllotoxin for human use for the treatment of warts other than anogenital warts except when included in Schedule 2.

 

PODOPHYLLUM EMODI (podophyllin) in preparations containing 20 per cent or less of podophyllin for human use for the treatment of warts other than anogenital warts except when included in Schedule 2.

 

PODOPHYLLUM PELTATUM (podophyllin) in preparations containing 20 per cent or less of podophyllin for human use for the treatment of warts other than anogenital warts except when included in Schedule 2.

 

PROCHLORPERAZINE in divided preparations for oral use in packs containing not more than 10 dosage units for the treatment of nausea associated with migraine.

 

PROMETHAZINE in oral preparations except:

 

 (a) when included in Schedule 2; or

 

 (b) in preparations for the treatment of children under 2 years of age.

 

PSEUDOEPHEDRINE (other than preparations for stimulant, appetite suppression or weight-control purposes) when supplied in a primary pack:

 

 (a) in liquid preparations containing 800 mg or less of pseudoephedrine hydrochloride (or its equivalent); or

 

 (b) in other preparations containing 720 mg or less of pseudoephedrine hydrochloride (or its equivalent).

 

RABEPRAZOLE in oral preparations containing 10 mg or less of rabeprazole per dosage unit for the relief of heartburn and other symptoms of gastro-oesophageal reflux disease, in packs containing not more than 14 days' supply.

 

SALBUTAMOL as the only therapeutically active substance:

 

 (a) in metered aerosols delivering 100 micrograms or less of salbutamol per metered dose; or

 

 (b) in dry powders for inhalation delivering 200 micrograms or less of salbutamol per dose.

 

SALICYLIC ACID in preparations for dermal use except in preparations containing 40 per cent or less of salicylic acid.

 

SANTONIN.

 

SODIUM PHOSPHATE in preparations for oral use for bowel cleansing prior to diagnostic medical and surgical procedures.

 

SODIUM PICOSULFATE in preparations for oral use for bowel cleansing prior to diagnostic medical or surgical procedures.

 

SULFACETAMIDE in preparations for ophthalmic use containing 10 per cent or less of sulfacetamide.

 

TERBUTALINE as the only therapeutically active substance:

 

 (a) in metered aerosols delivering 250 micrograms or less of terbutaline per metered dose; or

 

 (b) in dry powders for inhalation delivering 500 micrograms or less of terbutaline per dose.

 

THEOPHYLLINE in liquid oral preparations containing 2 per cent or less of theophylline.

 

TIOCONAZOLE in preparations for vaginal use.

 

TRIAMCINOLONE for buccal use in preparations containing 0.1 per cent or less of triamcinolone in a pack of 5 g or less.

 

TRIMEPRAZINE:

 

 (a) in solid oral preparations except when included in Schedule 2; or

 

 (b) in liquid oral preparations containing 10 mg or less of trimeprazine per 5 mL,

 

 except in preparations for the treatment of children under 2 years of age.

 

TRIPROLIDINE in oral preparations except:

 

 (a) when included in Schedule 2; or

 

 (b) for the treatment of children under 2 years of age.

 

VITAMIN D  for human internal therapeutic use in preparations containing 175 micrograms or less of vitamin D per recommended single weekly dose except in preparations containing 25 micrograms or less of vitamin D per recommended daily dose. 

 

(Substances marked # are listed in Appendix D)

 

ABACAVIR.

 

ABATACEPT.

 

ABIRATERONE ACETATE.

 

ABCIXIMAB.

 

ACAMPROSATE CALCIUM.

 

ACARBOSE.

 

ACEBUTOLOL.

 

ACEPROMAZINE.

 

ACETANILIDE and alkyl acetanilides (excluding when present as an excipient) for human therapeutic use.

 

ACETARSOL.

 

ACETAZOLAMIDE.

 

ACETOHEXAMIDE.

 

ACETYL ISOVALERYLTYLOSIN.

 

ACETYLCARBROMAL.

 

ACETYLCHOLINE.

 

ACETYLCYSTEINE except:

 

 (a) when included in Schedule 2; or

 

 (b) in preparations for oral use when labelled with a recommended daily dose of 1 g or less of acetylcysteine.

 

ACETYLDIGITOXIN.

 

ACETYLMETHYLDIMETHYLOXIMIDOPHENYLHYDRAZINE.

 

ACETYLSTROPHANTHIDIN.

 

ACICLOVIR except in preparations containing 5 per cent or less of aciclovir for the treatment of herpes labialis in packs containing 10 g or less.

 

ACIPIMOX.

 

# ACITRETIN.

 

ACLIDINIUM BROMIDE.

 

ACOKANTHERA OUABAIO.

 

ACOKANTHERA SCHIMPERI.

 

ACONITUM spp. except:

 

 (a) when included in Schedule 2;

 

 (b) in preparations for oral use in adults in packs containing 0.02 mg or less of total alkaloids; or

 

 (c) in preparations for dermal use in adults containing 0.02 per cent or less of total alkaloids in packs containing 0.02 mg or less of total alkaloids.

 

ACRIVASTINE.

 

ADALIMUMAB.

 

ADAPALENE.

 

ADEFOVIR.

 

ADENOSINE for human therapeutic use in preparations for injection.

 

ADIPHENINE.

 

ADONIS VERNALIS.

 

ADRAFINIL.

 

ADRENALINE. except:

 

(a) when included in Schedule 3; or

 

(b) in preparations containing 0.02 per cent or less of adrenaline unless packed and labelled for injection.

 

ADRENOCORTICAL HORMONES except when separately specified in these Schedules.

 

AFAMELANOTIDE.

 

afatinib dimaleate.

 

AFLIBERCEPT.

 

AGALSIDASE.

 

AGLEPRISTONE.

 

AGOMELATINE.

 

ALATROFLOXACIN MESYLATE.

 

ALBENDAZOLE except:

 

 (a) when included in Schedule 5 or 6; or

 

 (b) in intraruminal implants each containing 3.85 g or less of albendazole for the treatment of animals.

 

ALCLOFENAC.

 

ALCLOMETASONE except when included in Schedule 3.

 

ALCURONIUM.

 

ALDESLEUKIN.

 

ALDOSTERONE.

 

# ALEFACEPT.

 

ALEMTUZUMAB.

 

ALENDRONIC ACID.

 

ALFACALCIDOL.

 

ALFUZOSIN.

 

ALGLUCERASE.

 

ALGLUCOSIDASE.

 

ALISKIREN.

 

ALLERGENS.

 

ALLOPURINOL.

 

ALLYLOESTRENOL.

 

ALOGLIPTIN.

 

ALOSETRON.

 

ALPHA1-PROTEINASE INHIBITOR (HUMAN).

 

ALPHADOLONE.

 

ALPHAXALONE.

 

ALPRENOLOL.

 

ALPROSTADIL.

 

ALSEROXYLON.

 

ALTEPLASE.

 

ALTRENOGEST.

 

ALTRETAMINE (hexamethylmelamine).

 

AMANTADINE.

 

AMBENONIUM CHLORIDE.

 

# AMBRISENTAN.

 

AMBUCETAMIDE.

 

AMBUTONIUM BROMIDE.

 

AMCINONIDE.

 

AMETHOCAINE except:

 

 (a) when included in Schedule 2; or

 

 (b) in dermal preparations containing 2 per cent or less of total local anaesthetic substances.

 

AMIFOSTINE.

 

AMIKACIN.

 

AMILORIDE.

 

AMINOCAPROIC ACID.

 

AMINOGLUTETHIMIDE.

 

5-AMINOLEVULINIC ACID.

 

AMINOMETRADINE.

 

 AMINOPHENAZONE (amidopyrine) and derivatives for the treatment of animals.

 

AMINOPHYLLINE except when included in Schedule 3.

 

AMINOPTERIN.

 

4-AMINOPYRIDINE for therapeutic use.

 

AMINOREX.

 

AMINOSALICYLIC ACID.

 

AMIODARONE.

 

AMIPHENAZOLE.

 

AMISOMETRADINE.

 

AMISULPRIDE.

 

AMITRIPTYLINE.

 

AMLODIPINE.

 

AMMI VISNAGA.

 

AMMONIUM BROMIDE for therapeutic use.

 

AMODIAQUINE.

 

AMOROLFINE except:

 

 (a) when included in Schedule 2; or

 

 (b) in preparations for the treatment of tinea pedis.

 

AMOXAPINE.

 

AMOXYCILLIN.

 

AMPHOMYCIN.

 

AMPHOTERICIN.

 

AMPICILLIN.

 

AMPRENAVIR.

 

AMRINONE.

 

AMSACRINE.

 

AMYL NITRITE.

 

AMYLOBARBITONE when packed and labelled for injection.

 

AMYLOCAINE.

 

# ANABOLIC STEROIDAL AGENTS.

 

ANAGRELIDE.

 

ANAKINRA.

 

ANASTROZOLE.

 

ANCESTIM.

 

ANCROD and its immunoglobulin antidote.

 

ANECORTAVE.

 

# ANDROGENIC STEROIDAL AGENTS.

 

# ANDROISOXAZOLE.

 

# ANDROSTANOLONE.

 

# ANDROSTENEDIOL.

 

# ANDROSTENEDIONE.

 

ANGIOTENSIN AMIDE.

 

ANIDULAFUNGIN.

 

ANISTREPLASE.

 

ANTAZOLINE except when included in Schedule 2.

 

ANTIBIOTIC SUBSTANCES except:

 

 (a) when separately specified in these Schedules; or

 

 (b) nisin.

 

ANTIGENS for human therapeutic use except when separately specified in this Schedule.

 

ANTIHISTAMINES except:

 

 (a) when included in Schedule 2 or 3; or

 

 (b) when separately specified in this Schedule.

 

ANTIMONY for therapeutic use except when separately specified in these Schedules.

 

ANTISERA (immunosera) for human use by injection except when separately specified in these Schedules.

 

APIXABAN.

 

APOCYNUM spp.

 

APOMORPHINE.

 

APRACLONIDINE.

 

APRAMYCIN.

 

APREPITANT.

 

APRONAL.

 

APROTININ.

 

ARECOLINE.

 

ARIPIPRAZOLE.

 

ARSENIC for human therapeutic use except when separately specified in these Schedules.

 

ARTEMETHER.

 

ARTICAINE.

 

ASENAPINE.

 

ASPIRIN:

 

 (a) when combined with caffeine, paracetamol or salicylamide or any derivative of these substances; or

 

 (b) for injection.

 

ASTEMIZOLE.

 

# ATAMESTANE.

 

ATAZANAVIR.

 

ATENOLOL.

 

ATIPAMEZOLE.

 

ATOMOXETINE.

 

ATORVASTATIN.

 

ATOSIBAN.

 

ATOVAQUONE.

 

ATRACURIUM BESYLATE.

 

ATROPA BELLADONNA (belladonna) except when included in Schedule 2.

 

ATROPINE except when included in Schedule 2.

 

ATROPINE METHONITRATE.

 

AURANOFIN.

 

AUROTHIOMALATE SODIUM.

 

AVILAMYCIN except:

 

 (a) in animal feed premixes containing 15 per cent or less of avilamycin activity; or

 

 (b) in animal feeds containing 50 mg/kg or less of avilamycin activity.

 

AVIPTADIL.

 

AXITINIB.

 

AVOPARCIN.

 

AZACITIDINE.

 

AZACYCLONOL.

 

AZAPERONE.

 

AZAPROPAZONE.

 

AZARIBINE.

 

AZATADINE except when included in Schedule 3.

 

AZATHIOPRINE.

 

AZELAIC ACID except:

 

 (a) when included in Schedule 2; or

 

 (b) in preparations containing 1 per cent or less of azelaic acid for non-human use.

 

AZELASTINE except when included in Schedule 2.

 

AZITHROMYCIN.

 

AZLOCILLIN.

 

AZTREONAM.

 

BACAMPICILLIN.

 

BACITRACIN.

 

BACLOFEN.

 

BALSALAZIDE.

 

BAMBERMYCIN (flavophospholipol) except:

 

 (a) when included in Schedule 6; or

 

 (b) in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances.

 

BAMBUTEROL.

 

BAMETHAN.

 

BAMIPINE.

 

BARBITURATES except when separately specified in these Schedules.

 

BASILIXIMAB.

 

BAZEDOXIFENE.

 

BECAPLERMIN.

 

BECLAMIDE.

 

BECLOMETHASONE except when included in Schedule 2.

 

BELATACEPT.

 

BELIMUMAB.

 

BEMEGRIDE.

 

BENACTYZINE.

 

BENAZEPRIL.

 

BENDAMUSTINE.

 

BENDROFLUAZIDE.

 

BENETHAMINE PENICILLIN.

 

BENORYLATE.

 

BENOXAPROFEN.

 

BENPERIDOL.

 

BENSERAZIDE.

 

BENZATHINE PENICILLIN.

 

BENZHEXOL.

 

BENZILONIUM.

 

BENZOCAINE except:

 

 (a) when included in Schedule 2;

 

 (b) in dermal preparations containing 2 per cent or less of total local anaesthetic substances; or

 

 (c) in lozenges containing 30 mg or less of total local anaesthetic substances per dosage unit.

 

# BENZODIAZEPINE derivatives except when separately specified in these Schedules.

 

BENZOYL PEROXIDE in preparations for human therapeutic use except:

 

 (a) when included in Schedule 2; or

 

(b) in preparations for external use containing 5 per cent or less of benzoyl peroxide.

 

BENZPHETAMINE.

 

BENZTHIAZIDE.

 

BENZTROPINE (benzatropine).

 

BENZYDAMINE except:

 

 (a) when included in Schedule 2; or

 

 (b) in preparations for dermal use.

 

BENZYLPENICILLIN.

 

BEPRIDIL.

 

BERACTANT.

 

BESIFLOXACIN.

 

BETAHISTINE.

 

BETAMETHASONE.

 

BETAXOLOL.

 

BETHANECHOL CHLORIDE.

 

BETHANIDINE.

 

BEVACIZUMAB.

 

BEVANTOLOL.

 

# BEXAROTENE.

 

BEZAFIBRATE.

 

BICALUTAMIDE.

 

BIFONAZOLE except:

 

 (a) when included in Schedule 2;

 

 (b) in preparations for dermal use containing 1 per cent or less of bifonazole for the treatment of the scalp; or

 

 (c) in preparations for dermal use for the treatment of tinea pedis.

 

BIMATOPROST.

 

BIPERIDEN.

 

BISMUTH COMPOUNDS for cosmetic use, except:

 

 (a) bismuth citrate when incorporated in hair colourant preparations in concentrations of 0.5 per or less; or

 

 (b) bismuth oxychloride.

 

BISMUTH COMPOUNDS for human therapeutic use, except bismuth formic iodide or bismuth subiodide in dusting powders containing 3 per cent or less of bismuth.

 

BISOPROLOL.

 

BIVALIRUDIN.

 

BLEOMYCIN.

 

BOCEPREVIR.

 

# BOLANDIOL.

 

# BOLASTERONE.

 

# BOLAZINE.

 

# BOLDENONE (dehydrotestosterone).

 

# BOLENOL.

 

# BOLMANTALATE.

 

BORON, including boric acid and borax, for human therapeutic use except:

 

 (a) in preparations for internal use containing 6 mg or less of boron per recommended daily dose;

 

 (b) in preparations for dermal use containing 0.35 per cent or less of boron, which are not for paediatric or antifungal use; or

 

 (c) when present as an excipient.

 

BORTEZOMIB.

 

# BOSENTAN.

 

BOSUTINIB.

 

BOTULINUM TOXINS for human use except when separately specified in these Schedules.

 

BRENTUXIMAB VEDOTIN.

 

BRETYLIUM TOSYLATE.

 

BRIMONIDINE.

 

BRINZOLAMIDE.

 

# BROMAZEPAM.

 

BROMIDES, inorganic, for therapeutic use except when separately specified in

 these Schedules.

 

BROMOCRIPTINE.

 

BROMOFORM for therapeutic use.

 

BROMPHENIRAMINE except when included in Schedule 2 or 3.

 

BROMVALETONE.

 

BRUGMANSIA spp.

 

BUCLIZINE except when included in Schedule 3.

 

BUDESONIDE except when included in Schedule 2.

 

BUFEXAMAC except:

 

 (a) in preparations for dermal use containing 5 per cent or less of bufexamac; or

 

 (b) in suppositories.

 

BUMETANIDE.

 

BUPHENINE.

 

BUPIVACAINE except when included in Schedule 5.

 

BUPROPION.

 

BUSERELIN.

 

BUSPIRONE.

 

BUSULPHAN.

 

BUTACAINE.

 

BUTOCONAZOLE except when included in Schedule 3.

 

BUTRACONAZOLE.

 

BUTYL AMINOBENZOATE except in dermal preparations containing 2 per cent or less of total local anaesthetic substances.

 

BUTYLCHLORAL HYDRATE.

 

BUTYL NITRITE.

 

CABAZITAXEL.

 

CABERGOLINE.

 

CADMIUM COMPOUNDS for human therapeutic use.

 

CALCIPOTRIOL.

 

CALCITONIN.

 

CALCITRIOL.

 

CALCIUM CARBIMIDE for therapeutic use.

 

CALCIUM HYDROXYLAPATITE in preparations for injection or implantation:

 

 (a) for tissue augmentation; or

 

 (b) for cosmetic use.

 

CALCIUM POLYSTYRENE SULPHONATE.

 

CALOTROPIS GIGANTEA.

 

CALOTROPIS PROCERA.

 

# CALUSTERONE.

 

CAMPHORATED OIL for therapeutic use.

 

CAMPHOTAMIDE.

 

CANAGLIFLOZIN.

 

CANAKINUMAB.

 

CANDESARTAN CILEXETIL.

 

CANDICIDIN.

 

CANINE TICK ANTI-SERUM.

 

CANTHARIDIN.

 

CAPECITABINE.

 

CAPREOMYCIN.

 

CAPTODIAME.

 

CAPTOPRIL.

 

CAPURIDE.

 

CARAMIPHEN.

 

CARBACHOL.

 

CARBAMAZEPINE.

 

CARBARYL for human therapeutic use.

 

CARBAZOCHROME.

 

CARBENICILLIN.

 

CARBENOXOLONE for internal use.

 

CARBETOCIN.

 

CARBIDOPA.

 

CARBIMAZOLE.

 

CARBOCROMEN.

 

CARBOPLATIN.

 

CARBOPROST.

 

CARBROMAL.

 

CARBUTAMIDE.

 

CARBUTEROL.

 

CARGLUMIC ACID (N-carbomoyl-L-glutamic acid)

 

CARINDACILLIN.

 

CARISOPRODOL.

 

CARMUSTINE.

 

CARNIDAZOLE.

 

CARPROFEN.

 

CARVEDILOL.

 

CASPOFUNGIN.

 

CATHINE.

 

CATUMAXOMAB.

 

CEFACETRILE.

 

CEFACLOR.

 

CEFADROXIL.

 

CEFALORIDINE.

 

CEFAMANDOLE.

 

CEFAPIRIN.

 

CEFAZOLIN.

 

CEFEPIME.

 

CEFETAMET.

 

CEFIXIME.

 

CEFODIZIME.

 

CEFONICID.

 

CEFOPERAZONE.

 

CEFOTAXIME.

 

CEFOTETAN.

 

CEFOTIAM.

 

CEFOVECIN for veterinary use.

 

CEFOXITIN.

 

CEFPIROME.

 

CEFPODOXIME.

 

CEFQUINOME.

 

CEFTAROLINE FOSAMIL.

 

CEFSULODIN.

 

CEFTAZIDIME.

 

CEFTIBUTEN.

 

CEFTIOFUR.

 

CEFTRIAXONE.

 

CEFUROXIME.

 

CELECOXIB.

 

CELIPROLOL.

 

CEPHAELIS ACUMINATA (ipecacuanha) except in preparations containing 0.2 per cent or less of emetine.

 

CEPHAELIS IPECACUANHA except in preparations containing 0.2 per cent or less of emetine.

 

CEPHALEXIN.

 

CEPHALONIUM.

 

CEPHALOTHIN.

 

CEPHRADINE.

 

CERIVASTATIN.

 

CERTOLIZUMAB PEGOL.

 

CERULETIDE.

 

CETIRIZINE except

 

 (a) when included in Schedule 2; or

 

 (b)  in divided preparations for oral use for the treatment of seasonal allergic rhinitis in adults and children 12 years of age and over when:

 

   (i) in a primary pack containing not more than 5 days’ supply; and

 

   (ii)  labelled with a recommended daily dose not exceeding 10 mg  of cetirizine.

 

CETRORELIX.

 

CETUXIMAB.

 

CHENODEOXYCHOLIC ACID.

 

CHLORAL FORMAMIDE.

 

CHLORAL HYDRATE except in preparations for topical use containing 2 per cent or less of chloral hydrate.

 

CHLORALOSE except when included in Schedule 6.

 

CHLORAMBUCIL.

 

CHLORAMPHENICOL except when included in Schedule 3.

 

# CHLORANDROSTENOLONE.

 

CHLORAZANIL.

 

CHLORCYCLIZINE.

 

# CHLORDIAZEPOXIDE.

 

CHLORMERODRIN.  

 

CHLORMETHIAZOLE.

 

CHLORMEZANONE.

 

CHLOROFORM for use in anaesthesia.

 

# 4-CHLOROMETHANDIENONE.

 

2-(4-CHLOROPHENYL)-(1,2,4)TRIAZOLO[5,1-A]ISOQUINOLINE.

 

CHLOROQUINE.

 

CHLOROTHIAZIDE.

 

CHLOROTRIANISENE.

 

# CHLOROXYDIENONE.

 

CHLORPHENIRAMINE except when included in Schedule 2 or 3.

 

CHLORPHENTERMINE.

 

CHLORPROMAZINE.

 

CHLORPROPAMIDE.

 

CHLORPROTHIXENE.

 

CHLORQUINALDOL for human topical use.

 

CHLORTETRACYCLINE except when included in Schedule 5.

 

CHLORTHALIDONE.

 

CHLORZOXAZONE.

 

CHOLERA VACCINE.

 

CHOLESTYRAMINE (colestyramine) for human therapeutic use.

 

CHYMOPAPAIN for human therapeutic use.

 

CICLACILLIN.

 

CICLESONIDE.

 

CICLOPIROX except:

 

(a)            when included in Schedule 2 or 3; or

 

(b)           in preparations for the treatment of tinea pedis.

 

CIDOFOVIR.

 

CILASTATIN.

 

CILAZAPRIL.

 

CILOSTAZOL.

 

CIMETIDINE except when included in Schedule 3.

 

CINACALCET.

 

CINCHOCAINE except when included in Schedule 2.

 

CINOXACIN.

 

CIPROFLOXACIN.

 

CISAPRIDE.

 

CISATRACURIUM BESYLATE.

 

CISPLATIN.

 

CITALOPRAM.

 

CLADRIBINE.

 

CLANOBUTIN.

 

CLARITHROMYCIN.

 

CLAVULANIC ACID.

 

CLEMASTINE except when included in Schedule 3.

 

CLEMIZOLE.

 

CLENBUTEROL.

 

CLEVIDIPINE.

 

CLIDINIUM BROMIDE.

 

CLINDAMYCIN.

 

 CLIOQUINOL and other halogenated derivatives of 8-hydroxyquinoline for human topical use except when separately specified in this Schedule.

 

CLOBAZAM.

 

CLOBETASOL.

 

CLOBETASONE (clobetasone-17-butyrate) except when included in Schedule 3.

 

CLOCORTOLONE.

 

CLODRONIC ACID (includes sodium clodronate).

 

CLOFARABINE.

 

CLOFAZIMINE.

 

CLOFENAMIDE.

 

CLOFIBRATE.

 

# CLOMIPHENE.

 

CLOMIPRAMINE.

 

CLOMOCYCLINE.

 

# CLONAZEPAM.

 

CLONIDINE.

 

CLOPAMIDE.

 

CLOPIDOGREL.

 

CLOPROSTENOL.

 

# CLORAZEPATE.

 

CLOREXOLONE.

 

CLORPRENALINE.

 

# CLOSTEBOL (4-chlorotestosterone).

 

CLOTRIMAZOLE except:

 

 (a) when included in Schedule 2, 3 or 6; or

 

 (b) in preparations for dermal use for the treatment of tinea pedis.

 

CLOXACILLIN.

 

# CLOZAPINE.

 

COBALT for human therapeutic use except as dicobalt edetate in preparations for the treatment of cyanide poisoning.

 

COBICISTAT.

 

CODEINE when compounded with one or more other therapeutically active substances:

 

 (a) in divided preparations containing 30 mg or less of codeine per dosage unit; or

 

 (b) in undivided preparations containing 1 per cent or less of codeine,

 

 except when included in Schedule 2 or 3.

 

CO-DERGOCRINE.

 

COLASPASE.

 

COLCHICINE.

 

COLCHICUM AUTUMNALE.

 

COLESTIPOL.

 

COLFOSCERIL PALMITATE for human therapeutic use.

 

COLISTIN.

 

COLLAGEN in preparations for injection or implantation:

 

 (a) for tissue augmentation; or

 

 (b) for cosmetic use.

 

COLLAGENASE CLOSTRIDIUM HISTOLYTICUM.

 

CONVALLARIA KEISKI.

 

CONVALLARIA MAJALIS.

 

COPPER COMPOUNDS for human use except:

 

 (a) when separately specified in these Schedules;

 

 (b) in preparations for human internal use containing 5 mg or less of copper per recommended daily dose; or

 

 (c) in other preparations containing 5 per cent or less of copper compounds.

 

# CORIFOLLITROPIN ALFA.

 

CORONILLA spp.

 

CORTICOSTERONE.

 

CORTICOTROPHIN.

 

CORTISONE.

 

CO-TRIMOXAZOLE.

 

COUMARIN for therapeutic use (excluding when present as an excipient).

 

CRIZOTINIB.

 

CROFELEMER.

 

CRYSTAL VIOLET for human use except when used as a dermal marker.

 

CUPRIMYXIN.

 

CURARE.

 

CYCLANDELATE.

 

CYCLIZINE except when included in Schedule 3.

 

CYCLOBENZAPRINE.

 

# CYCLOFENIL.

 

CYCLOHEXIMIDE.

 

CYCLOPENTHIAZIDE.

 

CYCLOPENTOLATE.

 

CYCLOPHOSPHAMIDE.

 

CYCLOPROPANE for therapeutic use.

 

CYCLOSERINE.

 

CYCLOSPORIN.

 

CYCLOTHIAZIDE.

 

CYCRIMINE.

 

CYMARIN.

 

CYPROHEPTADINE except when included in Schedule 3.

 

CYPROTERONE.

 

CYSTEAMINE for human therapeutic use.

 

CYTARABINE.

 

DABRAFENIB MESILATE.

 

DABIGATRAN.

 

DACARBAZINE.

 

DACLIZUMAB.

 

DACTINOMYCIN.

 

DALFOPRISTIN.

 

DALTEPARIN (includes dalteparin sodium).

 

DANAPAROID (includes danaparoid sodium).

 

# DANAZOL.

 

DANTHRON for human use.

 

DANTROLENE.

 

DAPAGLIFLOZIN.

 

DAPOXETINE.

 

DAPSONE.

 

DAPTOMYCIN.

 

# DARBEPOETIN.

 

DARIFENACIN.

 

DARUNAVIR.

 

DATURA spp. except:

 

 (a) when included in Schedule 2; or

 

 (b) when separately specified in this Schedule.

 

DASATINIB.

 

DATURA STRAMONIUM (stramonium) except:

 

 (a) when included in Schedule 2; or

 

 (b) for smoking or burning.

 

DATURA TATULA (stramonium) except:

 

 (a) when included in Schedule 2; or

 

 (b) for smoking or burning.

 

DAUNORUBICIN.

 

DEANOL for therapeutic use.

 

DEBRISOQUINE.

 

DECAMETHONIUM.

 

DEFERASIROX.

 

DEFERIPRONE.

 

DEFLAZACORT.

 

DEGARELIX.

 

# DEHYDROCHLOROMETHYLTESTOSTERONE.

 

DEHYDROCORTICOSTERONE.

 

DELAVIRDINE (includes delavirdine mesylate).

 

DEMBREXINE except when included in Schedule 5.

 

DEMECARIUM.

 

DEMECLOCYCLINE.

 

DENOSUMAB.

 

DEOXYCORTONE.

 

DEOXYRIBONUCLEASE except:

 

 (a) when separately specified in this Schedule; or

 

 (b) for external use.

 

DERACOXIB.

 

DESFERRIOXAMINE.

 

DESFLURANE.

 

DESIPRAMINE.

 

DESIRUDIN.

 

DESLANOSIDE.

 

DESLORATADINE except when included in Schedule 2.

 

DESLORELIN.

 

DESMOPRESSIN (D.D.A.V.P.).

 

DESOGESTREL.

 

DESONIDE.

 

DESOXYMETHASONE.

 

DESVENLAFAXINE.

 

DETOMIDINE.

 

DEXAMETHASONE.

 

DEXCHLORPHENIRAMINE except when included in Schedule 2 or 3.

 

DEXFENFLURAMINE.

 

DEXMEDETOMIDINE.

 

DEXTROMETHORPHAN (excluding its stereoisomers) except when included in Schedule 2.

 

# DEXTROPROPOXYPHENE:

 

 (a) in divided preparations containing 135 mg of dextropropoxyphene or less per dosage unit; or

 

 (b) liquid preparations containing 2.5 per cent or less of dextropropoxyphene.

 

DEXTRORPHAN (excluding its stereoisomers).

 

DIAMTHAZOLE.

 

DIAVERIDINE.

 

# DIAZEPAM.

 

DIAZOXIDE.

 

DIBENZEPIN.

 

DIBOTERMIN.

 

DIBROMOPROPAMIDINE for therapeutic use except when included in Schedule 2.

 

DICHLORALPHENAZONE.

 

DICHLOROPHEN for human therapeutic use.

 

DICHLORPHENAMIDE.

 

DICLOFENAC except:

 

(a) when included in Schedule 2 or 3; or

 

(b)  in preparations for dermal use unless:

 

 (i) for the treatment of solar keratosis; or

 

  (ii) containing more than 4 per cent of diclofenac.

 

DICLOXACILLIN.

 

DICYCLOMINE.

 

DIDANOSINE.

 

DIENESTROL.

 

DIENOGEST.

 

DIETHAZINE.

 

DIETHYLCARBAMAZINE for human therapeutic use.

 

DIETHYLPROPION.

 

DIFENOXIN in preparations containing, per dosage unit, 0.5 mg or less of difenoxin and a quantity of atropine sulfate equivalent to at least 5 per cent of the dose of difenoxin.

 

DIFLORASONE.

 

DIFLOXACIN.

 

DIFLUCORTOLONE.

 

DIFLUNISAL.

 

DIGITALIS LANATA.

 

DIGITALIS PURPUREA.

 

DIGITOXIN.

 

DIGOXIN.

 

DIGOXIN-SPECIFIC ANTIBODY FRAGMENT F (Ab).

 

DIHYDRALAZINE.

 

DIHYDROCODEINE when compounded with one or more other therapeutically active substances:

 

 (a) in divided preparations containing not more than 100 mg of dihydrocodeine per dosage unit; or

 

 (b) in undivided preparations with a concentration of not more than 2.5 per cent of dihydrocodeine,

 

 except when included in Schedule 2 or 3.

 

DIHYDROERGOTOXINE.

 

# DIHYDROLONE.

 

DIHYDROSTREPTOMYCIN.

 

DIHYDROTACHYSTEROL.

 

 DI-IODOHYDROXYQUINOLINE (iodoquinol) except:

 

 (a) when included in Schedule 3; or

 

 (b) for human internal use.

 

DIISOPROPYLAMINE DICHLOROACETATE.

 

DILTIAZEM.

 

DIMENHYDRINATE except when included in Schedule 2 or 3.

 

DIMERCAPROL.

 

# DIMETHANDROSTANOLONE.

 

# DIMETHAZINE.

 

DIMETHINDENE except when included in Schedule 3.

 

DIMETHOTHIAZINE.

 

DIMETHOXANATE.

 

DIMETHYL FUMARATE.

 

DIMETHYL SULFOXIDE (excluding dimethyl sulfone) for therapeutic use except:

 

 (a) when included in Schedule 6; or

 

 (b) in in vitro test kits.

 

DIMETRIDAZOLE.

 

2,4-DINITROCHLOROBENZENE for therapeutic use.

 

DINITROCRESOLS for therapeutic use except when separately specified in these Schedules.

 

DINITRONAPHTHOLS for therapeutic use except when separately specified in these Schedules.

 

DINITROPHENOLS for therapeutic use.

 

DINITROTHYMOLS for therapeutic use except when separately specified in these Schedules.

 

# DINOPROST.

 

# DINOPROSTONE.

 

DIPERODON.

 

DIPHEMANIL except in preparations for dermal use.

 

DIPHENHYDRAMINE except when included in Schedule 2 or 3.

 

DIPHENIDOL.

 

DIPHENOXYLATE in preparations containing, per dosage unit, 2.5 mg or less of diphenoxylate and a quantity of atropine sulfate equivalent to at least 1 per cent of the dose of diphenoxylate except when included in Schedule 3.

 

DIPHENYLPYRALINE.

 

DIPHTHERIA TOXOID.

 

DIPIVEFRIN.

 

DIPYRIDAMOLE.

 

DIRITHROMYCIN.

 

DIRLOTAPIDE.

 

DISOPHENOL.

 

DISOPYRAMIDE.

 

DISTIGMINE.

 

DISULFIRAM for therapeutic use.

 

DISULPHAMIDE.

 

DITHIAZANINE except when included in Schedule 6.

 

DITIOCARB.

 

DOBUTAMINE.

 

DOCETAXEL.

 

DOFETILIDE.

 

DOLASETRON.

 

DOLUTEGRAVIR.

 

DOMPERIDONE.

 

DONEPEZIL.

 

DOPAMINE.

 

DOPEXAMINE.

 

DORIPENEM.

 

DORNASE.

 

DORZOLAMIDE.

 

DOTHIEPIN.

 

DOXANTRAZOLE.

 

DOXAPRAM.

 

DOXAZOSIN.

 

DOXEPIN.

 

DOXORUBICIN.

 

DOXYCYCLINE.

 

DOXYLAMINE except when included in Schedule 2 or 3.

 

DRONEDARONE.

 

DROPERIDOL.

 

DROSPIRENONE.

 

# DROSTANOLONE.

 

DROTRECOGIN.

 

DUBOISIA LEICHHARDTII except when included in Schedule 2.

 

DUBOISIA MYOPOROIDES except when included in Schedule 2.

 

DULOXETINE.

 

DUTASTERIDE.

 

DYDROGESTERONE.

 

ECONAZOLE except:

 

 (a) when included in Schedule 2, 3 or 6; or

 

 (b) in preparations for dermal use for the treatment of tinea pedis.

 

ECOTHIOPATE (includes ecothiopate iodide).

 

ECTYLUREA.

 

ECULIZUMAB.

 

EDETIC ACID for human therapeutic use except:

 

 (a) in preparations containing 0.25 per cent or less of edetic acid;

 

 (b) as dicobalt edetate in preparations for the treatment of cyanide poisoning; or

 

 (c) in contact lens preparations.

 

EDOXUDINE.

 

EDROPHONIUM.

 

EFALIZUMAB.

 

EFAVIRENZ.

 

EFLORNITHINE.

 

EFORMOTEROL.

 

ELETRIPTAN.

 

ELOSULFASE ALFA.

 

ELTENAC.

 

ELTROMBOPAG.

 

ELVITEGRAVIR.

 

EMEPRONIUM.

 

EMETINE except in preparations containing 0.2 per cent or less of emetine.

 

EMPAGLIFLOZIN.

 

EMTRICITABINE.

 

ENALAPRIL.

 

# ENESTEBOL.

 

ENFLURANE for therapeutic use.

 

ENFUVIRTIDE.

 

# ENOBOSARM.

 

ENOXACIN.

 

ENOXAPARIN.

 

ENOXIMONE.

 

ENPROSTIL.

 

ENROFLOXACIN.

 

ENTACAPONE.

 

ENTECAVIR.

 

EPHEDRA spp. except in preparations containing 0.001 per cent or less of ephedrine.

 

# EPHEDRINE.

 

EPICILLIN.

 

EPINASTINE.

 

EPIRUBICIN.

 

# EPITIOSTANOL.

 

EPLERENONE.

 

# EPOETINS.

 

EPOPROSTENOL.

 

EPROSARTAN.

 

EPTIFIBATIDE.

 

ERGOMETRINE.

 

ERGOT.

 

ERGOTAMINE.

 

ERGOTOXINE.

 

ERIBULIN MESYLATE.

 

ERLOTINIB.

 

ERTAPENEM.

 

ERYSIMUM spp.

 

ERYTHROMYCIN.

 

# ERYTHROPOIETIN.

 

# ERYTHROPOIETINS except when separately specified in these Schedules.

 

ESCITALOPRAM.

 

ESMOLOL.

 

ESOMEPRAZOLE except when included in Schedule 3.

 

ESTRAMUSTINE.

 

ESTROPIPATE (piperazine oestrone sulfate).

 

ETANERCEPT.

 

ETHACRYNIC ACID.

 

ETHAMBUTOL.

 

ETHAMIVAN.

 

ETHANOLAMINE in preparations for injection.

 

ETHCHLORVYNOL.

 

ETHER for use in anaesthesia.

 

ETHINAMATE.

 

ETHINYLOESTRADIOL.

 

ETHIONAMIDE.

 

ETHISTERONE.

 

ETHOGLUCID.

 

ETHOHEPTAZINE.

 

ETHOPROPAZINE.

 

ETHOSUXIMIDE.

 

ETHOTOIN.

 

ETHOXZOLAMIDE.

 

ETHYL CHLORIDE for human therapeutic use.

 

# ETHYLDIENOLONE.

 

 ETHYLHEXANEDIOL for animal use.

 

ETHYLMORPHINE when compounded with one or more other therapeutically active substances:

 

 (a) in divided preparations containing not more than 100 mg of ethylmorphine per dosage unit; or

 

 (b) in undivided preparations with a concentration of not more than 2.5 per cent of ethylmorphine;

 

 except when included in Schedule 2.

 

# ETHYLOESTRENOL.

 

ETHYNODIOL.

 

ETIDOCAINE.

 

ETIDRONIC ACID (includes disodium etidronate):

 

 (a) for internal use; or

 

(b) in topical preparations except in preparations containing 1 per cent or less of etidronic acid.

 

ETILEFRIN.

 

ETIPROSTON.

 

ETODOLAC.

 

ETOFENAMATE except when included in Schedule 2.

 

ETONOGESTREL.

 

ETOPOSIDE.

 

ETORICOXIB.

 

ETRAVIRINE.

 

# ETRETINATE.

 

EVEROLIMUS.

 

EXEMESTANE.

 

EXENATIDE.

 

EZETIMIBE.

 

FAMCICLOVIR except when included in Schedule 3.

 

FAMOTIDINE except when included in Schedule 2.

 

FEBUXOSTAT.

 

FELBINAC except when included in Schedule 2.

 

FELODIPINE.

 

FELYPRESSIN.

 

FENBUFEN.

 

FENCAMFAMIN.

 

FENCLOFENAC.

 

FENFLURAMINE.

 

FENOFIBRATE.

 

FENOLDOPAM.

 

FENOPROFEN.

 

FENOTEROL.

 

FENPIPRAMIDE.

 

FENPIPRANE.

 

FENPROPOREX.

 

FENPROSTALENE.

 

FEXOFENADINE except:

 

(a) when included in Schedule 2; or

 

(b) in divided preparations for oral use for the treatment of seasonal allergic rhinitis in adults and children 12 years of age and over when:

 

(i) in a primary pack containing 10 dosage units or less and not more than 5 days’ supply; and

 

(ii) labelled with a recommended daily dose not exceeding 120 mg of fexofenadine.

 

FIBRINOLYSIN except for external use.

 

FIDAXOMICIN.

 

FILGRASTIM.

 

FINASTERIDE.

 

FINGOLIMOD.

 

FIROCOXIB.

 

FLECAINIDE.

 

FLEROXACIN.

 

FLOCTAFENINE.

 

FLORFENICOL.

 

FLUANISONE.

 

FLUCLOROLONE.

 

FLUCLOXACILLIN.

 

FLUCONAZOLE except when included in Schedule 3.

 

FLUCYTOSINE.

 

FLUDARABINE.

 

FLUDROCORTISONE.

 

FLUFENAMIC ACID.

 

FLUMAZENIL.

 

FLUMETHASONE.

 

FLUMETHIAZIDE.

 

FLUNISOLIDE.

 

FLUNIXIN MEGLUMINE.

 

FLUOCINOLONE.

 

FLUOCINONIDE.

 

FLUOCORTIN.

 

FLUOCORTOLONE.

 

FLUORESCEIN in preparations for injection.

 

FLUORIDES in preparations for human use except when included in or expressly excluded from Schedule 2 or 3.

 

FLUOROMETHOLONE.

 

FLUOROURACIL.

 

FLUOXETINE.

 

# FLUOXYMESTERONE.

 

FLUPENTHIXOL.

 

FLUPHENAZINE.

 

FLUPROSTENOL.

 

FLURANDRENOLONE.

 

# FLURAZEPAM.

 

FLURBIPROFEN except when included in Schedule 2.

 

FLUROXENE for human therapeutic use.

 

FLUSPIRILENE.

 

FLUTAMIDE.

 

FLUTICASONE except when included in Schedule 2.

 

FLUVASTATIN.

 

FLUVOXAMINE.

 

FOLIC ACID in preparations for human use for injection.

 

FOLINIC ACID in preparations for human use for injection.

 

FOLLICLE-STIMULATING HORMONE except when separately specified in this Schedule.

 

# FOLLISTATIN.

 

# FOLLITROPIN ALPHA.

 

# FOLLITROPIN BETA.

 

FOMIVIRSEN.

 

FONDAPARINUX.

 

# FORMEBOLONE.

 

FORMESTANE.

 

FOSAMPRENAVIR.

 

FOSAPREPITANT.

 

FOSCARNET.

 

FOSFESTROL (diethylstilboestrol diphosphate).

 

FOSINOPRIL.

 

FOSPHENYTOIN.

 

FOTEMUSTINE.

 

FRAMYCETIN.

 

FULVESTRANT.

 

FURALTADONE.

 

# FURAZABOL.

 

FURAZOLIDONE.

 

FUROSEMIDE (frusemide).

 

FUSIDIC ACID.

 

GABAPENTIN.

 

GALANTAMINE.

 

GALANTHUS spp.

 

GALLAMINE.

 

GALSULFASE.

 

GANCICLOVIR.

 

GANIRELIX.

 

GATIFLOXACIN.

 

GEFITINIB.

 

GEMCITABINE.

 

GEMEPROST.

 

GEMFIBROZIL.

 

GEMIFLOXACIN.

 

GEMTUZUMAB OZOGAMICIN.

 

GENTAMICIN.

 

GESTODENE.

 

GESTONORONE.

 

GESTRINONE.

 

GHRH INJECTABLE PLASMID.

 

GITALIN.

 

GLATIRAMER ACETATE.

 

GLIBENCLAMIDE.

 

GLIBORNURIDE.

 

GLICLAZIDE.

 

GLIMEPIRIDE.

 

GLIPIZIDE.

 

GLISOXEPIDE.

 

GLUTATHIONE for parenteral use.

 

# GLUTETHIMIDE.

 

GLYCERYL TRINITRATE except when included in Schedule 3.

 

GLYCOPYRRONIUM in preparations for injection.

 

GLYMIDINE.

 

GnRH VACCINE.

 

GOLIMUMAB.

 

GONADORELIN.

 

GONADOTROPHIC HORMONES except when separately specified in this Schedule.

 

GOSERELIN.

 

GRAMICIDIN.

 

GRANISETRON.

 

GREPAFLOXACIN.

 

GRISEOFULVIN.

 

GUAIPHENESIN for human therapeutic use except:

 

 (a) when included in Schedule 2;

 

 (b) in oral liquid preparations containing 2 per cent or less of guaiphenesin; or

 

 (c) in divided preparations containing 200 mg or less of guaiphenesin per dosage unit.

 

GUANABENZ.

 

GUANACLINE.

 

GUANETHIDINE.

 

GUANIDINE for therapeutic use.

 

HACHIMYCIN.

 

HAEMATIN.

 

HAEMOPHILUS INFLUENZAE VACCINE.

 

HALCINONIDE.

 

HALOFANTRINE.

 

HALOFENATE.

 

HALOFUGINONE in preparations containing 0.1 per cent or less of halofuginone for the treatment of animals.

 

HALOPERIDOL.

 

HALOTHANE for therapeutic use.

 

HEMEROCALLIS (Hemerocallis flava).

 

HEPARINS for internal use except when separately specified in this Schedule.

 

HEPATITIS A VACCINE.

 

HEPATITIS B VACCINE.

 

HETACILLIN.

 

HEXACHLOROPHANE:

 

 (a) in preparations for use on infants; or

 

 (b) in other preparations except:

 

   (i) when included in Schedule 2 or 6; or

 

   (ii) in preparations containing 0.75 per cent or less of hexachlorophane.

 

HEXAMETHONIUM.

 

HEXETIDINE for human internal use.

 

HEXOBENDINE.

 

HEXOCYCLIUM.

 

HEXOPRENALINE.

 

HISTAMINE for therapeutic use except in preparations containing 0.5 per cent or less of histamine.

 

HMG-CoA REDUCTASE INHIBITORS (including "statins") except when separately specified in these Schedules.

 

HOMATROPINE.

 

HUMAN CHORIONIC GONADATROPHIN except in pregnancy test kits.

 

HUMAN PAPILLOMAVIRUS VACCINE.

 

HYALURONIC ACID AND ITS POLYMERS in preparations for injection or implantation:

 

 (a) for tissue augmentation;

 

 (b) for cosmetic use; or

 

 (c) for the treatment of animals.

 

HYDRALAZINE.

 

HYDRARGAPHEN.

 

HYDROCHLOROTHIAZIDE.

 

HYDROCORTISONE:

 

 (a) for human use except when included in Schedule 2 or 3; or

 

 (b) for the treatment of animals.

 

HYDROCYANIC ACID for therapeutic use.

 

HYDROFLUMETHIAZIDE.

 

HYDROQUINONE (other than its alkyl ethers separately specified in this Schedule) in preparations for human therapeutic or cosmetic use except:

 

(a)             when included in Schedule 2; or

 

(b)            in hair preparations containing 0.3 per cent or less of hydroquinone; or

 

(c)            in cosmetic nail preparations containing 0.02 per cent or less of hydroquinone.

 

HYDROXYCHLOROQUINE.

 

HYDROXYEPHEDRINE.

 

HYDROXYPHENAMATE.

 

HYDROXYPROGESTERONE.

 

# HYDROXYSTENOZOL.

 

HYDROXYUREA.

 

HYDROXYZINE.

 

HYGROMYCIN.

 

HYOSCINE except when included in Schedule 2.

 

HYOSCYAMINE except when included in Schedule 2.

 

HYOSCYAMUS NIGER except:

 

 (a) when included in Schedule 2; or

 

 (b) in a pack containing 0.03 mg or less of total solanaceous alkaloids.

 

HYPOTHALAMIC RELEASING FACTORS except when separately specified in this Schedule.

 

HYPROMELLOSE in preparations for injection.

 

IBAFLOXACIN for veterinary use.

 

IBANDRONIC ACID.

 

IBOGAINE.

 

IBRITUMOMAB.

 

IBUFENAC.

 

IBUPROFEN except:

 

 (a) when included in or expressly excluded from Schedule 2 or 3; or

 

 (b) in preparations for dermal use.

 

IBUTEROL.

 

IBUTILIDE.

 

ICATIBANT.

 

IDARUBICIN.

 

IDOXURIDINE except in preparations containing 0.5 per cent or less of idoxuridine for dermal use.

 

IDURSULFASE.

 

IFOSFAMIDE.

 

ILOPROST.

 

IMATINIB.

 

IMEPITOIN.

 

IMIDAPRIL.

 

IMIGLUCERASE.

 

IMIPENIM.

 

IMIPRAMINE.

 

IMIQUIMOD.

 

IMMUNOGLOBULINS for human parenteral use except when separately specified in these Schedules.

 

INDACATEROL.

 

INDAPAMIDE.

 

INDINAVIR.

 

INDOMETHACIN except when included in Schedule 2.

 

INDOPROFEN.

 

INDORAMIN.

 

INFLIXIMAB.

 

INFLUENZA AND CORYZA VACCINES:

 

 (a) for parenteral use; or

 

 (b) for nasal administration.

 

INGENOL MEBUTATE.

 

INSULIN GLARGINE.

 

# INSULIN-LIKE GROWTH FACTOR I.

 

# INSULIN-LIKE GROWTH FACTORS except when separately specified in this Schedule.

 

INSULINS.

 

INTERFERONS.

 

INTERLEUKINS except when separately specified in these Schedules.

 

IODOTHIOURACIL.

 

IPILIMUMAB.

 

IPRATROPIUM except when included in Schedule 2.

 

IPRIFLAVONE.

 

IPRINDOLE.

 

IPRONIAZID.

 

IRBESARTAN.

 

IRINOTECAN.

 

IRON COMPOUNDS in injectable preparations for human use.

 

ISOAMINILE.

 

ISOAMYL NITRITE.

 

ISOBUTYL NITRITE.

 

ISOCARBOXAZID.

 

ISOCONAZOLE except when included in Schedule 2, 3 or 6.

 

ISOETARINE.

 

ISOFLURANE for therapeutic use.

 

ISOMETHEPTENE.

 

ISONIAZID.

 

ISOPRENALINE.

 

ISOPRINOSINE.

 

ISOPROPAMIDE except when included in Schedule 2.

 

ISOSORBIDE DINITRATE except when included in Schedule 3.

 

ISOSORBIDE MONONITRATE.

 

# ISOTRETINOIN.

 

ISOXICAM.

 

ISOXSUPRINE.

 

ISRADIPINE.

 

ITRACONAZOLE.

 

IVABRADINE.

 

IVACAFTOR.

 

IVERMECTIN:

 

 (a) for human use; or

 

 (b) for the treatment of mange in dogs.

 

IXABEPILONE.

 

JAPANESE ENCEPHALITIS VACCINE.

 

KANAMYCIN.

 

KETANSERIN except in topical veterinary preparations containing 0.5 per cent or less of ketanserin.

 

# KETAZOLAM.

 

KETOCONAZOLE except:

 

 (a) when included in Schedule 2;

 

 (b) in preparations for dermal use containing 1 per cent or less of ketoconazole for the treatment of the scalp; or

 

 (c) in preparations for dermal use for the treatment of tinea pedis.

 

KETOPROFEN except:

 

 (a) in preparations for dermal use; or

 

 (b) when included in Schedule 3.

 

KETOROLAC (includes ketoralac trometamol).

 

KETOTIFEN except when included in Schedule 2.

 

KHELLIN.

 

KITASAMYCIN except:

 

 (a) when included in Schedule 5 ; or

 

 (b) in animal feeds for growth promotion containing 100 mg/kg or less of antibiotic substances.

 

LABETALOL.

 

LACIDIPINE.

 

LACOSAMIDE.

 

LAMIVUDINE.

 

LAMOTRIGINE.

 

LANATOSIDES.

 

LANREOTIDE.

 

LANSOPRAZOLE except when included in Schedule 3.

 

LANTHANUM for therapeutic use.

 

LAPATINIB.

 

LARONIDASE.

 

LAROPIPRANT.

 

LATAMOXEF.

 

LATANOPROST.

 

LAUDEXIUM.

 

LAUROMACROGOLS in preparations for injection except:

 

 (a) when present as an excipient; or

 

 (b) when separately specified in these Schedules.

 

 LEAD for human therapeutic use.

 

LEFETAMINE.

 

LEFLUNOMIDE.

 

# LENALIDOMIDE.

 

LENOGRASTIM.

 

LEPIRUDIN.

 

LEPTAZOL.

 

LERCANIDIPINE.

 

LETROZOLE.

 

LEUPRORELIN.

 

LEVALLORPHAN.

 

LEVAMISOLE:

 

 (a) for human therapeutic use; or

 

 (b) in preparations for the prevention or treatment of heartworm in dogs.

 

LEVETIRACETAM.

 

LEVOBUNOLOL.

 

LEVOBUPIVACAINE.

 

LEVOCABASTINE except when included in Schedule 2.

 

LEVODOPA.

 

LEVOMEPROMAZINE.

 

LEVONORGESTREL except when included in Schedule 3.

 

LEVOSIMENDAN.

 

LIDOFLAZINE.

 

LIGNOCAINE except:

 

(a) when included in Schedules 2 or 5;

 

(b)  in dermal preparations containing 2 per cent or less of total local anaesthetic substances per dosage unit; or

 

(c)  in lozenges containing 30 mg or less of total anaesthetic substances per dosage unit.

 

LINAGLIPTIN.

 

LINCOMYCIN.

 

LINDANE for human therapeutic use except when included in Schedule 2.

 

LINEZOLID.

 

LIOTHYRONINE.

 

LIRAGLUTIDE.

 

LISINOPRIL.

 

LISURIDE.

 

LITHIUM for therapeutic use except:

 

 (a) when included in Schedule 2;

 

 (b) when present as an excipient in preparations for dermal use containing 0.25 per cent or less of lithium; or

 

 (c) in preparations containing 0.01 per cent or less of lithium.

 

LIXISENATIDE.

 

LODOXAMIDE except when included in Schedule 2.

 

LOFEXIDINE.

 

LOGIPARIN for internal use.

 

LOMEFLOXACIN.

 

LOMUSTINE.

 

LOPERAMIDE except:

 

 (a) when included in Schedule 2; or

 

 (b) in divided oral preparations containing 2 mg or less of loperamide per dosage unit, in a primary pack containing 8 dosage units or less.

 

LOPINAVIR.

 

# LOPRAZOLAM.

 

LORACARBEF.

 

LORATADINE except:

 

(a)          when included in Schedule 2; or

 

(b)         in divided preparations for oral use for the treatment of seasonal allergic rhinitis in adults and children 12 years of age and over when:

 

(i)                  in a primary pack containing 5 dosage units or less; and

(ii)                labelled with a recommended daily dose not exceeding 10 mg of loratadine.

 

# LORAZEPAM.

 

# LORMETAZEPAM.

 

LOSARTAN.

 

LOTEPREDNOL.

 

LOXAPINE.

 

LUMEFANTRINE.

 

LUMIRACOXIB.

 

LURASIDONE.

 

# LUTEINISING HORMONE except in ovulation test kits.

 

LYMECYCLINE.

 

MACITENTAN for human use.

 

MAFENIDE except when included in Schedule 6.

 

MANDRAGORA OFFICINARUM.

 

MANNOMUSTINE.

 

MAPROTILINE.

 

MARAVIROC.

 

MARBOFLOXACIN.

 

MAROPITANT.

 

MAVACOXIB.

 

MAZINDOL.

 

MEASLES VACCINE.

 

MEBANAZINE.

 

MEBEVERINE.

 

MEBHYDROLIN.

 

# MEBOLAZINE.

 

MEBUTAMATE.

 

MECAMYLAMINE.

 

MECASERMIN.

 

MECILLINAM.

 

MECLOCYCLINE.

 

MECLOFENAMATE.

 

MECLOFENOXATE.

 

MECLOZINE except when included in Schedule 2.

 

# MEDAZEPAM.

 

MEDETOMIDINE.

 

MEDIGOXIN (methyldigoxin).

 

MEDROXYPROGESTERONE.

 

MEDRYSONE.

 

MEFENAMIC ACID except when included in Schedule 2.

 

MEFENOREX.

 

MEFLOQUINE.

 

MEFRUSIDE.

 

MEGESTROL.

 

MELAGATRAN.

 

MELATONIN for human use.

 

MELENGESTROL except when included in Schedule 6.

 

MELOXICAM.

 

MELPHALAN.

 

MEMANTINE.

 

MENINGOCOCCAL VACCINE.

 

MENOTROPHIN.

 

MEPACRINE.

 

MEPENZOLATE.

 

MEPHENESIN.

 

MEPHENTERMINE.

 

MEPINDOLOL.

 

# MEPITIOSTANE.

 

MEPIVACAINE.

 

MEPROBAMATE.

 

MEPTAZINOL.

 

MEPYRAMINE except when included in Schedule 2 or 3.

 

MEQUITAZINE.

 

MERCAPTOMERIN.

 

MERCAPTOPURINE.

 

MERCUROCHROME except when included in Schedule 2 or 6.

 

MERCURY for cosmetic or therapeutic use except:

 

 (a) when separately specified in these Schedules; or

 

 (b) in a sealed device which prevents access to the mercury.

 

MEROPENEM.

 

MERSALYL.

 

# MESABOLONE.

 

MESALAZINE.

 

MESNA.

 

# MESTANOLONE (androstalone).

 

# MESTEROLONE.

 

MESTRANOL.

 

# METANDIENONE.

 

METARAMINOL.

 

# METENOLONE.

 

METERGOLINE.

 

METFORMIN.

 

METHACHOLINE.

 

METHACYCLINE.

 

METHALLENOESTRIL.

 

# METHANDRIOL.

 

METHANTHELINIUM.

 

METHAZOLAMIDE.

 

METHDILAZINE except when included in Schedule 3.

 

# METHENOLONE.

 

METHICILLIN.

 

METHIMAZOLE.

 

METHISAZONE.

 

METHIXENE.

 

METHOCARBAMOL.

 

METHOHEXITONE.

 

METHOIN.

 

METHOTREXATE.

 

METHOXAMINE except:

 

 (a) when included in Schedule 2; or

 

 (b) in preparations for external use containing 1 per cent or less of methoxamine.

 

METHOXSALEN.

 

METHOXYFLURANE.

 

METHSUXIMIDE.

 

METHYCLOTHIAZIDE.

 

METHYL AMINOLEVULINATE.

 

#METHYLANDROSTANOLONE.

 

# METHYLCLOSTEBOL.

 

METHYLDOPA.

 

METHYLENE BLUE in preparations for injection.

 

METHYLERGOMETRINE.

 

METHYL MERCURY for therapeutic use.

 

METHYLNALTREXONE.

 

METHYLPENTYNOL.

 

METHYLPHENOBARBITONE.

 

METHYLPREDNISOLONE.

 

METHYL SALICYLATE in preparations for internal therapeutic use.

 

# METHYLTESTOSTERONE.

 

METHYLTHIOURACIL.

 

# METHYLTRIENOLONE.

 

METHYPRYLONE.

 

METHYSERGIDE.

 

METOCLOPRAMIDE except when included in Schedule 3.

 

METOLAZONE.

 

METOPROLOL.

 

# METRIBOLONE.

 

METRIFONATE (trichlorfon) for human therapeutic use.

 

METRONIDAZOLE.

 

METYRAPONE.

 

MEXILETINE.

 

MEZLOCILLIN.

 

MIANSERIN.

 

MIBEFRADIL.

 

# MIBOLERONE.

 

MICAFUNGIN.

 

MICONAZOLE except:

 

 (a) when included in Schedule 2, 3 or 6; or

 

 (b) in preparations for dermal use for the treatment of tinea pedis.

 

# MIDAZOLAM.

 

MIDODRINE.

 

MIFEPRISTONE.

 

MIGLITOL.

 

MIGLUSTAT.

 

MILBEMYCIN OXIME except when included in Schedule 5.

 

MILRINONE.

 

MINOCYCLINE.

 

MINOXIDIL except when included in Schedule 2.

 

MIRABEGRON.

 

MIRTAZAPINE.

 

MISOPROSTOL.

 

MITOBRONITOL.

 

MITOMYCIN.

 

MITOTANE.

 

MITOXANTRONE.

 

MITRATAPIDE.

 

MIVACURIUM CHLORIDE.

 

MOCLOBEMIDE.

 

MODAFINIL.

 

MOLGRAMOSTIM.

 

MOLINDONE.

 

MOMETASONE except when included in Schedule 2.

 

MONENSIN except:

 

 (a) when included in Schedule 5 or 6; or

 

 (b) in animal feeds containing 360 mg/kg or less of antibiotic substances.

 

MONOBENZONE and alkyl ethers of hydroquinone for human therapeutic use or cosmetic use except in cosmetic nail preparations containing 0.02 per cent or less of monobenzone or alkyl ethers of hydroquinone.

 

MONOCLONAL ANTIBODIES for therapeutic use except:

 

 (a) in diagnostic test kits; or

 

 (b) when separately specified in these Schedules.

 

MONTELUKAST.

 

MOPERONE.

 

MORAZONE.

 

MORICIZINE.

 

MOTRAZEPAM.

 

MOTRETINIDE.

 

MOXIDECTIN in preparations for injection containing 10 per cent or less of moxidectin except when included in Schedule 5.

 

MOXIFLOXACIN.

 

MOXONIDINE.

 

MUMPS VACCINE.

 

MUPIROCIN.

 

MURAGLITAZAR.

 

MUROMONAB.

 

MUSTINE (nitrogen mustard).

 

MYCOPHENOLIC ACID (includes mycophenolate mofetil).

 

NABUMETONE.

 

NADOLOL.

 

NADROPARIN.

 

NAFARELIN.

 

NAFTIDROFURYL.

 

NALBUPHINE.

 

NALIDIXIC ACID.

 

NALMEFENE.

 

NALORPHINE.

 

NALOXONE.

 

NALTREXONE.

 

# NANDROLONE.

 

NAPROXEN except when included in Schedule 3 or in Schedule 2.

 

NARASIN except:

 

 (a) when included in Schedule 6; or

 

 (b) in animal feeds containing 100 mg/kg or less of antibiotic substances.

 

NARATRIPTAN.

 

NATALIZUMAB.

 

NATAMYCIN except for use as a food additive.

 

NATEGLINIDE.

 

NEBACUMAB.

 

NEBIVOLOL.

 

NEDOCROMIL.

 

NEFAZODONE.

 

NEFOPAM.

 

NELFINAVIR (includes nelfinavir mesylate).

 

NEOMYCIN.

 

NEOSTIGMINE.

 

NEPAFENAC.

 

NERIUM OLEANDER.

 

NESIRITIDE.

 

NETILMICIN.

 

NEVIRAPINE.

 

NIALAMIDE.

 

NICARDIPINE.

 

NICERGOLINE.

 

NICOFURANOSE.

 

NICORANDIL.

 

NICOTINE in preparations for human therapeutic use except for use as an aid in withdrawal from tobacco smoking in preparations for oromucosal or transdermal use.

 

NICOTINIC ACID for human therapeutic use except:

 (a) when separately specified in these Schedules;

 

 (b) in preparations containing 100 mg or less of nicotinic acid per dosage unit; or

 

 (c) nicotinamide.

 

NICOUMALONE.

 

NIFEDIPINE.

 

NIFENAZONE.

 

NIKETHAMIDE.

 

NILOTINIB.

 

NILUTAMIDE.

 

NIMESULIDE.

 

NIMODIPINE.

 

NIMORAZOLE.

 

NIRIDAZOLE.

 

NISOLDIPINE.

 

NITISINONE.

 

# NITRAZEPAM.

 

NITRENDIPINE.

 

NITRIC OXIDE for human therapeutic use.

 

NITROFURANTOIN.

 

NITROFURAZONE.

 

NITROUS OXIDE for therapeutic use.

 

NITROXOLINE.

 

NIZATIDINE except when included in Schedule 2.

 

NOMEGESTROL.

 

NOMIFENSINE.

 

NORADRENALINE.

 

# 19-NORANDROSTENEDIOL.

 

# 19-NORANDROSTENEDIONE.

 

# NORANDROSTENOLONE.

 

# NORBOLETHONE.

 

# NORCLOSTEBOL.

 

NORELGESTROMIN.

 

# NORETHANDROLONE.

 

NORETHISTERONE.

 

NORFLOXACIN.

 

NORGESTREL.

 

NORIBOGAINE.

 

NORMAL HUMAN IMMUNOGLOBULIN.

 

# NORMETHANDRONE.

 

NORTRIPTYLINE.

 

NOVOBIOCIN.

 

NOXIPTYLINE.

 

NYSTATIN except when included in Schedule 2 or 3.

 

OCLACITNIB.

 

OCRIPLASMIN.

 

OCTAMYLAMINE.

 

OCTATROPINE.

 

OCTREOTIDE.

 

OCTYL NITRITE.

 

OESTRADIOL except when included in Schedule 5.

 

OESTRIOL.

 

OESTROGENS except when separately specified in these Schedules.

 

OESTRONE.

 

OFATUMUMAB.

 

OFLOXACIN.

 

OLANZAPINE.

 

OLEANDOMYCIN except:

 

 (a) when included in Schedule 5; or

 

 (b) in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic substances.

 

OLEANDRIN.

 

OLMESARTAN.

 

OLODATEROL.

 

OLOPATADINE.

 

OLSALAZINE.

 

OMALIZUMAB.

 

OMEGA-3-ACID ETHYL ESTERS (excluding salts and derivatives) for human therapeutic use, for the treatment of post-myocardial infarction and/or hypertriglyceridaemia.

 

OMEPRAZOLE except when included in Schedule 3.

 

ONDANSETRON.

 

OPIPRAMOL.

 

ORBIFLOXACIN.

 

ORCIPRENALINE.

 

ORGANOPHOSPHORUS COMPOUNDS with anticholinesterase activity for human therapeutic use except:

 

 (a) when separately specified in these Schedules; or

 

 (b) in preparations containing 2 per cent or less of malathion for external use.

 

ORLISTAT except when included in Schedule 3.

 

ORNIDAZOLE.

 

ORNIPRESSIN.

 

ORPHENADRINE.

 

ORTHOPTERIN.

 

OSELTAMIVIR.

 

OUABAIN.

 

# OVANDROTONE.

 

# OXABOLONE.

 

OXACILLIN.

 

OXALIPLATIN.

 

# OXANDROLONE.

 

OXAPROZIN.

 

# OXAZEPAM.

 

OXCARBAZEPINE.

 

OXEDRINE for human internal use except in preparations labelled with a recommended daily dose of 30 mg or less of oxedrine.

 

OXETACAINE (oxethazaine) except when included in Schedule 2.

 

OXICONAZOLE except:

 

 (a) when included in Schedule 2 or 3; or

 

 (b) in preparations for the treatment of tinea pedis.

 

OXITROPIUM.

 

OXOLAMINE.

 

OXOLINIC ACID.

 

OXPENTIFYLLINE (pentoxifylline).

 

OXPRENOLOL.

 

OXYBUPROCAINE.

 

OXYBUTYNIN.

 

# OXYMESTERONE.

 

# OXYMETHOLONE.

 

OXYPHENBUTAZONE.

 

OXYPHENCYCLIMINE.

 

OXYPHENONIUM.

 

OXYTETRACYCLINE except when included in Schedule 5.

 

OXYTOCIN.

 

PACLITAXEL.

 

PALIFERMIN.

 

PALIPERIDONE.

 

PALIVIZUMAB.

 

PALONOSETRON.

 

PAMAQUIN.

 

PAMIDRONIC ACID (includes disodium pamidronate).

 

PANCREATIC ENZYMES except:

 

 (a) in preparations containing 20,000 BP units or less of lipase activity per dosage unit; or

 

 (b) when separately specified in these Schedules.

 

PANCURONIUM.

 

PANITUMUMAB.

 

PANTOPRAZOLE except when included in Schedule 3.

 

PAPAVERINE in preparations for injection.

 

PARACETAMOL:

 

 (a) when combined with aspirin or salicylamide or any derivative of these substances except when separately specified in these Schedules;

 

 (b) when combined with ibuprofen in a primary pack containing more than 30 dosage units;

 

 (c) in slow release tablets or capsules containing more than 665 mg of paracetamol;

 

 (d) in non-slow release tablets or capsules containing more than 500 mg of paracetamol;

 

 (e) in individually wrapped powders or sachets of granules each containing more than 1000 mg of paracetamol; or

 

 (f) for injection.

 

PARALDEHYDE.

 

PARAMETHADIONE.

 

PARAMETHASONE.

 

PARECOXIB.

 

PARICALCITOL.

 

PAROMOMYCIN.

 

PAROXETINE.

 

PASIREOTIDE.

 

PAZOPANIB.

 

PECAZINE.

 

PEFLOXACIN.

 

PEGAPTANIB.

 

PEGFILGRASTIM.

 

PEGINTERFERON.

 

PEGVISOMANT.

 

PEMETREXED.

 

PEMOLINE.

 

PEMPIDINE.

 

PENBUTOLOL.

 

PENCICLOVIR except when included in Schedule 2.

 

PENETHAMATE.

 

PENICILLAMINE.

 

PENTAERYTHRITYL TETRANITRATE.

 

PENTAGASTRIN.

 

PENTAMETHONIUM.

 

PENTAMIDINE (includes pentamidine isethionate).

 

PENTHIENATE.

 

PENTOBARBITONE when packed and labelled for injection.

 

PENTOLINIUM.

 

PENTOSAN POLYSULFATE SODIUM.

 

# PERAMPANEL.

 

PERGOLIDE.

 

PERHEXILINE.

 

PERICYAZINE.

 

PERINDOPRIL.

 

PERMETHRIN for human therapeutic use except in preparations containing 5 per cent or less of permethrin.

 

PERPHENAZINE.

 

PERTUSSIS ANTIGEN.

 

PERTUZUMAB.

PHENACEMIDE.

 

PHENACETIN for therapeutic use (excluding when present as an excipient).

 

PHENAGLYCODOL.

 

PHENAZONE except when included in Schedule 2 or 5.

 

PHENAZOPYRIDINE.

 

PHENELZINE.

 

PHENETICILLIN.

 

PHENFORMIN.

 

PHENGLUTARIMIDE.

 

PHENINDIONE.

 

PHENIRAMINE except when included in Schedule 2 or 3.

 

PHENISATIN.

 

PHENOBARBITONE.

 

PHENOL in preparations for injection.

 

PHENOLPHTHALEIN for human therapeutic use.

 

PHENOXYBENZAMINE.

 

PHENOXYMETHYLPENICILLIN.

 

PHENSUXIMIDE.

 

# PHENTERMINE.

 

PHENTHIMENTONIUM.

 

PHENTOLAMINE.

 

PHENYLBUTAZONE.

 

PHENYLEPHRINE:

 

 (a) in preparations for injection; or

 

 (b) in preparations for human ophthalmic use containing 5 per cent or more of phenylephrine.

 

PHENYLPROPANOLAMINE.

 

PHENYLTOLOXAMINE.

 

PHENYTOIN.

 

PHOLCODINE:

 

 (a) in divided preparations containing 100 mg or less of pholcodine per dosage unit; or

 

 (b) in undivided preparations containing 2.5 per cent or less of pholcodine,

 

 except when included in Schedule 2.

 

PHOSPHODIESTERASE TYPE 5 INHIBITORS except:

 

 (a) when separately specified in these Schedules; or

 

 (b) when present as an unmodified, naturally occurring substance.

 

PHTHALYLSULFATHIAZOLE.

 

PHYSOSTIGMINE.

 

PICROTOXIN.

 

PILOCARPINE except in preparations containing 0.025 per cent or less of pilocarpine.

 

PIMECROLIMUS.

 

PIMOBENDAN.

 

PIMOZIDE.

 

PINACIDIL.

 

PINDOLOL.

 

PIOGLITAZONE.

 

PIPECURONIUM.

 

PIPEMIDIC ACID.

 

PIPENZOLATE.

 

PIPER METHYSTICUM (kava) in preparations for human use except when included on the Australian Register of Therapeutic Goods in preparations:

 

 (a) for oral use when present in tablet, capsule or teabag form that is labelled with a recommended maximum daily dose of 250 mg or less of kavalactones and:

 

   (i) the tablet or capsule form contains 125 mg or less of kavalactones per tablet or capsule; or

 

   (ii) the amount of dried whole or peeled rhizome in the teabag does not exceed 3 g;

 

  and, where containing more than 25 mg of kavalactones per dose, compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (b) in topical preparations for use on the rectum, vagina or throat containing dried whole or peeled rhizome or containing aqueous dispersions or aqueous extracts of whole or peeled rhizome; or

 

 (c) in dermal preparations.

 

PIPERACILLIN.

 

PIPERIDINE.

 

PIPERIDOLATE.

 

PIPOBROMAN.

 

PIPOTHIAZINE.

 

PIPRADROL.

 

PIRACETAM.

 

PIRBUTEROL.

 

PIRENOXINE (catalin).

 

PIRENZEPINE.

 

PIRETANIDE.

 

PIROXICAM except in preparations for dermal use.

 

PIRPROFEN.

 

PITAVASTATIN.

 

PITUITARY HORMONES except when separately specified in these Schedules.

 

PIVAMPICILLIN.

 

PIZOTIFEN.

 

PLICAMYCIN.

 

PLERIXAFOR.

 

PNEUMOCOCCAL VACCINE.

 

PODOPHYLLOTOXIN for human use:

 

 (a) internally;

 

 (b) in preparations for the treatment of anogenital warts; or

 

 (c) in other preparations except when included in Schedule 2 or 3.

 

PODOPHYLLUM EMODI (podophyllin) for human use:

 

 (a) internally;

 

 (b) in preparations for the treatment of anogenital warts; or

 

 (c) in other preparations except when included in Schedule 2 or 3.

 

PODOPHYLLUM PELTATUM (podophyllin) for human use:

 

 (a) internally;

 

 (b) in preparations for the treatment of anogenital warts; or

 

 (c) in other preparations except when included in Schedule 2 or 3.

 

POLIDEXIDE.

 

POLIOMYELITIS VACCINE.

 

POLYACRYLAMIDE in preparations for injection or implantation:

 

 (a) for tissue augmentation; or

 

 (b) for cosmetic use.

 

POLYCAPROLACTONE in preparations for injection or implantation:

 

 (a) for tissue augmentation; or

 

 (b) for cosmetic use.

 

POLYESTRADIOL.

 

POLYLACTIC ACID in preparations for injection or implantation:

 

 (a) for tissue augmentation; or

 

 (b) for cosmetic use.

 

POLYMYXIN.

 

POLYSULFATED GLYCOSAMINOGLYCANS in preparations for injection, except when separately specified in these Schedules.

 

POLYTHIAZIDE.

 

PORACTANT.

 

POSACONAZOLE.

 

POTASSIUM BROMIDE for therapeutic use.

 

POTASSIUM CHLORIDE in oral preparations for human therapeutic use except:

 

 (a) when containing less than 550 mg of potassium chloride per dosage unit;

 

 (b) in preparations for oral rehydration therapy;

 

 (c) in preparations for oral use for bowel cleansing prior to diagnostic medical and surgical procedures; or

 

 (d) in preparations for enteral feeding.

 

POTASSIUM PERCHLORATE for therapeutic use.

 

PRACTOLOL.

 

PRADOFLOXACIN.

 

PRALATREXATE.

 

PRALIDOXIME.

 

PRAMIPEXOLE.

 

PRAMOCAINE.

 

PRAMPINE.

 

# PRASTERONE (dehydroepiandrosterone, dehydroisoandrosterone).

 

PRASUGREL.

 

PRAVASTATIN.

 

# PRAZEPAM.

 

PRAZIQUANTEL for human therapeutic use.

 

PRAZOSIN.

 

PREDNISOLONE.

 

PREDNISONE.

 

PREGABALIN.

 

PREGNENOLONE.

 

PRENALTEROL.

 

PRENYLAMINE.

 

PRILOCAINE except when included in Schedule 2.

 

PRIMAQUINE.

 

PRIMIDONE.

 

PROBENECID.

 

PROBUCOL.

 

PROCAINAMIDE.

 

PROCAINE.

 

PROCAINE PENICILLIN.

 

PROCARBAZINE.

 

PROCHLORPERAZINE except when included in Schedule 3.

 

PROCYCLIDINE except when included in Schedule 2.

 

PROGESTERONE except when included in Schedule 5.

 

PROGESTOGENS except when separately specified in these Schedules.

 

PROGLUMIDE.

 

PROGUANIL.

 

PROLINTANE.

 

PROMAZINE.

 

PROMETHAZINE except when included in Schedule 2 or 3.

 

PROMOXOLANE.

 

PROPAFENONE.

 

PROPAMIDINE for therapeutic use except when included in Schedule 2.

 

PROPANIDID.

 

PROPANTHELINE.

 

PROPENTOFYLLINE.

 

# PROPETANDROL.

 

PROPIONIBACTERIUM ACNES for therapeutic use.

 

PROPOFOL.

 

PROPRANOLOL.

 

PROPYLHEXEDRINE.

 

PROPYLTHIOURACIL.

 

PROPYPHENAZONE.

 

PROQUAZONE.

 

PROSCILLARIDIN.

 

PROSTAGLANDINS except when separately specified in this Schedule.

 

PROSTIANOL.

 

PROTAMINE.

 

PROTHIONAMIDE.

 

PROTHIPENDYL.

 

PROTIRELIN.

 

PROTOVERATRINES.

 

PROTRIPTYLINE.

 

PROXYMETACAINE.

 

PRUCALOPRIDE.

 

PSEUDOEPHEDRINE except when included in Schedule 3.

 

PYRAZINAMIDE.

 

PYRIDINOLCARBAMATE.

 

PYRIDOSTIGMINE.

 

PYRIDOXINE, PYRIDOXAL OR PYRIDOXAMINE for human therapeutic use except:

 

 (a) in oral preparations containing 200 mg or less but more than 50 mg of pyridoxine, pyridoxal or pyridoxamine per recommended daily dose when compliant with the requirements of the Required Advisory Statements for Medicine Labels; or

 

 (b) in oral preparations containing 50 mg or less of pyridoxine, pyridoxal or pyridoxamine per recommended daily dose.

 

PYRIMETHAMINE.

 

PYROVALERONE.

 

PYRVINIUM.

 

# QUAZEPAM.

 

QUETIAPINE.

 

QUINAGOLIDE.

 

QUINAPRIL.

 

# QUINBOLONE.

 

QUINETHAZONE.

 

QUINIDINE.

 

QUININE for human therapeutic use except when the maximum recommended daily dose is 50 mg or less of quinine.

 

QUINISOCAINE (dimethisoquin).

 

QUINUPRISTIN.

 

RABEPRAZOLE except when included in Schedule 3.

 

RABIES VACCINE.

 

RACTOPAMINE except when included in Schedule 5.

 

RALOXIFENE.

 

RALTEGRAVIR.

 

RALTITREXED.

 

RAMIPRIL.

 

RANIBIZUMAB.

 

RANITIDINE except:

 

 (a) when included in Schedule 2;  or

 

 (b) in divided preparations for oral use containing 150mg or less of ranitidine per dosage unit when supplied in the manufacturer’s original pack containing not more than 14 dosage units.

 

RAPACURONIUM.

 

RASAGILINE.

 

RASBURICASE.

 

RAUWOLFIA SERPENTINA.

 

RAUWOLFIA VOMITORIA.

 

RAZOXANE.

 

REBOXETINE.

 

RED YEAST RICE for human therapeutic use.

 

REGORAFENIB.

 

REMOXIPRIDE.

 

REPAGLINIDE.

 

RESERPINE.

 

RETAPAMULIN.

 

RETEPLASE.

 

RETIGABINE.

 

RIBAVIRIN.

 

RIDAFOROLIMUS.

 

RIFABUTIN.

 

RIFAMPICIN.

 

RIFAMYCIN.

 

RIFAPENTINE.

 

RIFAXIMIN.

 

RILPIVIRINE.

 

RILUZOLE.

 

RIMEXOLONE.

 

RIMITEROL.

 

RIMONABANT.

 

RIOCIGUAT.

 

RISEDRONIC ACID.

 

RISPERIDONE.

 

RITODRINE.

 

RITONAVIR.

 

RITUXIMAB.

 

RIVAROXABAN.

 

RIVASTIGMINE.

 

RIZATRIPTAN.

 

ROBENACOXIB.

 

ROCURONIUM.

 

ROFECOXIB.

 

ROFLUMILAST.

 

ROLITETRACYCLINE.

 

romidepsin.

 

ROMIFIDINE.

 

ROMIPLOSTIM.

 

RONIDAZOLE.

 

ROPINIROLE.

 

ROPIVACAINE.

 

ROSIGLITAZONE.

 

ROSOXACIN.

 

ROSUVASTATIN.

 

ROTIGOTINE.

 

# ROXIBOLONE.

 

ROXITHROMYCIN.

 

RUBELLA VACCINE.

 

RUBOXISTAURIN.

 

RUPATADINE.

 

RUXOLITINIB.

 

SALBUTAMOL except when included in Schedule 3.

 

SALCATONIN.

 

SALICYLAMIDE when combined with aspirin, caffeine or paracetamol or any derivative of these substances.

 

SALINOMYCIN except:

 

 (a) when included in Schedule 6;  or

 

 (b) in animal feeds containing 60 mg/kg or less of antibiotic substances.

 

SALMETEROL.

 

SAPROPTERIN.

 

SAQUINAVIR.

 

SAXAGLIPTIN.

 

SCHOENOCAULON OFFICINALE (sabadilla) except in preparations containing 10 mg/kg or 10 mg/L or less of total alkaloids of Schoenocaulon officinale.

 

SCOPOLIA CARNIOLICA for therapeutic use.

 

# SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARM).

 

SELEGILINE.

 

SELENIUM:

 

 (a) for human oral use with a recommended daily dose of more than 300 micrograms; or

 

 (b) for the treatment of animals except:

 

   (i) when included in Schedule 6 or 7;

 

   (ii) in solid, slow release bolus preparations each weighing 100 g or more and containing 300 mg or less of selenium per dosage unit;

 

   (iii) in other divided preparations containing 30 micrograms or less of selenium per dosage unit;

 

   (iv) as elemental selenium, in pellets containing 100 g/kg or less of selenium; or

 

   (v) in feeds containing 1 g/tonne or less of selenium.

 

SERELAXIN.

 

SERMORELIN.

 

SERTINDOLE.

 

SERTRALINE.

 

SEVELAMER.

 

SEVOFLURANE.

 

SEX HORMONES and all substances having sex hormonal activity except when separately specified in these Schedules.

 

SIBUTRAMINE.

 

# SILANDRONE.

 

SILDENAFIL.

 

SILICONES for intra-ocular use. 

 

SILVER SULFADIAZINE.

 

SIMEPREVIR.

 

SIMVASTATIN.

 

SIROLIMUS.

 

SISOMICIN (sisomycin).

 

SITAGLIPTIN.

 

# SITAXENTAN.

 

SODIUM BROMIDE for therapeutic use.

 

SODIUM CELLULOSE PHOSPHATE for human internal use.

 

SODIUM CROMOGLYCATE except when included in Schedule 2.

 

SODIUM MORRHUATE in preparations for injection.

 

SODIUM NITROPRUSSIDE for human therapeutic use.

 

SODIUM PHOSPHATE in preparations for oral laxative use.

 

SODIUM POLYSTYRENE SULPHONATE for human therapeutic use.

 

SODIUM SALICYLATE in preparations for injection for the treatment of animals.

 

SODIUM TETRADECYLSULFATE in preparations for injection.

 

SOFOSBUVIR.

 

SOLASODINE.

 

SOLIFENACIN.

 

SOMATOSTATIN.

 

SOMATOTROPIN EQUINE.

 

# SOMATROPIN (human growth hormone).

 

SONTOQUINE.

 

SORAFENIB.

 

SOTALOL.

 

SPARFLOXACIN.

 

SPARTEINE.

 

SPECTINOMYCIN.

 

SPIRAMYCIN.

 

SPIRAPRIL.

 

SPIRONOLACTONE.

 

# STANOLONE.

 

# STANOZOLOL.

 

STAVUDINE.

 

# STENBOLONE.

 

STEROID HORMONES except when separately specified in these Schedules.

 

STILBOESTROL (diethylstilboestrol).

 

STREPTODORNASE.

 

STREPTOKINASE.

 

STREPTOMYCIN.

 

STRONTIUM RANELATE.

 

STROPHANTHINS.

 

STROPHANTHUS spp.

 

STRYCHNINE in preparations containing 1.5 per cent or less of strychnine for the treatment of animals.

 

STRYCHNOS spp. except in preparations containing 1 mg or less per litre or per kilogram of strychnine.

 

STYRAMATE.

 

SUCCIMER.

 

SUGAMMADEX.

 

SULBACTAM.

 

SULCONAZOLE except when included in Schedule 2.

 

SULFACETAMIDE except when included in Schedule 3 or 5.

 

SULFADIAZINE except when included in Schedule 5.

 

SULFADIMETHOXINE.

 

SULFADIMIDINE except when included in Schedule 5.

 

SULFADOXINE.

 

SULFAFURAZOLE.

 

SULFAGUANIDINE.

 

SULFAMERAZINE except when included in Schedule 5.

 

SULFAMETHIZOLE.

 

SULFAMETHOXAZOLE.

 

SULFAMETHOXYDIAZINE.

 

SULFAMETHOXYPYRIDAZINE.

 

SULFAMETROLE.

 

SULFAMONOMETHOXINE.

 

SULFAMOXOLE.

 

SULFAPHENAZOLE.

 

SULFAPYRIDINE.

 

SULFAQUINOXALINE.

 

SULFASALAZINE.

 

SULFATHIAZOLE except when included in Schedule 5.

 

SULFATROXAZOLE.

 

SULFINPYRAZONE.

 

SULFOMYXIN.

 

SULFONAMIDES except:

 

 (a) when separately specified in this Schedule;

 

 (b) when included in Schedule 3, 5 or 6; or

 

 (c) when packed and labelled solely for use as a herbicide. 

 

SULFONMETHANE (sulfonal and alkyl sulfonals).

 

SULINDAC.

 

SULTAMICILLIN.

 

SULTHIAME.

 

SUMATRIPTAN.

 

SUNITINIB.

 

SUPROFEN.

 

SUTILAINS.

 

SUXAMETHONIUM.

 

SUXETHONIUM.

 

SUVOREXANT.

 

TACRINE.

 

TACROLIMUS.

 

TADALAFIL.

 

TAFLUPROST.

 

TALIGLUCERASE ALFA.

 

TAMOXIFEN.

 

TAMSULOSIN.

 

TANACETUM VULGARE except in preparations containing 0.8 per cent or less of oil of tansy.

 

TASONERMIN.

 

TAZAROTENE.

 

TAZOBACTAM.

 

T-CELL RECEPTOR ANTIBODY.

 

TEGAFUR.

 

TEGASEROD.

 

TELAPREVIR.

 

TELITHROMYCIN.

 

TEICOPLANIN.

 

TELBIVUDINE.

 

TELMISARTAN.

 

# TEMAZEPAM.

 

TEMOZOLOMIDE.

 

TEMSIROLIMUS.

 

TENECTEPLASE.

 

TENIPOSIDE.

 

TENOFOVIR.

 

TENOXICAM.

 

TEPOXALIN.

 

TERAZOSIN.

 

TERBINAFINE except:

 

 (a) when included in Schedule 2; or

 

 (b) in preparations for dermal use for the treatment of tinea pedis.

 

TERBUTALINE except when included in Schedule 3.

 

TERFENADINE.

 

TERIFLUNOMIDE.

 

# TERIPARATIDE.

 

TERLIPRESSIN.

 

TERODILINE.

 

TEROPTERIN.

 

# TESTOLACTONE.

 

# TESTOSTERONE except when included in Schedule 6.

 

TETANUS ANTITOXIN except when used for short-term protection or treatment of tetanus in animals.

 

TETANUS TOXOID for human use.

 

TETRABENAZINE.

 

TETRACOSACTRIN.

 

TETRACYCLINE except when included in Schedule 5.

 

TETRAETHYLAMMONIUM.

 

TETROXOPRIM.

 

# THALIDOMIDE.

 

THENYLDIAMINE.

 

THEOPHYLLINE except when included in Schedule 3.

 

THEVETIA PERUVIANA.

 

THEVETIN.

 

THIACETARSAMIDE in preparations for the prevention or treatment of heartworm in dogs.

 

THIAMBUTOSINE.

 

THIAZOSULFONE.

 

THIETHYLPERAZINE.

 

THIOACETAZONE.

 

THIOCARLIDE.

 

THIOGUANINE.

 

# THIOMESTERONE (tiomesterone).

 

THIOPENTONE.

 

THIOPROPAZATE.

 

THIOPROPERAZINE.

 

THIORIDAZINE.

 

THIOSTREPTON.

 

THIOTEPA.

 

THIOTHIXENE.

 

THIOURACIL.

 

THIOUREA for therapeutic use except in preparations containing 0.1 per cent or less of thiourea.

 

THYMOXAMINE (includes thymoxamine hydrochloride).

 

THYROID except when separately specified in this Schedule.

 

THYROTROPHIN.

 

THYROXINE (includes thyroxine sodium).

 

TIAGABINE.

 

TIAMULIN.

 

TIAPROFENIC ACID.

 

TIARAMIDE.

 

TIBOLONE.

 

TICAGRELOR.

 

TICARCILLIN.

 

TICLOPIDINE.

 

TIEMONIUM.

 

TIENILIC ACID.

 

TIGECYCLINE.

 

TIGLOIDINE.

 

TILDIPIROSIN.

 

TILETAMINE.

 

TILMICOSIN.

 

TILUDRONIC ACID (includes disodium tiludronate).

 

TIMOLOL.

 

TINIDAZOLE.

 

TINZAPARIN (includes tinzaparin sodium).

 

TIOCONAZOLE except:

 

 (a) when included in Schedule 2 or 3; or

 

 (b) in preparations for dermal use for the treatment of tinea pedis.

 

TIOTROPIUM.

 

TIPEPIDINE.

 

TIPRANAVIR.

 

TIRILAZAD.

 

TIROFIBAN.

 

TOBRAMYCIN.

 

TOCAINIDE.

 

TOCERANIB.

 

TOCILIZUMAB.

 

TOLAZAMIDE.

 

TOLAZOLINE.

 

TOLBUTAMIDE.

 

TOLCAPONE.

 

TOLFENAMIC ACID.

 

TOLMETIN.

 

TOLONIUM.

 

TOLPROPAMINE.

 

TOLRESTAT.

 

TOLTERODINE.

 

TOLVAPTAN.

 

TOPIRAMATE.

 

TOPOTECAN.

 

TORASEMIDE.

 

TOREMIFENE.

 

TOXOIDS for human parenteral use except when separately specified in these Schedules.

 

TRAMADOL.

 

TRANDOLAPRIL.

 

trametinib dimethyl sulfoxide.

 

TRANEXAMIC ACID except in preparations containing 3 per cent or less of cetyl tranexamate hydrochloride for dermal cosmetic use. 

 

TRANYLCYPROMINE.

 

TRASTUZUMAB.

 

Trastuzumab emtansine.

 

TRAVOPROST.

 

TRAZODONE.

 

# TRENBOLONE (trienbolone, trienolone) except when included in Schedule 5.

 

TREOSULPHAN.

 

TREPROSTINIL.

 

# TRESTOLONE.

 

TRETAMINE.

 

# TRETINOIN.

 

TRIACETYLOLEANDOMYCIN.

 

TRIAMCINOLONE except when included in Schedule 2 or 3.

 

TRIAMTERENE.

 

TRIAZIQUONE.

 

# TRIAZOLAM.

 

TRICHLORMETHIAZIDE.

 

TRICHLOROACETIC ACID for human dermal use except when in preparations containing 12.5 per cent or less of trichloroacetic acid for the treatment of warts other than anogenital warts.

 

TRICHLOROETHYLENE for therapeutic use.

 

TRICLOFOS.

 

TRICYCLAMOL.

 

TRIDIHEXETHYL.

 

TRIETHANOLAMINE when in preparations for tattoo removal.

 

TRIFLUOPERAZINE.

 

TRIFLUPERIDOL.

 

TRIFLUPROMAZINE.

 

TRILOSTANE.

 

TRIMEPRAZINE except when included in Schedule 2 or 3.

 

TRIMETAPHAN.

 

TRIMETHOPRIM.

 

TRIMIPRAMINE.

 

TRIMUSTINE.

 

TRINITROPHENOL (excluding its derivatives) in preparations for human therapeutic use.

 

TRIOXYSALEN.

 

TRIPELENNAMINE.

 

TRIPLE ANTIGEN VACCINE.

 

TRIPROLIDINE except when included in Schedule 2 or 3.

 

TRIPTORELIN.

 

TROGLITAZONE.

 

TROMETAMOL in preparations for injection except in preparations containing 3 per cent or less of trometamol.

 

TROPICAMIDE.

 

TROPISETRON.

 

TROVAFLOXACIN.

 

TROXIDONE.

 

TRYPTOPHAN for human therapeutic use except in preparations labelled with a recommended daily dose of 100 mg or less of tryptophan.

 

TUBERCULIN.

 

TUBOCURARINE.

 

TULATHROMYCIN.

 

TULOBUTEROL.

 

TYLOSIN.

 

TYPHOID VACCINE.

 

UMECLIDINIUM.

 

UNOPROSTONE.

 

URACIL.

 

URAPIDIL.

 

URETHANE (excluding its derivatives) for therapeutic use.

 

# UROFOLLITROPIN.

 

UROKINASE.

 

URSODEOXYCHOLIC ACID.

 

USTEKINUMAB.

 

VACCINES for human therapeutic use except when separately specified in this Schedule.

 

VACCINES, veterinary live virus except:

 

 (a) poultry vaccines;

 

 (b) pigeon pox vaccine; or

 

 (c) scabby mouth vaccine.

 

VACCINIA VIRUS VACCINE.

 

VALACICLOVIR.

 

VALDECOXIB.

 

VALGANCICLOVIR.

 

VALNOCTAMIDE.

 

VALPROIC ACID.

 

VALSARTAN.

 

VANCOMYCIN.

 

VANDETANIB.

 

VARDENAFIL.

 

VARENICLINE.

 

VARICELLA VACCINE.

 

VASOPRESSIN.

 

VECURONIUM.

 

VEDAPROFEN.

 

vEDOLIZUMAB.

 

VELAGLUCERASE ALFA.

 

VEMURAFENIB.

 

VENLAFAXINE.

 

VERAPAMIL.

 

VERATRUM spp. except when separately specified in this Schedule.

 

VERNAKALANT.

 

VERTEPORFIN.

 

VIDARABINE.

 

VIGABATRIN.

 

VILANTEROL.

 

VILDAGLIPTIN.

 

VILOXAZINE.

 

VINBLASTINE.

 

VINCAMINE.

 

VINCRISTINE.

 

VINDESINE.

 

VINFLUNINE.

 

VINORELBINE.

 

VINYL ETHER for therapeutic use.

 

VIRGINIAMYCIN except when included in Schedule 5.

 

VISMODEGIB.

 

VISNADINE.

 

VITAMIN A for human therapeutic or cosmetic use except:

 

 (a) in preparations for topical use containing 1 per cent or less of Vitamin A;

 

 (b)      in preparations for internal use containing 3000 micrograms retinol equivalents or less of Vitamin A  per daily dose; or

 

 (c) in preparations for parenteral nutrition replacement.

 

VITAMIN D for human internal therapeutic use except:

 

(a)        in preparations containing 25 micrograms or less of vitamin D per recommended daily dose ; or

 

(b)        when included in Schedule 3.

 

VORICONAZOLE.

 

VORINOSTAT.

 

VORTIOXETINE.

 

WARFARIN for therapeutic use.

 

XAMOTEROL.

 

XANTHINOL NICOTINATE.

 

XIMELAGATRAN.

 

XIPAMIDE.

 

XYLAZINE.

 

YOHIMBINE.

 

ZAFIRLUKAST.

 

ZALCITABINE.

 

ZALEPLON.

 

ZANAMIVIR.

 

ZERANOL except when included in Schedule 6.

 

ZIDOVUDINE.

 

ZILPATEROL.

 

ZIMELDINE.

 

ZINC COMPOUNDS for human internal use except:

 

 (a) in preparations with a recommended daily dose of 25 mg or less of zinc; or

 

 (b) in preparations with a recommended daily dose of more than 25 mg but not more than 50 mg of zinc when compliant with the requirements of the Required Advisory Statements for Medicine Labels.

 

ZIPRASIDONE.

 

ZOLAZEPAM.

 

ZOLEDRONIC ACID.

 

ZOLMITRIPTAN.

 

ZOLPIDEM.

 

ZONISAMIDE.

 

ZOPICLONE.

 

ZOXAZOLAMINE.

 

ZUCLOPENTHIXOL.

 

 

ABAMECTIN in preparations, for internal use for the treatment of animals, containing 1 per cent or less of abamectin.

 

ABSCISIC ACID.

 

ACETIC ACID (excluding its salts and derivatives) in preparations containing more than 30 per cent of acetic acid (CH3COOH) except:

 

 (a) when included in Schedule 2 or 6; or

 

 (b) for therapeutic use.

 

ACETONE except in preparations containing 25 per cent or less of designated solvents.

 

ACRIFLAVINE in preparations for veterinary use containing 2.5 per cent or less of acriflavine.

 

AFOXOLANER for the treatment and prevention of flea infestations and control of ticks in dogs in oral divided preparations each containing 140 mg or less of afoxolaner per dosage unit.

 

AKLOMIDE.

 

ALBENDAZOLE for the treatment of animals, in preparations containing 12.5 per cent or less of albendazole except in intraruminal implants each containing 3.85 g or less of albendazole.

 

 ALKALINE SALTS, being the carbonate, silicate or phosphate salts of sodium or potassium alone or in any combination:

 

 (a) in solid orthodontic device cleaning preparations, the pH of which as an “in-use” aqueous solution is more than 11.5;

 

 (b) in solid automatic dishwashing preparations, the pH of which in a 500 g/L aqueous solution or mixture is more than 11.5 but less than or equal to 12.5;

 

 (c) in other solid preparations, the pH of which in a 10 g/L aqueous solution is more than 11.5; or

 

 (d) in liquid or semi-solid preparations, the pH of which is more than 11.5, unless:

 

   (i) in food additive preparations for domestic use; or

 

   (ii) in automatic dish washing preparations for domestic use with a pH of more than 12.5,

 

 except when separately specified in these Schedules.

 

ALKOXYLATED FATTY ALKYLAMINE POLYMER in preparations containing 50 per cent or less of alkoxylated fatty alkylamine polymer except in preparations containing 20 per cent or less of alkoxylated fatty alkylamine polymer.

 

ALLETHRIN in preparations containing 10 per cent or less of allethrin except:

 

 (a) in insecticidal mats; or

 

 (b) in other preparations containing 1 per cent or less of allethrin.

 

ALLOXYDIM.

 

ALPHA-CYPERMETHRIN:

 

 (a)  in aqueous preparations containing 3 per cent or less of alpha-cypermethrin; or

 

 (b) in other preparations containing 1.5 per cent or less of alpha-cypermethrin.

 

AMETRYN.

 

AMINACRINE in preparations for veterinary use containing 2.5 per cent or less of aminacrine.

 

AMINES for use as curing agents for epoxy resins except when separately specified in these Schedules.

 

AMINOPYRALID in water soluble gel formulations containing 0.5 per cent or less of aminopyralid.

 

AMITROLE.

 

AMINOCYCLOPYRACHLOR.

 

AMMONIA (excluding its salts and derivatives other than ammonium hydroxide) in preparations containing 5 per cent or less of ammonia except:

 

 (a) in preparations for human internal therapeutic use;

 

 (b) in preparations for inhalation when absorbed in an inert solid material; or

 

 (c) in preparations containing 0.5 per cent or less of free ammonia.

 

AMMONIUM THIOCYANATE except in preparations containing 10 per cent or less of ammonium thiocyanate.

 

ANHYDRIDES, ORGANIC ACID for use as curing agents for epoxy resins except when separately specified in these Schedules.

 

ANISE OIL except:

 

 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 50 mL or less fitted with a restricted flow insert and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (b) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 50 mL or less fitted with a restricted flow insert, and labelled with the warning:

 

  KEEP OUT OF REACH OF CHILDREN; or

 

 (c) in preparations containing 50 per cent or less of anise oil.

 

ASPIRIN for the treatment of animals, in divided preparations when packed in blister or strip packaging or in a container with a child-resistant closure.

 

ATRAZINE.

 

 AZADIRACHTA INDICA EXTRACTS (neem extracts), extracted from neem seed kernels using water, methanol or ethanol, in preparations containing 5 per cent or less of total limonoids, for agricultural use.

 

AZOXYSTROBIN.

 

BACILLUS THURINGIENSIS delta endotoxin encapsulated in killed Pseudomonas fluorescens.

 

BARIUM SILICOFLUORIDE when coated on paper in an amount not exceeding 8 mg of barium silicofluoride per sq. cm.

 

BASIL OIL except:

 

 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of               25 mL or less fitted with a restricted flow insert and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (b) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert, and labelled with the warning:

 

  KEEP OUT OF REACH OF CHILDREN; or

 

 (c) in preparations containing 5 per cent or less of methyl chavicol.

 

BEAUVERIA BASSIANA in preparations containing 1 x 108 Colony Forming Units (CFU)/mL or less of Beauveria bassiana.

 

BENALAXYL.

 

BENDIOCARB in preparations containing 2 per cent or less of bendiocarb.

 

BENTAZONE.

 

BENZALKONIUM CHLORIDE in preparations containing 10 per cent or less of benzalkonium chloride except in preparations containing 5 per cent or less of benzalkonium chloride.

 

BENZOFENAP.

 

BENZOYL PEROXIDE except:

 

 (a) when included in Schedule 2 or 4; or

 

 (b) in preparations containing 5 per cent or less of benzoyl peroxide.

 

BERGAMOT OIL except:

 

 (a) when steam distilled or rectified;

 

 (b) in preparations for internal use;

 

 (c) in preparations containing 0.4 per cent or less of bergamot oil;

 

 (d) in soaps or bath or shower gels that are washed off the skin;

 

 (e) in medicines for human therapeutic use when compliant with the requirements of the Required Advisory Statements for Medicine Labels; or

 

 (f) in other preparations when packed in containers labelled with the statement:

 

  Application to the skin may increase sensitivity to sunlight.

 

BETACYFLUTHRIN:

 

 (a) in aqueous preparations containing 2.5 per cent or less of betacyfluthrin; or

 

 (b) in solid preparations containing 8 per cent or less of betacyfluthrin in a plastic matrix.

 

BIFLUORIDES (including ammonium, potassium and sodium salts), in preparations containing 0.3 per cent or less of total bifluorides.

 

 

BIOALLETHRIN in preparations containing 10 per cent or less of bioallethrin except in preparations containing 1 per cent or less of bioallethrin.

 

BIORESMETHRIN except in preparations containing 10 per cent or less of bioresmethrin.

 

BISPYRIBAC except in preparations containing 10 per cent or less of bispyribac.

 

BORIC ACID (excluding its salts) and BORAX except:

 

 (a) when included in Schedule 4;

 

 (b) in preparations, other than insect baits, containing 1 per cent or less of boron; or

 

 (c) in hand cleaning preparations.

 

BORON TRIFLUORIDE in preparations containing 0.1 per cent or less of boron trifluoride (BF3).

 

BROMUCONAZOLE in preparations containing 20 per cent or less of bromuconazole.

 

BUPIVACAINE   in aqueous gel preparations containing 0.5 per cent or less of bupivacaine, for the dermal spray-on treatment of wounds associated with 'mulesing' of sheep.

 

BUPROFEZIN except in preparations containing 40 per cent or less of buprofezin.

 

BUTHIDAZOLE.

 

BUTOXYCARBOXIM in solid preparations containing 10 per cent or less of butoxycarboxim.

 

BUTRALIN.

 

BUTROXYDIM.

 

CAMPHOR as a natural component in essential oils containing 10 per cent or less of camphor except:

 

 (a) in medicines for human therapeutic use, in essential oils when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (b) in preparations other than medicines for human therapeutic use, in essential oils when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert, and labelled with the warnings:

 

  KEEP OUT OF REACH OF CHILDREN; and

 

  NOT TO BE TAKEN;

 

 (c) in rosemary oil, sage oil (Spanish), or lavandin oils; or

 

 (d) in preparations containing 2.5 per cent or less of camphor.

 

 CARBAMIDE PEROXIDE in preparations containing 18 per cent or less of carbamide peroxide except in preparations containing 9 per cent or less of carbamide peroxide.

 

CARBARYL:

 

 (a) in preparations containing 10 per cent or less of carbaryl except when included in Schedule 4; or

 

 (b) when impregnated into plastic resin material containing 20 per cent or less of carbaryl.

 

CASSIA OIL except:

 

 (a) in food additives;

 

 (b) in preparations for dermal use as a rubefacient containing 5 per cent or less of cassia oil; or

 

 (c) in other preparations containing 2 per cent or less of cassia oil.

 

CHLORFENAC.

 

CHLORFENAPYR. in preparations containing 0.5 per cent or less of chlorfenapyr.

 

CHLORFENSON.

 

CHLORHEXIDINE in preparations containing 3 per cent or less of chlorhexidine except:

 

 (a) in preparations containing 1 per cent or less of chlorhexidine; or

 

 (b) when in solid preparations.

 

CHLORINATING COMPOUNDS containing 20 per cent or less of available chlorine, except:

 

 (a) when separately specified in these Schedules;

 

 (b) sodium hypochlorite preparations with a pH of less than 11.5;

 

 (c) liquid preparations containing not less than 2 per cent but not more than 4 per cent of available chlorine when labelled with the statements:

 

  WARNING – Ensure adequate ventilation when using.  Vapour may be harmful.  May give off dangerous gas if mixed with other products;

 

 (d) liquid preparations containing less than 2 per cent of available chlorine; or

 

 (e) other preparations containing 4 per cent or less of available chlorine.

 

CHLORNIDINE.

 

CHLOROCRESOL except in preparations containing 3 per cent or less of chlorocresol.

 

CHLORPROPHAM.

 

CHLORPYRIFOS:

 

 (a) in aqueous preparations containing 20 per cent or less of microencapsulated chlorpyrifos;

 

 (b) in controlled release granular preparations containing 10 per cent or less of chlorpyrifos; or

 

 (c) in other preparations containing 5 per cent or less of chlorpyrifos,

 

 except in prepared potting or soil mixes containing 100 g or less of chlorpyrifos per cubic  metre.

 

CHLORSULFURON.

 

CHLORTETRACYCLINE in preparations:

 

 (a) for topical application to animals for ocular use only; or

 

 (b) containing 40 per cent or less of chlortetracycline, when packed and labelled for the treatment of ornamental caged birds or ornamental fish only.

 

CHLORTHAL-DIMETHYL.

 

CINMETHYLIN. 

 

CINNAMON BARK OIL except:

 

 (a) in food additives; or

 

 (b) in preparations containing 2 per cent or less of cinnamon bark oil.

 

CLETHODIM.

 

CLIMBAZOLE in preparations containing 40 per cent or less of climbazole except in preparations containing 2 per cent or less of climbazole.

 

CLOFENTEZINE.

 

CLOPYRALID.

 

CLOQUINTOCET-MEXYL.

 

CLORSULON.

 

CLOTHIANIDIN in preparations containing 20 per cent or less of clothianidin.

 

CLOVE OIL for topical use in the mouth in a pack containing 5 mL or less of clove oil except in preparations containing 25 per cent or less of clove oil.

 

COPPER ACETATE in preparations containing 20 per cent or less of copper acetate except in preparations containing 5 per cent or less of copper acetate.

 

COPPER COMPOUNDS in animal feed additives containing 5 per cent or less of copper except in preparations containing 1 per cent or less of copper.

 

COPPER HYDROXIDE in preparations containing 50 per cent or less of copper hydroxide except in preparations containing 12.5 per cent or less of copper hydroxide.

 

COPPER OXIDES in preparations containing 25 per cent or less of copper oxides except:

 

 (a) in preparations for internal use;

 

 (b) in marine paints; or

 

 (c) in other preparations containing 5 per cent or less of copper oxides.

 

COPPER OXYCHLORIDE in preparations containing 50 per cent or less of copper oxychloride except in preparations containing 12.5 per cent or less of copper oxychloride.

 

COPPER SULFATE in preparations containing 15 per cent or less of copper sulfate except:

 

 (a) in preparations for internal use; or

 

 (b) in other preparations containing 5 per cent or less of copper sulfate.

 

COUMATETRALYL in rodenticides containing 0.05 per cent or less of coumatetralyl.

 

4-CPA.

 

CYANATRYN.

 

CYANOACRYLATE ESTERS in contact adhesives except:

 

 (a) when labelled with the warning:

 

  KEEP OUT OF REACH OF CHILDREN.  Avoid contact with skin and eyes and avoid breathing vapour.  Bonds on contact.  Should fingers stick together apply a solvent such as acetone to contact areas then wash off with water.  Do not use solvents near eyes or open wounds.  In case of eye contact immediately flush with water; or

 

 (b) when packed in sealed measure packs each containing 0.5 g or less of cyanoacrylate esters:

 

  (i) labelled with the approved name or trade name of the poison, the quantity and the warning:

 

   Can cause eye injury.  Instantly bonds skin; and

 

  (ii)  enclosed in a primary pack labelled with the warning:

 

   KEEP OUT OF REACH OF CHILDREN.  Avoid contact with skin and eyes and avoid breathing vapour.  Bonds on contact.  Should fingers stick together apply a solvent such as acetone to contact areas then wash off with water.  Do not use solvents near eyes or open wounds.  In case of eye contact immediately flush with water.

 

CYANURIC ACID (excluding its salts and derivatives).

 

CYANTRANILIPROLE.

 

CYAZOFAMID.

 

CYCLOHEXANONE PEROXIDE.

 

CYCLOPROTHRIN except in preparations containing 10 per cent or less of cycloprothrin.

 

CYCLOXYDIM.

 

CYFLUFENAMID.

 

CYFLUTHRIN:

 

 (a) in wettable powders containing 10 per cent or less of cyfluthrin;

 

 (b) in emulsifiable concentrates containing 2 per cent or less of cyfluthrin; or

 

 (c) in emulsions containing 5 per cent or less of cyfluthrin.

 

cyhalofop-butyl.

 

CYMIAZOLE.

 

CYPERMETHRIN in preparations containing 10 per cent or less of cypermethrin.

 

CYPHENOTHRIN in preparations containing 10 per cent or less of cyphenothrin.

 

CYPROCONAZOLE except in preparations containing 10 per cent or less of cyproconazole.

 

CYPRODINIL.

 

CYSTEAMINE in cosmetic preparations containing 6 per cent or less of cysteamine except in preparations containing 1 per cent or less of cysteamine.

 

CYTHIOATE for the treatment of animals:

 

 (a) in divided preparations containing 30 mg or less of cythioate per dosage unit when packed in blister or strip packaging or in a container with a child-resistant closure; or

 

 (b)  in undivided preparations containing 5 per cent or less of cythioate.

 

2,4-D in preparations containing 20 per cent or less of 2,4-D.

 

DAMINOZIDE.

 

2,4-DB.

 

DECOQUINATE:

 

DELTAMETHRIN:

 

(a)       when impregnated in plastic resin strip material containing 4 per cent or less of deltamethrin;

 

(b)       in aqueous preparations containing 5 per cent or less of deltamethrin when no organic solvent other than a glycol is present;

 

(c)       in wettable granular preparations containing 25 per cent or less of deltamethrin when packed in child-resistant packaging each containing 3 grams or less of the formulation;

 

(d)       in water-dispersible tablets each containing 500 mg or less of deltamethrin in child-resistant packaging; or

 

(e)       in other preparations containing 0.5 per cent or less of deltamethrin,

 

except:

 

(a)     in factory prepared mosquito nets containing 1 per cent or less deltamethrin; or

 

(b)    in preparations containing 0.1 per cent or less of deltamethrin.

 

DEMBREXINE in oral preparations for the treatment of animals.

 

2,4-DES.

 

DIAFENTHIURON.

 

N,N-DIALLYLDICHLOROACETAMIDE except in preparations containing 10 per cent or less of N,N-diallyldichloroacetamide.

 

DIAZINON in dust preparations containing 2 per cent or less of diazinon.

 

DICAMBA (including its salts and derivatives) in preparations containing 20 per cent or less of dicamba.

 

DICHLONE.

 

para-DICHLOROBENZENE.

 

DICHLOROISOCYANURIC ACID containing 40 per cent or less of available chlorine, except in:

 

 (a) liquid preparations containing not less than 2 per cent but not more than 4 per cent of available chlorine when labelled with the statements:

 

  WARNING – Ensure adequate ventilation when using.  Vapour may be harmful.  May give off dangerous gas if mixed with other products;

 

 (b) liquid preparations containing less than 2 per cent of available chlorine; or

 

 (c) other preparations containing 4 per cent or less of available chlorine.

 

DICHLOROMETHANE (methylene chloride) except:

 

 (a) in preparations in pressurised spray packs labelled as degreasers, decarbonisers or paint strippers and containing 10 per cent or less of dichloromethane; 

 

 (b) in other preparations in pressurised spray packs; or

 

 (c) in paints and tinters containing 5 per cent or less of dichloromethane.

 

DICHLOROPHEN for the treatment of animals.

 

DICHLORVOS:

 

 (a) when impregnated in plastic resin strip material containing 20 per cent or less of dichlorvos;

 

 (b) in sustained release resin pellets containing 20 per cent or less of dichlorvos for the treatment of animals; or

 

 (c) in pressurised spray packs containing 10 grams or less of dichlorvos.

 

DICLOBUTRAZOL.

 

DICLORAN.

 

DICOFOL.

 

DIETHANOLAMINE (excluding its salts and derivatives) in preparations containing 20 per cent or less of diethanolamine except in preparations containing 5 per cent or less of diethanolamine.

 

 DIETHYLENE GLYCOL (excluding its salts and derivatives) in preparations containing not less than 10 mg/kg of denatonium benzoate as a bittering agent except:

 

 (a) in paints or paint tinters;

 

 (b) in toothpastes or mouthwashes containing more than 0.25 per cent of diethylene glycol; or

 

 (c) in other preparations containing 2.5 per cent or less of diethylene glycol.

 

DIETHYLENE GLYCOL MONOBUTYL ETHER except in preparations containing 10 per cent or less of diethylene glycol monobutyl ether.

 

DIETHYLTOLUAMIDE (DEET) except:

 

 (a) in medicines for human therapeutic use containing 20 per cent or less of diethyltoluamide, when compliant with the requirements of the Required Advisory Statements for Medicine Labels;  

 

 (b) in preparations for human use, other than medicines, containing 20 per cent or less of diethyltoluamide, when labelled with the warning statement:

  

  WARNING: May be dangerous, particularly to children, if you use large amounts on the skin, clothes or bedding or on large areas of the body, especially if you keep using it for a long time; or

 

  (c) in preparations other than for human use containing 20 per cent or less of diethyltoluamide.

 

DIFENOCONAZOLE.

 

DIFLUBENZURON.

 

DIMETHICODIETHYLBENZALMALONATE except when included in preparations containing 10 per cent or less of dimethicodiethylbenzalmalonate.

 

DIMETHIRIMOL.

 

DIMETHOMORPH except in preparations containing 10 per cent or less of dimethomorph.

 

DIMETHYLACETAMIDE in preparations containing 20 per cent or less of dimethylacetamide.

 

DIMETHYLFORMAMIDE in preparations containing 10 per cent or less of dimethylformamide except in silicone rubber mastic containing 2 per cent or less of dimethylformamide.

 

DINICONAZOLE.

 

DI-N-PROPYL ISOCINCHOMERONATE except in preparations containing 25 per cent or less of di-N-propyl isocinchomeronate.

 

DIPHENAMID.

 

DITHIOPYR.

 

N-(N-DODECYL)-2-PYRROLIDONE in preparations containing 50 per cent or less of N-(N-dodecyl)-2-pyrrolidone or preparations containing 50 per cent or less of a mixture of any two or more of N-(N-dodecyl)-2-pyrrolidone, N-methyl-2-pyrrolidone or N-(N-octyl)-2-pyrrolidone except in preparations containing 25 per cent or less of designated solvents.

 

DORAMECTIN for internal use for the treatment of animals, in preparations containing 2 per cent or less of doramectin.

 

EMAMECTIN in preparations containing 2 per cent or less of emamectin.

 

EMODEPSIDE in preparations:

 

(a) containing 2.5 per cent or less of emodepside for the external treatment of animals; or

 

(b) containing 30 mg or less of emodepside per dosage unit for the oral treatment of animals.

 

EPOXICONAZOLE.

 

EPOXY RESINS, LIQUID.

 

EPRINOMECTIN in preparations containing 0.5 per cent or less of eprinomectin.

 

ESBIOTHRIN in preparations containing 10 per cent or less of esbiothrin except in pressurised spray packs containing 1 per cent or less of esbiothrin.

 

ESFENVALERATE in preparations containing 0.1 per cent or less of esfenvalerate.

 

1,2-ETHANEDIAMINE POLYMERWITH (CHLOROMETHYL)OXIRANE AND N-METHYLMETHANAMINE.

 

ETHANOLAMINE (excluding its salts and derivatives) in preparations containing 20 per cent or less of ethanolamine except:

 

 (a) when included in Schedule 4; or

 

 (b) in preparations containing 5 per cent or less of ethanolamine.

 

ETHER in preparations containing more than 10 per cent of ether for use in internal combustion engines.

 

ETHOFUMESATE.

 

ETHOXYQUIN except in preparations containing 10 per cent or less of ethoxyquin.

 

ETHOXYSULFURON.

 

 ETHYLENE GLYCOL (excluding its salts and derivatives) in preparations containing not less than 10 mg/kg of denatonium benzoate as a bittering agent except:

 

 (a) in paints or paint tinters;

 

 (b) in toothpastes or mouthwashes containing more than 0.25 per cent of ethylene glycol; or

 

 (c) in other preparations containing 2.5 per cent or less of ethylene glycol.

 

ETHYL METHACRYLATE (excluding its derivatives) for cosmetic use except in preparations containing 1 per cent or less of ethyl methacrylate as residual monomer in a polymer.

 

ETRIDIAZOLE.

 

EUGENOL for topical use in the mouth in a pack containing 5 mL or less of eugenol except in preparations containing 25 per cent or less of eugenol.

 

EXTRACT OF LEMON EUCALYPTUS, being acid modified oil of lemon eucalyptus (Corymbia citriodora) , except in preparations containing 40 per cent or less of extract of lemon eucalyptus.

 

FENARIMOL.

 

FENBENDAZOLE for the treatment of animals.

 

FENBUCONAZOLE.

 

FENCHLORAZOLE-ETHYL.

 

FENOPROP.

 

FENOXAPROP-ETHYL.

 

FENOXAPROP-P-ETHYL.

 

FENSON.

 

FENTHION:

 

 (a) in preparations containing 25 per cent or less of fenthion when packed in single-use containers having a capacity of 2 mL or less; or

 

 (b) in preparations containing 10 per cent or less of fenthion.

 

FIPRONIL in preparations containing 10 per cent or less of fipronil except in preparations containing 0.05 per cent or less of fipronil.

 

FLAMPROP-METHYL.

 

FLAMPROP-M-METHYL.

 

FLAZASULFURON.

 

FLORASULAM.

 

FLUAZURON.

 

FLUBENDAZOLE for the treatment of animals.

 

FLUBENDIAMIDE.

 

FLUCHLORALIN.

 

FLUDIOXONIL except in preparations containing 10 per cent or less of fludioxonil.

 

FLUMETHRIN:

 

 (a) when impregnated in plastic resin strip material containing 3 per cent or less of flumethrin; or

 

 (b) in oil based preparations containing 1 per cent or less of flumethrin.

 

flumiclorac pentyl.

 

FLUORIDES in preparations containing 3 per cent or less of fluoride ion except:

 

 (a) in preparations for human use; or

 

 (b) in preparations containing 15 mg/kg or less of fluoride ion.

 

FLURALANER for the treatment and preventation of flea infestations and control of ticks in dogs in oral divided preparations each containing 1400 mg or less of fluralaner per dosage unit.

 

FLUVALINATE in aqueous preparations containing 25 per cent or less of fluvalinate.

 

FLUXAPYROXAD.

 

FORAMSULFURON.

 

FORMIC ACID (excluding its salts and derivatives) except in preparations containing 0.5 per cent or less of formic acid.

 

FOSPIRATE when impregnated in plastic resin strip material containing 20 per cent or less of fospirate.

 

FURALAXYL.

 

FURATHIOCARB in microencapsulated suspensions containing 50 per cent or less of furathiocarb.

 

GAMMA-CYHALOTHRIN in aqueous preparations containing 15 per cent or less of microencapsulated gamma-cyhalothrin.

 

GLUFOSINATE-AMMONIUM.

 

GLUTARALDEHYDE in preparations containing 5 per cent or less of glutaraldehyde except:

 

 (a) when included in Schedule 2; or

 

 (b) in preparations containing 0.5 per cent or less of glutaraldehyde when labelled with the statements:

 

  IRRITANT; and

 

  Avoid contact with eyes.

 

GLYPHOSATE.

 

HALOSULFURON-METHYL.

 

HEXACONAZOLE except in preparations containing 5 per cent or less of hexaconazole.

 

HEXAZINONE in preparations containing 25 per cent or less of hexazinone.

 

HYDRAMETHYLNON in solid baits containing 2 per cent or less of hydramethylnon in welded plastic labyrinths.

 

HYDROCARBONS, LIQUID, including kerosene, diesel (distillate), mineral turpentine, white petroleum spirit, toluene, xylene and light mineral  and paraffin oils (but excluding their derivatives), except:

 

 (a) toluene and xylene when included in Schedule 6;

 

 (b) benzene and liquid aromatic hydrocarbons  when included in Schedule 7;

 

 (c) food grade and pharmaceutical grade white mineral oils;

 

 (d) in solid or semi-solid preparations;

 

 (e)  in preparations containing 25 per cent or less of designated solvents;

 

 (f) in preparations packed in pressurised spray packs;

 

 (g) in adhesives packed in containers each containing 50 grams or less of adhesive;

 

 (h) in writing correction fluids and thinners for writing correction fluids packed in containers having a capacity of 20 mL or less; or

 

 (i) in other preparations when packed in containers with a capacity of 2 mL or less.

 

HYDROCHLORIC ACID (excluding its salts and derivatives) in preparations containing 10 per cent or less of hydrochloric acid (HCl) except:

 

 (a) in preparations containing 0.5 per cent or less of hydrochloric acid (HCl); or

 

 (b) for therapeutic use.

 

HYDROFLUORIC ACID (excluding its salts and derivatives) and admixtures that generate hydrofluoric acid, in preparations containing 0.1 per cent or less of hydrogen fluoride.

 

 HYDROGEN PEROXIDE (excluding its salts and derivatives):

 

 (a) in hair dye preparations containing 12 per cent or less of hydrogen peroxide except in hair dyes containing 6 per cent or less of hydrogen peroxide; or

 

 (b) in other preparations containing 6 per cent (20 volume) or less of hydrogen peroxide except in preparations containing 3 per cent (10 volume) or less of hydrogen peroxide.

 

HYDROSILICOFLUORIC ACID (excluding its salts and derivatives) in preparations containing 0.1 per cent or less of hydrosilicofluoric acid (H2SiF6).

 

IMAZALIL.

 

IMAZAMOX except in preparations containing 25 per cent or less of imazamox.

 

IMAZAPIC except in preparations containing 25 per cent or less of imazapic.

 

IMAZAPYR except in preparations containing 25 per cent or less of imazapyr.

 

IMAZETHAPYR except in preparations containing 25 per cent or less of imazethapyr.

 

IMIDACLOPRID in preparations containing 20 per cent or less of imidacloprid except in preparations containing 5 per cent or less of imidacloprid.

 

IMIPROTHRIN in preparations containing 50 per cent or less of imiprothrin except in preparations containing 10 per cent or less of imiprothrin.

 

 

INDOXACARB  (includes the R and S enantiomers) in preparations containing 1 per cent or less of

 indoxacarb.

 

3-IODO-2-PROPYNYL BUTYL CARBAMATE (Iodocarb) ) in preparations containing 10 per cent or less of 3-iodo-2-propynyl butyl carbamate except:

 

(a) in aqueous preparations not for cosmetic use containing 10 per cent or less 3-iodo-2-propynyl butyl carbamate; or

 

(b) in cosmetic preparations (other than aerosolised preparations) containing 0.1 per cent or less of 3-iodo-2-propynyl butyl carbamate.

 

IODOSULFURON-METHYL-SODIUM.

 

IPCONAZOLE in preparations containing 2 per cent or less of ipconazole.

 

IRON COMPOUNDS:

 

 (a) for the treatment of animals (excluding up to 1 per cent of iron oxides when present as an excipient):

 

  (i) in preparations for injection containing 20 per cent or less of iron except in preparations containing 0.1 per cent or less of iron; or

 

  (ii) in other preparations containing 4 per cent or less of iron except:

 

   (A) in liquid or gel preparations containing 0.1 per cent or less of iron; or

  

   (B) in animal feeds or feed premixes; or

 

 (b) in garden preparations except in preparations containing 4 per cent or less of iron.

 

ISOEUGENOL in preparations containing 25 per cent or less of isoeugenol except in preparations containing 10 per cent or less of isoeugenol.

 

ISOPHORONE.

 

ISOXABEN.

 

ISOXAFLUTOLE.

 

IVERMECTIN for use in animals:

 

 (a) in preparations for the prophylaxis of heartworm in cats and dogs;

 

 (b) in intraruminal implants containing 160 mg or less of ivermectin;

 

 (c) in preparations containing 3.5 per cent or less of ivermectin when packed in child-resistant packaging or in packaging approved by the relevant registration authority; or

 

 (d) in other preparations containing 2 per cent or less of ivermectin.

 

KITASAMYCIN in animal feed premixes for growth promotion containing 2 per cent or less of antibiotic substances.

 

LAMBDA-CYHALOTHRIN:

 

 (a) in aqueous preparations containing 1 per cent or less of lambda- cyhalothrin; or

 

 (b) in aqueous preparations containing 2.5 per cent or less of microencapsulated lambda-cyhalothrin.

 

 LEAD COMPOUNDS in preparations for use as hair cosmetics.

 

LEMON OIL except:

 

 (a) when steam distilled or rectified;

 

 (b) in preparations for internal use;

 

 (c) in preparations containing 0.05 per cent or less of lemon oil;

 

 (d) in soaps or bath or shower gels that are washed off the skin;

 

 (e) in medicines for human therapeutic use, when compliant with the requirements of the Required Advisory Statements for Medicine Labels; or

 

 (f) in other preparations when packed in containers labelled with the statement:

 

  Application to the skin may increase sensitivity to sunlight.

 

LEVAMISOLE in preparations containing 15 per cent or less of levamisole for the treatment of animals except:

 

 (a) when included in Schedule 4; or

 

 (b) in preparations for the treatment of ornamental birds or ornamental fish, in packs containing 10 mg or less of levamisole.

 

LIGNOCAINE   in aqueous gel preparations containing 4.5 per cent or less of lignocaine, for the dermal spray-on treatment of wounds associated with 'mulesing' of sheep.

 

LIME OIL except:

 

 (a) when steam distilled or rectified;

 

 (b) in preparations for internal use;

 

 (c) in preparations containing 0.5 per cent or less of lime oil;

 

 (d) in soaps or bath or shower gels that are washed off the skin;

 

 (e) in medicines for human therapeutic use, when compliant with the requirements of the Required Advisory Statements for Medicine Labels; or

 

 (f) in other preparations when packed in containers labelled with the statement:

 

  Application to the skin may increase sensitivity to sunlight.

 

LINDANE in preparations containing 10 per cent or less of lindane except when included in Schedule 2 or 4.

 

LUFENURON except:

 

 (a)  in divided preparations each containing 500 mg or less of lufenuron for the treatment of animals; or

 

 (b)  in single use syringes each containing 500 mg or less of lufenuron for the treatment of animals.

 

MADURAMICIN in animal feed premixes containing 1 per cent or less of antibiotic substances.

 

MAGNESIUM CHLORATE except in preparations containing 10 per cent or less of magnesium chlorate.

 

MALACHITE GREEN in preparations for veterinary use containing 10 per cent or less of malachite green.

 

MALATHION in preparations containing 10 per cent or less of malathion except:

 

 (a) for human therapeutic use; or

 

 (b) in dust preparations containing 2 per cent or less of malathion.

 

MANCOZEB.

 

MANDIPROPAMID.

 

MARJORAM OIL except:

 

 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 50 mL or less fitted with a restricted flow insert and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (b) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 50 mL or less fitted with a restricted flow insert, and labelled with the warning:

 

  KEEP OUT OF REACH OF CHILDREN; or

 

 (c) in preparations containing 50 per cent or less of marjoram oil.

 

MCPA:

 

 (a) in preparations containing 25 per cent or less of MCPA (acid); or

 

 (b) in preparations containing 50 per cent or less of the salts and esters of MCPA.

 

MCPB.

 

MEBENDAZOLE for the treatment of animals:

 

 (a) in divided preparations each containing 300 mg or less of mebendazole per dosage unit; or

 

 (b) in undivided preparations containing 25 per cent or less of mebendazole.

 

MECLOFENAMIC ACID for the treatment of animals.

 

MECOPROP in preparations containing 2 per cent or less of mecoprop.

 

MEFENPYR-DIETHYL.

 

MEPIQUAT.

 

MESOTRIONE.

 

METAFLUMIZONE.

 

METALAXYL in preparations containing 35 per cent or less of metalaxyl.

 

METALDEHYDE in preparations containing 2 per cent or less of metaldehyde.

 

METHABENZTHIAZURON.

 

METHANOL (excluding its derivatives) in preparations containing 10 per cent or less of methanol except in preparations containing 2 per cent or less of methanol.

 

METHIOCARB in pelleted preparations containing 2 per cent or less of methiocarb.

 

METHOXYCHLOR.

 

METHYLATED SPIRIT(S) (being ethanol denatured with denatonium benzoate, methyl isobutyl ketone and fluorescein) except:

 

 (a) when included in preparations or admixtures; or

 

 (b) when packed in containers having a capacity of more than 5 litres.

 

METHYLENE BLUE in preparations for veterinary use containing 50 per cent or less of methylene blue.

 

METHYL ETHYL KETONE except in preparations containing 25 per cent or less of designated solvents.

 

METHYL ETHYL KETONE PEROXIDE.

 

METHYL ISOAMYL KETONE except in preparations containing 25 per cent or less of designated solvents.

 

METHYL ISOBUTYL KETONE except in preparations containing 25 per cent or less of designated solvents.

 

N-METHYL-2-PYRROLIDONE:

 

 (a) when packed in single use containers having a capacity of 2 mL or less; or

 

 (b) in preparations containing 50 per cent or less of N-methyl-2-pyrrolidone or preparations containing 50 per cent or less of a mixture of any two or more of N-methyl-2-pyrrolidone, N-(N-octyl)-2-pyrrolidone or N-(N-dodecyl)-2-pyrrolidone except in preparations containing 25 per cent or less of designated solvents.

 

METHYL SALICYLATE in preparations containing 25 per cent or less of methyl salicylate except:

 

 (a) in preparations for therapeutic use; or

 

 (b) in preparations containing 5 per cent or less of methyl salicylate.

 

2-METHYLTHIO-4-(2-METHYLPROP-2-YL) AMINO-6-CYCLOPROPYLAMINO-5- TRIAZINE.

 

METIRAM.

 

METHOFLUTHRIN in impregnated fabric mosquito repellent preparations for use in a vaporiser containing 15 mg or less of metofluthrin per disk.

 

METOLACHLOR.

 

METRAFENONE in preparations containing 50 per cent or less of metrafenone.

 

MILBEMECTIN in preparations containing 1 per cent or less of milbemectin.

 

MILBEMYCIN OXIME for the prophylaxis of heartworm in dogs and cats.

 

MONENSIN in intraruminal implants for cattle, each containing 35 g or less of monensin.

 

MONEPANTEL.

 

MORANTEL in preparations containing 25 per cent or less of morantel except in preparations containing 10 per cent or less of morantel.

 

MOXIDECTIN:

 

 (a) in preparations for external use for the treatment of animals other than cats and dogs, containing 0.5 per cent or less of moxidectin;

 

 (b) in preparations for external use for the treatment of cats and dogs, containing 2.5 per cent or less of moxidectin packed in single dose tubes with a volume of 1 mL or less; or

 

 (c) for internal use for the treatment of animals:

   (i) in divided preparations for dogs, containing 250 micrograms or less of moxidectin per dosage unit in a pack containing six or less dosage units; or

   (ii) in other preparations containing 2 per cent or less of moxidectin.

 

MYCLOBUTANIL.

 

NAA except in preparations containing 25 per cent or less of NAA.

 

NALED when impregnated in plastic resin strip material containing 20 per cent or less of naled.

 

NAPTALAM.

 

NETOBIMIN for the treatment of animals, in preparations containing 12.5 per cent or less of netobimin.

 

NITRIC ACID (excluding its salts and derivatives) in preparations containing 10 per cent or less of nitric acid (HNO3) except in preparations containing 0.5 per cent or less of nitric acid.

 

NITROSCANATE for the treatment of animals.

 

NONOXINOL 9 in preparations containing 25 per cent or less of nonoxinol 9 except:

 

 (a) when labelled with the statements:

  IRRITANT; and

  Avoid contact with eyes;

 

 (b) in preparations containing 12.5 per cent or less of nonoxinol 9; or

 

 (c) in preparations for human use.

 

NORBORMIDE.

 

NUTMEG OIL except:

 

 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (b) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert, and labelled with the warning:

 

  KEEP OUT OF REACH OF CHILDREN; or

 

 (c) in preparations containing 50 per cent or less of nutmeg oil.

 

N-OCTYL BICYCLOHEPTENE DICARBOXIMIDE except in preparations containing 10 per cent or less of

 N-octyl bicycloheptene dicarboximide.

 

N-(N-OCTYL)-2-PYRROLIDONE in preparations containing 50 per cent or less of:

 

(a)       N-(N-octyl)-2-pyrrolidone or preparations containing 50 per cent or less of a mixture of any two or more of N-(N-octyl)-2-pyrrolidone, N-methyl-2-pyrrolidone or

 

(b)       N-(N-dodecyl)-2-pyrrolidone except in preparations containing 25 per cent or less of designated solvents.

 

OESTRADIOL in implant preparations for growth promotion in animals.

 

OLEANDOMYCIN in animal feed premixes for growth promotion.

 

OMETHOATE in pressurised spray packs containing 0.2 per cent or less of omethoate.

 

ORANGE OIL (BITTER) except:

 

  (a) when steam distilled or rectified;

 

 (b) in preparations for internal use;

 

 (c) in preparations containing 1.4 per cent or less of orange oil (bitter);

 

 (d) in soaps or bath or shower gels that are washed off the skin;

 

 (e) in medicines for human therapeutic use, when compliant with the requirements of the Required Advisory Statements for Medicine Labels; or

 

 (f) in other preparations when packed in containers labelled with the statement:

 

  Application to the skin may increase sensitivity to sunlight.

 

OXADIARGYL.

 

OXADIXYL.

 

OXANTEL EMBONATE for the treatment of animals.

 

OXFENDAZOLE for the treatment of animals.

 

OXIBENDAZOLE for the treatment of animals.

 

OXYCARBOXIN.

 

OXYTETRACYCLINE in preparations:

 

 (a) for topical application to animals for ocular use only; or

 

 (b) containing 40 per cent or less of oxytetracycline per dose, when packed and labelled for the treatment of ornamental caged birds or ornamental fish only.

 

OXYTHIOQUINOX.

 

PACLOBUTRAZOL.

 

PENCONAZOLE.

 

PENDIMETHALIN.

 

PENFLUFEN.

 

PENTHIOPYRAD except in preparations containing 20 per cent or less of penthiopyrad.

 

PERACETIC ACID in concentrations of 10 per cent or less of peracetic acid.

 

PERMETHRIN (excluding preparations for human therapeutic use):

 

 (a) in preparations containing 25 per cent or less of permethrin; or

 

 (b) in preparations for external use, for the treatment of dogs, containing 50 per cent or less of permethrin when packed in single use containers having a capacity of 4 mL or less,

 

 except in preparations containing 2 per cent or less of permethrin.

 

PETROL except preparations containing 25 per cent or less of petrol.

 

PHENAZONE for the external treatment of animals.

 

PHENISOPHAM.

 

PHENOL, including cresols and xylenols and any other homologue of phenol boiling below 220°C, when in animal feed additives containing 15 per cent or less of such substances, except in preparations containing 3 per cent or less of such substances.

 

PHENYL METHYL KETONE except in preparations containing 25 per cent or less of designated solvents.

 

ortho-PHENYLPHENOL except in preparations containing 5 per cent or less of o-phenylphenol.

 

PHOSPHONIC ACID (excluding its salts and derivatives) except in preparations containing 10 per cent or less of phosphonic acid (H3PO3).

 

PHOSPHORIC ACID (excluding its salts and derivatives) in preparations containing 35 per cent or less of phosphoric acid (H3PO4) except:

 

 (a) in preparations containing 15 per cent or less of phosphoric acid (H3PO4);

 

 (b) in solid or semi-solid preparations; or

 

 (c) in professional dental kits.

 

ortho-PHTHALALDEHYDE in preparations containing 1 per cent or less of ortho-phthalaldehyde.

 

PICARIDIN except in preparations containing 20 per cent or less of picaridin.

 

PINE OILS in preparations containing 25 per cent or less of pine oils when packed and labelled as a herbicide.

 

PINOXADEN in preparations containing 10 per cent or less of pinoxaden.

 

PIPERAZINE for animal use.

 

PIRIMICARB in preparations containing 0.5 per cent or less of pirimicarb.

 

POLIHEXANIDE except in preparations containing 5 percent or less of polihexanide.

 

POLIXETONIUM SALTS in preparations containing 60 per cent or less of polixetonium salts except in preparations containing 1 per cent or less of polixetonium salts.

 

POLYETHANOXY (15) TALLOW AMINE.

 

POLY(OXY-1,2-ETHANEDIYL), α -[2-[(2-HYDROXYETHYL)AMINO]-2-OXOETHYL]- α -HYDROXY-,MONO-C13-15-ALKYL ETHERS.

 

POTASSIUM CHLORATE except:

 (a) when included in Schedule 2; or

 (b) in preparations containing 10 per cent or less of potassium chlorate.

 

 POTASSIUM HYDROXIDE (excluding its salts and derivatives) in preparations containing 5 per cent or less of potassium hydroxide being:

 

 (a) solid preparations, the pH of which in a 10 g/L aqueous solution is more than 11.5; or

 

 (b) liquid or semi-solid preparations, the pH of which is more than 11.5 except in food additive preparations for domestic use.

 

POTASSIUM METABISULPHITE when packed for domestic use except in preparations containing 10 per cent or less of potassium metabisulphite.

 

POTASSIUM NITRITE in preparations containing 1 per cent or less of potassium nitrite except:

 

 (a) in preparations containing 0.5 per cent or less of potassium nitrite;

 

 (b) when present as an excipient in preparations for therapeutic use; or

 

 (c) in aerosols.

 

POTASSIUM PEROXOMONOSULFATE TRIPLE SALT in preparations containing 5 per cent or less of potassium peroxomonosulfate triple salt being:

 

 (a) solid preparations, the pH of which in a 10 g/L aqueous solution is less than 2.5; or

 

 (b) liquid or semi-solid preparations, the pH of which is less than 2.5.

 

POTASSIUM SULFIDE in preparations for metal treatment in containers each containing 50 g or less of potassium sulfide.

 

PRALLETHRIN (cis:trans=20:80) in preparations containing 10 per cent or less of prallethrin except in insecticidal mats containing 1 per cent or less of prallethrin.

 

PROFOXYDIM except in preparations containing 20 per cent or less of profoxydim.

 

PROGESTERONE:

 

 (a) in implant preparations or controlled release pessaries for synchronisation of oestrus in cattle, sheep or goats; or

 

 (b) in implant preparations for growth promotion in cattle.

 

PROHEXADIONE CALCIUM.

 

PROMETRYN.

 

PROPAMOCARB.

 

PROPANIL.

 

PROPAQUIZAFOP.

 

PROPICONAZOLE in preparations containing 20 per cent or less of propiconazole.

 

PROPIONIC ACID (excluding its salts and derivatives) in preparations containing 80 per cent or less of propionic acid, except:

 

 (a) in preparations containing 30 per cent or less of propionic acid; or

 

 (b) for therapeutic use.

 

PROPOXUR:

 

 (a) when impregnated in plastic resin strip material containing 10 per cent or less of propoxur;

 

 (b) in dust preparations containing 3 per cent or less of propoxur;

 

 (c) in granular sugar-based fly baits containing 1 per cent or less of propoxur, a dark colouring agent and a separate bittering agent;

 

 (d) in pressurised spray packs containing 2 per cent or less of propoxur; or

 

 (e) in printed paper sheets for pest control containing 0.5 per cent or less of propoxur and in any case not more than 100 mg of propoxur per sheet.

 

PROPYZAMIDE.

 

PROTHIOCONAZOLE-DESCHLORO except in preparations containing 0.5 per cent or less of prothioconazole-deschloro.

 

PROTHIOCONAZOLE-TRIAZOLIDINETHIONE except in preparations containing 0.5 per cent or less of prothioconazole-triazolidinethione.

 

PYMETROZINE.

 

PYRACLOSTROBIN.

 

PYRAFLUFEN-ETHYL.

 

PYRASULFOTOLE.

 

PYRETHRINS, naturally occurring, being pyrethrolone, cinerolone or jasmolone esters of chrysanthemic or pyrethric acids except:

 

 (a) in preparations for human therapeutic use; or

 

 (b) in preparations containing 10 per cent or less of such substances.

 

PYRIDABEN in preparations containing 25 per cent or less of pyridaben.

 

PYRIFENOX.

 

PYRITHIOBAC SODIUM.

 

PYRITHIONE ZINC in paints containing 0.5 per cent or less of pyrithione zinc calculated on the non-volatile content of the paint except in paints containing 0.1 per cent or less of pyrithione zinc calculated on the non-volatile content of the paint.

 

QUATERNARY AMMONIUM COMPOUNDS in preparations containing 20 per cent or less of quaternary ammonium compounds except:

 

 (a) when separately specified in these Schedules;

 

 (b) dialkyl or dialkoyl quaternary ammonium compounds where the alkyl or alkoyl groups are derived from tallow or hydrogenated tallow or similar chain length (C16/C18) sources; or

 

 (c) in preparations containing 5 per cent or less of such quaternary ammonium compounds.

 

QUINCLORAC.

 

QUININE in preparations for veterinary use containing 1 per cent or less of quinine.

 

QUINTOZENE.

 

QUIZALOFOP-P-ETHYL in aqueous preparations containing 40 per cent or less of

 quizalofop-p-ethyl.

 

RACTOPAMINE in animal feed premixes containing 10 per cent or less of ractopamine.

 

RESMETHRIN in preparations containing 10 per cent or less of resmethrin.

 

RIMSULFURON.

 

ROBENIDINE except in preparations containing 20 per cent or less of robenidine.

 

SAFLUFENACIL in water dispersible granule preparations.

 

SALICYLANILIDE.

 

SEDAXANE.

 

SELAMECTIN except in preparations containing 12 per cent or less of selamectin.

 

SETHOXYDIM.

 

SIDURON.

 

SILICOFLUORIDES in preparations containing 3 per cent or less of fluoride ion except:

 

 (a) barium silicofluoride when separately specified in this Schedule; or

 

 (b) in preparations containing 15 mg/kg or less of fluoride ion.

 

SINBIOALLETHRIN in preparations containing 10 per cent or less of sinbioallethrin except in preparations containing 1 per cent or less of sinbioallethrin.

 

SODIUM CHLORATE except in preparations containing 10 per cent or less of sodium chlorate.

 

SODIUM DIACETATE except in preparations containing 60 per cent or less of sodium diacetate.

 

SODIUM DODECYLBENZENE SULFONATE except in preparations containing 30 per cent or less of sodium dodecylbenzene sulfonate.

 

SODIUM HYDROGEN SULFATE except in preparations containing 10 per cent or less of sodium hydrogen sulfate.

 

SODIUM HYDROSULFITE when packed for domestic use except in preparations containing 10 per cent or less of sodium hydrosulfite.

 

 SODIUM HYDROXIDE (excluding its salts and derivatives) in preparations containing 5 per cent or less of sodium hydroxide being:

 

 (a) solid preparations, the pH of which in a 10 g/L aqueous solution is more than 11.5; or

 

 (b) liquid or semi-solid preparations, the pH of which is more than 11.5 except in food additive preparations for domestic use.

 

SODIUM LAURETH-6 CARBOXYLATE except in preparations containing 1 per cent or less of sodium laureth-6 carboxylate.

 

SODIUM METABISULPHITE when packed for domestic use except in preparations containing 10 per cent or less of sodium metabisulphite.

 

SODIUM NITRITE in preparations containing 1 per cent or less of sodium nitrite except:

 

 (a) in preparations containing 0.5 per cent or less of sodium nitrite;

 

 (b) when present as an excipient in preparations for therapeutic use; or

 

 (c) in aerosols.

 

SODIUM PERCARBONATE (CAS No. 15630-89-4) in preparations containing 35 per cent or less of sodium percarbonate except in preparations containing 15 per cent or less of sodium percarbonate.

 

SODIUM POLYSTYRENE SULPHONATE in preparations for cosmetic use except in preparations containing 10 per cent or less of sodium polystyrene sulphonate.

 

SODIUM STANNATE except in preparations for cosmetic use containing 1 per cent or less of sodium stannate.

 

SODIUM SULFIDE in preparations for metal treatment in containers each containing 50 g or less of sodium sulfide.

 

SPINETORAM.

 

SPINOSAD except in aqueous suspensions containing 25 per cent or less of spinosad.

 

STAR ANISE OIL except:

 

 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 50 mL or less fitted with a restricted flow insert and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (b) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 50 mL or less fitted with a restricted flow insert, and labelled with the warning:

 

  KEEP OUT OF REACH OF CHILDREN; or

 

 (c) in preparations containing 50 per cent or less of star anise oil.

 

STYRENE (excluding its derivatives).

 

SULFACETAMIDE when packed and labelled for the treatment of ornamental caged birds or ornamental fish only.

 

SULFADIAZINE when packed and labelled for treatment of ornamental caged birds or ornamental fish only.

 

SULFADIMIDINE when packed and labelled for treatment of ornamental caged birds or ornamental fish only.

 

SULFAMERAZINE when packed and labelled for treatment of ornamental caged birds or ornamental fish only.

 

SULFAMIC ACID (excluding its salts and derivatives) in preparations containing 10 per cent or less of sulfamic acid (H3NO3S).

 

SULFATHIAZOLE when packed and labelled for treatment of ornamental caged birds or ornamental fish only.

 

SULFOMETURON-METHYL.

 

SULFOXAFLOR in preparations containing 25 per cent or less of sulfoxaflor.

 

 SYMPHYTUM spp. (Comfrey) for dermal use.

 

2,3,6-TBA.

 

TDE (1,1-dichloro-2,2-bis[4-chlorophenyl]ethane) in preparations containing 10 per cent or less of TDE.

 

TEBUCONAZOLE.

 

TEBUFENOZIDE.

 

TEFLUTHRIN in preparations containing 2 per cent or less of tefluthrin.

 

TEMEPHOS:

 

 (a) in liquid preparations containing 10 per cent or less of temephos;

 

 (b) in powders containing 2 per cent or less of temephos; or

 

 (c) in preparations containing 40 per cent or less of temephos when packed in single use containers having a capacity of 2 mL or less.

 

TEPRALOXYDIM.

 

TERBUTRYN.

 

1,3,5,7-TETRAAZATRICYLO[3.3.1.13,7] DECANE in cosmetic preparations, except in preparations containing 0.15 per cent or less of 1, 3, 5, 7-tetraazatricyclo [3.3.1.13,7] decane.

 

TETRACHLOROETHYLENE in preparations containing 5 per cent or less of tetrachloroethylene except:

 

 (a) when included in Schedule 2;

 

 (b) in preparations for the treatment of animals; or

 

 (c) when absorbed into an inert solid.

 

TETRACHLORVINPHOS except in animal feeds containing 0.2 per cent or less of tetrachlorvinphos.

 

TETRACONAZOLE in preparations containing 20 per cent or less of tetraconazole.

 

TETRACYCLINE in preparations:

 

 (a) for topical application to animals for ocular use only; or

 

 (b) containing 40 per cent or less of tetracycline when packed and labelled for the treatment of ornamental caged birds or ornamental fish only.

 

TETRAMETHRIN [(R, cis): (R, trans) = 20:80] except in pressurised spray packs.

 

THIABENDAZOLE:

 

 (a) for the treatment of animals; or

 

 (b) when packed and labelled for use as a fungicide except in preparations containing 50 per cent or less of thiabendazole.

 

THIAMETHOXAM in preparations containing 60 per cent or less of thiamethoxam.

 

THIAZOPYR.

 

THIFENSULFURON.

 

THIOBENCARB.

 

THIODICARB in pelleted preparations containing 1.5 per cent or less of thiodicarb.

 

THIOPHANATE-METHYL in preparations containing 25 per cent or less of thiophanate-methyl.

 

THYME OIL except:

 

 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (b) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert, and labelled with the warning:

 

  KEEP OUT OF REACH OF CHILDREN; or

 

 (c) in preparations containing 50 per cent or less of thyme oil.

 

TIOCARBAZIL.

 

TOLCLOFOS-METHYL.

 

TOLTRAZURIL.

 

TRALKOXYDIM.

 

TRENBOLONE in implant preparations for growth promotion in animals.

 

TRIADIMEFON in wettable powders containing 25 per cent or less of triadimefon.

 

TRIADIMENOL.

 

TRI-ALLATE.

 

TRIBENURON-METHYL.

 

TRICHLOROACETIC ACID, alkali salts of.

 

 1,1,1-TRICHLOROETHANE except:

 

 (a) in preparations packed in pressurised spray packs;

 

 (b) in preparations containing 25 per cent or less of designated solvents;

 

 (c) in preparations, other than writing correction fluids or thinners for writing correction fluidsin containers having a capacity of 50 mL or less; or

 

 (d) in writing correction fluids or thinners for writing correction fluids, in containers having a capacity of 50 mL or less labelled with:

 

   (i) the word “Trichloroethane” written in letters not less than 1 mm in height and in

 

    distinct contrast to the background; and

 

   (ii) the expression:

 

    WARNING DO NOT DELIBERATELY SNIFF THIS PRODUCT. SNIFFING MIGHT HARM OR KILL YOU;

 

    written in bold face sans serif capital letters not less than 1 mm in height and in distinct contrast to the background.

 

TRIDIPHANE.

 

TRIETAZINE.

 

TRIETHANOLAMINE (excluding its salts and derivatives) except:
 

 (a) when in Schedule 4;or

 

 (b)  in preparations containing 5 per cent or less of triethanolamine.

 

TRIFLOXYSTROBIN.

 

TRIFLUMIZOLE.

 

TRIFLUMURON.

 

TRIISOPROPANOLAMINE LAURYL ETHER SULFATE except in preparations containing 30 per cent or less of triisopropanolamine lauryl ether sulfate when labelled with the statements:

 

 Avoid contact with eyes and skin; and

 

 Wash hands after handling.

 

TRINEXAPAC-ETHYL except:

 

 (a) when packed in a sealed water-soluble measure pack; or

 

 (b) in solid preparations containing 25 per cent or less of trinexapac-ethyl in packs of 50 g or less.

 

3,6,9-TRIOXAUNDECANEDIOIC ACID except in preparations containing 5 per cent or less of

 3,6,9-trioxaundecanedioic acid, the pH of which is 3.5 or greater.

 

TRITICONAZOLE.

 

TURPENTINE OIL except in preparations containing 25 per cent or less of turpentine oil.

 

VIRGINIAMYCIN in animal feed additives containing 1 per cent or less of virginiamycin for the prevention of laminitis in horses when in a pack of 5 kg or less.

 

VERNOLATE.

 

WARFARIN in rodent baits containing 0.1 per cent or less of warfarin.

 

ZINEB.

 

 

ABAMECTIN:

 

(a)             in preparations for pesticidal use containing 4 per cent or less of abamectin except when included in Schedule 5; or

 

(b)           in slow-release plastic matrix ear tags for livestock use containing 1 g or less of abamectin.

 

ACEPHATE.

 

ACETAMIPRID except in preparations containing 1 per cent or less of acetamiprid.

 

ACETIC ACID (excluding its salts and derivatives) and preparations containing more than 80 per cent of acetic acid (CH3COOH) except when included in Schedule 2.

 

ACETIC ANHYDRIDE excluding its derivatives.

 

ACIFLUORFEN.

 

ACINITRAZOLE except in preparations containing 20 per cent or less of acinitrazole.

 

ALBENDAZOLE for the treatment of animals except:

 

 (a) when included in Schedule 5; or

 

 (b) in intraruminal implants each containing 3.85 g or less of albendazole.

 

ALDRIN.

 

 ALKALINE SALTS, being the carbonate, silicate or phosphate salts of sodium or potassium alone or in any combination for non-domestic use:

 

 (a) in solid automatic dishwashing preparations, the pH of which in a 500 g/L aqueous solution or mixture is more than 12.5; or

 

 (b) in liquid or semi-solid automatic dishwashing preparations, the pH of which is more than 12.5.

 

ALKOXYLATED FATTY ALKYLAMINE POLYMER except:

 

 (a) when included in Schedule 5; or

 

 (b)  in preparations containing 20 per cent or less of alkoxylated fatty alkylamine polymer.

 

ALLETHRIN except:

 

 (a) when included in Schedule 5;

 

 (b) in insecticidal mats containing 20 per cent or less of allethrin; or

 

 (c) in other preparations containing 1 per cent or less of allethrin.

 


ALPHA-CYPERMETHRIN:

 

 (a) in aqueous preparations containing 25 per cent or less of alpha-cypermethrin; or

 

 (b) in other preparations containing 10 per cent or less of alpha-cypermethrin,

 

 except when included in Schedule 5.

 

AMICARBAZONE.

 

AMIDITHION.

 

AMINOCARB in preparations containing 25 per cent or less of aminocarb.

 

AMINOETHOXYVINYLGLYCINE except in preparations containing 15 per cent or less of aminoethoxyvinylglycine.

 

1-AMINOMETHANAMIDE DIHYDROGEN TETRAOXOSULFATE.

 

AMINOPYRALID except when included in Schedule 5.

 

AMITRAZ.

 

AMMONIA (excluding its salts and derivatives other than ammonium hydroxide) except:

 

 (a) when included in Schedule 5;

 

 (b) in preparations for human internal therapeutic use;

 

 (c) in preparations for inhalation when absorbed in an inert solid material; or

 

 (d) in preparations containing 0.5 per cent or less of ammonia.

 

AMMONIUM PERSULFATE in hair preparations.

 

ANILINE (excluding its salts and derivatives) except in preparations containing 1 per cent or less of aniline.

 

ANTIMONY COMPOUNDS except:

 

 (a) when included in Schedule 4;

 

 (b) antimony chloride in polishes;

 

 (c) antimony titanate pigments in paint; or

 

 (d) in paints or tinters containing 5 per cent or less of antimony calculated on the non-volatile content of the paint or tinter.

 

ARSENIC:

 

 (a) in ant poisons containing 0.4 per cent or less of arsenic;

 

 (b) in animal feed premixes containing 4 per cent or less of arsenic; or

 

 (c) in preparations for the treatment of animals except thiacetarsamide when included in Schedule 4,

 

 except when separately specified in this Schedule.

 

ASPIRIN for the treatment of animals except when included in Schedule 4 or 5.

 

AZACONAZOLE except in preparations containing 1 per cent or less of azaconazole.

 

 AZADIRACHTA INDICA (Neem) including its extracts and derivatives except:

 

 (a) when included in Schedule 5;

 

 (b) in preparations for human internal use;

 

 (c) debitterised neem seed oil;

 

 (d) in preparations for human dermal therapeutic use containing cold pressed neem seed oil, when in a container fitted with a child-resistant closure and compliant with the requirements of the Required Advisory Statements for Medicine Labels; or

 

 (e) in preparations for dermal use containing 1 per cent or less of cold pressed neem seed oil.

 

AZAMETHIPHOS.

 

AZOBENZENE.

 

BAMBERMYCIN (flavophospholipol) in animal feed premixes for growth promotion containing 2 per cent or less of antibiotic substances.

 

BARIUM SALTS except:

 

 (a) when included in Schedule 5;

 

 (b) barium sulfate; or

 

 (c) in paints or tinters containing 5 per cent or less of barium calculated on the non-volatile content of the paint or tinter.

 

 BASIC ORANGE 31 (2-[(4-aminophenyl)azo]-1,3-dimethyl-1H-imidazolium chloride) except:

 

 (a) in preparations for skin colouration and dyeing of eyelashes or eyebrows; or

 

 (b) in hair dye preparations containing 1 per cent or less of Basic Orange 31 when the immediate container and primary pack are labelled with the following statements:

 

  KEEP OUT OF REACH OF CHILDREN;

 

  If in eyes wash out immediately with water; and

 

  WARNING This product contains ingredients which may cause skin irritation to certain individuals.  A preliminary test according to the accompanying directions should be made before use.  This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye.

 

  written in letters not less than 1.5 mm in height.

 

BAY OIL except:

 

 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (c) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:

 

  KEEP OUT OF REACH OF CHILDREN; and

 

  NOT TO BE TAKEN;

 

 (d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and labelled with the warnings:

 

  KEEP OUT OF REACH OF CHILDREN; and

 

  NOT TO BE TAKEN; or

 

 (e) in preparations containing 25 per cent or less of bay oil.

 

BEAUVERIA BASSIANA except when included in Schedule 5.

 

BENDIOCARB:

 

 (a) in wettable powders containing 80 per cent or less of bendiocarb when packed in containers or primary packs containing not less than 100 g of bendiocarb;

 

 (b) in wettable powders containing 20 per cent or less of bendiocarb and not less than 0.002 per cent of denatonium benzoate when packed in containers or primary packs containing not less than 48 g of bendiocarb and labelled for use as a fly control preparation;

 

 (c) in insoluble granular preparations containing 5 per cent or less of bendiocarb; or

 

 (d) when impregnated in plastic resin strip material containing 10 per cent or less of bendiocarb,

 

 except when included in Schedule 5.

 

BENQUINOX.

 

BENSULIDE.

 

BENZALKONIUM CHLORIDE except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 5 per cent or less of benzalkonium chloride.

 

1,2-benzenediol.

 

6-BENZYLADENINE except in preparations containing 2 per cent or less of 6-benzyladenine.

 

BERYLLIUM.

 

BETACYFLUTHRIN in preparations containing 12.5 per cent or less of betacyfluthrin except when included in Schedule 5.

 

BETA-CYPERMETHRIN.

 

BHC (excluding lindane).

 

BIFENTHRIN in preparations containing 25 per cent or less of bifenthrin except in preparations containing 0.5 per cent or less of bifenthrin.

 

BIFLUORIDES (including ammonium, potassium and sodium salts)  in preparations containing 3 per cent or less of total bifluorides except when included in Schedule 5.

 

BIOALLETHRIN except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 1 per cent or less of bioallethrin.

 

N,N-BIS(PHENYLMETHYLENE)-BICYCLO-(2.2.1)HEPTANE-2,5-DIMETHANAMINE except in preparations containing 1 per cent or less of N,N-bis(phenylmethylene)-bicyclo- (2.2.1)heptane-2,5-dimethanamine,

 or a combination of N,N-bis(phenylmethylene)-bicyclo-(2.2.1)heptane-2,5-dimethanamine and  

 N,N-bis(phenylmethylene)-bicyclo-(2.2.1)heptane-2,6-dimethanamine, when labelled with statements to the effect of:

 

 IRRITANT;

 REPEATED EXPOSURE MAY CAUSE SENSITISATION;

 

 Avoid contact with eyes;

 Avoid contact with skin;

 Wear protective gloves when mixing or using; and

 Ensure adequate ventilation when using.

 

N,N-BIS(PHENYLMETHYLENE)-BICYCLO-(2.2.1)HEPTANE-2,6-DIMETHANAMINE except in preparations containing 1 per cent or less of N,N-bis(phenylmethylene)-bicyclo-(2.2.1)heptane-2,6-dimethanamine,

 or a combination of N,N-bis(phenylmethylene)-bicyclo-(2.2.1)heptane-2,5-dimethanamine and

 N,N-bis(phenylmethylene)-bicyclo-(2.2.1)heptane-2,6-dimethanamine,  when labelled with statements to the effect of:

 

 IRRITANT;

 REPEATED EXPOSURE MAY CAUSE SENSITISATION;

 

 Avoid contact with eyes;

 Avoid contact with skin;

 Wear protective gloves when mixing or using; and

 Ensure adequate ventilation when using.

 

 BITHIONOL for treatment of animals.

 

BORON TRIFLUORIDE in preparations containing 1 per cent or less of boron trifluoride (BF3) except when included in Schedule 5.

 

BRODIFACOUM in preparations containing 0.25 per cent or less of brodifacoum.

 

BROMADIOLONE in preparations containing 0.25 per cent or less of bromadiolone.

 

BROMETHALIN in rodent baits containing 0.01 per cent or less of bromethalin.

 

BROMOFORM except when included in Schedule 4.

 

BROMOPHOS.

 

BROMOPHOS-ETHYL.

 

BROMOXYNIL.

 

BROMUCONAZOLE except when included in Schedule 5.

 

BROTIANIDE.

 

BUNAMIDINE.

 

BUTACARB.

 

BUTOXYCARBOXIM except when included in Schedule 5.

 

2-BUTOXYETHANOL and its ACETATES  except in preparations containing 10 per cent or less of such substances.

 

2-BUTOXY-2’-THIOCYANODIETHYL ETHER.

 

BUTYRIC ACID in preparations for use as insect lures.

 

CACODYLIC ACID:

 

 (a) in animal feed premixes containing 4 per cent or less of arsenic; or

 

 (b)  in herbicide or defoliant preparations containing 10 per cent or less of cacodylic acid.

 

CADMIUM COMPOUNDS except:

 

 (a) when included in Schedule 4; or

 

 (b) in paints or tinters containing 0.1 per cent or less of cadmium calculated on the non-volatile content of the paint or tinter.

 

CADUSAFOS in aqueous preparations containing 20 per cent or less of microencapsulated cadusafos.

 

CAJUPUT OIL except:

 

 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (c) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:

 

  KEEP OUT OF REACH OF CHILDREN; and

 

  NOT TO BE TAKEN;

 

 (d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and labelled with the warnings:

 

  KEEP OUT OF REACH OF CHILDREN; and

 

  NOT TO BE TAKEN;

 

 (e) in preparations containing 25 per cent or less of cajuput oil; or

 

 (f) in oils containing 25 per cent or less of cajuput oil.

 

CALCIFEROL in rodent baits containing 0.1 per cent or less of calciferol.

 

CAMBENDAZOLE.

 

CAMPHOR except:

 

 (a) when included in Schedule 4 or 5;

 

 (b) when enclosed in an inhaler device which prevents ingestion of its contents;

 

 (c) in solid or semi-solid preparations containing 12.5 per cent or less of camphor;

 

 (d) in liquid preparations containing 2.5 per cent or less of camphor;

 

 (e) in essential oils when the camphor is present as a natural component of the oil:

 

   (i) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

   (ii) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

   (iii) in essential oils other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:

 

     KEEP OUT OF REACH OF CHILDREN; and

 

     NOT TO BE TAKEN; or

 

   (iv) in essential oils other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and labelled with the warnings:

 

    KEEP OUT OF REACH OF CHILDREN; and

 

    NOT TO BE TAKEN; or

 

 (f) in rosemary oil, sage oil (Spanish), or lavandin oil as such.

 

CAPTAN.

 

CARBARYL except when included in Schedule 4 or 5.

 

CARBON DISULFIDE.

 

 CARBAMIDE PEROXIDE except:

 

 (a) when included in Schedule 5; or

 

 (b) in other preparations containing 9 per cent or less of carbamide peroxide.

 

CASTOR OIL, MONOMALEATE (excluding its salts and derivatives) in preparations for cosmetic use except in wash-off preparations containing 1 per cent or less of castor oil, monomaleate.

 

CHLORALOSE (alpha-CHLORALOSE) when packed and labelled for use as a pesticide.

 

CHLORDANE.

 

CHLORFENAPYR in preparations containing 36 per cent or less of chlorfenapyr except when included in Schedule   5.

 

CHLORFENETHOL.

 

CHLORHEXIDINE in preparations containing 7 per cent or less of chlorhexidine except:

 

 (a) when included in Schedule 5;

 

 (b) in preparations containing 1 per cent or less of chlorhexidine; or

 

 (c) when in solid preparations.

 

CHLORINATING COMPOUNDS except:

 

 (a) when included in Schedule 5;

 

 (b) when separately specified in these Schedules;

 

 (c) sodium hypochlorite preparations with a pH of less than 11.5;

 

 (d) in liquid preparations containing not less than 2 per cent but not more than 4 per cent of available chlorine when labelled with the statements:

 

  WARNING – Ensure adequate ventilation when using.  Vapour may be harmful.  May give off dangerous gas if mixed with other products;

 

 (e) in liquid preparations containing less than 2 per cent of available chlorine; or

 

 (f) in other preparations containing 4 per cent or less of available chlorine.

 

CHLORMEQUAT.

 

CHLOROFORM except:

 

 (a) when included in Schedule 2 or 4;  or

 

 (b) in preparations containing 10 per cent or less of chloroform.

 

ALPHA-CHLOROHYDRIN.

 

CHLOROPHACINONE.

 

(E)-(S)-1-(4-CHLOROPHENYL)-4,4-DIMETHYL-2-(1H-1,2,4-TRIAZOL-1-YL)PENT-1-EN-3-OL

 (uniconazole-p) except in preparations containing 5 per cent or less of

 (E)-(S)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol.

 

CHLOROPICRIN in preparations containing 5 per cent or less of chloropicrin.

 

CHLOROTHALONIL except in water-based paint containing 0.5 per cent or less of chlorothalonil.

 

2-CHLORO-6-(TRICHLOROMETHYL)-PYRIDINE.

 

CHLORPYRIFOS except:

 

 (a) when included in Schedule 5; or

 

 (b) in prepared potting or soil mixes containing 100 g or less of chlorpyrifos per cubic metre.

 

CHLORPYRIFOS-METHYL.

 

CHLORTHIAMID.

 

CHROMATES (including dichromates) except in paints or tinters containing 5 per cent or less of chromium as the ammonium, barium, calcium, iron, potassium, sodium, strontium or zinc chromate calculated on the non-volatile content of the paint or tinter.

 

CHROMIUM TRIOXIDE (excluding its salts and derivatives).

 

CINEOLE except:

 

 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (c) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:

 

  KEEP OUT OF REACH OF CHILDREN; and

 

  NOT TO BE TAKEN;

 

 (d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and labelled with the warnings:

 

  KEEP OUT OF REACH OF CHILDREN; and

 

  NOT TO BE TAKEN;

 

 (e) in preparations containing 25 per cent or less of cineole;

 

 (f) in oils containing 25 per cent or less of cineole; or

 

 (g) in rosemary oil or camphor oil (white).

 

CINNAMON LEAF OIL except:

 

 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (c) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:

 

  KEEP OUT OF REACH OF CHILDREN; and

 

  NOT TO BE TAKEN;

 

 (d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and labelled with the warnings:

 

  KEEP OUT OF REACH OF CHILDREN; and

 

  NOT TO BE TAKEN; or

 

 (e) in preparations containing 25 per cent or less of cinnamon leaf oil.

 

CLIMBAZOLE except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 2 per cent or less of climbazole.

 

CLODINAFOP-PROPARGYL.

 

CLOMAZONE.

 

CLOSANTEL.

 

CLOTHIANIDIN except when included in Schedule 5.

 

CLOTRIMAZOLE for external treatment of animals.

 

CLOVE OIL except:

 

 (a) when included in Schedule 5;

 

 (b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (c) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:

 

  KEEP OUT OF REACH OF CHILDREN; and

 

  NOT TO BE TAKEN;

 

 (e) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and labelled with the warnings:

 

  KEEP OUT OF REACH OF CHILDREN; and

 

  NOT TO BE TAKEN; or

 

 (f) in preparations containing 25 per cent or less of clove oil.

 

N-COCO-1,3-DIAMINOPROPANE.

 

COCOYL GLYCINATE in cosmetic preparations except:

 

 (a) in leave-on preparations containing 5 per cent or less of cocoyl glycinate; or

 

 (b) in wash-off preparations containing 30 per cent or less of cocoyl glycinate and, when containing more than 5 per cent of cocoyl glycinate labelled with a warning to the following effect:

  

  IF IN EYES WASH OUT IMMEDIATELY WITH WATER.

 

COPPER ACETATE except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 5 per cent or less of copper acetate.

 

COPPER COMPOUNDS except:

 

 (a) when separately specified in these Schedules;

 

 (b) in preparations for human internal use containing 5 mg or less of copper per recommended daily dose;

 

 (c) pigments where the solubility of the copper compound(s) in water is 1 gram per litre or less;

 

 (d) in feed additives containing 1 per cent or less of copper; or

 

 (e) in other preparations containing 5 per cent or less of copper compounds.

 

COPPER HYDROXIDE except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 12.5 per cent or less of copper hydroxide.

 

COPPER NITRATE in preparations containing copper chloride for the treatment of footrot in sheep.

 

COPPER OXIDES except:

 

 (a) when included in Schedule 5;

 

 (b) in preparations for internal use;

 

 (c) in marine paints; or

 

 (d) in other preparations containing 5 per cent or less of copper oxides.

 

 

 

COPPER OXYCHLORIDE except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 12.5 per cent of less of copper oxychloride.

 

COPPER SULFATE except:

 

 (a) when included in Schedule 5;

 

 (b) in preparations for internal use; or

 

 (c) in other preparations containing 5 per cent or less of copper sulfate.

 

COUMAPHOS:

 

 (a) in slow-release plastic matrix ear tags for livestock use containing 6 g or less of coumaphos; or

 

 (b) in other preparations containing 5 per cent or less of coumaphos.

 

COUMATETRALYL in rodenticides containing 1 per cent or less of coumatetralyl except when included in Schedule 5.

 

CREOSOTE derived from wood other than beechwood  except:

 

 (a) when included in Schedule 2;

 

 (b) in preparations for human therapeutic use containing 10 per cent or less of creosote derived from wood other than beechwood; or

 

 (c) in other preparations containing 3 per cent or less of phenols and homologues of phenol boiling below 220°C.

 

CROTOXYPHOS.

 

CRUFOMATE.

 

CYANAMIDE.

 

CYANAZINE.

 

CYCLANILIDE.

 

N-cyclohexyldiazeniumdioxy-potassium.

 

CYFLUTHRIN except:

 

 (a) when included in Schedule 5; or

 

 (b) in pressurised spray packs containing 1 per cent or less of cyfluthrin.

 

CYOMETRINIL.

 

CYPERMETHRIN except when included in Schedule 5.

 

CYPHENOTHRIN except when included in Schedule 5.

 

CYSTEAMINE for cosmetic use except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 1 per cent or less of cysteamine.

 

CYTHIOATE except when included in Schedule 5.

 

2,4-D except when included in Schedule 5.

 

DAZOMET.

 

DELTAMETHRIN:

 

(a)       in aqueous preparations containing 25 per cent or less of deltamethrin, when no organic solvent, other than 10 per cent or less of a glycol, is present;

 

(b)       in wettable granular preparations containing 25 per cent or less of deltamethrin;

 

(c)       in water-dispersible tablets each containing 500 mg or less of deltamethrin;

 

(d)       in emulsifiable concentrates containing 11 per cent or less of deltamethrin in a solvent containing 40 per cent or less of acetophenone and 45 per cent or less of liquid hydrocarbons; or

 

(e)       in other preparations containing 3 per cent or less of deltamethrin,

 

except:

 

(a)       when included in Schedule 5;

 

(b)       in factory prepared mosquito nets containing 1 per cent or less of deltamethrin; or

 

(c)       in preparations containing 0.1 per cent or less of deltamethrin.

 

DERQUANTEL.

 

DIAZINON except when included in Schedule 5.

 

DICAMBA (including its salts and derivatives) except when included in Schedule 5.

 

DICHLOBENIL.

 

DICHLOFENTHION.

 

DICHLOFLUANID.

 

ortho-DICHLOROBENZENE.

 

DICHLOROETHYL ETHER.

 

DICHLOROISOCYANURIC ACID except:

 

 (a) when included in Schedule 5;

 

 (b) in liquid preparations containing not less than 2 per cent but not more than 4 per cent of available chlorine when labelled with the statements:

 

  WARNING – Ensure adequate ventilation when using.  Vapour may be harmful.  May give off dangerous gas if mixed with other products;

 

 (c) in liquid preparations containing less than 2 per cent of available chlorine; or

 

 (d) in other preparations containing 4 per cent or less of available chlorine.

 

4,5-DICHLORO-2-N-OCTYL-3(2H)-ISOTHIAZOLONE.

 

DICHLOROPHEN except:

 

 (a) when included in Schedules 4 or 5; or

 

 (b) in fabrics other than when:

 

   (i) for human therapeutic use; or

 

   (ii) as part of a registered pesticidal product.

 

1,2-DICHLOROPROPANE.

 

2,4-DICHLORPROP (including the R and S enantiomers).

 

DICHLORVOS in preparations containing 50 per cent or less of dichlorvos except when included in Schedule 5.

 

DICLOFOP-METHYL.

 

DICYCLANIL except in preparations containing 5 per cent or less of dicyclanil.

 

DIDECYLDIMETHYLAMMONIUM SALTS except in preparations containing 1 per cent or less of didecyldimethylammonium salts labelled with the statement:

 

 Avoid contact with eyes.

 

DIELDRIN.

 

DIETHANOLAMINE (excluding its salts and derivatives) except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 5 per cent or less of diethanolamine.

 

 DIETHYLENE GLYCOL (excluding its salts and derivatives) except:

 

 (a) when included in Schedule 5;

 

 (b) in paints or paint tinters;

 

 (c) in toothpastes or mouthwashes containing more than 0.25 per cent of diethylene glycol; or

 

 (d) in other preparations containing 2.5 per cent or less of diethylene glycol.

 

DIFENACOUM in preparations containing 0.25 per cent or less of difenacoum.

 

DIFENZOQUAT.

 

DIFETHIALONE in rodent baits containing 0.0025 per cent or less of difethialone.

 

 5,6-DIHYDROXYINDOLINE.

 

DIMETHENAMID-P.

 

DIMETHIPIN.

 

DIMETHOATE.

 

DIMETHYLACETAMIDE except when included in Schedule 5.

 

DIMETHYLFORMAMIDE except:

 

 (a) when included in Schedule 5; or

 

 (b) in silicone rubber mastic containing 2 per cent or less of dimethylformamide.

 

DIMETHYL SULFOXIDE (excluding dimethyl sulfone):

 

 (a) when not for therapeutic use; or

 

 (b) for the treatment of animals:

 

   (i) when combined with no other therapeutic substance(s);

 

   (ii) in liquid preparations containing copper salicylate and 1 per cent or less of methyl salicylate as the only other therapeutic substances; or

 

   (iii) in clay poultices containing 2 per cent or less of dimethyl sulfoxide.

 

DINITROCRESOLS and their homologues in preparations containing 5 per cent or less of such compounds except:

 

 (a) when included in Schedule 4; or

 

 (b) when separately specified in this Schedule.

 

DINITROPHENOLS and their homologues in preparations containing 5 per cent or less of such compounds except:

 

 (a) when included in Schedule 4; or

 

 (b) when separately specified in this Schedule.

 

DIOXACARB.

 

DIOXANE.

 

DIPHACINONE.

 

DIQUAT in preparations containing 20 per cent or less of diquat.

 

DISULFIRAM except when included in Schedule 4.

 

DISULFOTON in granular preparations containing 5 per cent or less of disulfoton.

 

DITHIANON.

 

DITHIAZANINE in preparations containing 2 per cent or less of dithiazanine for the treatment of animals.

 

DIUREDOSAN.

 

N-(N-DODECYL)-2-PYRROLIDONE except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 25 per cent or less of designated solvents.

 

DODINE.

 

DORAMECTIN for external use for the treatment of animals, in preparations containing 2 per cent or less of doramectin.

 

DSMA in herbicide or defoliant preparations containing 10 per cent or less of DSMA.

 

ECONAZOLE for external treatment of animals.

 

EMAMECTIN in preparations containing 5 per cent or less of emamectin except when included in Schedule 5.

 

EMODEPSIDE for the treatment of animals except when included in Schedule 5.

 

ENDOSULFAN in aqueous preparations containing 33 per cent or less of microencapsulated endosulfan.

 

ENDOTHAL in preparations containing 20 per cent or less of endothal.

 

EPTC.

 

ESBIOTHRIN except:

 

 (a) when included in Schedule 5; or

 

 (b) in pressurised spray packs containing 1 per cent or less of esbiothrin.

 

ESFENVALERATE except when included in Schedule 5.

 

ETHANOLAMINE (excluding its salts and derivatives) except:

 

 (a) when included in Schedule 4 or 5; or

 

 (b) in preparations containing 5 per cent or less of ethanolamine.

 

ETHEPHON (excluding its salts and derivatives).

 

ETHER except:

 

 (a) when included in Schedule 2, 4 or 5;  or

 

 (b) in preparations containing 10 per cent or less of ether.

 

ETHIOFENCARB.

 

ETHOATE-METHYL.

 

ETHOPROPHOS in granular formulations containing 10 per cent or less of ethoprophos and 2 per cent of linseed oil.

 

ETHYL BROMIDE.

 

Ethyl formate when packed and labelled for use as a fumigant.

 

ETHYLENE CHLOROHYDRIN.

 

ETHYLENE DICHLORIDE.

 

 ETHYLENE GLYCOL (excluding its salts and derivatives) except:

 

 (a) when included in Schedule 5;

 

 (b) in paints or paint tinters;

 

  (c) in toothpastes or mouthwashes containing more than 0.25 per cent of ethylene glycol; or

 

 (d) in other preparations containing 2.5 per cent or less of ethylene glycol.

 

ETHYLENE GLYCOL MONOALKYL ETHERS and their ACETATES, except:

 

 (a) when separately specified in these Schedules; or

 

 (b) in preparations containing 10 per cent or less of such substances.

 

ETRIMFOS.

 

EUCALYPTUS OIL except:

 

 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (c) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:

 

  KEEP OUT OF REACH OF CHILDREN; and

 

  NOT TO BE TAKEN;

 

 (d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and labelled with the warnings:

 

  KEEP OUT OF REACH OF CHILDREN; and

 

  NOT TO BE TAKEN; or

 

 (e) in preparations containing 25 per cent or less of eucalyptus oil.

 

EUGENOL except:

 

 (a) when included in Schedule 5;

 

 (b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (c) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:

 

  KEEP OUT OF REACH OF CHILDREN; and

 

  NOT TO BE TAKEN;

 

 (e) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and labelled with the warnings:

 

  KEEP OUT OF REACH OF CHILDREN; and

 

  NOT TO BE TAKEN; or

 

 (f) in preparations containing 25 per cent or less of eugenol.

 

FAMPHUR in preparations containing 20 per cent or less of famphur.

 

FEBANTEL except:

 

 (a) in divided preparations containing 1000 mg or less of febantel per dosage unit; or

 

 (b) in undivided preparations containing 10 per cent or less of febantel.

 

FENAMIPHOS in granular preparations containing 5 per cent or less of fenamiphos.

 

FENAZAFLOR.

 

FENBUTATIN OXIDE.

 

FENCHLORPHOS.

 

FENITROTHION.

 

FENOXACRIM in preparations for the treatment of carpets during manufacture.

 

FENPYROXIMATE.

 

FENTHION in preparations containing 60 per cent or less of fenthion except when included in Schedule 5.

 

FENVALERATE.

 

FIPRONIL except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 0.05 per cent or less of fipronil.

 

FLOCOUMAFEN in preparations containing 0.005 per cent or less of flocoumafen.

 

FLONICAMID.

 

FLUAZIFOP-BUTYL.

 

FLUAZIFOP-P-BUTYL.

 

FLUAZINAM.

 

FLUCOFURON in preparations for the treatment of carpets during manufacture.

 

fluensulfone.

 

FLUMETHRIN except when included in Schedule 5.

 

FLUMIOXAZIN when contained in water soluble bags individually packed in sealed sachets.

 

FLUORIDES except:

 

 (a) when included in Schedule 5;

 

 (b) in preparations for human use; or

 

 (c) in preparations containing 15 mg/kg or less of fluoride ion.

 

FLUPROPANATE.

 

FLUQUINCONAZOLE.

 

FLUSILAZOL.

 

FLUTRIAFOL except in fertilisers containing 0.5 per cent or less of flutriafol.

 

FLUVALINATE except when included in Schedule 5.

 

 FORMALDEHYDE (excluding its derivatives) in preparations containing 0.05 per cent or more of free formaldehyde except:

 

 (a) for human therapeutic use;

 

 (b) in oral hygiene preparations;

 

 (c) in nail hardener cosmetic preparations containing 5 per cent or more of free formaldehyde;

 

 (d) in nail hardener cosmetic preparations containing 0.2 per cent or less of free formaldehyde when labelled with the statement:

  PROTECT CUTICLES WITH GREASE OR OIL;

 

 (e) in all other cosmetic preparations; or

 

 (f) in other preparations containing 0.2 per cent or less of free formaldehyde when labelled with the warning statement:

  CONTAINS FORMALDEHYDE.

 

FORMOTHION.

 

FOSPIRATE except when included in Schedule 5.

 

FUMAGILLIN.

 

FURFURAL except in preparations containing 0.1 per cent or less of furfural.

 

GLUTARALDEHYDE except:

 

 (a) when included in Schedule 2 or 5; or

 

 (b) in preparations containing 0.5 per cent or less of glutaraldehyde when labelled with the statements:

 

  IRRITANT; and

 

  Avoid contact with eyes.

 

GLYCERYL THIOGLYCOLLATE in hair waving preparations except when labelled with directions for use that include the statement:

 

 Wear protective gloves when using.  Keep out of eyes.

 

GLYCOLIC ACID (including its salts and esters) in cosmetic products or when packed and labelled for use as an agricultural chemical except:

 

 (a) in cosmetic preparations for salon use only, when labelled in accordance with Safe Work Australia’s National Code of Practice for the Labelling of Workplace Substances [NOHSC:2012(1994)];

  

 (b) in preparations containing 5 per cent or less of glycolic acid; or

 

 (c) in preparations containing 20 per cent or less of glycolic acid with a pH of 3.5 or greater.

 

GUANIDINE except:

 

 (a) when included in Schedule 4; or

 

 (b) in preparations containing 1 per cent or less of guanidine.

 

GUAZATINE.

 

HALOXON.

 

HALOXYFOP.

 

HEPTACHLOR.

 

HEXACHLOROPHANE in preparations for the treatment of animals.

 

HEXAZINONE except when included in Schedule 5.

 

HEXYLOXYETHANOL   except in preparations containing 10 per cent or less of hexyloxyethanol.

 

HYDRAMETHYLNON except when included in Schedule 5.

 

HYDRAZINE.

 

HYDROCHLORIC ACID (excluding its salts and derivatives) except:

 

 (a) when included in Schedule 5;

 

 (b) in preparations for therapeutic use; or

 

 (c) in preparations containing 0.5 per cent or less of hydrochloric acid (HCl).

 

HYDROFLUORIC ACID (excluding its salts and derivatives) and admixtures that generate hydrofluoric acid, in preparations containing 1 per cent or less of hydrogen fluoride except when included in Schedule 5.

 

 HYDROGEN PEROXIDE (excluding its salts and derivatives) except:

 

 (a) when included in Schedule 5;

 

 (b) in hair dye preparations containing 6 per cent (20 volume) or less of hydrogen peroxide; or

 

  (c)  in other preparations containing 3 per cent (10 volume) or less of hydrogen peroxide.

 

HYDROQUINONE except:

 

 (a) when included in Schedule 2 or 4; or

 

 (b) in preparations containing 10 per cent or less of hydroquinone.

 

HYDROSILICOFLUORIC ACID (excluding its salts and derivatives) in preparations containing 1 per cent or less of hydrosilicofluoric acid (H2SiF6) except when included in Schedule 5.

 

IMIDACLOPRID except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 5 per cent or less of imidacloprid.

 

IMIDOCARB.

 

iminoctadine trialbesilate.

 

IMIPROTHRIN except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 10 per cent or less of imiprothrin.

 

INDAZIFLAM.

 

INDOXACARB (includes the R and S enantiomers) except when included in Schedule 5.

 

IODINE (excluding its salts, derivatives and iodophors) except:

 

 (a) when included in Schedule 2; or

 

 (b) in solid or semi-solid preparations containing 2.5 per cent or less of available iodine.

 

IODOPHORS except in preparations containing 1.5 per cent or less of available iodine.

 

3-IODO-2-PROPYNYL BUTYL CARBAMATE (Iodocarb) except:

 

(a) when included in Schedule 5;

 

(b) in aqueous preparations not for cosmetic use containing 10 per cent or less of 3-iodo-2-propynyl butyl carbamate (Iodocarb); or

 

(c) in cosmetic preparations (other than aerosolised preparations) containing 0.1 per cent or less of 3-iodo-2-propynyl butyl carbamate. 

 

IOXYNIL.

 

IPCONAZOLE except when included in Schedule 5.

 

IRON COMPOUNDS (excluding up to 1 per cent of iron oxides when present as an excipient) for the treatment of animals except:

 

 (a) when included in Schedule 5;

 

 (b) in liquid or gel preparations containing 0.1 per cent or less of iron; or

 

 (c) in animal feeds or feed premixes.

 

ISOCONAZOLE for external treatment of animals.

 

ISOCYANATES, free organic, boiling below 300° C, except in:

 

 (a)  viscous polyurethane adhesives; or

 

 (b)  viscous polyurethane sealants;

 

 containing not more than 0.7 per cent of free organic isocyanates boiling below 300°C.

 

ISOEUGENOL except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 10 per cent or less of isoeugenol.

 

LAMBDA-CYHALOTHRIN:

 

(a)       in aqueous preparations containing 25 per cent or less of microencapsulated lambda-cyhalothrin; or

 

(b)  in other preparations containing 1.6 per cent or less of lambda-cyhalothrin

 

 except when included in Schedule 5

 

LASALOCID except in animal feeds containing 100 mg/kg or less of antibiotic substances.

 

LAURETH CARBOXYLIC ACIDS (excluding its salts and derivatives) except:

 

 (a) in leave-on preparations containing 1.5 per cent or less of laureth carboxylic acids;

 

 (b) in wash-off preparations containing 30 per cent or less of laureth carboxylic acids and, if containing more than 5 per cent of laureth carboxylic acids, when labelled with a warning to the following effect:

 

  IF IN EYES WASH OUT IMMEDIATELY WITH WATER; or

 

 (c) in other preparations containing 30 per cent or less of laureth carboxylic acids and, if containing more than 5 per cent of laureth carboxylic acids, when labelled with warnings to the following effect:

 

 IF IN EYES WASH OUT IMMEDIATELY WITH WATER; and

 

 IF SKIN OR HAIR CONTACT OCCURS, REMOVE CONTAMINATED CLOTHING AND FLUSH SKIN AND HAIR WITH RUNNING WATER.

 

LAURYL ISOQUINOLINIUM BROMIDE.

 

 LEAD COMPOUNDS except:

 

 (a) when included in Schedule 4 or 5;

 

 (b) in paints, tinters, inks or ink additives;

 

 (c)  in preparations for cosmetic use containing 100 mg/kg or less of lead;

 

 (d) in pencil cores, finger colours, showcard colours, pastels, crayons, poster paints/colours or coloured chalks containing 100 mg/kg or less of lead; or

 

 (e) in ceramic glazes when labelled with the warning statement:

 

  CAUTION Harmful if swallowed. Do not use on surfaces which contact food or drink.

 

  written in letters not less than 1.5 mm in height.

 

LEPTOSPERMUM SCOPARIUM OIL (manuka oil) except:

 

 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

  (c) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:

KEEP OUT OF REACH OF CHILDREN; and


NOT TO BE TAKEN;

 

 (d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and labelled with the warnings;

KEEP OUT OF REACH OF CHILDREN; and


NOT TO BE TAKEN; or

 

 (e) in preparations containing 25 per cent or less of Leptospermum scoparium oil.

 

LEVAMISOLE for the treatment of animals except:

 

 (a) when included in Schedule 4 or 5; or

 

 (b) in preparations for the treatment of ornamental birds or ornamental fish, in packs containing 10 mg or less of levamisole.

 

LINDANE except when included in Schedule 2, 4 or 5.

 

MAFENIDE when packed and labelled for the treatment of ornamental fish only.

 

MALATHION except:

 

 (a) when included in Schedule 5;

 

 (b) for human therapeutic use; or

 

 (c) in dust preparations containing 2 per cent or less of malathion.

 

MCPA except when included in Schedule 5.

 

MEBENDAZOLE for the treatment of animals except when included in Schedule 5.

 

MECOPROP except when included in Schedule 5.

 

MECOPROP-P.

 

MEFLUIDIDE.

 

MELALEUCA OIL (tea tree oil) except:

 

 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (c) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:

  

  KEEP OUT OF REACH OF CHILDREN; and

 

  NOT TO BE TAKEN;

 

 (d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant closure and labelled with the warnings:

 

  KEEP OUT OF REACH OF CHILDREN; and

 

   NOT TO BE TAKEN; or

 

 (e) in preparations containing 25 per cent or less of melaleuca oil.

 

MELENGESTROL ACETATE when used as an animal feed additive.

 

MENAZON.

 

2-MERCAPTOETHANOL in preparations for use as insect lures.

 

MERCURIC OXIDE for the treatment of animals, in preparations for ocular use.

 

MERCUROCHROME for the treatment of animals, in preparations for topical use.

 

METACRESOLSULPHONIC ACID AND FORMALDEHYDE CONDENSATION PRODUCT for the treatment of animals.

 

METALAXYL except when included in Schedule 5.

 

METALDEHYDE except when included in Schedule 5.

 

METHACRIFOS in preparations containing 60 per cent or less of methacrifos.

 

METHAM.

 

METHANOL (excluding its derivatives) except:

 

 (a) when included in Schedule 5;  or

 

 (b) in preparations containing 2 per cent or less of methanol.

 

METHIOCARB in preparations containing 20 per cent or less of methiocarb except when included in Schedule 5.

 

METHOMYL in fly-baits containing 1 per cent or less of methomyl and not less than 0.002 per cent of denatonium benzoate as a bittering agent.

 

Methylcyclopentadienyl Manganese Tricarbonyl in preparations containing 10 per cent or less of methylcyclopentadienyl manganese tricarbonyl when fitted with a child-resistant closure.

 

 METHYLDIBROMO GLUTARONITRILE except in preparations intended to be in contact with the skin, including cosmetic use.

 

METHYLENE BISTHIOCYANATE except in preparations containing 1 per cent or less of methylene bisthiocyanate.

 

METHYLEUGENOL except in preparations containing 1 per cent or less of methyleugenol.

 

METHYL ETHYL KETONE OXIME except in preparations containing 1 per cent or less of methyl ethyl ketone oxime.

 

METHYL ISOTHIOCYANATE.

 

 METHYL METHACRYLATE (excluding its derivatives) except:

 

 (a) for cosmetic use; or

 

 (b) in preparations containing 1 per cent or less of methyl methacrylate as residual monomer in a polymer.

 

METHYL NEODECANAMIDE except in liquid preparations containing 2 per cent or less of methyl neodecanamide.

 

METHYLNORBORNYLPYRIDINE.

 

N-METHYL-2-PYRROLIDONE except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 25 per cent or less of designated solvents.

 

METHYL SALICYLATE except:

 

 (a) when included in Schedule 5;

 

 (b) in preparations for therapeutic use; or

 

 (c) in preparations containing 5 per cent or less of methyl salicylate.

 

METOFLUTHRIN except when included in Schedule 5.

 

METOSULAM.

 

METRAFENONE except when included in Schedule 5.

 

METRIBUZIN.

 

MICONAZOLE for the external treatment of animals.

 

MILBEMECTIN except when included in Schedule 5.

 

MONENSIN:

 

 (a) in animal feed premixes containing 12.5 per cent or less of antibiotic substances; or

 

 (b) in stockfeed supplements, blocks or licks containing 0.75 per cent or less of antibiotic substances.

 

MORANTEL except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 10 per cent or less of morantel.

 

MOXIDECTIN for external use:

 

 (a)  in preparations containing 2.5 per cent or less of moxidectin when packed in single dose tubes for the treatment of cats and dogs; or

 

 (b) in preparations containing 2 per cent or less of moxidectin for the treatment of animals,

 

 except when included in Schedule 5.

 

MSMA in herbicide or defoliant preparations containing 10 per cent or less of MSMA.

 

NALED except when included in Schedule 5.

 

NAPHTHALENE (excluding its derivatives) except in liquid hydrocarbons as an impurity.

  

NAPHTHALOPHOS in preparations containing 80 per cent or less of naphthalophos.

 

NARASIN in animal feed premixes containing 12 per cent or less of narasin.

 

NETOBIMIN for the treatment of animals except when included in Schedule 5.

 

NICKEL SULFATE.

 

NICOTINE in preparations containing 3 per cent or less of nicotine when labelled and packed for the treatment of animals.

 

NIMIDANE in preparations containing 25 per cent or less of nimidane.

 

NITENPYRAM except in divided preparations containing 100 mg or less of nitenpyram.

 

NITRIC ACID (excluding its salts and derivatives) except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 0.5 per cent or less of nitric acid (HNO3).

 

NITROBENZENE except:

 

 (a) in solid or semi-solid polishes;

 

 (b) in soaps containing 1 per cent or less of nitrobenzene; or

 

 (c) in other preparations containing 0.1 per cent or less of nitrobenzene.

 

NITROPHENOLS, ortho, meta and para, except when separately specified in these Schedules.

 

NITROPRUSSIDES in preparations containing 2.5 per cent or less of nitroprussides except when included in Schedule 4.

 

NITROXYNIL.

 

NONOXINOL 9 except:

 

 (a) when included in Schedule 5;

 

 (b) in preparations containing 25 per cent or less of nonoxinol 9 when labelled with the statements:

 

  IRRITANT; and

 

  Avoid contact with eyes;

 

 (c) in preparations containing 12.5 per cent or less of nonoxinol 9; or

 

 (d) in preparations for human use.

 

1-Octen-3-ol except in preparations containing 5 per cent or less of 1-octen-3-ol.

 

OCTHILINONE except in paints, jointing compounds and sealants containing 1 per cent or less of octhilinone calculated on the non-volatile content.

 

N-(N-OCTYL)-2-PYRROLIDONE except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 25 per cent or less of designated solvents.

 

OLAQUINDOX except in preparations containing 10 per cent or less of olaquindox.

 

N-OLEYL-1,3-DIAMINOPROPANE.

 

OMETHOATE in preparations containing 30 per cent or less of omethoate except when included in Schedule 5.

 

OXADIAZON.

 

OXALIC ACID except its derivatives and insoluble salts.

 

OXYCLOZANIDE.

 

PAECILOMYCES LILACINUS Strain 251.

 

 PARAFORMALDEHYDE (excluding its derivatives) in preparations containing 0.05 per cent or more of free formaldehyde except:

 

 (a) for human therapeutic use;

 

 (b) in oral hygiene preparations;

 

 (c) in nail hardener cosmetic preparations containing 5 per cent or more of free formaldehyde;

 

 (d) in nail hardener cosmetic preparations containing 0.2 per cent or less of free formaldehyde when labelled with the statement:

  PROTECT CUTICLES WITH GREASE OR OIL;

 (e) in all other cosmetic preparations; or

 

 (f) in other preparations containing 0.2 per cent or less of free formaldehyde when labelled with the warning statement:

  CONTAINS FORMALDEHYDE.

 

PARATHION-METHYL in aqueous preparations containing 45 per cent or less of microencapsulated parathion-methyl.

 

PARBENDAZOLE.

 

PEBULATE.

 

PENNYROYAL OIL except:

 

 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and a child-resistant closure and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (b) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and a child-resistant closure and labelled with the warnings:

 

  KEEP OUT OF REACH OF CHILDREN; and

 

  NOT TO BE TAKEN; or

 

 (c) in preparations containing 4 per cent or less of d-pulegone.

 

PENTACHLOROPHENOL in preparations containing 1.5 per cent or less of pentachlorophenol.

 

PERACETIC ACID except when included in Schedule 5.

 

PERFLUIDONE.

 

PERMANGANATES except potassium permanganate in aqueous solutions containing 1 per cent or less of potassium permanganate.

 

PERMETHRIN except:

 

 (a) when included in Schedule 4 or 5;

 

 (b) in preparations for human therapeutic use containing 5 per cent or less of permethrin; or

 

 (c) in preparations containing 2 per cent or less of permethrin.

 

2-PHENOXYETHANOL except:

 

(a)  in cosmetic preparations containing 1 per cent or less of 2-phenoxyethanol; or

(b)  in other preparations containing 15 per cent or less of 2-phenoxyethanol.

 

PHENOL, including cresols and xylenols and any other homologue of phenol boiling below 220°C, except: 

 

 (a) when separately specified in these Schedules;

 

 (b) when included in Schedule 5; or

 

 (c) in preparations containing 3 per cent or less of such substances.

 

PHENOTHIAZINE (excluding its derivatives) except in preparations containing 10 per cent or less of phenothiazine.

 

 PHENYLENEDIAMINES and alkylated phenylenediamines not elsewhere specified in these Schedules:

 

 (a) in preparations packed and labelled for photographic purposes;

 

 (b) in preparations packed and labelled for testing water except tablets containing 10 mg or less of diethyl-para-phenylenediamine or dimethyl-para-phenylenediamine in opaque strip packaging provided the directions for use include the statement, “Do not discard testing solutions into the pool”;

 

 (c) in hair dye preparations except when the immediate container and primary pack are  labelled with the following statements:

 

  KEEP OUT OF REACH OF CHILDREN, and

 

  WARNING This product contains ingredients which may cause skin irritation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye.

 

  written in letters not less than 1.5 mm in height; or

 

 (d) in eyelash and eyebrow tinting products when the immediate container and primary pack are labelled with the following statement:

 

  WARNING This product contains ingredients which may cause skin irritation to certain individuals, and when used for eyelash and eyebrow tinting may cause injury to the eye. A preliminary test according to the accompanying directions should be made before use.

 

  written in letters not less than 1.5 mm in height.

 

PHOSALONE.

 

PHOSMET.

 

PHOSPHORIC ACID (excluding its salts and derivatives) except:

 

 (a) when included in Schedule 5;

 

 (b) in preparations containing 15 per cent or less of phosphoric acid (H3PO4);

 

 (c) in solid or semi-solid preparations; or

 

 (d) in professional dental kits.

 

PHOXIM.

 

ortho-PHTHALALDEHYDE except when included in Schedule 5.

 

PINDONE.

 

PINE OILs when packed and labelled as a herbicide except when included in Schedule 5.

 

PINOXADEN except when included in Schedule 5.

 

PIPEROPHOS.

 

PIRIMICARB except when included in Schedule 5.

 

PIRIMIPHOS-ETHYL.

 

PIRIMIPHOS-METHYL.

 

POLIXETONIUM SALTS except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 1 per cent or less of polixetonium salts.

 

POTASSIUM AZELOYL DIGLYCINATE except in preparations for cosmetic use containing 1 per cent or less of potassium azeloyl diglycinate.

 

POTASSIUM BROMATE except in preparations containing 0.5 per cent or less of potassium bromate.

 

POTASSIUM CYANATE.

 

 POTASSIUM HYDROXIDE (excluding its salts and derivatives) except:

 

 (a) when included in Schedule 5;

 

 (b) in preparations containing 5 per cent or less of potassium hydroxide being:

 

   (i) solid preparations, the pH of which in a 10 g/L aqueous solution is 11.5 or less; or

 

   (ii) liquid or semi-solid preparations, the pH of which is 11.5 or less; or

 

 (c) in liquid or semi-solid food additive preparations, the pH of which is more than 11.5, for domestic use.

 

POTASSIUM NITRITE in preparations containing 40 per cent or less of potassium nitrite except:

 

 (a) when included in Schedule 5;

 

 (b) in preparations containing 0.5 per cent or less of potassium nitrite;

 

 (c) when present as an excipient in preparations for therapeutic use; or

 

 (d) in aerosols containing 2 per cent or less of potassium nitrite.

 

POTASSIUM PEROXOMONOSULFATE TRIPLE SALT except:

 

 (a) when included in Schedule 5;

 

 (b) in solid orthodontic device cleaning preparations, the pH of which as an “in-use” aqueous solution is 2.5 or more, but not more than 11.5; or

 

 (c) in preparations containing 5 per cent or less of potassium peroxomonosulfate triple salt being:

 

   (i) solid preparations, the pH of which in a 10 g/L aqueous solution is 2.5 or more; or

 

   (ii) liquid or semi-solid preparations, the pH of which is 2.5 or more.

 

POTASSIUM PERSULFATE in hair preparations.

 

PRALLETHRIN (cis:trans=20:80) except:

 

 (a) when included in Schedule 5; or

 

 (b) in insecticidal mats containing 1 per cent or less of prallethrin.

 

PROCHLORAZ.

 

PROFENOFOS.

 

PROMACYL.

 

PROPACHLOR.

 

PROPARGITE.

 

PROPETAMPHOS.

 

PROPICONAZOLE except when included in Schedule 5.

 

PROPINEB.

 

PROPIONIC ACID (excluding its salts and derivatives) except:

 

 (a) when included in Schedule 5;

 

 (b) in preparations containing 30 per cent or less of propionic acid; or

 

 (c) for therapeutic use.

 

PROPOXUR except when included in Schedule 5.

 

PROQUINAZID.

 

PROSULFOCARB.

 

PROSULFURON.

 

PROTHIOFOS.

 

d-PULEGONE except in preparations containing 4 per cent or less of d- pulegone.

 

PYRACLOFOS.

 

PYRAZOPHOS.

 

PYRIDABEN except when included in Schedule 5.

 

Pyridalyl.

 

PYRIDATE.

 

PYRIPROLE.

 

pyrithione copper.

 

PYRITHIONE ZINC except:

 

 (a) when included in Schedule 2 or 5;

 

 (b) for human use in preparations for the treatment of the scalp containing 2 per cent or less of pyrithione zinc when compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (c) in semi-solid hair preparations for animal use;

 

 (d) in shampoos for animal use containing 2 per cent or less of pyrithione zinc when labelled with the statements “Keep out of eyes” and “If in eyes rinse well with water”;

 

 (e) when immobilised in solid preparations containing 0.5 per cent or less of pyrithione zinc; or

 

 (f) in paints, jointing materials or sealants containing 0.1 per cent or less of pyrithione zinc calculated on the non-volatile content.

 

PYRIOFENONE.

 

PYROXASULFONE.

 

PYROXSULAM.

 

QUATERNARY AMMONIUM COMPOUNDS except:

 

 (a) when separately specified in these Schedules;

 

 (b) when included in Schedule 5;

 

 (c) dialkyl or dialkoyl quaternary ammonium compounds where the alkyl or alkoyl groups are derived from tallow or hydrogenated tallow or similar chain length (C16/C18) sources; or

 

 (d) in preparations containing 5 per cent or less of such quaternary ammonium compounds.

 

QUIZALOFOP ETHYL.

 

QUIZALOFOP-P-ETHYL except when included in Schedule 5.

 

QUIZALOFOP-P-TEFURYL.

 

RESMETHRIN except when included in Schedule 5.

 

ROTENONE except in solid or semi-solid preparations containing 2 per cent or less of rotenone.

 

 SAFROLE except:

 

 (a)  for internal use; or

 

 (b)  in other preparations containing 1 per cent or less of safrole.

 

SAGE OIL (Dalmatian) except:

 

 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and a child-resistant closure and compliant with the requirements of the Required Advisory Statements for Medicine Labels;

 

 (b) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and a child-resistant closure and labelled with the warnings:

 

  KEEP OUT OF REACH OF CHILDREN; and

 

  NOT TO BE TAKEN; or

 

 (c) in preparations containing 4 per cent or less of thujone.

 

SALINOMYCIN in animal feed premixes containing 12 per cent or less of antibiotic substances.

 

SASSAFRAS OIL except:

 

 (a) for internal use; or

 

 (b) in other preparations containing 1 per cent or less of safrole.

 

SELENIUM:

 

 (a) in preparations containing 2.5 per cent or less of selenium when packed and labelled:

 

   (i) for the blueing of gun barrels;

 

   (ii) for photographic purposes; or

 

   (iii) for the colouring of lead or lead alloys;

 

 (b) in coated granules containing 1 per cent or less of selenium for application to pasture except in fertilisers containing 200 g/tonne or less of selenium; or

 

 (c) for the treatment of animals:

 

   (i) in a drench, injection, paste, stocklick, vaccine or horse feed supplement containing 0.5 per cent or less of selenium;

 

   (ii) in animal feed premixes containing 2 per cent or less of selenium for the preparation of feeds containing 1 g/tonne or less of selenium;

 

   (iii) in controlled release bolus preparations containing 25 mg or less of selenium with a release rate not greater than 0.25 mg/day; or

 

   (iv) as barium selenate in preparations for injection containing 5 per cent or less of selenium.

 

SEMDURAMICIN in animal feed premixes for coccidiosis prevention containing 5 per cent or less of antibiotic substances.

 

SILICOFLUORIDES except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 15 mg/kg or less of fluoride ion.

 

SILVER NITRATE except:

 

 (a) when included in or expressly excluded from Schedule 2; or

 

 (b) in preparations containing 1 per cent or less of silver.

 

SINBIOALLETHRIN except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 1 per cent or less of sinbioallethrin.

 

SODIUM ALUMINATE (excluding its salts and derivatives) except:

 

 (a) in solid preparations, the pH of which in a 10 g/L aqueous solution is 11.5 or less; or

 

 (b) in liquid preparations, the pH of which is 11.5 or less.

 

SODIUM BROMATE except in preparations containing 0.5 per cent or less of sodium bromate.

 

 SODIUM HYDROXIDE (excluding its salts and derivatives) except:

 

 (a) when included in Schedule 5;

 

 (b) in preparations containing 5 per cent or less of sodium hydroxide being:

 

   (i) solid preparations, the pH of which in a 10 g/L aqueous solution is 11.5 or less; or

 

   (ii) liquid or semi-solid preparations, the pH of which is 11.5 or less; or

 

 (c) liquid or semi-solid food additive preparations, the pH of which is more than 11.5, for domestic use.

 

SODIUM LAURYL SULFATE (excluding its salts and derivatives) except:

 

 (a) in wash-off preparations containing 30 per cent or less of sodium lauryl sulfate and, if containing more than 5 per cent of sodium lauryl sulfate, when labelled with a warning to the following effect:

 

  IF IN EYES WASH OUT IMMEDIATELY WITH WATER;

 

 (b)  in leave-on preparations containing 1.5 per cent or less of sodium lauryl sulfate;

 

 (c) in toothpaste and oral hygiene preparations containing 5 per cent or less of sodium lauryl sulfate;

 

 (d) in other preparations for animal use containing 2 per cent or less of sodium lauryl sulfate; or

 

 (e) in other preparations containing 30 per cent or less of sodium lauryl sulfate and, if containing more than 5 per cent of sodium lauryl sulfate, when labelled with warnings to the following effect:

 

 IF IN EYES WASH OUT IMMEDIATELY WITH WATER; and

 

 IF SKIN OR HAIR CONTACT OCCURS, REMOVE CONTAMINATED CLOTHING AND FLUSH SKIN AND HAIR WITH RUNNING WATER.

 

SODIUM NITRITE in preparations containing 40 per cent or less of sodium nitrite except:

 

 (a) when included in Schedule 2 or 5;

 

 (b) in preparations containing 0.5 per cent or less of sodium nitrite;

 

 (c) when present as an excipient in preparations for therapeutic use; or

 

 (d) in aerosols containing 2 per cent or less of sodium nitrite.

 

SODIUM PERCARBONATE (CAS No. 15630-89-4) except:

 

 (a) when included in Schedule 5; or

 

 (b) in preparations containing 15 per cent or less of sodium percarbonate.

 

SODIUM PERSULFATE:

 

 (a) in hair preparations; or

 

 (b) in products for the treatment of water for swimming pools and spas.

 

SODIUM SULFIDE in preparations for use as insect lures.

 

SPIROTETRAMAT.

 

SPIROXAMINE.

 

SULCOFURON in preparations for the treatment of carpets during manufacture.

 

SULFAMIC ACID (excluding its salts and derivatives) except when included in Schedule 5.

 

SULFLURAMID.

 

SULFOXAFLOR except when included in Schedule 5.

 

SULFURIC ACID (excluding its salts and derivatives) except:

 

 (a) in fire extinguishers; or

 

 (b) in preparations containing 0.5 per cent or less of sulfuric acid (H2SO4).

 

SULFURYL FLUORIDE.

 

SULPROFOS.

 

2,4,5-T.

 

N-TALLOW ALKYL-1,3-PROPANEDIAMINE DIACETATE and TALLOW ALKYLAMINE ACETATES.

 

TAR ACIDS distilling within the range 230-290°C inclusive.

 

TCMTB (2-[thiocyanomethylthio]benzothiazole).

 

TDE (1,1-dichloro-2,2-bis[4-chlorophenyl]ethane)  except when included in Schedule 5.

 

TEBUFENPYRAD.

 

TEBUTHIURON.

 

TEMEPHOS except when in Schedule 5.

 

TERBUTHYLAZINE except in preparations containing 5 per cent or less of terbuthylazine.

 

TERPENES, CHLORINATED.

 

TESTOSTERONE in implant preparations for use in animals.

 

TETRACHLOROETHYLENE except:

 

 (a) when included in Schedule 2 or 5;

 

 (b) in preparations containing 6 per cent or less of tetrachloroethylene when absorbed into an inert solid; or

 

 (c) in preparations for the treatment of animals.

 

TETRACONAZOLE except when included in Schedule 5.

 

TETRADIFON.

 

2,2’,6,6’-TETRAISOPROPYL-DIPHENYL-CARBODIIMIDE in amitraz formulations containing 2 per cent or less of 2,2’,6,6’-tetraisopropyl-diphenyl-carbodiimide.

 

TETRAMISOLE in preparations for the treatment of animals.

 

THIACLOPRID.

 

THIAMETHOXAM except when included in Schedule 5.

 

THIAZAFLURON.

 

THIODICARB except when included in Schedule 5.

 

THIOMETON.

 

THIOPHANATE-METHYL except when included in Schedule 5.

 

THIOUREA AND ALKYL THIOUREAS except:

 

 (a) when separately specified in these Schedules; or

 

 (b) for therapeutic use.

 

THIRAM except in paint containing 0.5 per cent or less of thiram.

 

THUJONE except in preparations containing 4 per cent or less of thujone.

 

THYMOL when packed and labelled for the control of Varroa mites in bee hives.

 

TOLUENE (excluding its derivatives) except in preparations containing 50 per cent or less of toluene or toluene and xylene.

 

TOLUENEDIAMINE not elsewhere specified in these Schedules:

 

 (a) in hair dye preparations except when the immediate container and primary pack are labelled with the following statements:

 

  KEEP OUT OF REACH OF CHILDREN, and

 

  WARNING This product contains ingredients which may cause skin irritation to certain individuals. A preliminary test according to the accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye.

 

  written in letters not less than 1.5 mm in height; or

 

 (b) in eyelash and eyebrow tinting products when the immediate container and primary pack are labelled with the following statement:

 

  WARNING This product contains ingredients which may cause skin irritation to certain individuals, and when used for eyelash and eyebrow tinting may cause injury to the eye. A preliminary test according to the accompanying directions should be made before use.

 

  written in letters not less than 1.5 mm in height.

 

TOLYLFLUANID.

 

TRANSFLUTHRIN except:

 

 (a) in preparations containing 1 per cent or less of transfluthrin; or

 

 (b) in a cartridge for vaporiser use containing 600 mg or less of transfluthrin per cartridge.

 

TRIADIMEFON except:

 

 (a) when included in Schedule 5; or

 

 (b) in fertilisers containing 5 g/kg or less of triadimefon.

 

TRICHLORFON except metrifonate included in Schedule 4.

 

TRICHLOROACETIC ACID except:

 

 (a) when included in Schedule 4 or 5; or

 

 (b) in human dermal preparations containing 12.5 per cent or less of trichloroacetic acid for the treatment of warts other than anogenital warts.

 

TRICHLOROETHYLENE except when included in Schedule 4.

 

TRICHLOROPHENOL.

 

TRICLABENDAZOLE except in preparations containing 20 per cent or less of triclabendazole.

 

TRICLOPYR.

 

TRICLOSAN in cosmetic preparations for human use containing more than 0.3 per cent of triclosan.

 

TRIDEMORPH.

 

TRIETHYL PHOSPHATE.

 

TRIFLUOROMETHANESULFONIC ACID.

 

TRINITROPHENOL (excluding its derivatives) except:

 

 (a) in preparations for human therapeutic use; or

 

 (b) in preparations containing 5 per cent or less of trinitrophenol.

 

TRISODIUM NITRILOTRIACETATE except in preparations containing 20 per cent or less of trisodium nitrilotriacetate.

 

VAMIDOTHION.

 

WARFARIN except when included in Schedule 4 or 5.

 

XYLENE (excluding its derivatives) except in preparations containing 50 per cent or less of xylene or xylene and toluene.

 

ZERANOL in ear implants for use as a growth promotant in steer cattle.

 

ZETA-CYPERMETHRIN in preparations containing 10 per cent or less of zeta-cypermethrin.

 

ZINC BORATE (excluding its derivatives) for use as an agricultural chemical.

 

ZINC CHLORIDE except:

 

 (a) when included in Schedule 2; or

 

 (b) in preparations containing 5 per cent or less of zinc chloride.

 

ZINC para-PHENOLSULFONATE except in preparations containing 5 per cent or less of zinc para-phenolsulfonate.

 

ZINC SULFATE except:

 

 (a) when included in or expressly excluded from Schedule 4; or

 

 (b) in other preparations containing 5 per cent or less of zinc sulfate.

 

ZIRAM in granular preparations.

 

ABAMECTIN except when included in Schedule 5 or 6.

 

ACIBENZOLAR-S-METHYL.

 

ACRIFLAVINE for veterinary use except when in Schedule 5.

 

ACROLEIN.

 

ACRYLONITRILE.

 

ALACHLOR.

 

ALDICARB.

 

ALDOXYCARB.

 

ALLYL ALCOHOL.

 

ALPHA-CYPERMETHRIN except when included in Schedule 5 or 6.

 

AMINACRINE for veterinary use except when included in Schedule 5.

 

AMINOCARB except when included in Schedule 6.

 

4-AMINOPYRIDINE except when included in Schedule 4.

 

AMITON.

 

ARPRINOCID.

 

ARSENIC except:

 

 (a) when separately specified in this Schedule;

 

 (b) when included in Schedule 4 or 6;

 

 (c) as selenium arsenide in photocopier drums;

 

 (d) as 10,10’-oxydiphenoxarsine in silicone rubber mastic containing 120 mg/kg or less of arsenic;

 

 (e) as 10,10’-oxydiphenoxarsine contained in polyvinyl chloride and polyurethane extruded and moulded articles containing 160 mg/kg or less of arsenic other than when included in articles:

 

   (i) in contact with food stuffs, animal feeds or potable water;

 

   (ii) of clothing and footwear in contact with the skin;

 

   (iii) used as infant wear; or

 

   (iv) intended for use as packaging materials;

 

 (f) in animal feeds containing 75 g/tonne or less of arsenic; or

 

 (g) in paints containing 0.1 per cent or less of arsenic calculated on the non-volatile content of the paint.

 

AZAFENIDIN.

 

AZINPHOS-ETHYL.

 

AZINPHOS-METHYL.

 

AZOCYCLOTIN.

 

BENDIOCARB except when included in Schedule 5 or 6.

 

BENOMYL except in paints containing 0.5 per cent or less of benomyl.

 

BENZENE (excluding its derivatives) except:

 

 (a) preparations containing 15 mL/L or less of benzene; or

 

 (b) petrol containing 50 mL/L or less of benzene.

 

BENZIDINE-BASED AZO DYES being:

2,2'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[N-(4-chlorophenyl)-3-oxobutanamide]

CAS No. 94249-03-3

 

Acid Red 85 (Acid Fast Red A)

1,3-Naphthalenedisulfonic acid, 7-hydroxy-8-[[4'-[[4-[[(4-methylphenyl)sulfonyl]oxy]phenyl]azo][1,1'-biphenyl]-4-yl]azo]-, disodium salt

CAS No. 3567-65-5

 

Direct Black 38

2,7-Naphthalenedisulfonic acid, 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)-, disodium salt

CAS No. 1937-37-7

 

Direct Blue 2

2,7-Naphthalenedisulfonic acid, 5-amino-3-[[4'-[(7-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo][1,1'-biphenyl]-4-yl]azo]-4-hydroxy-, trisodium salt

CAS No. 2429-73-4

 

Direct Blue 6

2,7-Naphthalenedisulfonic acid, 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxy-, tetrasodium salt

CAS No. 2602-46-2

 

Direct Brown 2

5-[[4'-[(7-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo][1,1'-biphenyl]-4-yl]azo]-2-hydroxy- benzoic acid disodium salt

CAS No. 2429-82-5

 

Direct Brown 95

Cuprate(2-), [5-[[4'-[[2,6-dihydroxy-3-[(2-hydroxy-5-sulfophenyl)azo]phenyl]azo][1,1'-biphenyl]-4-yl]azo]-2-hydroxybenzoato(4-)]-, disodium salt

CAS No. 16071-86-6

 

Direct Green 1

2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3-[[4'-[(4-hydroxyphenyl)azo][1,1'-biphenyl]-4-yl]azo]-6-(phenylazo)-, disodium salt

CAS No. 3626-28-6

Direct Green 6

2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-6-[[4'-[(4-hydroxyphenyl)azo][1,1'-biphenyl]-4-yl]azo]-3-[(4-nitrophenyl)azo]-, disodium salt

CAS No. 4335-09-5

 

Direct Red 28 (Congo Red)

1-Naphthalenesulfonic acid, 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[4-amino-, disodium salt

CAS No. 573-58-0

 

Direct Red 37

1,3-Naphthalenedisulfonic acid, 8-[[4'-[(4-ethoxyphenyl)azo][1,1'-biphenyl]-4-yl]azo]-7-hydroxy-, disodium salt

CAS No. 3530-19-6

 

BETACYFLUTHRIN except when included in Schedule 5 or 6.

 

BIFENTHRIN except:

 

 (a) when included in Schedule 6; or

 

 (b) in preparations containing 0.5 per cent or less of bifenthrin.

 

BIFLUORIDES (including ammonium, potassium and sodium salts) except when included in Schedule 5 or 6.

 

BORON TRIFLUORIDE except when included in Schedule 5 or 6.

 

BRODIFACOUM except when included in Schedule 6.

 

BROMADIOLONE except when included in Schedule 6.

 

BROMETHALIN except when included in Schedule 6.

 

BROMINE (excluding its salts and derivatives).

 

BRUCINE except in alcohol containing 0.02 per cent or less of brucine as a denaturant.

 

CACODYLIC ACID except:

 

 (a) when included in Schedule 6; or

 

 (b) in animal feeds containing 75 g/tonne or less of arsenic.

 

CADUSAFOS except when included in Schedule 6.

 

CALCIFEROL for use as a rodenticide except when included in Schedule 6.

 

CAPTAFOL.

 

CARBADOX.

 

CARBENDAZIM except in paints, jointing compounds and sealants containing 0.1 per cent or less of carbendazim.

 

CARBOFURAN.

 

CARBON TETRACHLORIDE except in chlorinated rubber based paint containing 1 per cent or less of carbon tetrachloride.

 

CARBONYL SULFIDE when packed and labelled for use as a fumigant.

 

CARBOPHENOTHION.

 

CARBOSULFAN.

 

CHLORDECONE.

 

CHLORDIMEFORM.

 

CHLORFENAPYR except when included in Schedule 5 or 6.

 

CHLORFENVINPHOS.

 

CHLORINE (excluding its salts and derivatives).

 

CHLORHEXIDINE except:

 

 (a) when included in Schedule 5 or 6;

 

 (b) in preparations containing 1 per cent or less of chlorhexidine; or

 

 (c) in solid preparations.

 

CHLOROMETHIURON.

 

5-CHLORO-3-METHYL-4-NITROPYRAZOLE.

 

4-CHLORO-o-TOLUIDINE.

 

CHLOROPICRIN except when included in Schedule 6.

 

CHLORTHIOPHOS.

 

COLECALCIFEROL for use as a rodenticide.

 

COUMAPHOS except when included in Schedule 6.

 

COUMATETRALYL except when included in Schedule 5 or 6.

 

CREOSOTE derived from coal.

 

CREOSOTE derived from beechwood.

 

CYANIDES, metallic except:

 

 (a) ferricyanides;

 

 (b) ferrocyanides; or

 

 (c) when separately specified in these Schedules.

 

CYANOGEN.

 

CYHALOTHRIN (aRS,1R,cis,Z):(aRS,1S,cis,Z) = 50:50.

 

CYHEXATIN.

 

DELTAMETHRIN except:

 

(a)       when included in Schedules 5 or 6; or

 

(b)       in factory prepared mosquito nets containing 1 per cent or less of deltamethrin; or

 

(c)       in preparations containing 0.1 per cent or less of deltamethrin.

 

DEMETON.

 

DEMETON-O-METHYL.

 

DEMETON-S-METHYL.

 

DIALIFOS.

 

4,4-DIAMINODIPHENYLMETHANE (Methylene dianiline).

 

1,2-DIBROMO-3-CHLOROPROPANE.

 

1,3-DICHLOROPROPENE.

 

DICHLORVOS except when included in Schedule 5 or 6.

 

DICROTOPHOS.

 

DIFENACOUM except when included in Schedule 6.

 

DIFETHIALONE except when included in Schedule 6.

 

DIMEFOX.

 

4-DIMETHYLAMINOAZOBENZENE (N,N-dimethyl-4-[phenylazo]-benzenamine).

 

DIMETHYL SULFATE.

 

DIMETILAN.

 

DINITROCRESOLS except when included in Schedule 4 or 6.

 

DINITROPHENOLS except when included in Schedule 4 or 6.

 

DINOCAP.

 

DINOSEB.

 

DIQUAT except when included in Schedule 6.

 

DISULFOTON except when included in Schedule 6.

 

DORAMECTIN except when included in Schedule 5 or 6.

 

DSMA except when included in Schedule 6.

 

EMAMECTIN except when included in Schedule 5 or 6.

 

ENDOSULFAN except when included in Schedule 6.

 

ENDOTHAL except when included in Schedule 6.

 

ENDRIN.

 

EPICHLOROHYDRIN.

 

EPIDERMAL GROWTH FACTOR except in preparations for human therapeutic use.

 

EPRINOMECTIN except when included in Schedule 5.

 

ETACONAZOLE.

 

ETHION.

 

ETHOPROPHOS except when included in Schedule 6.

 

ETHYLENE DIBROMIDE.

 

ETHYLENE OXIDE.

 

FAMPHUR except when included in Schedule 6.

 

FENAMIPHOS except when included in Schedule 6.

 

FENOXACRIM except:

 

 (a) when included in Schedule 6; or

 

 (b) in treated carpets.

 

FENSULFOTHION.

 

FENTHION except when included in Schedule 5 or 6.

 

FENTHION-ETHYL.

 

FLOCOUMAFEN except when included in Schedule 6.

 

FLUCOFURON except:

 

 (a) when included in Schedule 6; or

 

 (b) in treated carpets.

 

FLUCYTHRINATE.

 

FLUMIOXAZIN except when included in Schedule 6.

 

FLUOROACETAMIDE.

 

FLUOROACETIC ACID.

 

FOLPET.

 

FORMETANATE.

 

FOSTHIAZATE.

 

FURATHIOCARB except when included in Schedule 5.

 

GAMMA-CYHALOTHRIN except when included in Schedule 5.

 

HALOFUGINONE except when included in Schedule 4.

 

HALOGENATED DIBENZODIOXINS AND DIBENZOFURANS.

 

HCB.

 

HYDROCARBONS LIQUID AROMATIC (including aromatic extract oils), any

 fraction of which boils above 350°C except:

 

 (a) when in solid polymers;

 

 (b) when containing 1 per cent or less of total polycyclic aromatic compounds as measured by IP 346; or

 

 (c)  when having a Mutagenicity Index of zero as measured by ASTM E1687-95.

 

HYDROCYANIC ACID except:

 

 (a) when included in Schedule 4; or

 

 (b) its salts and derivatives other than cyanides separately specified in this Schedule.

 

HYDROFLUORIC ACID (excluding its salts and derivatives) except when included in Schedule 5 or 6.

 

HYDROGEN SULFIDE.

 

HYDROSILICOFLUORIC ACID (excluding its salts and derivatives) except when included in Schedule 5 or 6.

 

IODOMETHANE.

 

ISOCARBOPHOS.

 

ISOFENPHOS.

 

ISOPROTURON.

 

IVERMECTIN except when included in Schedule 4 or 5.

 

LAMBDA-CYHALOTHRIN except when included in Schedule 5 or 6.

 

LEPTOPHOS.

 

LITHIUM PERFLUOROOCTANE SULFONATE except in sealed bait stations containing 1 per cent or less of lithium perfluorooctane sulfonate.

 

MADURAMICIN except:

 

 (a) when included in Schedule 5; or

 

 (b) in animal feeds containing 5 mg/kg or less of antibiotic substances.

 

MALACHITE GREEN for veterinary use except when included in Schedule 5.

 

MAZIDOX.

 

MECARBAM.

 

MERCURIC CHLORIDE when prepared for use for agricultural, industrial, pastoral or horticultural purposes.

 

MERCURY except:

 

 (a) when separately specified in this Schedule;

 

 (b) when included in Schedule 2, 4 or 6;

 

 (c) in preparations containing 0.01 per cent or less of mercury in organic form as a preservative;

 

 (d) mercury (metallic) in scientific instruments;

 

 (e) dental amalgams; or

 

 (f) in a sealed device, for therapeutic use, which prevents access to the mercury.

 

METHACRIFOS except when included in Schedule 6.

 

METHAMIDOPHOS.

 

METHAPYRILENE.

 

METHAZOLE.

 

METHIDATHION.

 

METHIOCARB except when included in Schedule 5 or 6.

 

METHOMYL except when included in Schedule 6.

 

METHOXYETHYLMERCURIC ACETATE.

 

METHOXYETHYLMERCURIC CHLORIDE.

 

METHYL BROMIDE.

 

Methylcyclopentadienyl Manganese Tricarbonyl except:

 

 (a) when included in Schedule 6;

 

 (b) when used in laboratory analysis; or

 

 (c) when packed for industrial use in containers with a nominal capacity of 100 L or more.

 

4,4’-METHYLENEBIS[2-CHLOROANILINE] (MOCA).

 

METHYLENE BLUE for veterinary use except when included in Schedules 4 or 5.

 

MEVINPHOS.

 

MIPAFOX.

 

MIREX.

 

MOLINATE.

 

MONOCROTOPHOS.

 

MOXIDECTIN except when included in Schedule 4, 5 or 6.

 

MSMA except when included in Schedule 6.

 

NAPHTHALOPHOS except when included in Schedule 6.

 

NICOTINE except:

 

 (a) when included in Schedule 6;

 

 (b) in preparations for human therapeutic use; or

 

 (c) in tobacco prepared and packed for smoking.

 

NIMIDANE except when included in Schedule 6.

 

NITROFEN.

 

 

NITROPRUSSIDES except when included in Schedule 4 or 6.

 

2-NITROTOLUENE.

 

OMETHOATE except when included in Schedule 5 or 6.

 

OXAMYL.

 

OXYDEMETON METHYL.

 

PARAQUAT.

 

PARATHION.

 

PARATHION-METHYL except when included in Schedule 6.

 

PENTACHLOROPHENOL except when included in Schedule 6.

 

PHENYLMERCURIC ACETATE except in preparations containing 0.01 per cent or less of mercury as a preservative.

 

PHORATE.

 

PHOSFOLAN.

 

PHOSPHIDES, METALLIC.

 

PHOSPHINE.

 

PHOSPHORUS, YELLOW (excluding its salts and derivatives).

 

POTASSIUM NITRITE except:

 

 (a) when included in Schedule 5 or 6;

 

 (b) in preparations containing 0.5 per cent or less of potassium nitrite;

 

 (c) when present as an excipient in preparations for therapeutic use; or

 

 (d) in aerosols containing 2 per cent or less of potassium nitrite.

 

PROCYMIDONE.

 

PROPYLENE OXIDE.

 

PYRINURON.

 

QUININE for veterinary use except when included in Schedule 5.

 

SAFLUFENACIL except when included in Schedule 5.

 

SCHRADAN.

 

SELENIUM except:

 

 (a) when included in Schedule 6;

 

 (b) as selenium arsenide in photocopier drums;

 

 (c) in preparations for therapeutic use other than:

 

  (i) drench concentrates containing 2.5 per cent or less of selenium; or

 

  (ii) pour-on preparations containing 0.5 per cent or less of selenium;

 

 (d) in paints or tinters containing 0.1 per cent or less of selenium calculated on the non-volatile content of the paint or tinter; or

 

 (e) in fertilisers containing 200 g/tonne or less of selenium.

 

SEMDURAMICIN except:

 

 (a) when included in Schedule 6; or

 

 (b) in animal feeds containing 25 mg/kg or less of antibiotic substances.

 

SODIUM NITRITE except:

 

 (a) when included in Schedule 2, 5 or 6;

 

 (b) in preparations containing 0.5 per cent or less of sodium nitrite;

 

 (c) when present as an excipient in preparations for therapeutic use; or

 

 (d) in aerosols containing 2 per cent or less of sodium nitrite.

 

STRYCHNINE except when included in Schedule 4.

 

SULCOFURON except:

 

 (a) when included in Schedule 6; or

 

 (b) in treated carpets.

 

SULFENTRAZONE.

 

SULFOTEP.

 

TEFLUTHRIN except when included in Schedule 5.

 

TEPP.

 

TERBUFOS.

 

TETRACHLOROETHANE.

 

2,2’,6,6’-TETRAISOPROPYL-DIPHENYL-CARBODIIMIDE except when included in Schedule 6.

 

THALLIUM.

 

THIOFANOX.

 

TIN ORGANIC COMPOUNDS, being di-alkyl, tri-alkyl and tri-phenyl tin compounds where the alkyl group is methyl, ethyl, propyl or butyl except:

 

 (a) when separately specified in this Schedule;

 

 (b) in plastics;

 

 (c) in semi-solid sealants, adhesives or elastomers containing 1 per cent or less of the dialkyl, trialkyl or triphenyl tin component; or

 

 (d) in paint containing 1 per cent or less of such compounds calculated as tin in the non-volatile content of the paint.

 

ortho-TOLIDINE except in solid-state diagnostic therapeutic reagents.

 

TRIAMIPHOS.

 

TRIAZBUTIL.

 

TRIBUFOS (s,s,s-tributylphosphorotrithioate).

 

VINCLOZOLIN.

 

VINYL CHLORIDE.

 

ZETA-CYPERMETHRIN except when included in Schedule 6.

 

ZIRAM except when included in Schedule 6.

 

(Substances marked # are listed in Appendix D.)

 

ACETYLDIHYDROCODEINE.

 

ACETYLMETHADOL.

 

ACETYLMORPHINES.

 

ALFENTANIL.

 

ALPHACETYLMETHADOL.

 

ALPHAPRODINE.

 

# ALPRAZOLAM.

 

AMPHETAMINE.

 

AMYLOBARBITONE except when included in Schedule 4.

 

ANILERIDINE.

 

BENZYLMORPHINE.

 

BEZITRAMIDE.

 

BUPRENORPHINE.

 

BUTOBARBITONE.

 

BUTORPHANOL.

 

CARFENTANYL.

 

COCAINE.

 

CODEINE except when included in Schedule 2, 3 or 4.

 

CODEINE-N-OXIDE.

 

CONCENTRATE OF POPPY STRAW (the material arising when poppy straw has entered into a process for concentration of its alkaloids).

 

4-CYANO-1-METHYL-4-PHENYLPIPERIDINE (Pethidine intermediate A).

 

CYCLOBARBITONE.

 

DEXAMPHETAMINE.

 

DEXTROMORAMIDE.

 

DEXTROPROPOXYPHENE except when included in Schedule 4.

 

DIFENOXIN except when included in Schedule 4.

 

DIHYDROCODEINE except when included in Schedule 2, 3 or 4.

 

DIHYDROMORPHINE.

 

DIPHENOXYLATE except when included in Schedule 3 or 4.

 

DIPIPANONE.

 

# DRONABINOL (delta-9-tetrahydrocannabinol) when prepared and packed for therapeutic use.

 

DROTEBANOL.

 

ETHYLAMPHETAMINE.

 

ETHYLMORPHINE except when included in Schedule 2 or 4.

 

FENTANYL.

 

# FLUNITRAZEPAM.

 

HYDROCODONE.

 

HYDROMORPHINOL.

 

HYDROMORPHONE.

 

KETAMINE.

 

LEVAMPHETAMINE.

 

LEVOMETHAMPHETAMINE.

 

LEVOMORAMIDE.

 

LEVORPHANOL (excluding its stereoisomers).

 

LISDEXAMFETAMINE.

 

METHADONE.

 

METHYLAMPHETAMINE.

 

METHYLDIHYDROMORPHINE.

 

METHYLPHENIDATE.

 

1-METHYL-4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID (Pethidine intermediate C).

 

MORPHINE.

 

MORPHINE METHOBROMIDE.

 

MORPHINE-N-OXIDE.

 

NABILONE.

 

# NABIXIMOLS (botanical extract of Cannabis sativa which includes the following cannabinoids: tetrahydrocannabinol, cannabidiol, cannabinol, cannabigerol, cannabichromene, cannabidiolic acid, tetrahydrocannabinolic acid, tetrahydrocannabivarol, and cannabidivarol, where tetrahydrocannabinol and cannabidiol (in approximately equal proportions) comprise not less than 90 per cent of the total cannabinoid content) in a buccal spray for human therapeutic use.

 

NORCODEINE.

 

NORMETHADONE.

 

OPIUM except the alkaloids noscapine in Schedule 2 and papaverine when included in Schedule 2 or 4.

 

OXYCODONE.

 

OXYMORPHONE.

 

PENTAZOCINE.

 

PENTOBARBITONE except when included in Schedule 4.

 

PETHIDINE.

 

PHENDIMETRAZINE.

 

PHENMETRAZINE.

 

PHENOPERIDINE.

 

4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID ETHYL ESTER (Pethidine intermediate B).

 

PHOLCODINE except when included in Schedule 2 or 4.

 

PIRITRAMIDE.

 

PROPIRAM.

 

QUINALBARBITONE.

 

RACEMORAMIDE.

 

REMIFENTANIL.

 

SECBUTOBARBITONE.

 

# SODIUM OXYBATE for human therapeutic use.

 

SUFENTANIL.

 

TAPENTADOL.

 

THEBACON.

 

THEBAINE.

 

TILIDINE.

 

(Trivial or unofficial names are marked *)

 

ACETORPHINE.

 

ACETYL-ALPHA-METHYLFENTANYL.

 

ALKOXYAMPHETAMINES and substituted alkoxyamphetamines except when separately specified in these schedules.

 

ALKOXYPHENYLETHYLAMINES and substituted alkoxyphenylethylamines except when separately specified in these Schedules.

 

ALKYLTHIOAMPHETAMINES and substituted alkylthioamphetamines except when separately specified in these schedules.

 

ALLYLPRODINE.

 

ALPHAMEPRODINE.

 

ALPHA-METHYLFENTANYL.

 

ALPHA-METHYLTHIOFENTANYL.

 

ALPHAMETHADOL.

 

2-AMINO-1-(2,5-DIMETHOXY-4-METHYL)PHENYLPROPANE *(STP or DOM).

 

5-(2-AMINOPROPYL)INDAN and substituted 5-(2-aminopropyl)indans except when separately specified in these schedules.

 

BENZETHIDINE.

 

BENZOYLINDOLES except when separately specified in these Schedules.

 

BENZYLPIPERAZINE *(BZP).

 

BETACETYLMETHADOL.

 

BETA-HYDROXYFENTANYL.

 

BETA-HYDROXY-3-METHYLFENTANYL.

 

BETAMEPRODINE.

 

BETAMETHADOL.

 

BETAPRODINE.

 

1-(8-BROMOBENZO[1,2-B;4,5-B]DIFURAN-4-YL)-2-AMINOPROPANE *(Bromo-Dragonfly).

 

4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE *(BDMPEA).

 

BUFOTENINE.

 

 

CANNABIS except:

 

 (a) when separately specified in these Schedules; or

 

 (b) processed hemp fibre containing 0.1 per cent or less of tetrahydrocannabinol and products manufactured from such fibre.

 

CATHINONE.

 

CLONITAZENE.

 

COCA LEAF.

 

CODOXIME.

 

4-CYANO-2-DIMETHYLAMINO-4,4’-DIPHENYLBUTANE.

 

CYCLOHEXYLPHENOLS except when separately specified in these Schedules.

 

DESOMORPHINE.

 

DIAMPROMIDE.

 

DIBENZOPYRANS except when separately specified in these Schedules.

 

3,4-DICHLORO-N-{[1- (DIMETHYLAMINO)CYCLOHEXYL]METHYL}BENZAMIDE *(AH-7921).

 

DIETHYLTHIAMBUTENE.

 

N,N-DIETHYLTRYPTAMINE  *(DET).

 

DIMENOXADOL.

 

DIMEPHEPTANOL.

 

2,5-DIMETHOXYAMPHETAMINE *(DMA).

 

2,5-DIMETHOXY-4-BROMOAMPHETAMINE *(DOB).

 

2,5-DIMETHOXY-4-ETHYL-a-AMPHETAMINE *(DOET).

 

2,5-DIMETHOXY-4-ETHYLTHIOPHENETHYLAMINE *(2C-T-2).

 

2,5-DIMETHOXY-4-IODOPHENETHYLAMINE *(2C-I).

 

2,5-DIMETHOXY-4-(N)-PROPYLTHIOPHENETHYLAMINE *(2C-T-7).

 

3-(2-DIMETHYLAMINOETHYL)-4-HYDROXYINDOLE *(PSILOCINE or PSILOTSIN).

 

3-(1,2-DIMETHYLHEPTYL)-1-HYDROXY-7,8,9,10-TETRAHYDRO-6,6,9- TRIMETHYL-6H-DIBENZO (b,d) PYRAN                            *(DMHP).

 

N, α -DIMETHYL-3,4-(METHYLENEDIOXY)PHENYLETHYLAMINE *(MDMA).

 

N,N-DIMETHYLAMPHETAMINE (Dimetamfetamine).

 

DIMETHYLTHIAMBUTENE.

 

N,N-DIMETHYLTRYPTAMINE *(DMT).

 

DIOXAPHETYL BUTYRATE.

 

ECGONINE.

 

N-ETHYL-α-METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE *(N-ETHYL MDA).

 

ETHYLMETHYLTHIAMBUTENE.

 

ETICYCLIDINE  *(PCE).

 

ETONITAZENE.

 

ETORPHINE.

 

ETOXERIDINE.

 

FENETYLLINE.

 

4-FLUORO-N-METHYLAMPHETAMINE.

 

1-(5-FLUOROPENTYL)-3-(2-IODOBENZOYL)INDOLE *(AM-694).

 

FURETHIDINE.

 

HARMALA ALKALOIDS except in herbs, or preparations, for therapeutic use:

 

 (a) containing 0.1 per cent or less of harmala alkaloids; or

 

 (b) in divided preparations containing 2 mg or less of harmala alkaloids per recommended daily dose.

 

HEROIN.

 

3-HEXYL-1-HYDROXY-7,8,9,10-TETRAHYDRO-6,6,9-TRIMETHYL-6H-DIBENZO (b,d) PYRAN *(PARAHEXYL).

 

4-HYDROYXBUTANOIC ACID and its salts except for sodium oxybate when in Schedule 8. *(GAMMA HYDROXYBUTYRATE (GHB)).

 

2-[(1R,3S)-3-HYDROXYCYCLOHEXYL]-5-(2-METHYLNONAN-2-YL)PHENOL *(Cannabicyclohexanol or CP 47,497 C8 homologue).

 

2-[(1R,3S)-3-HYDROXYCYCLOHEXYL]-5-(2-METHYLOCTAN-2-YL)PHENOL *(CP 47,497).

 

HYDROXYPETHIDINE.

 

ISOMETHADONE.

 

KETOBEMIDONE.

 

LEVOMETHORPHAN (excluding its stereoisomers).

 

LEVOPHENACYLMORPHAN.

 

LYSERGIC ACID.

 

LYSERGIDE.

 

MECLOQUALONE.

 

METAZOCINE.

 

METHAQUALONE.

 

METHCATHINONE.

 

5-METHOXY- α -METHYLTRYPTAMINE *(5-MeO-AMT).

 

5-METHOXY-3,4-METHYLENEDIOXYAMPHETAMINE *(MMDA).

 

4-METHOXY- α -METHYLPHENYLETHYLAMINE *(PMA).

 

2-(2-METHOXYPHENYL)-1-(1-PENTYLINDOL-3-YL)ETHANONE *(JWH-250).

 

METHYL (2S, 4aR, 6aR, 7R, 9S, 10aS, 10bR)-9-ACETOXY-6a,10b-DIMETHYL-4,10-DIOXO-DODECAHYDRO-2-(3-FURYL)-2H-NAPHTHO[2,1-c]PYRAN-7-CARBOXYLATE              *(SALVINORIN A).

 

4-METHYLAMINOREX.

 

METHYLDESORPHINE.

 

3,4-METHYLENEDIOXYAMPHETAMINE *(MDA).

 

3,4-METHYLENEDIOXYPYROVALERONE *(MDPV).

 

3-METHYLFENTANYL.

 

4-METHYLMETHCATHINONE *(MEPHEDRONE).

 

N- α -[METHYL-3,4-(METHYLENEDIOXY)PHENETHYL]HYDROXYLAMINE *(N-HYDROXY MDA).

 

N-METHYL-1-(3,4-METHYLENEDIOXYPHENYL)-2-BUTANAMINE *(MBDB).

 

2-METHYL-3-MORPHOLINO-1, 1-DIPHENYLPROPANE CARBOXYLIC ACID (Moramide intermediate).

 

1-METHYL-4-PHENYL-4-PIPERIDINOL PROPIONATE *(MPPP).

 

4-METHYLTHIOAMPHETAMINE.

 

3-METHYLTHIOFENTANYL.

 

METOPON. 

 

MITRAGYNA SPECIOSA.

 

MITRAGYNINE.

 

MORPHERIDINE.

 

(1-(2-MORPHOLIN-4-YLETHYL)INDOL-3-YL)-NAPTHALEN-1-YLMETHANONE *(JWH-200).

 

MUSCIMOL.

 

MYROPHINE.

 

NAPHTHOYLINDOLES except when separately specified in these Schedules.

 

NAPHTHYLMETHYLINDOLES except when separately specified in these Schedules.

 

NAPHTHOYLPYRROLES except when separately specified in these Schedules.

 

NAPHTHYLMETHYLINDENES except when separately specified in these Schedules.

 

NAPTHALEN-1-YL-(1-BUTYLINDOL-3-YL)METHANONE *(JWH-073).

 

NICOCODINE.

 

NICODICODINE.

 

NICOMORPHINE.

 

NORACYMETHADOL.

 

NORLEVORPHANOL.

 

NORMORPHINE.

 

NORPIPANONE.

 

PARA-FLUOROFENTANYL.

 

1-PENTYL-3-(4-METHYL-1-NAPTHOYL)INDOLE. *(JWH-122).

 

1-PENTYL-3-(1-NAPHTHOYL)INDOLE *(JWH-018).

 

PHENADOXONE.

 

PHENAMPROMIDE.

 

PHENAZOCINE.

 

PHENCYCLIDINE *(PCP).

 

N-PHENETHYL-4-PIPERIDONE.

 

PHENOMORPHAN.

 

PHENYLACETYLINDOLES except when separately specified in these Schedules.

 

1-PHENYLETHYL-4-PHENYL-4-PIPERIDINOL ACETATE *(PEPAP).

 

PIMINODINE.

 

PROHEPTAZINE.

 

PROPERIDINE.

 

PSILOCYBINE.

 

RACEMETHORPHAN.

 

RACEMORPHAN.

 

ROLICYCLIDINE *(PHP or PCPY).

 

SALVIA DIVINORUM.

 

TENOCYCLIDINE *(TCP).

 

SYNTHETIC CANNABINOMIMETICS except when separately specified in these Schedules.

 

TETRAHYDROCANNABINOLS and their alkyl homologues except:

 

 (a)  when separately specified in this Schedule;

 

 (b) when included in Schedule 8;

 

 (c) in hemp seed oil, containing 50 mg/kg or less of tetrahydrocannabinols when labelled with a warning statement:

 

  Not for internal use; or

 

  Not to be taken; or

 

 (d) in products for purposes other than internal human use containing 50 mg/kg or less of tetrahydrocannabinols.

 

THIOFENTANYL.

 

1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE *(TFMPP).

 

TRIMEPERIDINE.

 

3,4,5-TRIMETHOXY- α -METHYLPHENYLETHYLAMINE  *(TMA).

 

3,4,5-TRIMETHOXYPHENETHYLAMINE (mescaline) and other substances structurally derived from methoxy-phenylethylamine except:

 

 (a) methoxyphenamine; or

 

 (b) when separately specified in this Schedule.

 

1-(3,4,5-TRIMETHOXYPHENYL)-2-AMINOBUTANE.

 

 

 

 

ABRUS PRECATORIUS (Jequirity) seed or root for therapeutic use.

 

ACORUS CALAMUS (calamus) for human therapeutic use.

 

ALKALINE SALTS, being the carbonate, silicate or phosphate salts of sodium or potassium alone or in any combination for domestic use:

 

(a)     in liquid or semi-solid food additive preparations, the pH of which is more than 11.5;

 

(b)    in solid automatic dishwashing preparations, the pH of which in a 500 g/L aqueous solution or mixture is more than 12.5; or

 

(c)     in liquid or semi-solid automatic dishwashing preparations, the pH of which is more than 12.5;

 

 except:

 

(a)     when in Schedule 5; or

 

(b)    when in Scheule 6.

 

ALLYLISOPROPYLACETYLUREA for therapeutic use.

 

AMINOPHENAZONE (amidopyrine) and its derivatives for human therapeutic use except:

 

(a)     when in Schedule 4; or
 

(b)    when in Schedule 6.

 

AMYGDALIN for therapeutic use.

 

ANCHUSA OFFICINALIS for therapeutic use.

 

ARISTOLOCHIA spp. for therapeutic use.

 

ARISTOLOCHIC ACID(S) for human therapeutic use.

 

ASARUM spp. containing aristolochic acid(s) for human therapeutic use.

 

AZADIRACHTA INDICA (neem) including its extracts and derivatives, in preparations for human internal use except:

 

(a)     debitterised neem seed oil’; or
 

(b)    when in Schedule 5; or
 

(c)     when in Schedule 6.

 

BASIC ORANGE 31 (2-[(4-aminophenyl)azo]-1,3-dimethyl-1H-imidazolium chloride) in preparations for skin colouration and dyeing of eyelashes or eyebrows except when in Schedule 6.

 

1,2-BENZENEDIAMINE in preparations for cosmetic use and skin colouration (including tattooing).

 

1,3-BENZENEDIAMINE in preparations for cosmetic use and skin colouration (including tattooing).

 

BITHIONOL for human therapeutic use except when in Schedule 6.

 

BORAGO OFFICINALIS (Borage) for therapeutic use except the fixed oil derived from the seeds of Borago officinalis.

 

BRAGANTIA spp. containing aristolochic acid(s) for human therapeutic use.

 

BUCLOSAMIDE for therapeutic use.

 

BUNIODYL SODIUM for therapeutic use.

 

1,4-BUTANEDIOL (excluding its derivatives) in non-polymerised form in preparations for domestic use.

 

CACALIA spp. for therapeutic use.

 

CARBAMIDE PEROXIDE  (excluding its salts and derivatives) in teeth whitening preparations containing more than 18 per cent of carbamide peroxide except:

 

(a)     in preparations manufactured for, and supplied solely by, registered dental practitioners as part of their dental practice; or
 

(b)    when in Schedule 5; or
 

(c)     when in Schedule 6.

 

CINCHOPHEN and its derivatives for therapeutic use.

 

CLIOQUINOL and other halogenated derivatives of 8-hydroxyquinoline for human internal use except when in Schedule 4 or when being used solely for experimental purposes in humans and where such use:

 

 (a) is in accordance with:

 

  (i) an approval granted under paragraph 19(1)(b) of the Therapeutic Goods Act 1989, including any conditions specified in the notice of approval; and

  (ii) any conditions specified in the Therapeutic Goods Regulations 1990 for the purposes of subsection 19(1A) of the Therapeutic Goods Act 1989; and

  (iii) any conditions specified in the Therapeutic Goods Regulations 1990 for the purposes of subsection 19(4A) of the Therapeutic Goods Act 1989; or

 

 (b) is in accordance with the requirements of item 3 of Schedule 5A to the Therapeutic Goods Regulations 1990.

 

COAL TAR for cosmetic use other than in therapeutic goods.

 

CONIUM MACULATUM (coniine) for therapeutic use.

 

COTARNINE for therapeutic use.

 

CROTALARIA spp. for therapeutic use.

 

CROTON TIGLIUM for therapeutic use.

 

CYNOGLOSSUM spp. for therapeutic use.

 

DICOPHANE (DDT) for therapeutic use.

 

DIETHYLENE GLYCOL for use in toothpastes or mouthwashes except:

 

(a)     in preparations containing 0.25 per cent or less of diethylene glycol; or
 

(b)    when in Schedule 5; or
 

(c)     when in Schedule 6

 

DIETHYLHEXYL PHTHALATE for cosmetic use.

 

DIETHYLPHTHALATE  in sunscreens, personal insect repellents or body lotion preparations for human use except in preparations containing 0.5 per cent or less of diethylphthalate.

 

5,6-DIHYDROXYINDOLINE for cosmetic use in preparations containing more than 2 per cent of 5,6-dihydroxyindoline except when in Schedule 6.

 

1,3-DIMETHYLAMYLAMINE (DMAA).

 

DIMETHYLPHTHALATE  in sunscreens, personal insect repellents or body lotion preparations for human use except in preparations containing 0.5 per cent or less of dimethylphthalate.

 

DULCIN for therapeutic use.

 

ETHYLENE GLYCOL for use in toothpastes or mouthwashes except:

 

(a)     in preparations containing 0.25 per cent or less of  ethylene glycol; or
 

(b)    when in Schedule 5; or
 

(c)     when in Schedule 6.

 

ETHYLHEXANEDIOL for human use except when in Schedule 4.

 

EUPATORIUM CANNABINUM (Hemp Agrimony) for therapeutic use.

  

FARFUGIUM JAPONICUM for therapeutic use.

 

FORMALDEHYDE (excluding its derivatives):

 (a) in oral hygiene preparations containing more than 0.1 per cent of free formaldehyde;

 (b) in aerosol sprays for cosmetic use containing 0.005 per cent or more of free formaldehyde;

 (c) in nail hardener cosmetic preparations containing 5 per cent or more of free formaldehyde; o

 (d) in all other cosmetic preparations containing 0.05 per cent or more of free formaldehyde ;

 except:

(a)     in preparations containing 0.2 per cent or less of free formaldehyde when labelled with the warning statement:

  CONTAINS FORMALDEHYDE;

(b)    when in Schedule  2; or

(c)     when in Schedule 6.

HELIOTROPIUM spp. for therapeutic use.

 

HYDROGEN PEROXIDE (excluding its salts and derivatives) in teeth whitening preparations containing more than 6 per cent (20 volume) of hydrogen peroxide except:
 

(a)     in preparations manufactured for, and supplied solely by, registered dental practitioners as part of their dental practice;

(b)    when in Schedule 5; or

(c)     when in Schedule 6.

 

JUNIPERUS SABINE [savin(e)]  for therapeutic use.

 

LEAD COMPOUNDS in paints, tinters, inks or ink additives except;

 

(a) in preparations containing 0.1 per cent or less of lead calculated on the non-volatile content of the paint, tinter, ink or ink additive;
 

(b) when in Schedule 4;
 

(c) when in Schedule 5; or
 

(d) when in Schedule 6.

 

LIGULARIA DENTATA for therapeutic use.

 

MELIA AZEDARACH including its extracts and derivatives.

 

METHYLDIBROMO GLUTARONITRILE in preparations intended to be in contact with the skin, including cosmetic use except when in Schedule 6.

 

METHYL METHACRYLATE for cosmetic use except in preparations containing 1 per cent or less of methyl methacrylate as residual monomer in a polymer except when in Schedule 6.

 

OXYPHENISATIN for therapeutic use.

 

PARAFORMALDEHYDE (excluding its derivatives):

 (a) in oral hygiene preparations containing more than 0.1 per cent of free formaldehyde;

 (b) in aerosol sprays for cosmetic use containing 0.005 per cent or more of free formaldehyde;

 (c) in nail hardener cosmetic preparations containing 5 per cent or more of free formaldehyde; o

 (d) in all other cosmetic preparations containing 0.05 per cent or more of free formaldehyde ;

 except:

(a)     in preparations containing 0.2 per cent or less of free formaldehyde when labelled with the warning statement:

  CONTAINS FORMALDEHYDE;

(b)    when in Schedule  2; or

(c)     when in Schedule 6.

PETASITES spp. for therapeutic use.

 

PHENYLENEDIAMINES, including alkylated and arylated derivatives, in preparations for skin colouration and dyeing of eyelashes or eyebrows except when included in Schedule 6.

 

POTASSIUM HYDROXIDE (excluding its salts and derivatives), in liquid or semi-solid food additive preparations, for domestic use, the pH of which is more than 11.5 except:
 

(a)     when in Schedule 5; or
 

(b)    when in Schedule 6.

 

PTERIDIUM spp. for therapeutic use.

 

PULMONARIA spp. for therapeutic use.

 

SAFROLE for internal therapeutic use except

 

(a)     in preparations containing 0.1 per cent or less of safrole; or
 

(b)    when in Schedule 6.

 

SENECIO spp. for therapeutic use.

 

SILICONES for injection or implantation except when included in Schedule 4.

 

SODIUM HYDROXIDE (excluding its salts and derivatives), in liquid or semi-solid food additive preparations, for domestic use, the pH of which is more than 11.5 except:
 

(a)     when in Schedule 5; or
 

(b)    when in Schedule 6.

 

SYMPHYTUM spp. (Comfrey) for therapeutic or cosmetic use except when included in Schedule 5.

 

2,4-TOLUENEDIAMINE in preparations for skin colouration (including tattooing) and dyeing of hair, eyelashes or eyebrows.

 

TOLUENEDIAMINE in preparations for skin colouration and dyeing of eyelashes or eyebrows except when included in Schedule 6.

 

1,1,1-TRICHLOROETHANE in pressurised spray packs for therapeutic use except when in Schedule 5.

 

TRICHODESMA AFRICANA for therapeutic use.

 

TRIPARANOL for therapeutic use.

 

TUSSILAGO FARFARA for therapeutic use.

PART 5

 

THE APPENDICES

 

 

 

This Standard does not apply to a poison in any of the following products:

 

ALGICIDES, BACTERIOCIDES OR SLIMICIDES for industrial use that do not fit the definition of an agvet chemical product.

 

BACTERIAL CULTURE MEDIA containing antibiotics.

 

CERAMICS.

 

CHEMISTRY SETS for toy and educational use, when complying with the requirements of Australian Standard AS 8124.4-2003 Safety of toys entitled Part 4: Experimental sets for chemistry and related activities.

 

COPPER COMPOUNDS in paints.

 

DEXTRANS, GELATIN SUCCINYLATED & ETHERIFIED STARCHES used as plasma substitutes/blood volume expanders.

 

ELECTRICAL ACCUMULATORS, BATTERIES, COMPONENTS or LAMPS.

 

ELECTRONIC COMPONENTS.

 

ENHANCING AGENTS for use in ultrasonic and magnetic resonance imaging.

 

EXPLOSIVES.

 

FOOD except:

 

 (a)  food additives before incorporation into food; or

 

 (b) when used as a means of administering a poison for therapeutic use.

 

FRITTED GLAZING OR ENAMELLING PREPARATIONS in which the poison is confined as a non-migratory component of glassy solid flakes or granules.

 

GLASS (including CRYSTAL WARE).

 

GLAZED POTTERY.

 

HUMAN BLOOD PRODUCTS including:

 

 (a) whole blood;

 

 (b)  blood components including red cells, white cells, platelets and plasma (including cryoprecipitate); and

 

(c)  the following plasma-derived therapeutic proteins; and their equivalent recombinant alternatives:

 

    (i) albumin;

 

   (ii)  anticoagulation complex;

 

   (iii) C1 esterase inhibitors;

 

   (iv) clotting factors;

 

   (v)  fibrinogen;

 

   (vi) protein C;

 

   (vii) prothrombin complex concentrate (PCC) ; and

 

   (viii) thrombin.

 

IN VITRO DIAGNOSTIC AND ANALYTICAL PREPARATIONS containing 0.001 per cent or less of a poison included in Schedules 1 to 8.

 

INTRAOCULAR VISCOELASTIC PRODUCTS.

 

LUBRICANTS except soluble oils and solvent-deposited lubricating agents.

 

MATCHES.

 

MEDICAL AND VETERINARY ADHESIVES, GLUES AND CEMENTS.

 

MEDICAL DEVICES classified as Class III by the classification rules set out in Schedule 2 to the Therapeutic Goods (Medical Devices) Regulation 2002, except:

 

 (a) injectable tissue reconstructive, augmentation and restoration materials, including collagen;

 

 (b) medical devices which include anticoagulants;

 

 (c) artificial tears;

 

 (d) urinary catheters; or

 

 (e) intra-articular fluids.

 

MOTOR, HEATING or FURNACE FUELS except:

 

 (a) when the contrary intention appears in any Schedule;

 

 (b) when containing methanol;

 

 (c) toy or hobby fuels; or

 

 (d) petrol or kerosene when packed in containers having a capacity of 20 litres or less.

 

NUTRITION REPLACEMENT PREPARATIONS FOR PARENTERAL ADMINISTRATION.

 

PAPER except:

 

 (a) when prepared for pesticidal use; or

 

 (b) when containing a poison included in Schedule 8 or 9.

 

PHOTOGRAPHIC PAPER or FILM.

 

PIGMENTS when immobilised in a polymer.

 

PORCELAIN.

 

PRINTING INKS or INK ADDITIVES except:

 

 (a) when containing a pesticide; or

 

 (b) preparations containing more than 0.1 per cent of lead calculated on the non-volatile content of the ink or ink additive.

 

RADIOGRAPHIC CONTRAST MEDIA (radiopaques) for therapeutic use.

 

RADIOISOTOPES for therapeutic use.

 

SEEDS treated with seed protectants.

 

SINGLE-USE TUBES for the estimation of alcohol content of breath.

 

TERMITE BARRIERS consisting of an active ingredient, other than arsenic, approved by the relevant registration authority, and laminated between impervious sheeting.

 

TIMBER or WALLBOARD.

 

VITREOUS ENAMELS.

 

WRITING CORRECTION PENS which do not allow ingestion of the contents and which contain no scheduled poison other than designated solvents included in Schedule 5.

 

 

(This Appendix should be read in conjunction with Appendix A.)

 

 

Substances for which the available information suggests that inclusion in the Poisons Schedules is not necessary, or not the most appropriate means of controlling the risk to public health, have been considered at various times.

 

Listing in Appendix B indicates that a decision has been taken not to list substances anywhere in the Schedules, either for a specific purpose, or generally.  It is an inclusive, but not an exhaustive, list i.e. there may be substances not included in the Schedules, and not included in Appendix B, which may be hazardous or non-hazardous, but have not been considered in relation to the need for scheduling.

 

Substances may be included in Appendix B because they have intrinsically low toxicity, or where other factors suggest that the potential public health risk would be minimal.  Factors which are considered when determining an Appendix B entry include:

 

 the toxicology profile was adequately characterised and not consistent with inclusion in any of the Schedules;

 

 the use, purpose or product presentation minimised any hazard to the public such as to not require scheduling; or

 

 the public access was limited such that scheduling was inappropriate or unnecessary.

 

The list was developed from scheduling files and historical records.  For transparency, where the reason for entry and/or purpose or use for the substance was apparent in the consideration, this has been included in the columns “Reason for Entry” and “Area of Use”.

 

Inclusion in Appendix B will not prevent reconsideration of the scheduling of a substance where adverse information becomes available about the Appendix B entry for that substance.

 

Applications are considered for scheduling.  Applications for inclusion in Appendix B will not be accepted.

 

APPENDIX B

 

PART 1

 

REASONS FOR ENTRY

 

a Low Toxicity.

b Use pattern restricts hazard.

c Presentation/packaging restricts hazard.

d Industrial use only.

 

PART 2

 

AREAS OF USE

 

1. Agricultural

 1.1 Herbicide

 1.2 Insecticide

  1.2.1 Insecticide for codling moth

  1.2.2 Termiticide

 1.3 Fungicide

  1.3.1 On seed fungicide

 1.4 Bird Repellent

 1.5 Fertiliser

 1.6 Plant Growth Regulator

 1.7 Insect Pheromone

 1.8 Mushroom Bactericide

 1.9 Acaricide

 1.10 Biological control agent

2. Veterinary

 2.1 For animal use

 2.2 Treatment of mastitis in cows

 2.3 Coccidiostat

 2.4 Feed additive

 2.5 Antiseptic

 2.6 Scabicide

 2.7 Anthelmintic

 2.8 Vitamin/Mineral

 2.9 Growth Promotant

 2.10 Ectoparasiticide

3. Domestic

 3.1 Aromatherapy

 3.2 Food additive

 3.3 Cosmetic

 3.4 Human use

 3.5 Miticide

4. Industrial

 4.1 Water treatment

 4.2 Biological control agent

5. Environmental

 5.1 Mosquito control

6. Human therapeutic use

 6.1 Diagnostic agent

 6.2 Medical device

 6.3 Antiseptic

 6.4 Sunscreen

 6.5 External use

 6.6 Laxative

 6.7 Antiseborrheic

 6.8 Cytoprotective

 6.9 Vitamin/Mineral

 6.10 Eye Drops

7. General

 7.1 Any use

 7.2 Excipient

 7.3 Synergist

 7.4 Flux

 7.5 Pesticide

 7.6 Insect repellent

 7.7 Solvent

 7.8 Disinfectant

 7.9 Preservative

 7.10 Antioxidant

 7.11 Resin activator/accelerant

 7.12 Sweetener artificial

 7.13 Food additive

APPENDIX B

 

PART 3

 

SUBSTANCES CONSIDERED NOT TO REQUIRE CONTROL
BY SCHEDULING

 

_____________________________________________________________________________________

   REASON AREA
 DATE OF FOR OF
SUBSTANCE ENTRY LISTING USE

_____________________________________________________________________________________

 

4-[4-(ACETYLOXY)PHENYL]-2-

  BUTANONE Feb 2005 b 1.7

AGROBACTERIUM RADIOBACTER Nov 1989 a 1

ALCOHOL, DEHYDRATED Aug 2000 b 6

ALUM May 1997 a 7.1

ALUMINIUM AMMONIUM SULFATE May 1997 a 7.1

ALUMINIUM POTASSIUM SULFATE May 1997 a 7.1

ALUMINIUM SILICATE Nov 1974 a 7.1

ALUMINIUM tris (ETHYLPHOSPHONATE) Aug 1986 a 1

AMETOCTRADIN May 2012 a 1.3

AMMONIUM PHOSPHATE Nov 1974 a 7.1

AMMONIUM THIOSULPHATE Nov 1974 a 7.1

AMPROLIUM Jun 1969 a 2.3

AMYL ACETATE Nov 1974 a 7.1

α -AMYLASE derived from Aspergillus niger   Feb 2005 a 2.4

ANDROSTENEDIONE ALBUMEN

CONJUGATE WITH DEA DEXTRAN

ADJUNCT Jun 2004 a 2.1

ASPARTIC ACID - a 6

ASULAM May 1986 a 1

AZIMSULFURON Jun 2003 a 1.1

BACILLUS SPHAERICUS STRAIN 2362 Feb 2003 a 5.1

BACILLUS THURINGIENSIS  May 1992 a 5.1
(excluding endotoxin) Jun 2003 a 2.10

BACILLUS TOYOI Aug 1980 a 2.9

BACULOVIRUS CYDIA POMONELLA Jun 2006 a 1.2

BENFLURALIN - a 1.1

BENSULFURON-METHYL Aug 1987 a 1

BENTONITE Jun 2002 a 7.1

BENZYL BENZOATE Aug 1989 a 1.3.4

BETAINE HYDROCHLORIDE Nov 1974 a 7.1

BIFENAZATE Oct 2002 a 1.9

BISMUTH SUBNITRATE Nov 1999 b, c 2.1

BISTRIFLURON Feb 2014 a 1.2.2

BIURET Nov 1974 a 2.4

BOSCALID June 2003 a 1.3

BOVINE SOMATOTROPHIN May 1992 a 2

BROMACIL Aug 1987 a 1

BROMOPROPYLATE Nov 1994 a 1

BUPIRIMATE Nov 1990 a 1

BUTAFENACIL May 2000 a 1

BUTOXYPOLYPROPYLENE GYLCOL Nov 1974 a 7.7

n-BUTYL BUTYRATE - a 7.1

n-BUTYL LACTATE - a 7.1

CARBETAMIDE Aug 1991 a 1

CARBOXIN Aug 1987 a 1

CARFENTRAZONE-ETHYL Aug 1998 a 1

CELLULASE derived from
  Aspergillus niger    Feb 2005 a 2.4

CETYL ALCOHOL Nov 1974 a 7.1

CHAMOMILE OIL Feb 2000 a 3.1

CHINA CLAY Nov 1974 a 7.1

CHLORANTRANILIPROLE Sep 2008 a 1.2

CHLORFLUAZURON Oct 2005 a 1.2.2

CHLORFLURENOL Feb 1974 a 1.6

CHLORIDAZON May 1988 a 1

CHLOROXYLENOLS Feb 1975 a 7.8

CITRONELLA OIL Feb 2000 a 7.1

CLARY SAGE OIL Feb 2000 a 7.1

CLOPIDOL Nov 1974 d 2.3

COBALT NAPHTHENATE - d 7.1

COLOPHONY Feb 1997 b 7.4

CROSPOVIDONE Aug 1996 a 2

CULICINOMYCES CLAVOSPORUS Nov 1982 a 5.1

CYCLAMIC ACID Nov 1971 a 7.1

CYCLOHEXANE Nov 1974 a 7.7

CYCLOHEXANOL ACETATE - a 7.7

CYROMAZINE Nov 1980 a 2

DICLAZURIL Nov 2001 a 2.3

DIETHYL CARBONATE - a 7.1

DIFLUFENICAN Feb 1987 a 1

DIKEGULAC-SODIUM Mar 1980 a 1.6

DIMETHICONE  a 7.1

DIMETHYL ETHER Nov 1988 d 4

DIPHENYLAMINE Feb 1988 a 1

DIPROPYLENE GLYCOL
MONOMETHYL ETHER Nov 1987 a 4

DIURON Nov 1987 a 1

DOCUSATE SODIUM
(DIOCTYL SODIUM SULFOSUCCINATE)  Feb 1970 a 7.1

2,2-DPA Nov 1989 a 1

drometrizole trisiloxane Oct 2003 a 6.4

EPSIPRANTEL Nov 1991 a 2

ETHAMETSULFURON-METHYL Nov 2000 a 1.1

ETHOPABATE Jun 1969 d 2.3

ETHYL ACETATE Nov 1974 a 7.1

ETHYL ALCOHOL Nov 1974 a 7.1

ETHYLBUTYLACETYL-
AMINOPROPRIONATE Aug 2000 a 3.4

ETHYL BUTYRATE - a 7.1

ETHYL LACTATE - a 7.1

ETOXAZOLE Oct 2003 a 1.2

EUBACTERIUM sp. strain DSM11798  Sep 2013  a 2.4

FENFURAM May 1977 a 1.3.1

FENHEXAMID Feb 1999 a 1

FENOXYCARB Feb 1988 a 1

FLUFENOXURON Feb 1997 a 1

FLUMETSULAM Feb 1992 a 1

FLUOMETURON Aug 1989 a 1

FLUTOLANIL Nov 2001 a 1.3

FLUROXYPYR May 1986 a, c 1

FORCHLORFENURON Feb 2005 a 1.6

FULLERS EARTH Nov 1974 a 7.1

FUNGAL PROTEASE derived from

  Aspergillus niger Feb 2005 a 2.4

GERANIUM OIL Feb 2000 a 7.1

GIBBERELLIC ACID Nov 1974 a 1.6

-GLUCANASE derived from Aspergillus niger Feb 2005 a 2.4

HALAUXIFEN METHYL Oct 2014 a 1, 1.1

HEXAFLURON Nov 1988 a 1

HEXYL ACETATE - a 7.7

HEXYTHIAZOX Feb 1988 a 1

HUMAN OSTEOGENIC PROTEIN-1 (OP-1) Aug 2001 b 6.2

HYDROPRENE Feb 1988 a 1

HYDROXYPROPYL CELLULOSE Nov 1982 a 7.1

ICODEXTRIN Nov 2000 b 6

INDOLE-3-ACETIC ACID Feb 1985 b 1.6

ISOPRENE ALCOHOL - a 7.1

IPRODIONE Feb 1997 a 1

ISOSTEARYL ALCOHOL ETHOXYLATE Nov 1999 a 5.1

KAOLIN Nov 1974 a 7.1

KRESOXIM-METHYL Aug 1999 a 1

KUNZEA OIL Feb 2000 a 7.1

LAURIC ACID Oct 2005 a 7.1

LAURYL ALCOHOL (1-DODECANOL) Nov 1974 a 7.1

LAVANDIN OIL Feb 2000 a 7.1

LAVENDER OIL Feb 2000 a 7.1

LEAD METALLIC - a 7.1

LEMONGRASS OIL Feb 2000 a 7.1

LEPIDOPTEROUS SEX PHEROMONES Nov 1990 a 1

LIMONENE (DIPENTENE) Jun 2002 a 7.1

LINOLEIC ACID Oct 2005 a 7.1

LINSEED FATTY ACIDS Aug 1990 a 2.1

LINURON Feb 1990 a 1

LIQUORICE, DEGLYCYRRHISINISED May 1999 a 7.1

MALEIC HYDRAZIDE Nov 1992 a 1

MANGANESE DIOXIDE May 1999 b 1

MEGASPHAERA ELSDENII strain 41125  Sep 2013 a 2.4

MESOLSULFURON-METHYL Feb 2002 a 1.1

METARHIZIUM ANISOPLIAE Feb 2000 b 4.2

METARHIZIUM ANISOPLIAE Jun 2003 a 1.10

METHOPRENE Aug 1987 a 1

METHOXYFENOZIDE Nov 2000 a 1

METHYL ACETATE - a 7.7

METHYL BENZOQUATE Nov 1974 d 2.3

1-METHYLCYCLOPROPENE Jun 2003 a 1.6

METHYL p-HYDROXYBENZOATE Nov 1974 a 7.9

METSULFURONMETHYL Nov 1985 a 1.1

MYRISTIC ACID Oct 2005 a 7.1

NAPROPAMIDE Aug 1987 a 1

NAPTHYL ACETAMIDE Nov 1974 a 1.6

NEROLI OIL Feb 2000 a 7.1

NICARBAZIN Jun 1969 d 2.3

NISIN Jun 2003 a 3.2

NORFLURAZON Nov 1983 a 1.1

NOVALURON Nov 2000 a 1

Nuclear Polyhedrosis Virus of
Helicoverpa armigera  occlusion bodies Feb 2004 a 1.2

OCTYL ALCOHOLS Nov 1974 a 7.1

OLEIC ACID Oct 2005 a 7.1

ORANGE OIL, SWEET Aug 2000 a 7.1

OXABETRINIL Feb 1987 a 1

OXYFLUORFEN May 2001 a 1

PALMAROSA OIL Feb 2000 a 7.1

PALMITIC ACID Oct 2005 a 7.1

PATCHOULI OIL Feb 2000 a 7.1

PECTINASE derived from Aspergillus niger Feb 2005 a 2.4

PENCYCURON Aug 1994 a 1

PENTADECANOIC ACID Oct 2005 a 7.1

PEPPERMINT OIL Feb 2000 a 7.1

PHENMEDIPHAM May 1989 a 1.1

d-PHENOTHRIN Feb 1982 a 7.5, 1.2

PHYTASE Feb 1996 a 2.4

PICLORAM Aug 1987 a 1

PICOLINAFEN May 2000 a 1

PIMELIC ACID Oct 2005 a 7.1

PIPERONYL BUTOXIDE Aug 1991 a 7.5

POLOXALENE Nov 1974 a 7.1

POLY DIALLYL DIMETHYL AMMONIUM
CHLORIDE (PolyDADMAC) Nov 1997 a 4.1

POLYHEDROSIS VIRUS of
Helico zea occlusion bodies Nov 1996 a 1

POLY (GNRF) OVALBUMIN Feb 1990 a 2

POLYSORBATE 20 May 2001 a 1

PORCINE SOMATOTROPHIN Nov 1991 c 2

potassium sorbate Oct 2004 a 1.3

POTASSIUM BICARBONATE Jun 2004 a 1

PROPYL ACETATES - a 7.1

PROPYLENE GLYCOL Nov 1974 a 7.1

2-PROPYLENE GLYCOL 1-MONOMETHYL
ETHER Nov 1987 a  4

PROTHIOCONAZOLE June 2005 a 1.3.1

PSEUDOMONAS FLUORESCENS May 1985 a 1.8

PYRIMETHANIL Feb 1996 a 1

PYRIPROXYFEN Aug 1994 a 1

QUASSIA Nov 1974 d 6, 2.1

QUINOXYFEN Nov 2001 a 1.3

ROSEMARY OIL Feb 2000 a 7.1

SAGE OIL (Spanish) Feb 2000 a 7.1

SANDALWOOD OIL Feb 2000 a 7.1

SEAWEED & UNFRACTIONED
SEAWEED EXTRACTS Feb 1985 d 1.5

SIMAZINE Nov 1987 a 1.1

SODIUM BICARBONATE Jun 2004 a 1

sodium propionate Oct 2004 a 1.3

STERIC ACID Oct 2005 a 7.1

SUCRALFATE Aug 1982 a 6.8

SULESOMAB Jun 2002 b 6.1

SULFOSULFURON Feb 1998 a 1

SULPHATED POLYSACCHARIDES - a 7.1

TANNIC ACID Dec 1965 a 7.1

TANNIC ACID/BENZYL ALCOHOL
PRODUCT Nov 1993 a 7.1

TERBACIL Aug 1987 a 1

THAUMATIN Nov 1990 a 3.2

THIDIAZURON Nov 1989 a 1

TRIASULFURON Feb 1988 a 1

TRICHODERMA HARZIANUM May 1996 a 1

(Z)-9-TRICOSENE Aug 1991 a 1

TRIETHYLENE GLYCOL Nov 1974 a 7.1

TRIFLOXYSULFURON Feb 2002 a 1.1

TRIFLURALIN Aug 1990 a 1

TRIFORINE Aug 1987 a 1

Ulocladium oudemansii Oct 2003 a 1.10

UREA Nov 1974 a 7.1

13C-UREA May 2001 a 6.1

VETIVER OIL Feb 2000 a 7.1

VINYL ETHER Nov 1987 b 6

VITAMIN K Jul 1963 a 6.9, 2.8

XANTHOPHYLL (lutein) Nov 1974 a 7.1

XYLANASE derived from Aspergillus niger Feb 2005 a 2.4

YLANG YLANG OIL Feb 2000 a 7.1

ZINC NAPHTHENATE - a 1.3

 

 

This Appendix is intentionally blank

 

 

(The following controls apply for the substances shown only when included in Schedule 4 or Schedule 8.)

 

1. Poisons available only from or on the prescription or order of an authorised medical practitioner.

 

 CLOMIPHENE for human use.

 CLOZAPINE for human use.

 CORIFOLLITROPIN ALFA (recombinant follicle stimulant) for human use.

 CYCLOFENIL for human use.

 DINOPROST for human use.

 DINOPROSTONE for human use.

 FOLLITROPIN ALPHA (recombinant human follicle-stimulating hormone) for human use.

 FOLLITROPIN BETA (recombinant human follicle-stimulating hormone) for human use.

 LUTEINISING HORMONE for human use.

 NABIXIMOLS. 

 SODIUM OXYBATE for human use.

 TERIPARATIDE for human use.

 UROFOLLITROPIN (human follicle-stimulating hormone) for human use.

 

2. Poisons available only from or on the prescription or order of a specialist physician or a dermatologist and for which the prescriber must, where the patient is a woman of child-bearing age:

 

 (1) ensure that the possibility of pregnancy has been excluded prior to commencement of treatment; and

 

 (2)  if the drug is -

 

  (a) acitretin or etretinate, advise the patient to avoid becoming pregnant during or for a period of 24 months after completion of treatment; or

 

  (b) bexarotene, isotretinoin or thalidomide, advise the patient to avoid becoming pregnant during or for a period of 1 month after completion of treatment.

 

 ACITRETIN for human use.

 BEXAROTENE for human use.

 ETRETINATE for human use.

 ISOTRETINOIN for human oral use.

 THALIDOMIDE for human use.

 

3. Poisons available only from or on the prescription or order of a medical practitioner authorised or approved by the Secretary of the Commonwealth Department of Health and Ageing under section 19 of the Therapeutic Goods Act 1989.

 

 DRONABINOL (delta-9-tetrahydrocannabinol).

 

4. Poisons available only from or on the order of a specialist physician and for which the prescriber must, where the patient is a woman of child bearing age:

 

 (a) ensure that the possibility of pregnancy has been excluded prior to commencement of treatment; and

 

 (b) advise the patient to avoid becoming pregnant during or for a period of 1 month after completion of treatment.

 

 LENALIDOMIDE.

 RIOCIGUAT for human use.

 TRETINOIN for human oral use.

 

5. Poisons for which possession without authority is illegal (e.g. possession other than in accordance with a legal prescription).

 

 ANABOLIC STEROIDAL AGENTS, including those separately specified in Schedule 4.

 ANDROGENIC STEROIDAL AGENTS, including those separately specified in Schedule 4.

 BENZODIAZEPINE DERIVATIVES, including those separately specified in Schedule 4 and Schedule 8.

 DARBEPOETIN.

 DEXTROPROPOXYPHENE.

 EPHEDRINE.

 EPOETINS.

 ERYTHROPOIETIN.

 ERYTHROPOIETINS except when separately specified in this Appendix.

 FOLLISTATIN.

 GLUTETHIMIDE.

 INSULIN-LIKE GROWTH FACTORS. 

 PERAMPANEL for human use.

 PHENTERMINE.

              SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARM), including those separately specified in Schedule 4.

 SOMATROPIN (human growth hormone).

 

6. Poisons available only from or on the prescription or order of a specialist physician and for which the prescriber must, where the patient is a woman of child-bearing age:

 

 (a) ensure that the possibility of pregnancy has been excluded prior to commencement of treatment; and

 

 (b) advise the patient to avoid becoming pregnant during and for a period of 3 months after completion of treatment.

 

 AMBRISENTAN for human use.

 BOSENTAN for human use.

 MACITENTAN for human use.

 SITAXENTAN for human use.

 

7. Poisons available only from or on the prescription or order of a dermatologist.

 

 ALEFACEPT for human use.

 

 

(other than agricultural and veterinary chemicals (including pesticides) registered by the Australian Pesticides and Veterinary Medicines Authority and medicines for human use when compliant with the requirements of the Required Advisory Statements for Medicine Labels)

 

INTRODUCTION

 

Directions for First Aid Attention

 

Under poisons legislation, scheduled substances and their preparations are required to be labelled with appropriate directions for first aid attention in case of poisoning. It is the responsibility of the manufacturer, packer and supplier of a drug or poison to ensure that the first aid instructions included on the label of a poison are appropriate for a specific product. The following code has been prepared as a guide for health authorities and manufacturers in drafting suitable first aid directions for this purpose.  Standard statements specified in this Appendix may be varied provided that the intent is not changed.

 

The directions listed for any particular substance may require modification to take into account combination of that substance with other substances, both toxic and non toxic, in a formulation, as well as the physical form and presentation of the product.  Any such modification should be concise and readily understood.

 

These First Aid Instructions include action to be taken in case of eye contamination from substances recognised as causing direct poisoning via the eye, causing severe eye damage or requiring prolonged flushing to free the absorbed substance from the eye tissue.  However, it is recognised that many other substances or preparations will require a statement of varying nature depending on the detailed formulation.  While the necessity to flush the eyes in case of accident will be so self-evident as not to justify label space in many instances, a statement such as “If in eyes rinse well with water” may be appropriate.

 

Modified First Aid Instruction on Primary Pack 

 

Where a primary pack contains two or more immediate containers of poisons each requiring different first aid instructions:

 (a)  each immediate container must be labelled with first aid instructions appropriate for its contents; and

 (b) the primary pack must be labelled with the statement:

   FIRST AID: See inner packs.

 

Exempt Preparations

 

This Appendix applies only to scheduled poisons. The directions are for substances and their preparations at the concentrations at which the Schedules apply. If it is thought desirable to show first aid instructions for a substance exempted from the schedules, it is the responsibility of the manufacturer to ensure they are appropriate.

 

Poisons Information Centre Telephone Numbers

 

Companies should use the Poisons Information Centre telephone number(s) (Australia 13 11 26; New Zealand 0800 764 766) appropriate to the country(ies) of sale for the product.

 

Companies wishing to use a poisons information centre telephone number other than the national telephone numbers for Australia and New Zealand must meet the following criteria:

 

1. the poisons information service whose number is used must be attended by adequately trained staff for 24 hour emergency poisons information; and

 

2. calls must be logged and submitted for incorporation into the official collection of poisoning data.

APPENDIX E

 

PART 1

 

STANDARD STATEMENTS

 

To be grouped together and prefaced with the words “FIRST AID” (see subparagraph 7(p) of this Standard).

 

Basic

 

 A For advice, contact a Poisons Information Centre (e.g. phone Australia 13 11 26; New Zealand 0800 764 766) or a doctor (at once).

 

 Z First aid is not generally required.  If in doubt, contact a Poisons Information Centre (e.g. phone Australia 13 11 26; New Zealand 0800 764 766) or a doctor.

 

General

 

 G1 Urgent hospital treatment is likely to be needed. 
(Note the words ‘at once’ to be added to instruction A).

 

 G2 If swallowed, give activated charcoal if instructed.
(Note the words ‘at once’ to be added to instruction A).

 

 G3 If swallowed, do NOT induce vomiting.

 

 G4 Immediately give a glass of water.

 

 G5 Avoid giving milk or oils.

 

 G6 If sprayed in mouth, rinse mouth with water.

 

Eyes

 

 E1 If in eyes wash out immediately with water.

 

 E2 If in eyes, hold eyelids apart and flush the eye continuously with running water.  Continue flushing until advised to stop by a Poisons Information Centre (e.g. phone Australia 13 11 26; New Zealand 0800 764 766) or a doctor, or for at least 15 minutes.

 

Respiratory system

 

 R1 If inhaled, remove from contaminated area.  Apply artificial respiration if not breathing.

 

 R2 If swallowed or inhaled, remove from contaminated area.  Apply artificial respiration if not breathing.  Do not give direct mouth-to-mouth resuscitation.  To protect rescuer, use air-viva, oxy-viva or one-way mask.  Resuscitate in a well-ventilated area.

Skin

 

 S1 If skin or hair contact occurs, remove contaminated clothing and flush skin and hair with running water.

 

 S2 If skin or hair contact occurs, remove contaminated clothing and flush skin and hair with running               water.  Continue flushing with water until advised to stop by a Poisons Information Centre (e.g. phone Australia 13 11 26; New Zealand 0800 764 766) or a doctor.

 

 

 S3 If on skin, remove any contaminated clothing, wash skin thoroughly with soap and water, then               methylated spirit if available.  Contact a Poisons Information Centre (e.g. phone Australia 13 11 26; New Zealand 0800 764 766) or a doctor.

 

 S4 If on skin, immediately remove any contaminated clothing, wash skin with methylated spirit or PEG (polyethylene glycol) 300 or 400 if available, then flush under running water until advised to stop by a Poisons Information Centre (e.g. phone Australia 13 11 26; New Zealand 0800 764 766) or a doctor.

 

 S5 If skin contact occurs, immediately remove contaminated clothing.  Flush skin under running water for 15 minutes.  Then apply calcium gluconate gel.  Contact a Poisons Information Centre (e.g. phone Australia 13 11 26; New Zealand 0800 764 766).

 

Special Purpose

 

 SP1 If swallowed, splashed on skin or in eyes, or inhaled, contact a Poisons Information Centre (e.g. phone Australia 13 11 26; New Zealand 0800 764 766) or a doctor at once.  Remove any contaminated clothing and wash skin thoroughly.  If swallowed, activated charcoal may be advised.  Give atropine if instructed.

APPENDIX E

 

PART 2

 

FIRST AID INSTRUCTIONS

 

Standard statements in this Appendix apply to poisons other than agricultural and veterinary chemicals (including pesticides) registered by the Australian Pesticides and Veterinary Medicines Authority. Labelling is not required at concentrations below scheduled levels (see the Introduction to this Appendix).

 

 

POISON STANDARD STATEMENTS

 

ACeTIC ACID A,G3,E2,S1

 

ACETIC ANHYDRIDE A,G3,E2,S1

 

ACETONE  A,G3

 

ACROLEIN A,G1,G2,G3,E2,R2,S2

 

ALKALINE SALTS  A,G3,E2,S1  

 

AMINES for use as curing agents A,G3,E1,S1

 

4-AMINOPYRIDINE A,G1,G2,E1,S1

 

AMMONIA    

 

 5 per cent or less A

 

 above 5 per cent A,G3,E1,R1,S1 

 

AMMONIUM PERSULFATE A,G3,E2

 

AMMONIUM THIOCYANATE A

 

ANHYDRIDES, organic acid, for use as
curing agents for epoxy resins A,G3,E1,S1

 

ANILINE  A,E2,R1,S1

 

ANISE OIL A,G3

 

ANITMONY CHLORIDE A,E2,S2

  

ANTIMONY COMPOUNDS, except antimony chloride A 

 

AZADIRACHTA INDICA (neem) including its extracts
and derivatives when included in Schedule 6.  A,E1

 

BARIUM SALTS, except barium sulfate A

  

BASIL OIL A,G3

   

BAY OIL A,G3   

 

 

BENZALKONIUM CHLORIDE 

 

 when included in Schedule 5 A,G3,E2

  

 when included in Schedule 6  A,G3,E2,S1  

 

BENZENE A,G3,E1,R1,S1

 

1,2-BENZENEDIOL (Catechol)   A,E1,S1

 

BENZOYL PEROXIDE   

 

 above 20 per cent A,E2,S1

  

 above 10 per cent up to 20 per cent A,E1  

 

 10 per cent or less A  

 

BERGAMOT OIL A,G3   

 

BIFLUORIDES
(including ammonium, potassium and sodium salts)

 

 when included in Schedule 5 A

 

 when included in Schedule 6 or 7 A,G3,E2,S5

 

BORAX A

 

BORIC ACID A

 

BORON TRIFLUORIDE

 

 when included in Schedule 5 A

 when included in Schedule 6 or 7 A,G3,E2,S5

 

BROMOFORM A,G3,E2,R1,S2

 

BRUCINE A,G1,G2,G3,R2

 

2-BUTOXYETHANOL and its acetates A,E2,S1 

 

CADMIUM COMPOUNDS A  

 

CAJUPUT OIL A,G3 

 

CAMPHOR  A,G1,G3,G5

 

CARBAMIDE PEROXIDE

 

 more than 9 per cent up to 60 per cent A,G3,E2,S1

 

 more than 60 per cent A,G1,G3,G4,E2,S1

 

CARBON DISULFIDE A,G3,E2,R1,S2

 

CARBON TETRACHLORIDE A,G3,E1,R1,S1

 

CASSIA OIL A,G3  

 

CHLORINATING COMPOUNDS, except when
separately specified, containing    

 

 above 4 per cent and below 10 per cent
 of available chlorine A,G3,E1,S1

 

 10 per cent or more of available chlorine A,G3,E2,S1 

 

CHLORIDE (gas) A,E1,R1 

 

CHLOROCRESOL A,G3,E2,S2 

 

CHLOROFORM A,G3,E1,R1,S1

 

CHROMATES A,G3,E2,S1

 

CHROMIUM TRIOXIDE A,G3,E2,S1 

 

CINEOLE A,G1,G3  

 

CINNAMON BARK OIL A,G3  

 

CINNAMON LEAF OIL A,G3 

 

CLIMBAZOLE A

 

CLOVE OIL A,G1,G3,E2 

 

COCOYL GLYCINATE E1

 

COPPER SULFATE A,G3,E2,S1

  

CREOSOTE A,G3,E2,S1 

 

CRESOLS A,G3,E2,S3  

 

CRESOLS in pressurised spray packs A,G6,E1,S1  

 

CYANIDES A,G1,E1,R2  

 

CYANOACRYLIC ACID ESTERS A  

 

CYANURIC ACID A  

 

CYCLOHEXANONE PEROXIDE A,G3,E2,S1 

 

CYCTEAMINE  E1

 

ortho-DICHLOROBENZENE      A,G3,E1,S1

 

para-DICHLOROBENZENE (PDB) A 

 

DICHLOROETHYL ETHER A,G3,E1,R1,S1

 

DICHLOROISOCYANURATES A,G3,E1,S1

  

DICHLOROMETHANE (methylene chloride) A,G3,G5,E1,R1,S1

  

 in pressurised spray packs A,G6,S1 

 

DICHROMATES A,G1,G3,E2,S1

 

DIDECYLDIMETHYLAMMONIUM SALTS A,G3

 

DIESEL (distillate)  A,G3  

 

DIETHANOLAMINE   

 

 when included in Schedule 5  A,G3 

  

 when included in Schedule 6  A,G3,E2,S1  

 

5,6-DIHYDROXYINDOLINE  E1

 

DIMETHYLFORMAMIDE    

 

 less than 75 per cent A 

  

 75 per cent or more A,E1,R1,S1  

 

DIMETHYL SULFOXIDE A,G3,E1,S1 

 

DINITROCRESOLS A,G1,E1,S1  

 

DINITROPHENOLS A,G1,E1,S1  

 

DIOXANE A,G3,E1,R1,S1 

 

DISTILLATE A,G3  

 

N-(N-Dodecyl)-2-pyrrolidone

    

 when included in Schedule 5   A,G3,E1  

 

 when included in Schedule 6  A,G3,E2,S1 

 

EPOXY RESINS liquid A,G3,E2,S1  

 

Essential oils containing CAMPHOR as natural
component unless otherwise specified. A,G3

 

ETHANOLAMINE    

 

 when included in Schedule 5  A,G3,E1 

  

 when included in Schedule 6  A,G3,E2,S1  

 

ETHER A,G3,E1,R1 

 

ETHYL BROMIDE A,E2,S1,R1   

 

ETHYLENE GLYCOL A 

 

Ethylene glycol monoalkyl ethers and their
acetates, except when separately specified A,G3,E2,S1  

 

ETHYLENE OXIDE A,E2,R1  

 

EUCALYPTUS OIL A,G1,G3  

 

EUGENOL A,G1,G3,E2  

 

FLUORIDE except when separately specified    

 

 when included in Schedule 5   A 

  

 when included in Schedule 6  A,G1,G3,E2,S1  

 

FORMALDEHYDE (see also paraformaldehyde) A,G3,E2,R1,S1

   

FORMIC ACID A,G3,E2,S1   

 

FURFURAL        A,E1,S1

 

GLUTARALDEHYDE    

 

 below 5 per cent A,G3,E1 

  

 5 per cent or more A,G3,E2,S1  

 

GLYCOLIC ACID A,G3,E2  

 

GUANIDINE when included in Schedule 6 A,G3,E2,S1

 

HEXACHLOROPHANE when included in Schedule 6  A  

 

HEXYLOXYETHANOL    A,G3,E2,S1

 

HYDRAZINE A,G1,G3,E2,R1,S1 

 

HYDROCARBONS, liquid A,G3 

 

HYDROCHLORIC ACID A,G3,E2,S1  

 

 when included in Schedule 5  A,G3   

 

Hydrofluoric acid and admixtures that
generate hydrofluoric acid   

 

 when included in Schedule 5  A 

  

 when included in Schedule 6 or 7 A,G3,E2,S5  

 

 

 

 

HYDROGEN PEROXIDE     

 

 more than 3 per cent up to 20 per cent A,G3,E2,S1 

  

 more than 20 per cent  A,G1,G3,G4,E2,S1  

 

HYDROQUINONE

 

 when included in Schedule 2  A

 

 when included in Schedule 4 or 6 A,G2,G3,E2,R2,S1

 

HYDROSILICOFLUORIC ACID    

 

 when included in Schedule 5  A 

  

 when included in Schedule 6 or 7 A,G3,E2,S5   

 

IODINE (excluding salts, derivatives and iodophors)   

 

 2.5 per cent or more for human external use A,E2  

 

 2.5 per cent or more for other uses A,E2,S1  

 

 below 2.5 per cent A   

 

IODOPHORS  A  

 

ISOCYANATES, free organic A,E2,S1

 

ISOPHORONE A,G3,E2,S1  

 

KEROSENE A,G3   

 

LAURETH CARBOXYLIC ACIDS

 

 leave-on or wash-off preparations above 5 per cent  E1

 

 other preparations above 5 per cent E1,S1

 

LAURYL ISOQUINOLINIUM BROMIDE A,E1   

 

LEAD COMPOUNDS     

 

 in hair cosmetics  A 

  

 in other preparations A,S1  

 

LEMON OIL A,G3   

 

Leptospermum scoparium oil (manuka oil) A,G1,G3

 

LIME OIL A,G3  

 

MAGNESIUM CHLORATE A  

 

MALATHION at 20 per cent or less A  

MARJORAM OIL A,G3  

 

MELALEUCA OIL A,G1,G3  

 

MERURIC CHLORIDE     

 

 for external therapeutic use  A  

 for other uses A,G1,G3,E2,R2,S1  

 

MERCURIC IODIDE A,G1,G3,E2,R2,S1 

 

MERCURIC NIRATE A,G1,G3,E2,R2,S1  

 

MERCURIC OXIDE A,G1,G3  

 

MERCURIC POTASSIUM IODIDE A,G1,G3,E2,R2,S1  

 

MERCURIC THIOCYANATE A,G1,G3,E2,R2,S1  

 

MERCUROCHROME A  

 

MERCUROUS CHLORIDE A  

 

MERCURY metallic A  

 

MERCURY, organic compounds A,S1 

  

 in preparations for human external use A  

 

METALDEHYDE  A,E1,S1 

 

METHANOL     

 

 above 10 per cent A,G3  

 

 10 per cent or less A   

 

METHYLATED SPIRIT A,G3  

 

METHYL ETHYL KETONE A,G3   

 

METHYL ETHYL KETONE OXIME    A,E1,S1

 

METHYL ETHYL KETONE PEROXIDE  A,G3,E2,S1 

 

METHYLEUGENOL  A

 

METHYL ISOAMYL KETONE  A,G3  

 

METHYL ISOBUTYL KETONE  A,G3   

 

N-METHYL-2-PYRROLIDONE    

 

 when included in Schedule 5  A,G3,E1 

  

 when included in Schedule 6 A,G3,E2  

 

Methyl salicylate liquid when included
in Schedule 5 or 6  A,G3,E1  

 

NAPHTHALENE A,G1,G3 

 

NITRIC ACID A,G3,E2,S1  

 

NITROBENZENE A,G3,E1,S1  

 

NITROPHENOL A,G3,E2,S1 

 

NITROPRUSSIDES

 

 in aerosols A,G6,R1

 

 in other preparations A,G3

 

NONOXINOL 9  A,E2 

 

NUTMEG OIL A,G3 

 

2-Octyl-4-isothiazolin-3-one (Ocithilinone)  A,G3,E2,S1

 

N-(N-Octyl)-2-pyrrolidone

 

 when included in Schedule 5 A,G3,E1  

 

 when included in Schedule 6 A,G3,E2  

 

ORANGE OIL (bitter) A,G3   

 

OXALIC ACID A,G3,E2,S1 

 

PARAFORMALDEHYDE A,G3,E2,R1,S1

 

PENNYROYAL OIL A,G3  

 

PERACETIC ACID   

 

 when included in Schedule 5  A,G3,E1,S1 

  

 when included in Schedule 6  A,G3,E2,S1   

 

PETROL A,G3,R1   

 

2-PHENOXYETHANOL       A, E1

 

PHENOLS   

 

 25 per cent and less A,G3,E2,S3 

 

 above 25 per cent A,G3,E2,S4 

 

PEHNOLS in pressurised spray packs A,E1  

 

Phenylenediamines and
alkylated phenylenediamines    

 

 in hair dyes   A,E1   

 

 in other preparations  A,G1,G3,E1,S1  

 

PHENYL METHYL KETONE   

 

 as such, or in preparations of similar viscosity A,G3,E1  

 

N,N-bis(phenylmethylene)-bicyclo
-(2.2.1)heptane-2,5-dimethanamine A,E2,S1  

 

N,N-bis(phenylmethylene)-bicyclo-
(2.2.1)heptane-2,6-dimethanamine A,E2,S1   

 

ortho-PHENYLPHENOL A,G3,E2,S1 

 

 in pressurised spray packs  A,G6,E2,S1   

 

PHOSPHONIC ACID A,G3,E2,S1   

 

 neutralised to pH 6 (approx) A   

 

 in spray packs  A,E2,S1  

 

PHOSPHORIC ACID  A,G3,E2,S1 

 

PHOSPHORUS, yellow A,G1,G3,E2,R2,S2 

 

ortho-PHTHALALDEHYDE   

 

 when included in Schedule 5  A,E1 

  

 when included in Schedule 6  A,G3,E2,S1   

 

PICRIC ACID A,G1,G3,E2,R1,S1 

 

Polyethanoxy (15) tallow amine A,E2,S1 

 

Poly(oxy-1,2-ethanediyl), α -
[2-[(2-hydroxyethyl)amino]-2-
oxoethyl]- α -hydroxy-,mono-C13-15
-alkyl ethers A,E1   

 

POTASIUM BROMATE A   

 

POTASIUM CHLORATE A  

 

POTASSIUM CYANATE A,E1,S1  

 

POTASSIUM HYDROXIDE A,G3,E2,S1   

POTASSIUM METABISULPHITE A  

 

POTASSIUM NITRITE

 

 when included in Schedule 7 A,G1,G3

 

 when included in Schedule 5 or 6 A,G3

 

POTASSIUM PEROXOMONOSULFATE TRIPLE SALT    

 when included in Schedule 5  A,G3,E1 

  

 when included in Schedule 6  A,G3,E2,S1  

 

POTASSIUM PERSULFATE A,G3,E2   

 

POTASSIUM SULFIDE A,G3,E2,S1  

 

PROPIONIC ACID A,G3,E1,S1 

 

d-PULEGONE A,G3   

 

PYRITHIONE ZINC A,E1 

 

QUATERNARY AMMONIUM COMPOUDSError! Bookmark not defined.  except

 when separately specified    

 

 above 20 per cent A,G3,E2 

  

 20 per cent and below A,E2 

  

 in pressurised spray packs A,E2,G6   

 

SALFROLE A,G1,G3  

 

SAGE OIL (Dalmatian) A,G3  

 

SASSAFRAS OIL A,G1,G3   

 

SELENIUM COMPOUNDS  A,G1,E1,S1   

 

SILICOFLUORIDES     

 

 when included in Schedule 5  A 

  

 when included in Schedule 6  A,G1,G3,E2,S1  

 

SILVER SALTS A,E2  

 

SODIUM ALUMINATE A,G3,E2,S1 

  

SODIUM BROMATE A,G1

 

SODIUM CHLORATE A   

 

SODIUM DIACETATE A,G3,E2,S1  

 

SODIUM DICHLOROISOCYANURATE A,G3,E1,S1 

 

SODIUM DODECYLBENZENE SULFONATE A,G3,E2,S1 

 

SODIUM HYDROGEN SULFATE A,G3,E1,S1   

 

SODIUMHYDROSULFITE A,G3,E2,S1  

 

SODIUM HYDROXIDE A,G3,E2,S1  

 

SODIUM LAURETH-6 CABOXYLATE A 

 

SODIUM LAURYL SULFATE

 

 leave-on or wash-off preparations above 5 per cent  E1

 

 other preparations above 5 per cent  E1,S1

 

SODIUM METABISULPHITE A, G3   

 

SODIUM NITRITE  

 

 when included in Schedule 7  A,G1,G3 

  

 when included in Schedule 5 or 6  A,G3  

 

SODIUM PRECARBONATE    

 

 when included in Schedule 5  A,G3,S1 

  

 when included in Schedule 6  A,G3,E2,S1  

 

SODIUM PERSULFATE A,G3,E2   

 

SODIUM STANNATE A,E1  

 

SODIUM SULFIDE A,G3,E2,S1  

 

SODIUM TRICHLOROACETATE A 

 

STRCHNINE A,G1,G2,G3,R2 

 

STYRENE A,G3,S1,E1 

 

SULCOFURON A  

 

SULFAMIC ACID A,G3,E2,S1 

 

SULFURIC ACID A,G3,E2,S1 

 

TERPENES, chlorinated A,G3   

 

TETRACHLOROETHANE A,G3,E1,R1,S1 

 

TETRACHLOROETHYLENE A,G3,E2,R1,S1 

THIOUREA A 

 

THUJONE A,G3  

 

THYME OIL A,G3   

ortho-TOLIDINE A 

 

TOLUENE     

 

 above 75 per cent A,G3,E1,R1,S1

  

 75 per cent and below A,G3 

  

 in pressurised spray packs  A    

 

TOLUENEDIAMINE    

 

 in hair dyes  A,E1 

 

 in other preparations  A,G1,G3,E1,S1   

 

TRICHLOROACETIC ACID A,G3,E2,S1 

 

Trichloroacetic acid alkali salts  A 

 

1,1,1-TRICHLOROETHANE A,G3,E1,R1,S1 

 

TRICHLOROETHYLENE A,G3,E1,R1,S1 

 

TRICHLOROISOCYANURIC ACID A,G3,E1,S1 

 

TRIETHANOLAMINE A,G3,E1,S1  

 

TRIETHYL PHOSPHATE A,E1  

 

TRIFLUOROMETHANESULFONIC ACID A,G3,E2   

 

TRIISOPROPANOLAMINE LAURYL ETHER SULFATE A,E1,S1  

 

TURPENTINE (mineral) A,G3 

 

TURPENTINE OIL (vegetable) A,G3,E2 

 

WHITE SPIRIT A,G3 

 

XYLENE

 

 above 75 per cent A,G3,E1,R1,S1 

 

 75 per cent and below A,G3  

 

 in pressurised spray packs A,G6,E1,S1  

 

XYLENOLS       A,G3,E2,S3   

 

 in pressurised spray packs  A,E1  

 

ZINC CHLORIDE A,G3,E2,S1  

 

ZINC SULFATE       A,G3,E2,S1

 

 

(other than agricultural and veterinary chemicals (including pesticides) registered by the

Australian Pesticides and Veterinary Medicines Authority and medicines for human use

 when compliant with the requirements of the Required Advisory Statements for Medicine Labels)

 

 

INTRODUCTION

 

Warning Statements and Safety Directions

 

It is the responsibility of the manufacturer, packer and supplier of a drug or poison to ensure that the purchaser or user of a product is given sufficient information to be able to use it correctly and safely.

 

Under poisons legislation, scheduled substances, which may be harmful to the user, must be labelled with appropriate warning statements and/or safety directions.  The selection of warning statements and safety directions will depend on the formulation of the product, and the use for which it is sold or supplied.  The following code has been prepared as a guide for this purpose.

 

The wording of warning statements and safety directions specified in this Appendix may be varied provided that the intent is not changed.  Additional statements also may be added to ensure that the user of a product is sufficiently advised of its harmful nature and how to avoid any deleterious effects.

 

Poisons Information Centre Telephone Numbers

 

Companies should use the Poisons Information Centre telephone number(s) (Australia 13 11 26; New Zealand 0800 764 766) appropriate to the country(ies) of sale for  the product.

 

Companies wishing to use a poisons information centre telephone number other than the national telephone numbers for Australia and New Zealand in warning statement No. 99 in Part 1 of this Appendix must meet the following criteria:

 

1. the poisons information service whose number is used must be attended by adequately trained staff for 24 hour emergency poisons information; and

 

2. calls must be logged and submitted for incorporation into the official collection of poisoning data.

 

APPENDIX F

 

PART 1

 

WARNING STATEMENTS

 

1. Highly corrosive.

 

2. Corrosive.

 

3. Corrosive liquid.

 

4. Strongly alkaline.

 

5. Irritant.

 

6. May cause cancer.

 

7. WARNING  Causes birth defects.

 

8. WARNING  May be fatal to children.

 

9. Can be fatal to children if sucked or swallowed.

 

10. May produce severe burns.

 

11. WARNING Vapour may be harmful.

 

12. Vapour is harmful to health on prolonged exposure.

 

13. May be fatal if inhaled, swallowed or absorbed through skin.

 

14. Dust will irritate and burn eyes, nose and skin.

 

15. Liquid will cause burns.

 

16. Forms dangerous gas near radiators or naked flames.

 

17. Contact with eyes even for short periods can cause blindness.

 

18. Product will irritate the eyes, nose, throat and skin.

 

19. WARNING  Skin contact may be dangerous. Take every precaution to avoid contact - wash off after spillage and after use.

 

20. May give off dangerous gas if mixed with other products.

 

21. WARNING  This product contains ingredients which may cause skin irritation to certain individuals. A preliminary test according to accompanying directions should be made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so may be injurious to the eye.

 

22. Highly reactive oxidising chlorine compound.

 

23. May cause fire or explosion.

 

24. For external washing only.  Rinse skin thoroughly after use.

 

25. Do not use on broken skin. Wash hands thoroughly after use.

 

26. (Powder) (and) (concentrated solutions) are dangerous if swallowed.

 

27. Not for therapeutic use.

 

28. (Over) (Repeated) exposure may cause sensitisation.

 

29. If congestion persists, consult your doctor or pharmacist.

 

30. WARNING  Do not use on face or on anal or genital areas.

 

31. WARNING  Do not use on face or on anal or genital areas except on doctor’s advice.

 

32. This preparation should be part of an overall treatment plan regularly assessed with your doctor.

 

33. Do not take for periods longer than four weeks except on medical advice.

 

34. WARNING  This medication may be dangerous when used in large amounts or for a long time (period).

 

35. CAUTION  This preparation is for the relief of minor and temporary ailments and should be used strictly as directed.  Prolonged use without medical supervision could be harmful.

 

    or

 

 CAUTION  This preparation is for the relief of minor and temporary ailments and should be used strictly as directed.  Prolonged or excessive use without medical supervision could be harmful.

 

36. For use under medical supervision only.

 

37. Consult a doctor before giving this medication to children or teenagers with chicken pox, influenza or fever.

 

38. CAUTION  Do not use for children under 2 years old unless a doctor has told you to.

 

39. This medication may cause drowsiness. If affected do not drive a vehicle or operate machinery. Avoid alcohol.

 

40. This medication may cause drowsiness and may increase the effects of alcohol.  If affected do not drive a motor vehicle or operate machinery.

 

41. Do not give to children under 12 years of age.  Do not use beyond 48 hours or in pregnancy or lactation except on doctor’s advice.

 

42. WARNING  Overuse may stain the skin or mouth.

 

43. Use of this product is not necessary in areas supplied with fluoridated water.

 

44. WARNING  May be dangerous, particularly to children, if you use large amounts on the skin, clothes or bedding or on large areas of the body, especially if you keep using it for a long time.

 

45. WARNING  If a pigmented spot or mole has recently become darker, changed colour, become enlarged or itchy, or bleeds, do not use this product, see your doctor immediately.  Do not use on children.  Do not use near the eyes.  Mild irritation may occur; stop use if it becomes severe.  If fading is not evident in three months, seek doctor’s advice.

 

46. WARNING  Contains (name of substance) which causes birth defects in laboratory animals. Women of child bearing age should avoid contact with (name of substance).

 

47. WARNING  This product contains (name of substance) which causes birth defects in certain laboratory animals.  Women of child bearing age are advised not to mix, load or spray this product.  They should keep out of crops being sprayed.

 

48. WARNING  This product forms cyhexatin which causes birth defects in certain laboratory animals.  Women of child bearing age are advised not to mix, load or spray this product. They should keep out of crops being sprayed.

 

49. WARNING  Do not mix with other medication except on veterinarian’s advice.

 

50. Unless adequately fired, utensils glazed with this preparation must not be used as containers for food or beverages; to do so may cause lead poisoning.

 

51.  Irritant to skin, eyes, mucous membranes and upper respiratory tract.

 

52. Breathing vapour or spray mist is harmful and may cause an asthma-like reaction.

 

53. CAUTION  (Name of substance) should not be used by pregnant women.

 

54.  Seek medical advice before first course of treatment.

 

55 Keep from eyes, lips, mouth and sensitive areas of the neck. If excessive swelling, irritation, redness or peeling occurs, discontinue use. If these persist, consult a physician. Avoid excessive exposure to sunlight and other sources of ultra violet light.

 

56. WARNING  Can cause elevated blood pressure and interact adversely with other medication.

 

57. Not to be applied to infants under 12 months of age unless on doctor’s advice.

 

58. Highly reactive oxidising bromine and chlorine compound.

 

59. May cause allergy.

 

60. Do not mix with detergents or other chemicals.

 

61. WARNING  Can react with other medicines. Ask your doctor or pharmacist before taking.

 

62. Do not use if pregnant.

 

63. See a doctor if you are pregnant or diabetic.

 

64. See a doctor (or) (dentist) if no better after (Insert number of days as per approved Product Information) days.

 

65. If getting better, keep using for (Insert number of days as per approved Product Information ) days.

 

66. See a doctor if problem returns.

 

67. Do not use if pregnant or likely to become pregnant.

 

68. If symptoms persist beyond 5 days consult a doctor (or) (dentist).

 

69. If symptoms recur within two weeks of completing the course, consult a doctor.

 

70. Use only under medical supervision if you are taking other medicines.

 

71. Do not use during the last three months of pregnancy.

 

72. Do not use in the eyes.

 

73. Do not use for acne.

 

74. Do not use under waterproof bandages unless a doctor has told you to.

 

75. Do not use for more than 7 days unless a doctor has told you to.

 

76. Do not become pregnant during use or within (Insert number of months as per approved Product Information) month(s) of stopping treatment.

 

77. WARNING May cause birth defects.

 

78. Attacks skin and eyes.

 

79. Will irritate eyes.

 

80. (Intentionally blank)

 

81. (Intentionally blank)

 

82. (Intentionally blank)

 

83. This paint is dangerous to health, even when dry.

 For industrial use only.

 Do not use on toys or furniture.

 Do not use on, in or around the home.

 

84. Breathing the vapour is dangerous.

 Provide adequate ventilation during application.

 Do not use in the presence of a naked flame.

 Do not smoke.

 

85. This paint contains lead and is dangerous to health, even when dry.

 For industrial use only.

 Do not use on toys or furniture.

 Do not use for painting any building or fixed structure.

 Do not use where contact with food or drinking water is possible.

 

86. This tinter contains lead.

 Do not add to any paint which is for application to any toy, furniture, building (interior or exterior), fixed structure or to anything which may contact food or drinking water.

 

87.   (Insert brand name) remains in the body for many months after treatment has stopped.  Do not become pregnant or father a child before consulting your doctor.

 

88. This product is not recommended for dyeing eyelashes or eyebrows.  To do so may be injurious to the eye.

 

89. Application to skin may increase sensitivity to sunlight.

 

90. This preparation is to aid sleep. Drowsiness may continue the following day. If affected do not drive or operate machinery.  Avoid alcohol.

 

91. CAUTION  Total iodine intake may exceed recommended level when taking this preparation.

 

92. WARNING  Contains iodine - do not take when pregnant except on physician’s advice.

 

93. Causes severe burns, which are not likely to be immediately painful or visible.

 

94. WARNING  Contains nitrite. Substitution for table or cooking salt may be dangerous, particularly for young children.

 

95. CAUTION  Do not use for children under 12 years old unless a doctor has told you to.

 

96. CAUTION  This preparation is for the relief of minor and temporary ailments and should be used strictly as directed. If symptoms persist or recur within two weeks, consult a doctor.

 

97. Adults:  Keep to the recommended dose. Don’t take this medicine for longer than a few days at a time unless advised to by a doctor.

 

98. Children and adolescents:  Keep to the recommended dose. Do not give this medicine for longer than 48 hours at a time unless advised to by a doctor.

 

99. If an overdose is taken or suspected, ring the Poisons Information Centre (Australia 13 11 26; New  Zealand 0800 764 766) or go to a hospital straight away even if you feel well because of the risk of delayed, serious liver damage.

 

100. Do not take with other products containing paracetamol, unless advised to do so by a doctor or pharmacist.

 

101. Don’t use [this product/name of the product]:
If you have a stomach ulcer

 In the last 3 months of pregnancy [This statement may be omitted in preparations used exclusively for the treatment of dysmenorrhoea.]

 If you are allergic to (name of substance) or anti-inflammatory medicines.

 

102. Unless a doctor has told you to, don’t use [this prouct/name of the product]:

 For more than a few days at a time

 With other medicines containing aspirin or other anti-inflammatory medicines

 If you have asthma

 In children under 12 years of age

 In children 12-16 years of age with or recovering from chicken pox, influenza or fever

 If you are pregnant.

 

103. See a doctor before taking [this product/name of the product] for thinning the blood or for your heart. [This statement may be omitted in products for inhibition of platelet aggregation or with additional active ingredients.]

 

104. Unless a doctor has told you to, don’t use [this product/name of the product]:

 For more than a few days at a time

 With other medicines containing (name of substance) or other anti-inflammatory medicines

 If you have asthma

 If you are pregnant [This statement may be omitted in preparations used exclusively for the treatment of dysmenorrhoea].

 

105. Do not use on the bedding or clothing of infants or in the bedrooms of children 3 years of age or less.

 

106. Contains formaldehyde.

APPENDIX F

 

PART 2

 

SAFETY DIRECTIONS - GENERAL

 

To be grouped together and prefaced with the words “SAFETY DIRECTIONS” (see Part 2, Labels and Containers, subparagraph 7(n) to this Standard).

 

1. Avoid contact with eyes.

 

2. Attacks eyes protect eyes when using.

 

3. Wear eye protection when mixing or using.

 

4. Avoid contact with skin.

 

5. Wear protective gloves when mixing or using.

 

6. Wash hands after use.

 

7. Wash hands thoroughly after use.

 

8. Avoid breathing dust (or) vapour (or) spray mist.

 

9. Use only in well ventilated area.

 

10. Ensure adequate ventilation when using.

 

11.  No smoking.

 

12. Do not allow product to come into contact with other chemicals, especially acids.

 

13. Do not allow product to come into contact with combustible materials such as paper, fabric, sawdust or kerosene.

 

14. Do not allow to get damp.

 

15. Store under cover in a dry, clean, cool, well ventilated place away from sunlight.

 

16. Store and transport in an upright container.

 

17. Do not mix with other chemicals.

 

18. Do not mix with different types of chlorinating chemicals.

 

19. Use clean containers for dispensing.

 

20. Mix with water only.

 

21. Do not add water to product add product to water, but in case of fire drench with water.

 

22. In case of spillage flush with large quantities of water.

 

23. Keep away from heat, sparks and naked flames.

 

24. Avoid contact of the crystals or strong solutions with the eyes, mouth, nose and other mucous membranes.

 

25. Avoid contact with food.

 

26. Avoid contact with clothing.

 

27. Wear a positive-pressure air-supplied full-face respirator whilst spraying and until spray mist has been effectively dispersed. 

 

28. Do not mix with hot water.

 

29. Obtain a supply of calcium gluconate gel.

 

30. (Intentionally blank.)

 

31. Do not use on broken skin.

 

32. Do not use under occlusive dressing.

 

33. Mix strictly according to instructions.

 

34. May cause fire if it comes into contact with other chemicals, paper or other flammable materials.

 

35. Wash gloves thoroughly, immediately after use.

 

36. Protect cuticles with grease or oil.

APPENDIX F

 

PART 3

 

POISONS (other than agricultural and veterinary chemicals)
TO BE LABELLED WITH WARNING STATEMENTS

OR SAFETY DIRECTIONS

 

(Where more than one statement or direction is required, they may be combined to form simple sentences where appropriate.)

 

__________________________________________________________________________________________

    WARNING SAFETY

POISON  STATEMENTS DIRECTION

________________________________________________________________________________________

 

ACETIC ACID in concentrations of 80 per cent  2 1,4,8

 or more except when in Schedule 2.

 

ACETIC ANHYDRIDE 2 1,4,8

 

ACETONE in concentrations greater than 75 per cent.  1,4,8

   

 

ACITRETIN  7,62,76

 

ADAPALENE for topical use. 62,77

 

ALCLOMETASONE when included in Schedule 3. 38,72,73,74,75

 

ALKALINE SALTS 4 1,4

 

AMBRISENTAN 7,62,76

 

AMINES used as curing agentsfor epoxy resins.   1,3,4,5,8

 

AMMONIA/AMMONIUM HYDROXIDE in concentrations  4 1,4,8

 greater than 20 per cent ammonia except

 in smelling salts.

 

AMMONIUM PERSULFATE  5,21,25 1,5,23,33,34

 

ANHYDRIDES, organic acid, for use as curing agents  1,3,4,5,8

 for epoxy resins.  

 

ANILINE  13 1,4,8

 

ANTIHISTAMINES not separately specified  39 or 40

 in this Appendix except:

 

 (a) dermal, ocular, parenteral and
paediatric preparations;

 

 (b) oral preparations of astemizole,

  desloratadine, fexofenadine,

  loratadine or terfenadine;

 (c) nasal preparations of azelastine; or

 

 (d) preparations for the treatment of animals.

 

AROMATIC EXTRACT OILS  1,3,4,5,6

 

ASPIRIN

 

 (a) for inhibition of platelet aggregation. 36
 

 

 (b) in sustained release  preparations 36
containing 650 mg or more of aspirin.

 

 (c) in other preparations. 101,102,103

 

ASTEMIZOLE  61

 

Azadirachta indica  including its  extracts
and derivatives when included in Schedule 6. 67

 

AZOCYCLOTIN 48

 

BENOMYL 46

 

BENZENE  12 1,4,9

 

1,2-BENZENEDIOL (Catechol)  51,59 1,4,8

 

BENZOYL PEROXIDE when included in Schedule 2. 55

 

BENZOYL PEROXIDE when included in Schedule 5.  1,4,8

 

BERGAMOT OIL 89

 

BERYLLIUM   1,4,8

 

BEXAROTENE

 

 (a) for human use. 7,62,76

 

 (b) for topical use. 62,77

 

BIFLUORIDES (including ammonium, potassium and sodium salts)

 

 (a) when included in Schedule 5. 2 1,4

 

 (b) when included in Schedule 6 or 7. 1,17,93  1,3,4,5,8,29,35

 

BITHIONOL for the treatment of animals.  1,4,8

 

BORON TRIFLUORIDE (including mixtures that

 generate boron trifluoride)

 (a) when included in Schedule 5.  2 1,4

 

 (b) when included in Schedule 6 or 7. 1,17,93 1,3,4,5,8,29,35

 

BOSENTAN  7,62,76

 

BROMOFORM  1,4,8

 

2-Butoxy-2’-thiocyanodiethyl ether  1,4,8

 

2-Butoxyethanol and its acetates  1,4,8

 

CAMPHOR

 

 (a) in block, ball, disc, pellet or flake form, 9 

   enclosed in a device which, in normal use,

   prevents removal or ingestion of its contents.

 

 (b) in other forms. 9 1

 

CARAMIDE PEROXIDE

 

 (a) more than 9 per cent up to 30 per cent. 5 1

 

 (b) more than 30 per cent up to 60 per cent. 5 2

 

 (c) more than 60 per cent. 2 2,4

 

CARBON DISULFIDE 12 1,4,8,9,23

 

CARBON TETRACHLORIDE 12 1,4,8,9

 

CASSIA OIL   4

 

CHLORINATING COMPOUNDS

 

 (a) in household cleaning or bleaching 20

   preparations.

 

 (b) in preparations containing less than 11 1,4,10

   10 per cent of available chlorine.

 

 (c) in liquid preparations containing 3,18 1,4,6,8,10, 15,16,

   10 per cent or more of available chlorine.  17,18, 19,20,22,26

 

 (d) in dry preparations containing 10 per cent  10,18,22,23 1,4,8,12,13,

   or more of available chlorine.  14,15,16,17, 18,

     19,20,21, 22,26

 

 (e) in dry preparations containing 10 per cent 10,18,22 1,4,8,12,13,
  or more of available chlorine certified by a  14,15,16,17,
  relevant State or  Territory authority as not  18,19,20,21,
  being a Dangerous Good of Class 5,  22,26
  Division 5.1:Oxidising substances, as

   specified in the Australian Code for the

   Transport of Dangerous Goods by Road

  and Rail.

 

 (f) in compressed block or tablets containing 10,22,23 12,13,14,15,
  10 per cent or more of  available chlorine  17,18,19,21
  except in preparations for use in toilet
  cisterns only, containing 15 g or less of  

   trichloroisocyanuric acid.

 

 (g) in other compressed blocks or tablets 10,22 12,13,14,15,

   containing 10 per cent or more of available  17,18,19,21

   chlorine certified by a relevant State or

   Territory authority as not being a Dangerous

   Good of Class 5, Division 5.1: Oxidising

   substances, as specified in the Australian

   Code for the Transport of Dangerous Goods

   by Road and Rail except in preparations for

   use in toilet cisterns only, containing 15 g or

   less of trichloroisocyanuric acid.

 

CHLOROFORM when included in Schedule 6  1,4,8

 

alpha-CHLOROHYDRIN 13,51 1,4,8,9

 

CHROMATES (including dichromates) of alkali metals or ammonia  1,4,8

 

CHROMIUM TRIOXIDE 2,14,15,23 1,4,8,13

 

CIMETIDINE when included in Schedule 3 70,96

 

CINNAMON BARK OIL  4

 

CLOBETASONE when included in Schedule 3. 72,73,74,75,95

 

CLOTRIMAZOLE in vaginal preparations when included 54,63,64,66

 in Schedule 3.

  

CLOVE OIL   1

 

CYANIDES when included in Schedule 7. 13 4,8

 

CYANURIC ACID  1,4,8

 

CYCLOHEXANONE PEROXIDE  1,4,8

 

CYCTEAMINE   1

 

4,4-Diaminodiphenylmethane (methylene dianiline)  1,4,8

 

ortho-DICHLOROBENZENE  1,4,8

 

para-DICHLOROBENZENE  1,4

 

DICHLOROETHYLENE  1,4,8

 

DICHLOEOETHYL ETHER  1,4,8

 

DICHLOROISOCYANURATES

 

 (a) in household cleaning or bleaching 20
   preparations. 

 

 (b) in preparations containing less than 11 1,4,10
  10 per cent of  available chlorine. . 

 

 (c) in liquid preparations containing 10 per cent 3,18 1,4,6,8,10,
  or more of available chlorine.  15,16,17,18,
  .  19,20,22,26

 

 (d) in dry preparations containing 10 per cent 10,18,22,23 1,4,8,12,13,14,
  or more of available chlorine.  15,16,17,18,19,
  .  20,21,22,26

 

 (e) in dry preparations containing 10 per cent 10,18,22 1,4,8,12,13,14,

   or more of available chlorine certified by a  15,16,17,18,19,

   relevant State or Territory authority as not  20,21,22,26

   being a Dangerous Good of Class 5,

   Division 5.1: Oxidising substances, as

   specified in the Australian Code for the

   Transport of Dangerous Goods by Road

   and Rail.

 

 (f) in anti-bacterial tablets containing 2.5 g or 60
  less of sodium  dichloroisocyanurate..

  

 (g) in other compressed blocks or tablets containing 10,22,23 12,13,14,15,
  10 per cent or more of available chlorine except  17,18,19,21
  in preparations containing 21 g or less of sodium

    dichloroisocyanurate for use in toilet cisterns only. 

 

 (h) in other compressed blocks or tablets containing 10,22 12,13,14,15,17,

   10 per cent or more of available chlorine  18,19,21

   certified by a relevant State or Territory authority

   as not being a Dangerous Good of Class 5,

   Division 5.1: Oxidising substances, as specified

   in the Australian Code for the Transport of

   Dangerous Goods by Road and Rail except in

   preparations containing 21 g less of sodium

   dichloroisocyanurate for use in toilet cisterns only.

 

 (i) in other compressed blocks or tablets containing

   10 per cent or more of available chlorine  in

   preparations containing 5 g or less of sodium

   dichloroisocyanurate for use in toilet bowls only:

 

  

  (i) during storage 10,22,23 12,13,14,15,17,

      18,21

 

  (ii) during use 5 1,4,7,12

 

 (j) in other compressed blocks or tablets containing

   10 per cent or more of available chlorine certified

   by a relevant State or Territory authority as not

   being a Dangerous Good of Class 5, Division 5.1:

   Oxidising substances, as specified in the

   Australian Code for the Transport of Dangerous

   Goods by Road and Rail in preparations

   containing 5 g or less of sodium dichloroisocyanurate

   for use in toilet bowls only.

  

  (i) during storage 10,22 12,13,14,15,17,

      18,21

 

  (ii) during use 5 1,4,7,12

 

DICHLORMETHANE (methylene chloride)

 

 (a) in paint or lacquer removers. 12,16 1,4,8,11

 

 (b) other than in paint or lacquer removers  1,4,8,25

 

DICLOFENAC  101,104

 

DIENESTROL 67

 

DIETHANOLAMINE when included in Schedule 5. 5 1,4

 

DIETHANOLAMINE when included in Schedule 6. 2,11,18 1,4,8

 

DIETHYLTOLUAMIDE for human use. 44

 

5,6-DIHYDROXYINDOLINE 21,28

 

DIMETHYLFORMAMIDE  1,4,8

 

DIMETHYL SULFATE 2 1,4,8

 

DIMETHYL SULFOXIDE

 

 (a) when not packed and labelled for therapeutic use. 27 1,4,5,8

 

 (b) when packed and labelled for treatment of animals. 49 1,4,5,8

 

DINITROCRESOLS (and their homologues) except when for  1,4,8

  therapeutic use.

 

DINITROPHENOLS (and their homologues) except when  1,4,8

  for therapeutic use.

 

DINOCAP  47

 

DIOXANE   1,4,8

 

DIPHENOXYLATE when included in Schedule 3. 39 or 40,41

 

ECONAZOLE in vaginal preparations when included 54,63,64,66

 in Schedule 3. 

 

EPHEDRINE in nasal preparations for topical use. 29

 

EPICHLOROHYDRIN  2 1,4,8

 

EPOXY RESINS, liquid.  1,3,4,5,8

 

ETHANOLAMINE when included in Schedule 5. 5 1,4

 

ETHANOLAMINE when included in Schedule 6. 2,11,18 1,4,8

 

ETHER when included in Schedule 5 or 6.  1,4,8

 

ETHOXYETHYLMERCURIC CHLORIDE  1,4

 

ETHYL BROMIDE  1,4,8

 

ETHYLENE  CHLOROHYDRIN  1,4,8

 

Ethylene glycol monoalkyl ethers and their acetates  1,4,8

 except when separately specified.

 

ETHYLENE OXIDE  1,4,8

 

ETHYLMERCURIC CHLORIDE  1,4

 

ETHYL METHACRYLATE 28 4,9,23

 

ETRETINATE  7,62,76

 

EUGENOL   1

 

FAMOTIDINE when included in Schedule 2. 96

 

FENTEROL in metered aerosols. 32

 

FLUCONAZOLE in oral preparations when included in 64 
Schedule 3.

 

FLUORIDES (including silicofluorides) when included in  1,4

 Schedule 5 or 6 except when separately specified.

 

FORMALDEHYDE 

 

 (a) in nail hardener cosmetics. 106 1,4,8,36

 

 (b) in other preparations. 106 1,4,8

 

FORMIC ACID   1,4,8

 

FURFURAL  5 1,4

 

Glazing preparations containing LEAD COMPOUNDS. 50

 

GLUTARALDEHYDE except when in Schedule 2

 

 (a) 25 per cent or less. 5,59 1,4,5

 

 (b) more than 25 per cent. 3,59 1,4,5,8

 

GLYCOLIC ACID 79 1,5,6,31

 

HEXACHLOROPHANE in preparations for skin cleansing 24

 purposes containing 3 per cent or less of

 hexachlorophane.

 

HEXLOXYETHANOL    2 1,4,8

 

HYDRAZINE   1,4,8

 

HYDROCLORIC ACID

 

 (a) 30 per cent or less of HCl.  1,4

 

 (b) more than 30 per cent of HCl.  1,4,8

 

HYDROCORTISONE

 

 (a) for dermal use when included in 38,72,73,74,75

   Schedule 2 or 3.

 

 (b) for topical rectal use when includeed 38,75

   in Schedule 2 or 3.

 

HYDROCYANIC ACID when included in Schedule 7. 13 4,8

 

HYDROFLUORIC ACID (including mixtures that generate

 hydrofluoric acid)

 

 (a) when included in Schedule 5. 2 1,4

 

 (b) when included in Schedule 6 or 7. 1,17,93 1,3,4,5,8,29,35

 

HYDROGEN PEROXIDE

 

 (a) more than 3 per cent up to 10 per cent. 5 1

 

 (b) more than 10 per cent up to 20 per cent. 5 2

 

 (c) more than 20 per cent. 2 2,4

 

HYDROQUINONE

 

 (a) when in Schedule 2. 45

 

 (b) except when in Schedule 2 or 4.  1,4

 

HYDROSILICOFLUORIC ACID (including mixtures

 that generate hydrosilicofluoric acid)

 

 (a) when included in Schedule 5. 2 1,4

 

 (b) when included in Schedule 6 or 7. 1,17,93 1,3,4,5,8,29,35

 

8-HYDROXYQUINOLINE (including salts and 33

 derivatives) when prepared for

 internal use.

 

IBUPROFEN   101,104

 

IODINE

 

 (a) more than 20 per cent.  1,4,8

 

 (b) in preparations for human internal therapeutic 91,92
  use containing 300 micrograms or more of

   iodine per recommended daily dose. 

 

IPRATROPIUM BROMIDE in metered aerosols. 32

 

ISOCYANATES (free organic)

 

 (a) when in paint. 28,52 1,5,8,10,27

 

 (b) other than in paint. 28,52 1,4,8

 

ISOPRENALINE in metered aerosols 32

 

ISOTRETINOIN

 

 (a) for human oral use. 7,62,76 

 

 (b) for topical use. 62,77 

 

LEAD COMPOUNDS

 (a) in hair cosmetics. 25

 (b) when in Schedule 6.  1,4,8

 

LEFLUNOMIDE 7,62,87

 

LEMON OIL  89

 

LENALIDOMIDE 7,62,76

 

LEVOCABASTINE

 (a) in eye or nasal preparations containing  62

  0.5 mg/mL or less of levocabastine.

 (b)  in other preparations.  62 and

     either 39 or 40

 

LIME OIL  89

 

LOPERAMIDE when in Schedule 2. 41

 

MAGNESIUM CHLORATE  1,4

 

MEFENAMIC ACID 101,104

 

MERCURIC THIOCYANATE  1,4

 

Metacresolsulphonic acid and formaldehyde  1,4

 condensation product for the treatment of animals.

 

METHANOL except in methylated spirit.  1,4,8

 

METHOXAMINE in nasal preparations for topical use. 29

 

METHYL CHLORIDE  1,4,8

 

METHYL ETHYL KETONE 5 1,4,8

 

METHYL ETHYL KETONE OXIME 5,28 1,4

 

METHYL ETHYL KETONE PEROXIDE 2 2,3,4,6

 

Methyl isoamyl ketone  1,4,8

 

Methyl isobutyl ketone  1,4,8

 

Methyl isothiocyanate 5,12 1,4,8

 

Methyl methacrylate 28 4,9,23

 

METHYLDIBROMO GLUTARONITRILE 28 1,4,7

 

METHYLENE BISTHIOCYANATE  1,4

 

METHYLEUGENOL  1,6

 

METHYLNORBORNYLPYRIDINE 59

 

1-(beta-Methyl sulphonamidoethyl)- 2-amino-3-

 N,N-diethylaminobenzene  1,4,8

 

MICONAZOLE in vaginal preparations when included 54,63,64,66

 in Schedule 3.

 

MISOPROSTOL  53

 

NAPHAZOLINE in nasal preparations for topical use. 29

 

NAPHTHALENE

 

 (a) in block, ball, disc, pellet or flake form, 9,105

  enclosed in a device which, in normal

  use, prevents removal or ingestion of its

  contents.

 

 (b) in other forms. 9,105 1

 

NAPROXEN  101,104

 

NICOTINE except when in tobacco or when included  1,4
in Schedule 2.  

 

NITRIC ACID

 

 (a) 75 per cent or less HNO3. 2 1,4

 

 (b) more than 75 per cent HNO3. 2 1,4,8

 

NITROBENZENE  1,4,8

 

NITROPHENOLS  1,4

 

NITROPRUSSIDES in aerosols. 84 8

 

NIZATIDINE when included in Schedule 2. 96

 

NORADRENALINE in metered aerosols. 32

 

NYSTATIN in vaginal preparations when included 54,63,64,65,66

 in Schedule 3.

 

ORANGE OIL (bitter) 89

 

ORCIPRENALINE in metered aerosols. 32

 

OXALATES, metallic  4,8

 

OXALIC ACID  2 4,8

 

OXYMETAZOLINE in nasal preparations for topical use. 29

 

PAINT

 

 (a)  First Schedule paints. 83

 

 (b)  Second Schedule paints. 84

 

PARACETAMOL 97 and/or 98,99,100

 

PENTACHLOROPEHNOL  1,4,8

 

PERACETIC ACID 2 1,4,8

 

PERMANGANATES 2 24

 

2-PEHNOXYETHANOL        5 1

 

PHENOL and any other homologue of phenol.  1,4

 

PHENOLS   5

 

Phenylenediamines and alkylated
phenylenediamines

 

 (a) in hair dyes. 21

 

 (b) in preparations other than hair dyes.  1,4,8

 

PHENYLEPHRINE in nasal preparations 29

 for topical use.

 

N,N-bis(phenylmethylene)-bicyclo-

(2.2.1)heptane-2,5-dimethanamine 5,28 1,4,5,10

 

N,N-bis(phenylmethylene)-bicyclo-

(2.2.1)heptane-2,6-dimethanamine 5,28 1,4,5,10

 

ortho-PHENYLPHENOL except when in  1,4

 antiseptics.

 

PHENYLPROPANOLAMINE 56

 

PHENYTOIN in pastes for the treatment of horses. 9

 

PHOSPHONIC ACID  1,4

 

PHOSPHORIC ACID  1,4

 

PHOSPHORUS (yellow) 2 1,4

 

ortho-PHTHALADEHYDE 

 

 (a) when included in Schedule 5. 51,52,59 1,4,5,8,10

 

 (b) when included in Schedule 6. 51,52,59 2,4,5,8,10

 

PICRIC ACID (more than 20 per cent).  1,4

 

PODOPHYLLIN

 

 (a) in preparations specifically for use on 36

   anal or genital area. 

 

 (b) in other liquid preparations when included 31

   in Schedule 2 or Schedule 3. 

 

 (c) in other solid or semi-solid preparations 30

   when included in Schedule 2.  

 

PODOPHYLLOTOXIN

 

 (a) in preparations specifically for  36

   use on anal or genital area. 

 

 (b)  in other liquid preparations when included 31

   in Schedule 2 or Schedule 3. 

 

 (c)  in other solid or semi-solid preparations 30

   when included in Schedule 2.  

 

POLIHEXANIDE  1,4,8

 

Polyethanoxy (15) tallow amine  1,4

 

Poly(oxy-1,2-ethanediyl), α -[2-[(2-hydroxyethyl)amino] 5,88 1,5

 -2-oxoethyl]- α -hydroxy-,mono-C13-15 -alkyl ethers    

 

POTASSIUM HYDROXIDE

 

 (a) in preparations containing  5 1,4,6
  0.5 per cent or less of potassium

   hydroxide.

 

 (b) in solid preparations containing  2,10,78 3,5,28

   more than 0.5 per cent of potassium
  hydroxide. 

 

 (c) in liquid preparations containing  2,10,78 3,5
  more than 0.5 per cent of potassium
  hydroxide.

 

POTASSIUM METABISULPHITE 5,26 1,4

 

POTASSIUM NITRITE in pickling or curing salts. 94

 

POTASSIUM PERSULFATE 5,21,25 1,5,23,33,34

 

POTASSIUM SULFIDE 2 1,4

 

PROPIONIC ACID when in Schedule 6. 2 1,4

 

RANITIDINE when included in Schedule 2. 96

 

SAFROLE

 

 (a) in preparations for therapeutic use.  1

 

 (b) other than for therapeutic use.  1,4

 

SALBUTAMOL in metered aerosols or in dry 32
powder formulations. 

 

SALICYLAMIDE 34 or 35

 

SASSAFRAS OIL

 

 (a) in preparations for therapeutic use.  1

 

 (b) other than for therapeutic use.  1,4

 

SELENIUM COMPOUNDS except when for  1,4,8

 therapeutic use (human or animal).

 

SLIVER in smoking deterrents. 42

 

SITAXENTAN     7, 62, 76

 

SODIUM ALUMINATE 2 1,4

 

SODIUM CHLORATE  1,4

 

Sodium dodecylbenzene sulfonate 79 1

 

SODIUM FLUORIDE in preparations for 43

 human ingestion when in Schedule 2.

 

Sodium hydrogen sulfate  1,4,8

 

Sodium hydrosulfite 5,26 1,4,8

 (more than 50 per cent)

 

SODIUM HYDROXIDE

 

 (a) in preparations containing 0.5 per cent 5 1,4,6
  or less of sodium hydroxide. 

 

 (b) in solid preparations containing more than 2,10,78 3,5,28
  0.5 per cent of sodium hydroxide.

 

 (c) in liquid preparations containing more than 2,10,78 3,5
  0.5 per cent of sodium hydroxide. 

 

Sodium laureth-6 carboxylate 79 1

 

SODIUM METABISULPHITE 5,26 1,4

  (more than 50 per cent)

 

SODIUM NITRITE in pickling or curing salts 94

 

SODIUM PERSULFATE 5,21,25 1,5,23,33,34

 

SODIUM SULFIDE 2 1,4

 

STYRENE   1,4,8

 

SULFAMIC ACID 2 1,4

 

SULFURIC ACID 2 1,4

 

SYMPHYTUM SPP. (Comfrey) when included in Schedule 5.  31,32

 

TAZAROTENE for topical use. 77,62

 

TERBUTALINE in metered aerosols or in dry powder formulations. 32 

 

TERFENADINE  61

 

TERIFLUNOMIDE.    7,62,87

 

TERPENES, chlorinated  1,4,8

 

TETRACHLOROETHANE 12 8

 

TETRACHLOROETHYLENE when in Schedule 5 or 6. 12,16 1,4,8,11

 

TETRAHYDROZOLINE in nasal preparations for topical use. 29

 

THALIDOMIDE 7,62,76

 

THIOUREA   1,4

 

TOLUENE   1,4,8

 

TOLUENEDIAMINE

 

 (a)  in hair dyes. 21

 

 (b)  in preparations other than hair dyes.  1,4,8

 

TRAMAZOLINE in nasal preparations for topical use. 29

 

TRETINOIN

 

 (a) for human oral use. 7,62,76 

 

 (b) for topical use. 62,77 

 

TRIAMCINOLONE when in topical preparations 64 or 68

 for the treatment of mouth ulcers.

 

TRICHLOROACETIC ACID except when for 2 1,4

 therapeutic use.

 

1,1,1-trichloroethane  8,9

 

TRICHLOROETHYLENE except when for  12 1,4,5,8,9
therapeutic use.

 

TRICHLOROPHENOL  1,4,8

 

TRIETHANOLAMINE 5 1,4

 

TRIETHYL PHOSPHATE  1,4,8

 

Trifluoromethanesulfonic acid

 

 (a) more than 10 per cent. 1,17 1,4,8

 

 (b) 10 per cent or less.  1,4,8

 

Triisopropanolamine lauryl ether sulfate   1,4,6

 

3,6,9-TRIOXAUNDECANEDIOIC ACID 5 1

 

TYMAZOLINE in nasal preparations for topical use. 29

 

VINCLOZOLIN  46

 

XYLENE   1,4,8

 

XYLOMETAZOLINE in nasal preparations for topical use. 29

  

ZINC CHLORIDE  1,4

 

ZINC SULFATE when in Schedule 6.  1,4

 

 

 

The requirements of this Standard do not apply to a poison listed in Column 1 of this Appendix at a concentration not more than that specified in Column 2 in respect of that poison.

 

Column 1 Column 2

Poison Concentration

 (quantity per litre

 or kilogram)

ACETYLCHOLINE 1 mg

ALDOSTERONE  10 micrograms

ANTIMONY COMPOUNDS 1 mg

APOMORPHINE 1 mg

ARSENIC 1 mg

ATROPA BELLADONNA (belladonna) 300 micrograms

ATROPINE 300 micrograms

CANTHARIDIN 10 micrograms

CHLORINE 5 mg

CROTON TIGLIUM (croton oil) 1 mg

DIOXANE 100 mg

ERYSIMUM spp. 1 mg

FOLLICLE-STIMULATING HORMONE 100 micrograms

GELSEMIUM SEMPERVIRENS 1 mg

GLUCAGON 100 micrograms

GLYCERYL TRINITRATE 100 micrograms

GROWTH HORMONE 10 micrograms

HALOPERIDOL 1 mg

HYDROCYANIC ACID 1 microgram

HYOSCINE 300 micrograms

HYOSCYAMINE 300 micrograms

HYOSCYAMUS NIGER 300 micrograms

HYPOTHALAMIC RELEASING FACTORS 10 micrograms

INDOMETHACIN 1 mg

MERCURY 1 mg

METHYLMERCURY 300 micrograms

NAPHTHALENE 1 mg

NERIUM OLEANDER 1 mg

OESTRADIOL 10 micrograms

OESTRONE 100 micrograms

OXYTOCIN 1 microgram

PHOSPHORUS 1 mg

PODOPHYLLUM RESIN (podophyllin) 1 mg

PROGESTERONE 1 mg

PROPRANOLOL 1 mg

SELENIUM 100 micrograms

STROPHANTHUS spp. 1 mg

STRYCHNINE 1 mg

TESTOSTERONE 1 mg

THYROXINE 10 micrograms

 

 

BUTOCONAZOLE.

CLOTRIMAZOLE.

DICLOFENAC.

DIMENHYDRINATE for the prevention and relief of motion sickness.

DIPHENOXYLATE.

ECONAZOLE.

FLUCONAZOLE.

HYDROCORTISONE.

MICONAZOLE.

NYSTATIN.

 

 

This Appendix is intentionally blank

 

 

 

PART 1

 

CONDITIONS FOR AVAILABILITY AND USE

 

The following controls are recommended for poisons only when included in Schedule 7. These conditions for availability and use may be implemented through poisons controls or other State or Territory legislation.

 

1. Not to be available except to authorised or licensed persons.

 

2. Not to be used in printing inks.

 

3. Not to be used except by or in accordance with the directions of accredited government vermin control officers.

 

4. Not to be used in industries which handle, process or store foods, animal feeds or packaging materials.

 

APPENDIX J

 

PART 2

 

A poison listed in this Appendix is to be available only in accordance with the conditions specified beside it in the “Conditions” column. The conditions apply only when the poison is included in Schedule 7.

 

_________________________________________________________________________________

 

POISONS CONDITIONS

_________________________________________________________________________________

 

ABAMECTIN 1

ACIBENZOLAR-S-METHYL 1

ACROLEIN 1

ACRYLONITRILE 1

ALACHLOR 1

ALLYL ALCOHOL 1

4-AMINOPYRIDINE 1

ARPINOCID 1

ARSENIC 1

AZOCYCLOTIN 1

BENZENE 1

BIFLUORIDE (including ammonium, potassium and sodium salts) 1

BORON TRIFLUORIDE 1

BRODIFACOUM 1

BROMADIOLENE 1

BROMINE 1

BRUCINE    1

CALCIFEROL 1

CAPTAFOL 1

CARBADOX 1

CARBON TETRACHLORIDE 1

CARBONYL SULFIDEError! Bookmark not defined.   1

CHLORDECONE 1

CHLORDIMEFORM 1

CHLORINE 1

CHLOROMETHIURON 1

CHLOROPRCRIN 1

4-CHLORO-O-TOLURIDINE 1

COLECALCIFEROL 1

COUMATETRALYL 1

CYANOGEN 1

CYCHEXATIN 1

4,4-DIAMINODIPHENYLMETHANE (methylene dianiline) 1

1,2-DIBROMO-3-CHLOROPROPANE 1

1,3-DICHLOROPROPENE  1

DIFENACOUM 1

4-DIMETHYLAMINOAZOBENZENE 1

DINITROCRESOLS 1

DINITROPHENOLS 1

DINOSEB 1

EPICHLOROHYDRIN 1

EPIDERMAL GROWTH FACTOR 1

ETACONAZOLE 1

ETHYLENE DIBROMIDE 1

ETHYLENE OXIDE 1

FLUROACETAMIDE   3

FLUOROACETIC ACID 3

FOLPET 1

HALOFUGINONE 1

HALOGENATED DIBENZODIOXINS AND DIBENZOFURANS  1

HCB 1

HYDROCYANIC ACID AND CYANIDES 1

HYDROFLUORIC ACID 1

HYDROSILICOFLUORIC ACID 1

IODOMETHANE 1

MADURAMICIN 1

MERCURY 1

METHACRIFOS 1

METHOXYETHYLMERCURIC ACETATE 1

METHOXYETHYLMERCURIC CHLORIDE 1

METHYL BROMIDE  1

4,4’-METHYLENEBIS[2-CHLOROANILINE] 1

MIREX 1

MOLINATE 1

NICOTINE 1

NITROFEN 1

PHENYLMERCURIC ACETATE 1

PHOSPHIDE,  metallic 1

PHOSPHINE 1

PROPYLENE OXIDE 1

PYRINURON 1

STRYCHNINE 1

SULCOFURON 1

TETRACHLOROETHANE 1

2,2’,6,6’-TETRAISOPROPYL-DIPHENYL-CARBODIMIDE 1

THALLIUM 3

ORTHO-TOLIDINE 1

TRICHLOROISOCYANURIC ACID 1

VINYL CHLORIDE 1  

 

 

 

(see Part 2Controls on Medicines and Poisons, Section 1 – Labels, subsection 1.5.6)

 

Alprazolam

Amisulpride

Amitriptyline

Amylobarbitone

Aripiprazole

ASENAPINE

Azatadine

Baclofen

Benztropine

Bromazepam

Brompheniramine

Buclizine

Buprenorphine

Butobarbitone

Cetirizine

Chloral hydrate

Chlordiazepoxide

Chlormethiazole

Chlorpheniramine

Chlorpromazine

Clemastine

Clomipramine

Clonazepam

Clonidine

Clorazepate

Clozapine

Codeine except when included in Schedule 2 or 3.

Cyclizine

Cyclobarbitone

Cycloserine

Cyproheptadine

Cysteamine

Dantrolene

Desipramine

Dexchlorpheniramine

Dextromoramide

Dextropropoxyphene

Diazepam

Difenoxin

Dihydrocodeine

Dimenhydrinate

Dimethindene

Diphenhydramine

Diphenoxylate

Diphenylpyraline

Dothiepin

Doxepin

Doxylamine

Dronabinol (delta-9-tetrahydrocannabinol)

Droperidol

Duloxetine

Ethylmorphine

Fenfluramine

Flunitrazepam

Flupenthixol

Fluphenazine

Flurazepam

Gabapentin

Gemcitabine

Glutethimide

Haloperidol

Hydrocodone

Hydromorphone

Hydroxyzine

Imipramine

Lamotrigine

Levetiracetam

Levocabastine

Lorazepam

LURASIDONE.

Mazindol

Mebhydrolin

Meclozine

Medazepam

Meprobamate

Mepyramine

Methadone

Methdilazine

Methocarbamol

Methylphenobarbitone

Mianserin

Mirtazapine

Morphine

NABIXIMOLS .

Nalbuphine

Nitrazepam

Normethadone

Nortriptyline

Olanzapine

Opium in any form except the alkaloids noscapine and papaverine.

Oxazepam

Oxycodone

Paliperidone

Papaveretum

Pentazocine

Pentobarbitone

PERAMPANEL

Pericyazine

Perphenazine

Pethidine

Phenelzine

Pheniramine

Phenobarbitone

Phenoperidine

Phenyltoloxamine

Pholcodine

Pimozide

Pizotifen

Prazepam

Pregabalin

Prochlorperazine

Promazine

Promethazine

Protriptyline

Quetiapine

Quinalbarbitone

RETIGABINE

Risperidone

Rotigotine

RUPATADINE

Secbutobarbitone

suvorexant

TAPENTADOL

Temazepam

Thenyldiamine

Thiethylperazine

Thiopropazate

Thioridazine

Thiothixene

Tramadol

Tranylcypromine

Trifluoperazine

Trimeprazine

Trimipramine

Triprolidine

Ziprasidone

Zolpidem

Zonisamide

Zopiclone

 

 

 

 

PART 1

 

GENERAL REQUIREMENTS FOR DISPENSING LABELS

 

(see Part 2, Labels and Containers, subparagraph 14(1))

 

(1) All details, words and other required information on a label on a container of a substance for therapeutic use must be in the English language in letters at least 1.5 millimetres in height.

 

(2) All symbols, numbers and words on a label must be in durable characters.

 

(3) The label on a container of a substance for therapeutic use must contain the following details:

 

 (a) the name, address and telephone number of the dispenser supplying the substance;

 (b) the approved name of the substance and/or its proprietary name (unless it is a preparation compounded in accordance with the dispenser’s own formula);

 (c) adequate directions for use;

 (d) the strength and form of the substance;

 (e) the total quantity of the goods in the container;

 (f) the words “KEEP OUT OF REACH OF CHILDREN” in red on a white background;

 (g) if the substance is intended for external use only, the word “POISON”, or the words “FOR EXTERNAL USE ONLY”, in red on a white background;

 (h) if the substance is a medicine, the name of the person for whom it was dispensed; and

 (i) if the substance is a veterinary chemical, the species of animal, the name of the animal’s owner and the words “FOR ANIMAL TREATMENT ONLY”.

 

(4) The label on a container of a medicine or veterinary chemical that is supplied on prescription must also include:

 

 (a) the prescription reference number;

 (b) the date on which the prescription was supplied (unless that date is clear from the prescription reference number); and

 (c) the directions for use set out in the prescription.

APPENDIX L

 

PART 2

 

ADDITIONAL LABELLING REQUIREMENTS FOR CERTAIN HUMAN MEDICINES

 

(see Part 2, Labels and Containers, subparagraph 14(2))

 

Medicines required to be labelled with certain warning statements A substance listed in Column 1 of the following table must be labelled with the warning statement in Appendix F, Part 1, as specified opposite in Column 2.

 

______________________________________________________________

 Column 1  Column 2

 Substance  Warning statement

 ______________________________________________________________

 

ACITRETIN:

(i)         for oral use. 7,62 and 76

(ii)       for topical use. 62 and 77

 

ADAPALENE:

(i)         for oral use. 7, 62 and 76

(ii)       for topical use. 62 and 77

 

AMBRISENTAN. 7, 62 and 76

 

BEXAROTENE:

(i)         for oral use. 7, 62 and 76

(ii)       for topical use. 62 and 77

 

BOSENTAN. 7, 62 and 76

 

DIENESTROL. 67

 

ETRETINATE:

(i)         for oral use. 7, 62 and 76

(ii)       for topical use. 62 and 77

 

FINGOLIMOD. 76

 

ISOTRETINOIN:

(i)         for oral use. 7, 62 and 76

(ii)       for topical use. 62 and 77

 

LEFLUNOMIDE. 7, 62 and 76

 

LENALIDOMIDE:

(i)         for oral use. 7, 62 and 76

(ii)       for topical use. 62 and 77

 

LEVOCABASTINE. 62

 

MACITENTAN. 7, 62 and 76

 

MISOPROSTOL. 53

 

RIOCIGUAT. 7, 62 and 76

 

SITAXENTAN. 7, 62 and 76

 

___________________________________________________________

 Column 1  Column 2

 Substance  Warning statement

 ______________________________________________________________

 

TERIFLUOMIDE. 7, 62 and 87

 

THALIDOMIDE:

(i)         for oral use. 7, 62 and 76

(ii)       for topical use. 62 and 77

 

TRETINOIN:

(i)         for oral use. 7, 62 and 76

(ii)       for topical use. 62 and 77


INDEX

 

(

(1-(2-MORPHOLIN-4-YLETHYL)INDOL-3-YL)-NAPTHALEN-1-YLMETHANONE...................213

(E)-(S)-1-(4-CHLOROPHENYL)-4,4-DIMETHYL-2-(1H-1,2,4-TRIAZOL-1-YL)PENT-1-EN-3-OL............165

(Z)-9-TRICOSENE.............................................................233

1

1-(3,4,5-TRIMETHOXYPHENYL)-2-AMINOBUTANE.......................................215

1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE........................................215

1-(5-FLUOROPENTYL)-3-(2-IODOBENZOYL)INDOLE.....................................212

1-(8-BROMOBENZO[1,2-B;4,5-B]DIFURAN-4-YL)-2-AMINOPROPANE..........................210

1-(beta-Methyl sulphonamidoethyl)- 2-amino-3-...........................................269

1,1,1-TRICHLOROETHANE................................................156, 220, 251, 274

1,2-BENZENEDIAMINE.........................................................216

1,2-BENZENEDIOL............................................................241, 261

1,2-DIBROMO-3-CHLOROPROPANE................................................200

1,2-DICHLOROPROPANE........................................................171

1,2-ETHANEDIAMINE POLYMERWITH (CHLOROMETHYL)OXIRANE AND N-METHYLMETHANAMINE...140

1,3,5,7-TETRAAZATRICYLO[3.3.1.13,7] DECANE........................................155

1,3-BENZENEDIAMINE.........................................................217

1,3-DICHLOROPROPENE.....................................................200, 280

1,3-DIMETHYLAMYLAMINE.....................................................218

1,4-BUTANEDIOL............................................................217

13C-UREA.................................................................233

19-NORANDROSTENEDIOL......................................................103

19-NORANDROSTENEDIONE.....................................................103

1-AMINOMETHANAMIDE DIHYDROGEN TETRAOXOSULFATE..............................159

1-METHYL-4-PHENYL-4-PIPERIDINOL PROPIONATE.....................................213

1-METHYL-4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID..................................208

1-METHYLCYCLOPROPENE.....................................................231

1-Octen-3-ol.................................................................184

1-PENTYL-3-(1-NAPHTHOYL)INDOLE...............................................214

1-PENTYL-3-(4-METHYL-1-NAPTHOYL)INDOLE........................................214

1-PHENYLETHYL-4-PHENYL-4-PIPERIDINOL ACETATE...................................214

2

2-(2-METHOXYPHENYL)-1-(1-PENTYLINDOL-3-YL)ETHANONE.............................213

2-(4-CHLOROPHENYL)-(1,2,4)TRIAZOLO[5,1-A]ISOQUINOLINE...............................68

2,2’,6,6’-TETRAISOPROPYL-DIPHENYL-CARBODIIMIDE...............................193, 205, 281

2,2-DPA...................................................................229

2,3,6-TBA..................................................................154

2,4,5-T....................................................................192

2,4-D..................................................................138, 170

2,4-DB....................................................................138

2,4-DES...................................................................138

2,4-DICHLORPROP............................................................171

2,4-DINITROCHLOROBENZENE....................................................77

2,4-TOLUENEDIAMINE.........................................................220

2,5-DIMETHOXY-4-(N)-PROPYLTHIOPHENETHYLAMINE..................................211

2,5-DIMETHOXY-4-BROMOAMPHETAMINE...........................................211

2,5-DIMETHOXY-4-ETHYL-a-AMPHETAMINE..........................................211

2,5-DIMETHOXY-4-ETHYLTHIOPHENETHYLAMINE.....................................211

2,5-DIMETHOXY-4-IODOPHENETHYLAMINE..........................................211

2,5-DIMETHOXYAMPHETAMINE..................................................211

2-[(1R,3S)-3-HYDROXYCYCLOHEXYL]-5-(2-METHYLNONAN-2-YL)PHENOL.....................212

2-[(1R,3S)-3-HYDROXYCYCLOHEXYL]-5-(2-METHYLOCTAN-2-YL)PHENOL.....................212

2-AMINO-1-(2,5-DIMETHOXY-4-METHYL)PHENYLPROPANE...............................210

2-BUTOXY-2’-THIOCYANODIETHYL ETHER..........................................163, 262

2-BUTOXYETHANOL.........................................................163, 241, 262

2-CHLORO-6-(TRICHLOROMETHYL)-PYRIDINE........................................166

2-MERCAPTOETHANOL........................................................181

2-METHYL-3-MORPHOLINO-1, 1-DIPHENYLPROPANE CARBOXYLIC ACID......................213

2-METHYLTHIO-4-(2-METHYLPROP-2-YL) AMINO-6-CYCLOPROPYLAMINO-5- TRIAZINE............147

2-NITROTOLUENE............................................................204

2-Octyl-4-isothiazolin-3-one.......................................................247

2-PHENOXYETHANOL......................................................185, 247, 270

2-PROPYLENE GLYCOL 1-MONOMETHYL............................................232

3

3-(1,2-DIMETHYLHEPTYL)-1-HYDROXY-7,8,9,10-TETRAHYDRO-6,6,9- TRIMETHYL-6H-DIBENZO (b,d) PYRAN211

3-(2-DIMETHYLAMINOETHYL)-4-HYDROXYINDOLE....................................211

3,4,5-TRIMETHOXY- α -METHYLPHENYLETHYLAMINE...................................215

3,4,5-TRIMETHOXYPHENETHYLAMINE.............................................215

3,4-DICHLORO-N-{[1- (DIMETHYLAMINO)CYCLOHEXYL]METHYL}BENZAMIDE.................211

3,4-METHYLENEDIOXYAMPHETAMINE.............................................213

3,4-METHYLENEDIOXYPYROVALERONE............................................213

3,6,9-TRIOXAUNDECANEDIOIC ACID............................................157, 274

3-HEXYL-1-HYDROXY-7,8,9,10-TETRAHYDRO-6,6,9-TRIMETHYL-6H-DIBENZO (b,d) PYRAN..........212

3-IODO-2-PROPYNYL BUTYL CARBAMATE........................................144, 178

3-METHYLFENTANYL.........................................................213

3-METHYLTHIOFENTANYL......................................................213

4

4,4’-METHYLENEBIS[2-CHLOROANILINE]...........................................203, 281

4,4-DIAMINODIPHENYLMETHANE................................................200, 263, 280

4,5-DICHLORO-2-N-OCTYL-3(2H)-ISOTHIAZOLONE......................................171

4-[4-(ACETYLOXY)PHENYL]-2-...................................................228

4-AMINOPYRIDINE...................................................57, 196, 240, 280

4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE........................................210

4-CHLOROMETHANDIENONE.....................................................68

4-CHLORO-O-TOLURIDINE.....................................................199, 280

4-CPA....................................................................136

4-CYANO-1-METHYL-4-PHENYLPIPERIDINE..........................................207

4-CYANO-2-DIMETHYLAMINO-4,4’-DIPHENYLBUTANE..................................211

4-DIMETHYLAMINOAZOBENZENE.............................................200, 280

4-FLUORO-N-METHYLAMPHETAMINE..............................................212

4-HYDROYXBUTANOIC ACID....................................................212

4-METHOXY- α -METHYLPHENYLETHYLAMINE.......................................213

4-METHYLAMINOREX..........................................................213

4-METHYLMETHCATHINONE....................................................213

4-METHYLTHIOAMPHETAMINE..................................................213

4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID ETHYL ESTER................................209

5

5-(2-AMINOPROPYL)INDAN.....................................................210

5,6-DIHYDROXYINDOLINE.............................................171, 218, 243, 265

5-AMINOLEVULINIC ACID.......................................................57

5-CHLORO-3-METHYL-4-NITROPYRAZOLE...........................................199

5-METHOXY- α -METHYLTRYPTAMINE.............................................213

5-METHOXY-3,4-METHYLENEDIOXYAMPHETAMINE....................................213

8

8-HYDROXYQUINOLINE.....................................................40, 267

A

ABACAVIR.................................................................54

ABAMECTIN.......................................................131, 158, 196, 280

ABATACEPT................................................................54

ABCIXIMAB.................................................................54

ABIRATERONE ACETATE.......................................................54

ABRUS PRECATORIUS.........................................................216

ABSCISIC ACID..............................................................131

ACAMPROSATE CALCIUM.......................................................54

ACARBOSE.................................................................54

ACEBUTOLOL...............................................................54

ACEPHATE.................................................................158

ACEPROMAZINE.............................................................54

ACETAMIPRID..............................................................158

ACETANILIDE...............................................................54

ACETARSOL................................................................54

ACETAZOLAMIDE............................................................54

ACETIC ACID.........................................................33, 131, 158, 240, 260

ACETIC ANHYDRIDE....................................................158, 240, 260

ACETOHEXAMIDE............................................................54

ACETONE............................................................131, 240, 260

ACETORPHINE..............................................................210

ACETYL ISOVALERYLTYLOSIN...................................................54

ACETYL-ALPHA-METHYLFENTANYL..............................................210

ACETYLCARBROMAL..........................................................54

ACETYLCHOLINE..........................................................54, 276

ACETYLCYSTEINE..........................................................33, 54

ACETYLDIGITOXIN............................................................54

ACETYLDIHYDROCODEINE......................................................207

ACETYLMETHADOL..........................................................207

ACETYLMETHYLDIMETHYLOXIMIDOPHENYLHYDRAZINE................................54

ACETYLMORPHINES..........................................................207

ACETYLSTROPHANTHIDIN......................................................54

ACIBENZOLAR-S-METHYL...................................................196, 280

ACICLOVIR.................................................................54

ACIFLUORFEN..............................................................158

ACINITRAZOLE.............................................................158

ACIPIMOX..................................................................54

ACITRETIN........................................................54, 235, 260, 286

ACLIDINIUM BROMIDE.........................................................54

ACOKANTHERA OUABAIO.......................................................54

ACOKANTHERA SCHIMPERI.....................................................54

ACONITUM spp...............................................................33, 54

ACORUS CALAMUS...........................................................216

ACRIFLAVINE............................................................131, 196

ACRIVASTINE...............................................................55

ACROLEIN...........................................................196, 240, 280

ACRYLONITRILE..........................................................196, 280

ADALIMUMAB...............................................................55

ADAPALENE..........................................................55, 260, 286

ADEFOVIR..................................................................55

ADENOSINE.................................................................55

ADIPHENINE................................................................55

ADONIS VERNALIS............................................................55

ADRAFINIL.................................................................55

ADRENALINE.............................................................48, 55

ADRENOCORTICAL HORMONES...................................................55

AFAMELANOTIDE............................................................55

afatinib dimaleate..............................................................55

AFLIBERCEPT...............................................................55

AFOXOLANER..............................................................131

AGALSIDASE................................................................55

AGLEPRISTONE..............................................................55

AGOMELATINE..............................................................55

AGROBACTERIUM RADIOBACTER..................................................228

AKLOMIDE................................................................131

ALACHLOR.............................................................196, 280

ALATROFLOXACIN MESYLATE...................................................55

ALBENDAZOLE........................................................55, 131, 158

ALCLOFENAC...............................................................55

ALCLOMETASONE.......................................................48, 55, 260

ALCOHOL, DEHYDRATED......................................................228

ALCURONIUM...............................................................55

ALDESLEUKIN...............................................................55

ALDICARB.................................................................196

ALDOSTERONE...........................................................56, 276

ALDOXYCARB..............................................................196

ALDRIN...................................................................158

ALEFACEPT..............................................................56, 236

ALEMTUZUMAB..............................................................56

ALENDRONIC ACID...........................................................56

ALFACALCIDOL..............................................................56

ALFENTANIL...............................................................207

ALFUZOSIN.................................................................56

ALGICIDES.................................................................222

ALGLUCERASE..............................................................56

ALGLUCOSIDASE.............................................................56

ALISKIREN.................................................................56

ALKALINE SALTS................................................131, 158, 216, 240, 260

ALKOXYAMPHETAMINES......................................................210

ALKOXYLATED FATTY ALKYLAMINE POLYMER...................................131, 158

ALKOXYPHENYLETHYLAMINES..................................................210

alkylated phenylenediamines.......................................................248

ALKYLTHIOAMPHETAMINES....................................................210

ALLERGENS................................................................56

ALLETHRIN.............................................................131, 158

ALLOPURINOL...............................................................56

ALLOXYDIM...............................................................131

ALLYL ALCOHOL.........................................................196, 280

ALLYLISOPROPYLACETYLURE...................................................216

ALLYLOESTRENOL............................................................56

ALLYLPRODINE.............................................................210

ALOGLIPTIN................................................................56

ALOSETRON................................................................56

ALOXIPRIN.................................................................33

ALPHA1-PROTEINASE INHIBITOR (HUMAN)...........................................56

ALPHACETYLMETHADOL......................................................207

ALPHA-CHLOROHYDRIN.......................................................165, 263

ALPHA-CYPERMETHRIN.................................................131, 159, 196

ALPHADOLONE..............................................................56

ALPHAMEPRODINE...........................................................210

ALPHAMETHADOL...........................................................210

ALPHA-METHYLFENTANYL.....................................................210

ALPHA-METHYLTHIOFENTANYL.................................................210

ALPHAPRODINE.............................................................207

ALPHAXALONE..............................................................56

ALPRAZOLAM..............................................................207, 282

ALPRENOLOL...............................................................56

ALPROSTADIL...............................................................56

ALSEROXYLON..............................................................56

ALTEPLASE.................................................................56

ALTRENOGEST..............................................................56

ALTRETAMINE (hexamethylmelamine)................................................56

ALUM....................................................................228

ALUMINIUM AMMONIUM SULFATE...............................................228

ALUMINIUM POTASSIUM SULFATE................................................228

ALUMINIUM SILICATE.........................................................228

ALUMINIUM tris (ETHYLPHOSPHONATE)............................................228

AMANTADINE...............................................................56

AMBENONIUM CHLORIDE.......................................................56

AMBRISENTAN........................................................56, 236, 260

AMBRISENTAN..............................................................286

AMBUCETAMIDE.............................................................56

AMBUTONIUM BROMIDE........................................................56

AMCINONIDE................................................................56

AMETHOCAINE............................................................33, 56

AMETOCTRADIN.............................................................228

AMETRYN.................................................................132

AMICARBAZONE............................................................159

AMIDITHION...............................................................159

AMIFOSTINE................................................................57

AMIKACIN..................................................................57

AMILORIDE.................................................................57

AMINACRINE............................................................132, 196

AMINES.............................................................132, 240, 260

AMINOCAPROIC ACID..........................................................57

AMINOCARB............................................................159, 196

AMINOCYCLOPYRACHLOR.....................................................132

AMINOETHOXYVINYLGLYCINE..................................................159

AMINOGLUTETHIMIDE.........................................................57

AMINOMETRADINE...........................................................57

AMINOPHENAZONE..........................................................57, 216

AMINOPHYLLINE...........................................................48, 57

AMINOPTERIN...............................................................57

AMINOPYRALID..........................................................132, 159

AMINOREX.................................................................57

AMINOSALICYLIC ACID........................................................57

AMIODARONE...............................................................57

AMIPHENAZOLE.............................................................57

AMISOMETRADINE............................................................57

AMISULPRIDE...............................................................57, 282

AMITON..................................................................196

AMITRAZ..................................................................159

AMITRIPTYLINE..............................................................57, 282

AMITROLE.................................................................132

AMLODIPINE................................................................57

AMMI VISNAGA..............................................................57

AMMONIA........................................................132, 159, 240, 260

AMMONIUM BROMIDE.........................................................57

AMMONIUM HYDROXIDE......................................................260

AMMONIUM PERSULFATE................................................159, 240, 260

AMMONIUM PHOSPHATE.......................................................228

AMMONIUM THIOCYANATE..................................................132, 240

AMMONIUM THIOSULPHATE....................................................228

AMODIAQUINE..............................................................57

AMOROLFINE.............................................................33, 57

AMOXAPINE................................................................57

AMOXYCILLIN...............................................................57

AMPHETAMINE.............................................................207

AMPHOMYCIN...............................................................57

AMPHOTERICIN..............................................................58

AMPICILLIN.................................................................58

AMPRENAVIR...............................................................58

AMPROLIUM...............................................................228

AMRINONE.................................................................58

AMSACRINE................................................................58

AMYGDALIN...............................................................216

AMYL ACETATE.............................................................228

AMYL NITRITE...............................................................58

α -AMYLASE derived from Aspergillus niger.............................................228

AMYLOBARBITONE........................................................58, 207, 282

AMYLOCAINE...............................................................58

ANABOLIC STEROIDAL AGENTS................................................58, 236

ANAGRELIDE................................................................58

ANAKINRA.................................................................58

ANASTROZOLE..............................................................58

ANCESTIM..................................................................58

ANCHUSA OFFICINALIS........................................................216

ANCROD...................................................................58

ANDROGENIC STEROIDAL AGENTS.............................................58, 236

ANDROISOXAZOLE............................................................58

ANDROSTANOLONE...........................................................58

ANDROSTENEDIOL............................................................58

ANDROSTENEDIONE...........................................................58

ANDROSTENEDIONE ALBUMEN..................................................228

ANECORTAVE...............................................................58

ANGIOTENSIN AMIDE..........................................................58

ANHYDRIDES............................................................240, 260

ANHYDRIDES, ORGANIC ACID...................................................132

ANIDULAFUNGIN.............................................................58

ANILERIDINE...............................................................207

ANILINE............................................................159, 240, 260

ANISE OIL..............................................................132, 240

ANISTREPLASE..............................................................58

ANITMONY CHLORIDE........................................................240

ANTAZOLINE.............................................................33, 58

ANTIBIOTIC SUBSTANCES.......................................................58

ANTIGENS..................................................................58

ANTIHISTAMINES..........................................................58, 260

ANTIMONY.................................................................59

ANTIMONY COMPOUNDS.................................................159, 240, 276

ANTISERA..................................................................59

APIXABAN.................................................................59

APOCYNUM spp...............................................................59

APOMORPHINE...........................................................59, 276

APRACLONIDINE.............................................................59

APRAMYCIN................................................................59

APREPITANT................................................................59

APRONAL..................................................................59

APROTININ.................................................................59

ARECOLINE.................................................................59

ARIPIPRAZOLE...............................................................59, 282

ARISTOLOCHIA spp............................................................216

ARISTOLOCHIC ACID(S)........................................................216

AROMATIC EXTRACT OILS......................................................261

ARPINOCID................................................................280

ARPRINOCID...............................................................196

ARSENIC.......................................................59, 159, 196, 276, 280

ARTEMETHER...............................................................59

ARTICAINE.................................................................59

ASARUM spp................................................................216

ASENAPINE..............................................................59, 282

ASPARTIC ACID.............................................................228

ASPIRIN........................................................33, 59, 132, 159, 261

ASTEMIZOLE.............................................................59, 261

ASULAM..................................................................228

ATAMESTANE...............................................................59

ATAZANAVIR...............................................................59

ATENOLOL.................................................................59

ATIPAMEZOLE...............................................................59

ATOMOXETINE..............................................................59

ATORVASTATIN..............................................................59

ATOSIBAN..................................................................59

ATOVAQUONE...............................................................59

ATRACURIUM BESYLATE.......................................................60

ATRAZINE.................................................................132

ATROPA BELLADONNA (belladonna)...........................................34, 60, 276

ATROPINE.............................................................34, 60, 276

ATROPINE METHONITRATE......................................................60

AURANOFIN................................................................60

AUROTHIOMALATE SODIUM.....................................................60

AVILAMYCIN................................................................60

AVIPTADIL.................................................................60

AVOPARCIN................................................................60

AXITINIB...................................................................60

AZACITIDINE................................................................60

AZACONAZOLE.............................................................160

AZACYCLONOL..............................................................60

AZADIRACHTA INDICA.....................................................160, 216, 240, 261

AZADIRACHTA INDICA EXTRACTS................................................132

AZAFENIDIN...............................................................197

AZAMETHIPHOS.............................................................160

AZAPERONE................................................................60

AZAPROPAZONE.............................................................60

AZARIBINE.................................................................60

Azatadine..................................................................282

AZATADINE..............................................................48, 60

AZATHIOPRINE..............................................................60

AZELAIC ACID.............................................................34, 60

AZELASTINE..............................................................34, 60

AZIMSULFURON.............................................................228

AZINPHOS-ETHYL............................................................197

AZINPHOS-METHYL..........................................................197

AZITHROMYCIN..............................................................60

AZLOCILLIN................................................................60

AZOBENZENE...............................................................160

AZOCYCLOTIN........................................................197, 261, 280

AZOXYSTROBIN.............................................................132

AZTREONAM................................................................60

B

BACAMPICILLIN.............................................................60

BACILLUS SPHAERICUS STRAIN 2362...............................................228

BACILLUS THURINGIENSIS......................................................228

BACILLUS THURINGIENSIS delta endotoxin............................................132

BACILLUS TOYOI.............................................................228

BACITRACIN................................................................60

BACLOFEN.................................................................60, 282

BACTERIAL CULTURE MEDIA....................................................222

BACTERIOCIDES.............................................................222

BACULOVIRUS CYDIA POMONELLA................................................228

BALSALAZIDE...............................................................60

BAMBERMYCIN...........................................................61, 160

BAMBUTEROL...............................................................61

BAMETHAN.................................................................61

BAMIPINE..................................................................61

BARBITURATES..............................................................61

BARIUM SALTS...........................................................160, 240

BARIUM SILICOFLUORIDE......................................................132

BASIC ORANGE 31.........................................................160, 216

BASIL OIL..............................................................133, 240

BASILIXIMAB...............................................................61

BAY OIL...............................................................160, 240

BAZEDOXIFENE..............................................................61

BEAUVERIA BASSIANA.....................................................133, 161

BECAPLERMIN...............................................................61

BECLAMIDE................................................................61

BECLOMETHASONE.........................................................34, 61

BELATACEPT................................................................61

BELIMUMAB................................................................61

BEMEGRIDE................................................................61

BENACTYZINE...............................................................61

BENALAXYL...............................................................133

BENAZEPRIL................................................................61

BENDAMUSTINE.............................................................61

BENDIOCARB.........................................................133, 161, 197

BENDROFLUAZIDE............................................................61

BENETHAMINE PENICILLIN......................................................61

BENFLURALIN..............................................................228

BENOMYL..............................................................197, 261

BENORYLATE...............................................................61

BENOXAPROFEN.............................................................61

BENPERIDOL................................................................61

BENQUINOX................................................................161

BENSERAZIDE...............................................................61

BENSULFURON-METHYL.......................................................228

BENSULIDE................................................................161

BENTAZONE...............................................................133

BENTONITE................................................................228

BENZALKONIUM CHLORIDE...............................................133, 161, 241

BENZATHINE PENICILLIN.......................................................61

BENZENE.........................................................197, 241, 261, 280

BENZETHIDINE..............................................................210

BENZHEXOL................................................................61

BENZIDINE-BASED AZO DYES...................................................197

BENZILONIUM...............................................................61

BENZOCAINE.............................................................34, 61

BENZODIAZEPINE DERIVATIVES.................................................62, 236

BENZOFENAP...............................................................133

BENZOYL PEROXIDE...............................................34, 62, 133, 241, 261

BENZOYLINDOLES...........................................................210

BENZPHETAMINE.............................................................62

BENZTHIAZIDE..............................................................62

BENZTROPINE...............................................................62, 282

BENZYDAMINE............................................................34, 62

BENZYL BENZOATE..........................................................228

BENZYLMORPHINE...........................................................207

BENZYLPENICILLIN...........................................................62

BENZYLPIPERAZINE..........................................................210

BEPHENIUM SALTS............................................................34

BEPRIDIL..................................................................62

BERACTANT................................................................62

BERGAMOT OIL.......................................................133, 241, 261

BERYLLIUM.............................................................161, 261

BESIFLOXACIN..............................................................62

BETACETYLMETHADOL.......................................................210

BETACYFLUTHRIN.....................................................133, 161, 198

BETA-CYPERMETHRIN........................................................161

BETAHISTINE...............................................................62

BETA-HYDROXY-3-METHYLFENTANYL.............................................210

BETA-HYDROXYFENTANYL.....................................................210

BETAINE HYDROCHLORIDE.....................................................228

BETAMEPRODINE............................................................210

BETAMETHADOL............................................................210

BETAMETHASONE............................................................62

BETAPRODINE..............................................................210

BETAXOLOL................................................................62

BETHANECHOL CHLORIDE......................................................62

BETHANIDINE...............................................................62

BEVACIZUMAB..............................................................62

BEVANTOLOL...............................................................62

BEXAROTENE......................................................62, 235, 261, 286

BEZAFIBRATE...............................................................62

BEZITRAMIDE..............................................................207

BHC.....................................................................161

BICALUTAMIDE..............................................................62

BIFENAZATE...............................................................228

BIFENTHRIN.............................................................162, 198

BIFLUORIDES...................................................133, 162, 198, 241, 261, 280

BIFONAZOLE..............................................................35, 62

BIMATOPROST...............................................................62

BIOALLETHRIN...........................................................134, 162

BIORESMETHRIN............................................................134

BIPERIDEN.................................................................63

BISMUTH COMPOUNDS.........................................................63

BISMUTH SUBNITRATE........................................................228

BISOPROLOL................................................................63

BISPYRIBAC................................................................134

BISTRIFLURON..............................................................228

BITHIONOL.............................................................217, 261

BIURET...................................................................228

BIVALIRUDIN...............................................................63

BLEOMYCIN................................................................63

BOCEPREVIR................................................................63

BOLANDIOL................................................................63

BOLASTERONE..............................................................63

BOLAZINE..................................................................63

BOLDENONE (dehydrotestosterone)...................................................63

BOLENOL..................................................................63

BOLMANTALATE.............................................................63

BORAGO OFFICINALIS.........................................................217

BORAX...................................................................241

BORIC ACID.............................................................134, 241

BORON....................................................................63

BORON TRIFLUORIDE..........................................134, 162, 198, 241, 261, 280

BORTEZOMIB...............................................................63

BOSCALID.................................................................228

BOSENTAN........................................................63, 236, 261, 286

BOSUTINIB.................................................................63

BOTULINUM TOXINS..........................................................63

BOVINE SOMATOTROPHIN......................................................228

BRAGANTIA spp.............................................................217

BRENTUXIMAB VEDOTIN.......................................................63

BRETYLIUM TOSYLATE........................................................63

BRIMONIDINE...............................................................63

BRINZOLAMIDE..............................................................63

BRODIFACOUM.......................................................162, 198, 280

BROMACIL.................................................................228

BROMADIOLENE.............................................................280

BROMADIOLONE.........................................................162, 198

BROMAZEPAM...............................................................63, 282

BROMETHALIN...........................................................162, 198

BROMHEXINE...............................................................35

BROMIDES.................................................................64

BROMINE...............................................................198, 280

BROMOCRIPTINE.............................................................64

BROMOFORM.......................................................64, 162, 241, 262

BROMOPHOS...............................................................162

BROMOPHOS-ETHYL..........................................................163

BROMOPROPYLATE..........................................................229

BROMOXYNIL..............................................................163

BROMPHENIRAMINE......................................................35, 48, 64, 282

BROMUCONAZOLE........................................................134, 163

BROMVALETONE.............................................................64

BROTIANIDE...............................................................163

BRUCINE............................................................198, 241, 280

BRUGMANSIA spp.............................................................64

Buclizine...................................................................282

BUCLIZINE...............................................................48, 64

BUCLOSAMIDE..............................................................217

BUDESONIDE.............................................................35, 64

BUFEXAMAC................................................................64

BUFOTENINE...............................................................210

BUMETANIDE...............................................................64

BUNAMIDINE...............................................................163

BUNIODYL SODIUM..........................................................217

BUPHENINE.................................................................64

BUPIRIMATE...............................................................229

BUPIVACAINE............................................................64, 134

BUPRENORPHINE............................................................207, 282

BUPROFEZIN...............................................................134

BUPROPION.................................................................64

BUSERELIN.................................................................64

BUSPIRONE.................................................................64

BUSULPHAN................................................................64

BUTACAINE.................................................................64

BUTACARB................................................................163

BUTAFENACIL..............................................................229

BUTHIDAZOLE..............................................................134

BUTOBARBITONE............................................................207, 282

BUTOCONAZOLE........................................................48, 64, 277

BUTORPHANOL.............................................................207

BUTOXYCARBOXIM.......................................................134, 163

BUTOXYPOLYPROPYLENE GYLCOL...............................................229

BUTRACONAZOLE............................................................64

BUTRALIN.................................................................134

BUTROXYDIM..............................................................134

BUTYL AMINOBENZOATE.......................................................64

BUTYL NITRITE..............................................................64

BUTYLCHLORAL HYDRATE......................................................64

BUTYRIC ACID..............................................................163

C

CABAZITAXEL...............................................................64

CABERGOLINE...............................................................64

CACALIA spp...............................................................217

CACODYLIC ACID.........................................................163, 198

CADMIUM COMPOUNDS..................................................64, 163, 241

CADUSAFOS.............................................................163, 198

CAJUPUT OIL............................................................163, 241

CALCIFEROL.........................................................164, 198, 280

CALCIPOTRIOL..............................................................64

CALCITONIN................................................................64

CALCITRIOL................................................................65

CALCIUM CARBIMIDE..........................................................65

CALCIUM HYDROXYLAPATITE...................................................65

CALCIUM POLYSTYRENE SULPHONATE.............................................65

CALOTROPIS GIGANTEA........................................................65

CALOTROPIS PROCERA.........................................................65

CALUSTERONE..............................................................65

CAMBENDAZOLE............................................................164

CAMPHOR........................................................134, 164, 241, 262

CAMPHORATED OIL...........................................................65

CAMPHOTAMIDE.............................................................65

CANAGLIFLOZIN.............................................................65

CANAKINUMAB..............................................................65

CANDESARTAN CILEXETIL......................................................65

CANDICIDIN................................................................65

CANINE TICK ANTI-SERUM......................................................65

CANNABIS.................................................................210

CANTHARIDIN............................................................65, 276

CAPECITABINE..............................................................65

CAPREOMYCIN..............................................................65

CAPTAFOL..............................................................198, 280

CAPTAN..................................................................164

CAPTODIAME...............................................................65

CAPTOPRIL.................................................................65

CAPURIDE..................................................................65

CARAMIDE PEROXIDE.........................................................262

CARAMIPHEN...............................................................65

CARBACHOL................................................................65

CARBADOX.............................................................198, 280

CARBAMAZEPINE............................................................65

CARBAMIDE PEROXIDE...............................................134, 164, 217, 241

CARBARYL...........................................................65, 134, 164

CARBAZOCHROME............................................................65

CARBENDAZIM.............................................................198

CARBENICILLIN..............................................................65

CARBENOXOLONE............................................................65

CARBETAMIDE..............................................................229

CARBETAPENTANE...........................................................35

CARBETOCIN................................................................65

CARBIDOPA.................................................................66

CARBIMAZOLE..............................................................66

CARBOCISTEINE.............................................................35

CARBOCROMEN..............................................................66

CARBOFURAN..............................................................198

CARBON DISULFIDE.......................................................164, 241

CARBON TETRACHLORIDE.............................................198, 242, 262, 280

CARBONYL SULFIDE..........................................................198

CARBOPHENOTHION..........................................................198

CARBOPLATIN...............................................................66

CARBOPROST...............................................................66

CARBOSULFAN.............................................................198

CARBOXIN.................................................................229

CARBROMAL................................................................66

CARBUTAMIDE..............................................................66

CARBUTEROL...............................................................66

CARFENTANYL.............................................................207

CARFENTRAZONE-ETHYL......................................................229

CARGLUMIC ACID............................................................66

CARINDACILLIN.............................................................66

CARISOPRODOL..............................................................66

CARMUSTINE...............................................................66

CARNIDAZOLE...............................................................66

CARPROFEN................................................................66

CARVEDILOL................................................................66

CASPOFUNGIN...............................................................66

CASSIA OIL..........................................................134, 242, 262

CASTOR OIL, MONOMALEATE...................................................165

CATHINE...................................................................66

CATHINONE................................................................211

CATUMAXOMAB.............................................................66

CEFACETRILE...............................................................66

CEFACLOR.................................................................66

CEFADROXIL................................................................66

CEFALORIDINE..............................................................66

CEFAMANDOLE..............................................................66

CEFAPIRIN.................................................................66

CEFAZOLIN.................................................................66

CEFEPIME..................................................................66

CEFETAMET................................................................66

CEFIXIME..................................................................66

CEFODIZIME................................................................66

CEFONICID.................................................................66

CEFOPERAZONE..............................................................67

CEFOTAXIME................................................................67

CEFOTETAN................................................................67

CEFOTIAM..................................................................67

CEFOVECIN.................................................................67

CEFOXITIN.................................................................67

CEFPIROME.................................................................67

CEFPODOXIME...............................................................67

CEFQUINOME...............................................................67

CEFSULODIN................................................................67

CEFTAROLINE FOSAMIL........................................................67

CEFTAZIDIME...............................................................67

CEFTIBUTEN................................................................67

CEFTIOFUR.................................................................67

CEFTRIAXONE...............................................................67

CEFUROXIME...............................................................67

CELECOXIB.................................................................67

CELIPROLOL................................................................67

CELLULASE................................................................229

CEPHAELIS ACUMINATA........................................................67

CEPHAELIS IPECACUANHA......................................................67

CEPHALEXIN................................................................67

CEPHALONIUM..............................................................67

CEPHALOTHIN...............................................................67

CEPHRADINE................................................................67

CERAMICS.................................................................222

CERIVASTATIN..............................................................67

CERTOLIZUMAB PEGOL........................................................67

CERULETIDE................................................................67

Cetirizine...................................................................282

CETIRIZINE...............................................................35, 67

CETRORELIX................................................................68

CETUXIMAB................................................................68

CETYL ALCOHOL............................................................229

CHAMOMILE OIL............................................................229

CHEMISTRY SETS............................................................222

CHENODEOXYCHOLIC ACID.....................................................68

CHINA CLAY...............................................................229

CHLOPHEDIANOL.............................................................35

CHLORAL FORMAMIDE.........................................................68

CHLORAL HYDRATE...........................................................68, 282

CHLORALOSE............................................................68, 165

CHLORAMBUCIL.............................................................68

CHLORAMPHENICOL........................................................48, 68

CHLORANDROSTENOLONE......................................................68

CHLORANTRANILIPROLE.......................................................229

CHLORAZANIL...............................................................68

CHLORBUTOL.............................................................35, 48

CHLORCYCLIZINE............................................................68

CHLORDANE...............................................................165

CHLORDECONE..........................................................198, 280

CHLORDIAZEPOXIDE..........................................................68, 282

CHLORDIMEFORM........................................................199, 280

CHLORFENAC..............................................................135

CHLORFENAPYR.......................................................135, 165, 199

CHLORFENETHOL............................................................165

CHLORFENSON..............................................................135

CHLORFENVINPHOS..........................................................199

CHLORFLUAZURON..........................................................229

CHLORFLURENOL............................................................229

CHLORHEXIDINE......................................................135, 165, 199

CHLORIDAZON..............................................................229

CHLORIDE.................................................................242

CHLORINATING COMPOUNDS..........................................135, 165, 242, 262

CHLORINE...........................................................199, 276, 280

CHLORMEQUAT.............................................................165

CHLORMERODRIN............................................................68

CHLORMETHIAZOLE...........................................................68, 282

CHLORMEZANONE............................................................68

CHLORNIDINE..............................................................135

CHLOROCRESOL..........................................................135, 242

CHLOROFORM....................................................35, 68, 165, 242, 263

CHLOROMETHIURON......................................................199, 280

CHLOROPHACINONE..........................................................165

CHLOROPICRIN..........................................................165, 199

CHLOROPRCRIN.............................................................280

CHLOROQUINE..............................................................68

CHLOROTHALONIL...........................................................166

CHLOROTHIAZIDE............................................................68

CHLOROTRIANISENE..........................................................68

CHLOROXYDIENONE..........................................................68

CHLOROXYLENOLS..........................................................229

CHLORPHENIRAMINE.....................................................35, 48, 68, 282

CHLORPHENTERMINE..........................................................68

CHLORPROMAZINE...........................................................68, 282

CHLORPROPAMIDE............................................................68

CHLORPROPHAM............................................................135

CHLORPROTHIXENE...........................................................68

CHLORPYRIFOS..........................................................135, 166

CHLORPYRIFOS-METHYL.......................................................166

CHLORQUINALDOL...........................................................69

CHLORSULFURON............................................................135

CHLORTETRACYCLINE......................................................69, 135

CHLORTHAL-DIMETHYL.......................................................135

CHLORTHALIDONE............................................................69

CHLORTHIAMID.............................................................166

CHLORTHIOPHOS............................................................199

CHLORZOXAZONE............................................................69

CHOLERA VACCINE...........................................................69

CHOLESTYRAMINE............................................................69

CHROMATES.........................................................166, 242, 263

CHROMIUM TRIOXIDE...................................................166, 242, 263

CHYMOPAPAIN..............................................................69

CICLACILLIN................................................................69

CICLESONIDE...............................................................69

CICLOPIROX............................................................35, 48, 69

CIDOFOVIR.................................................................69

CILASTATIN................................................................69

CILAZAPRIL................................................................69

CILOSTAZOL................................................................69

CIMETIDINE...........................................................48, 69, 263

CINACALCET................................................................69

CINCHOCAINE.............................................................36, 69

CINCHOPHEN...............................................................217

CINEOLE...............................................................166, 242

CINMETHYLIN..............................................................136

CINNAMEDRINE..............................................................36

CINNAMON BARK OIL...................................................136, 242, 263

CINNAMON LEAF OIL......................................................166, 242

CINOXACIN.................................................................69

CIPROFLOXACIN.............................................................69

CISAPRIDE.................................................................69

CISATRACURIUM BESYLATE.....................................................69

CISPLATIN..................................................................69

CITALOPRAM...............................................................69

CITRONELLA OIL............................................................229

CLADRIBINE................................................................69

CLANOBUTIN...............................................................69

CLARITHROMYCIN............................................................69

CLARY SAGE OIL............................................................229

CLAVULANIC ACID...........................................................69

Clemastine..................................................................282

CLEMASTINE.............................................................48, 69

CLEMIZOLE.................................................................70

CLENBUTEROL..............................................................70

CLETHODIM................................................................136

CLEVIDIPINE................................................................70

CLIDINIUM BROMIDE..........................................................70

CLIMBAZOLE.........................................................136, 167, 242

CLINDAMYCIN...............................................................70

CLIOQUINOL.............................................................70, 217

CLOBAZAM.................................................................70

CLOBETASOL...............................................................70

CLOBETASONE.........................................................48, 70, 263

CLOCORTOLONE.............................................................70

CLODINAFOP-PROPARGYL......................................................167

CLODRONIC ACID............................................................70

CLOFARABINE...............................................................70

CLOFAZIMINE...............................................................70

CLOFENAMIDE..............................................................70

CLOFENTEZINE.............................................................136

CLOFIBRATE................................................................70

CLOMAZONE...............................................................167

CLOMIPHENE.............................................................70, 235

CLOMIPRAMINE..............................................................70, 282

CLOMOCYCLINE.............................................................70

CLONAZEPAM...............................................................70, 282

Clonidine...................................................................282

CLONIDINE.................................................................70

CLONITAZENE..............................................................211

CLOPAMIDE................................................................70

CLOPIDOGREL...............................................................70

CLOPIDOL.................................................................229

CLOPROSTENOL..............................................................70

CLOPYRALID...............................................................136

CLOQUINTOCET-MEXYL.......................................................136

CLORAZEPATE...............................................................70, 282

CLOREXOLONE..............................................................70

CLORPRENALINE.............................................................70

CLORSULON...............................................................136

CLOSANTEL................................................................167

CLOSTEBOL.................................................................70

CLOTHIANIDIN...........................................................136, 167

CLOTRIMAZOLE................................................36, 48, 70, 167, 263, 277

CLOVE OIL........................................................136, 167, 242, 263

CLOXACILLIN...............................................................71

CLOZAPINE..............................................................71, 235, 282

COAL TAR.................................................................217

COBALT...................................................................71

COBALT NAPHTHENATE.......................................................229

COBICISTAT................................................................71

COCA LEAF................................................................211

COCAINE..................................................................207

COCOYL GLYCINATE......................................................168, 242

CODEINE...........................................................36, 48, 71, 207, 282

CODEINE-N-OXIDE...........................................................207

CO-DERGOCRINE.............................................................71

CODOXIME................................................................211

COLASPASE.................................................................71

COLCHICINE................................................................71

COLCHICUM AUTUMNALE......................................................71

COLECALCIFEROL........................................................199, 280

COLESTIPOL................................................................71

COLFOSCERIL PALMITATE......................................................71

COLISTIN..................................................................71

COLLAGEN.................................................................71

COLLAGENASE CLOSTRIDIUM HISTOLYTICUM........................................71

COLOPHONY...............................................................229

CONCENTRATE OF POPPY STRAW.................................................207

CONIUM MACULATUM........................................................217

CONVALLARIA KEISKI.........................................................71

CONVALLARIA MAJALIS........................................................71

COPPER ACETATE.........................................................136, 168

COPPER COMPOUNDS.................................................71, 136, 168, 222

COPPER HYDROXIDE.......................................................136, 168

COPPER NITRATE............................................................168

COPPER OXIDES..........................................................136, 168

COPPER OXYCHLORIDE.....................................................136, 168

COPPER SULFATE......................................................136, 169, 242

CORIFOLLITROPIN ALFA.....................................................71, 235

CORONILLA spp...............................................................71

CORTICOSTERONE............................................................71

CORTICOTROPHIN............................................................71

CORTISONE.................................................................72

COTARNINE................................................................217

CO-TRIMOXAZOLE............................................................72

COUMAPHOS............................................................169, 199

COUMARIN.................................................................72

COUMATETRALYL..................................................136, 169, 199, 280

CREOSOTE.........................................................36, 169, 199, 242

CRESOLS..................................................................242

CRIZOTINIB.................................................................72

CROFELEMER...............................................................72

CROSPOVIDONE.............................................................229

CROTALARIA spp.............................................................217

CROTON TIGLIUM.........................................................217, 276

CROTOXYPHOS.............................................................169

CRUFOMATE...............................................................169

CRYSTAL VIOLET.............................................................72

CULICINOMYCES CLAVOSPORUS..................................................229

CUPRIMYXIN................................................................72

CURARE...................................................................72

CYANAMIDE...............................................................169

CYANATRYN...............................................................136

CYANAZINE................................................................169

CYANIDES...........................................................199, 242, 263

CYANOACRYLATE ESTERS.....................................................136

CYANOACRYLIC ACID ESTERS...................................................242

CYANOGEN.............................................................199, 280

CYANTRANILIPROLE..........................................................137

CYANURIC ACID.......................................................137, 242, 263

CYAZOFAMID..............................................................137

CYCHEXATIN...............................................................280

CYCLAMIC ACID.............................................................229

CYCLANDELATE.............................................................72

CYCLANILIDE..............................................................169

CYCLIZINE...............................................................49, 72, 282

CYCLOBARBITONE...........................................................207, 282

CYCLOBENZAPRINE...........................................................72

CYCLOFENIL.............................................................72, 235

CYCLOHEXANE.............................................................229

CYCLOHEXANOL ACETATE.....................................................229

CYCLOHEXANONE PEROXIDE.............................................137, 242, 263

CYCLOHEXIMIDE.............................................................72

CYCLOHEXYLPHENOLS........................................................211

CYCLOPENTHIAZIDE..........................................................72

CYCLOPENTOLATE............................................................72

CYCLOPHOSPHAMIDE..........................................................72

CYCLOPROPANE.............................................................72

CYCLOPROTHRIN............................................................137

CYCLOSERINE...............................................................72, 282

CYCLOSPORIN...............................................................72

CYCLOTHIAZIDE.............................................................72

CYCLOXYDIM..............................................................137

CYCRIMINE.................................................................72

CYCTEAMINE............................................................242, 263

CYFLUFENAMID.............................................................137

CYFLUTHRIN............................................................137, 169

cyhalofop-butyl...............................................................137

CYHALOTHRIN..............................................................199

CYHEXATIN................................................................199

CYMARIN..................................................................72

CYMIAZOLE................................................................137

CYNOGLOSSUM spp...........................................................217

CYOMETRINIL..............................................................169

CYPERMETHRIN..........................................................137, 169

CYPHENOTHRIN..........................................................137, 169

CYPROCONAZOLE...........................................................137

CYPRODINIL...............................................................137

CYPROHEPTADINE..........................................................49, 72, 282

CYPROTERONE..............................................................72

CYROMAZINE..............................................................229

CYSTEAMINE..........................................................72, 137, 169, 282

CYTARABINE................................................................72

CYTHIOATE.............................................................137, 170

D

DABIGATRAN...............................................................72

DABRAFENIB MESILATE........................................................72

DACARBAZINE..............................................................72

DACLIZUMAB...............................................................72

DACTINOMYCIN.............................................................73

DALFOPRISTIN...............................................................73

DALTEPARIN................................................................73

DAMINOZIDE...............................................................138

DANAPAROID...............................................................73

DANAZOL..................................................................73

DANTHRON.................................................................73

DANTROLENE...............................................................73, 282

DAPAGLIFLOZIN.............................................................73

DAPOXETINE................................................................73

DAPSONE..................................................................73

DAPTOMYCIN...............................................................73

DARBEPOETIN............................................................73, 236

DARIFENACIN...............................................................73

DARUNAVIR................................................................73

DASATINIB.................................................................73

DATURA spp................................................................36, 73

DATURA STRAMONIUM......................................................36, 73

DATURA TATULA..........................................................36, 73

DAUNORUBICIN..............................................................73

DAZOMET.................................................................170

DEANOL...................................................................73

DEBRISOQUINE..............................................................73

DECAMETHONIUM............................................................73

DECOQUINATE..............................................................138

DEFERASIROX...............................................................73

DEFERIPRONE...............................................................73

DEFLAZACORT..............................................................74

DEGARELIX.................................................................74

DEHYDROCHLOROMETHYLTESTOSTERONE..........................................74

DEHYDROCORTICOSTERONE.....................................................74

DELAVIRDINE...............................................................74

DELPHINIUM STAPHISAGRIA.....................................................37

DELTAMETHRIN.......................................................138, 170, 199

DEMBREXINE............................................................74, 138

DEMECARIUM...............................................................74

DEMECLOCYCLINE............................................................74

DEMETON.................................................................199

DEMETON-O-METHYL.........................................................200

DEMETON-S-METHYL.........................................................200

DENOSUMAB................................................................74

DEOXYCORTONE.............................................................74

DEOXYRIBONUCLEASE.........................................................74

DERACOXIB................................................................74

DERQUANTEL..............................................................170

DESFERRIOXAMINE...........................................................74

DESFLURANE...............................................................74

DESIPRAMINE...............................................................74, 282

DESIRUDIN.................................................................74

DESLANOSIDE...............................................................74

DESLORATADINE...........................................................37, 74

DESLORELIN................................................................74

DESMOPRESSIN..............................................................74

DESOGESTREL...............................................................74

DESOMORPHINE.............................................................211

DESONIDE..................................................................74

DESOXYMETHASONE..........................................................74

DESVENLAFAXINE............................................................74

DETOMIDINE................................................................74

DEXAMETHASONE............................................................74

DEXAMPHETAMINE..........................................................207

DEXCHLORPHENIRAMINE..................................................37, 49, 74, 282

DEXFENFLURAMINE...........................................................74

DEXMEDETOMIDINE...........................................................75

DEXTRANS, GELATIN SUCCINYLATED & ETHERIFIED STARCHES..........................222

DEXTROMETHORPHAN.......................................................37, 75

DEXTROMORAMIDE..........................................................207, 282

DEXTROPROPOXYPHENE.................................................75, 207, 236, 282

DEXTRORPHAN..............................................................75

DIAFENTHIURON............................................................138

DIALIFOS..................................................................200

DIAMPROMIDE..............................................................211

DIAMTHAZOLE..............................................................75

DIAVERIDINE...............................................................75

DIAZEPAM.................................................................75, 282

DIAZINON..............................................................138, 170

DIAZOXIDE.................................................................75

DIBENZEPIN................................................................75

DIBENZOPYRANS............................................................211

DIBOTERMIN................................................................75

DIBROMOPROPAMIDINE......................................................37, 75

DICAMBA..............................................................138, 170

DICHLOBENIL..............................................................170

DICHLOEOETHYL ETHER.......................................................263

DICHLOFENTHION...........................................................170

DICHLOFLUANID............................................................170

DICHLONE.................................................................138

DICHLORALPHENAZONE........................................................75

DICHLORMETHANE...........................................................265

DICHLOROBENZENE....................................................138, 170, 242

DICHLOROETHYL ETHER....................................................170, 242

DICHLOROETHYLENE.........................................................263

DICHLOROISOCYANURATES.................................................243, 263

DICHLOROISOCYANURIC ACID................................................138, 170

DICHLOROMETHANE......................................................138, 243

DICHLOROPHEN........................................................75, 139, 171

DICHLORPHENAMIDE..........................................................75

DICHLORVOS.........................................................139, 171, 200

DICHROMATES..............................................................243

DICLAZURIL...............................................................229

DICLOBUTRAZOL............................................................139

DICLOFENAC.....................................................37, 49, 75, 265, 277

DICLOFOP-METHYL..........................................................171

DICLORAN.................................................................139

DICLOXACILLIN..............................................................75

DICOFOL..................................................................139

DICOPHANE................................................................217

DICROTOPHOS..............................................................200

DICYCLANIL...............................................................171

DICYCLOMINE...............................................................75

DIDANOSINE................................................................75

DIDECYLDIMETHYLAMMONIUM SALTS............................................171

DIELDRIN.................................................................171

DIENESTROL.............................................................75, 265, 286

DIENOGEST.................................................................75

DIESEL...................................................................243

DIETHANOLAMINE..................................................139, 171, 243, 265

DIETHAZINE................................................................75

DIETHYL CARBONATE........................................................229

DIETHYLCARBAMAZINE........................................................75

DIETHYLENE GLYCOL...................................................139, 171, 217

DIETHYLENE GLYCOL MONOBUTYL ETHER..........................................139

DIETHYLHEXYL PHTHALATE....................................................218

DIETHYLPHTHALATE.........................................................218

DIETHYLPROPION............................................................75

DIETHYLTHIAMBUTENE.......................................................211

DIETHYLTOLUAMIDE.........................................................265

DIETHYLTOLUAMIDE (DEET)....................................................139

DIFENACOUM.........................................................171, 200, 280

DIFENOCONAZOLE...........................................................139

Difenoxin..................................................................282

DIFENOXIN..............................................................75, 207

DIFENZOQUAT..............................................................171

DIFETHIALONE...........................................................171, 200

DIFLORASONE...............................................................76

DIFLOXACIN................................................................76

DIFLUBENZURON............................................................139

DIFLUCORTOLONE............................................................76

DIFLUFENICAN..............................................................229

DIFLUNISAL................................................................76

DIGITALIS LANATA...........................................................76

DIGITALIS PURPUREA..........................................................76

DIGITOXIN.................................................................76

DIGOXIN...................................................................76

DIGOXIN-SPECIFIC ANTIBODY FRAGMENT F (Ab).......................................76

DIHYDRALAZINE.............................................................76

DIHYDROCODEINE....................................................37, 49, 76, 207, 282

DIHYDROERGOTOXINE.........................................................76

DIHYDROLONE..............................................................76

DIHYDROMORPHINE..........................................................207

DIHYDROSTREPTOMYCIN.......................................................76

DIHYDROTACHYSTEROL........................................................76

DI-IODOHYDROXYQUINOLINE...................................................49, 76

DIISOPROPYLAMINE DICHLOROACETATE............................................76

DIKEGULAC-SODIUM.........................................................229

DILTIAZEM.................................................................76

DIMEFOX..................................................................200

DIMENHYDRINATE....................................................37, 49, 76, 277, 282

DIMENOXADOL.............................................................211

DIMEPHEPTANOL............................................................211

DIMERCAPROL..............................................................76

DIMETHANDROSTANOLONE.....................................................76

DIMETHAZINE...............................................................76

DIMETHENAMID-P...........................................................171

DIMETHICODIETHYLBENZALMALONATE...........................................139

DIMETHICONE..............................................................229

DIMETHINDENE............................................................49, 76, 282

DIMETHIPIN................................................................171

DIMETHIRIMOL.............................................................139

DIMETHOATE...............................................................172

DIMETHOMORPH............................................................140

DIMETHOTHIAZINE...........................................................76

DIMETHOXANATE............................................................77

DIMETHYL ETHER...........................................................229

DIMETHYL FUMARATE.........................................................77

DIMETHYL SULFATE.......................................................200, 265

DIMETHYL SULFOXIDE................................................77, 172, 243, 265

DIMETHYLACETAMIDE.....................................................140, 172

DIMETHYLFORMAMIDE...............................................140, 172, 243, 265

DIMETHYLPHTHALATE........................................................218

DIMETHYLTHIAMBUTENE......................................................211

DIMETILAN................................................................200

DIMETRIDAZOLE.............................................................77

DINICONAZOLE.............................................................140

DINITROCRESOLS.................................................77, 172, 200, 243, 280

DINITRONAPHTHOLS..........................................................77

DINITROPHENOLS.............................................77, 172, 200, 243, 265, 280

DINITROTHYMOLS............................................................77

DINOCAP...............................................................200, 265

DINOPROST..............................................................77, 235

DINOPROSTONE...........................................................77, 235

DINOSEB...............................................................200, 280

DI-N-PROPYL ISOCINCHOMERONATE..............................................140

DIOXACARB................................................................172

DIOXANE.........................................................172, 243, 265, 276

DIOXAPHETYL BUTYRATE......................................................211

DIPERODON.................................................................77

DIPHACINONE..............................................................172

DIPHEMANIL................................................................77

DIPHENAMID...............................................................140

DIPHENHYDRAMINE......................................................37, 49, 77, 282

DIPHENIDOL................................................................77

DIPHENOXYLATE.................................................49, 77, 208, 265, 277, 282

DIPHENYLAMINE............................................................229

DIPHENYLPYRALINE..........................................................77, 282

DIPHTHERIA TOXOID..........................................................77

DIPIPANONE...............................................................208

DIPIVEFRIN.................................................................77

DIPROPYLENE GLYCOL........................................................229

DIPYRIDAMOLE..............................................................77

DIQUAT................................................................172, 200

DIRITHROMYCIN.............................................................77

DIRLOTAPIDE...............................................................77

DISOPHENOL................................................................77

DISOPYRAMIDE..............................................................77

DISTIGMINE................................................................77

DISTILLATE................................................................243

DISULFIRAM.............................................................77, 172

DISULFOTON............................................................172, 200

DISULPHAMIDE..............................................................77

DITHIANON................................................................172

DITHIAZANINE............................................................78, 172

DITHIOPYR................................................................140

DITHRANOL................................................................49

DITIOCARB.................................................................78

DIUREDOSAN...............................................................172

DIURON...................................................................229

DOBUTAMINE...............................................................78

DOCETAXEL................................................................78

DOCUSATE SODIUM..........................................................229

DODINE...................................................................173

DOFETILIDE................................................................78

DOLASETRON...............................................................78

DOLUTEGRAVIR.............................................................78

DOMPERIDONE..............................................................78

DONEPEZIL.................................................................78

DOPAMINE.................................................................78

DOPEXAMINE...............................................................78

DORAMECTIN.........................................................140, 173, 200

DORIPENEM................................................................78

DORNASE..................................................................78

DORZOLAMIDE..............................................................78

DOTHIEPIN.................................................................78, 282

DOXANTRAZOLE.............................................................78

DOXAPRAM.................................................................78

DOXAZOSIN................................................................78

DOXEPIN...................................................................78, 282

DOXORUBICIN...............................................................78

DOXYCYCLINE..............................................................78

DOXYLAMINE...........................................................38, 49, 78, 282

d-PHENOTHRIN..............................................................232

d-PULEGONE............................................................188, 249

drometrizole trisiloxane..........................................................229

DRONABINOL............................................................208, 235, 282

DRONEDARONE..............................................................78

DROPERIDOL................................................................78, 282

DROSPIRENONE..............................................................78

DROSTANOLONE.............................................................78

DROTEBANOL..............................................................208

DROTRECOGIN..............................................................78

DSMA.................................................................173, 200

DUBOISIA LEICHHARDTII.....................................................38, 78

DUBOISIA MYOPOROIDES.....................................................38, 78

DULCIN...................................................................218

DULOXETINE................................................................78, 282

DUTASTERIDE...............................................................79

DYDROGESTERONE...........................................................79

E

ECGONINE.................................................................211

ECONAZOLE...................................................38, 49, 79, 173, 265, 277

ECOTHIOPATE...............................................................79

ECTYLUREA................................................................79

ECULIZUMAB...............................................................79

EDETIC ACID................................................................79

EDOXUDINE................................................................79

EDROPHONIUM..............................................................79

EFALIZUMAB................................................................79

EFAVIRENZ.................................................................79

EFLORNITHINE..............................................................79

EFORMOTEROL..............................................................79

ELECTRICAL ACCUMULATORS, BATTERIES, COMPONENTS or LAMPS........................222

ELECTRONIC COMPONENTS.....................................................222

ELETRIPTAN................................................................79

ELOSULFASE ALFA............................................................79

ELTENAC..................................................................79

ELTROMBOPAG..............................................................79

ELVITEGRAVIR..............................................................79

EMAMECTIN.........................................................140, 173, 200

EMEPRONIUM...............................................................79

EMETINE...................................................................79

EMODEPSIDE............................................................140, 173

EMPAGLIFLOZIN.............................................................79

EMTRICITABINE..............................................................79

ENALAPRIL.................................................................79

ENDOSULFAN............................................................173, 200

ENDOTHAL.............................................................173, 200

ENDRIN...................................................................200

ENESTEBOL.................................................................79

ENFLURANE................................................................79

ENFUVIRTIDE...............................................................80

ENHANCING AGENTS.........................................................222

ENOBOSARM................................................................80

ENOXACIN.................................................................80

ENOXAPARIN...............................................................80

ENOXIMONE................................................................80

ENPROSTIL.................................................................80

ENROFLOXACIN..............................................................80

ENTACAPONE...............................................................80

ENTECAVIR.................................................................80

EPHEDRA spp................................................................80

EPHEDRINE...........................................................80, 236, 265

EPICHLOROHYDRIN....................................................200, 265, 280

EPICILLIN..................................................................80

EPIDERMAL GROWTH FACTOR................................................200, 280

EPINASTINE.................................................................80

EPIRUBICIN.................................................................80

EPITIOSTANOL...............................................................80

EPLERENONE................................................................80

EPOETINS...............................................................80, 236

EPOPROSTENOL..............................................................80

EPOXICONAZOLE............................................................140

EPOXY RESINS...........................................................243, 265

EPOXY RESINS, LIQUID........................................................140

EPRINOMECTIN..........................................................140, 200

EPROSARTAN...............................................................80

EPSIPRANTEL...............................................................229

EPTC.....................................................................173

EPTIFIBATIDE...............................................................80

ERGOMETRINE..............................................................80

ERGOT....................................................................80

ERGOTAMINE...............................................................80

ERGOTOXINE................................................................80

ERIBULIN MESYLATE..........................................................80

ERLOTINIB.................................................................80

ERTAPENEM................................................................80

ERYSIMUM spp...............................................................80, 276

ERYTHRITYL TETRANITRATE....................................................49

ERYTHROMYCIN.............................................................80

ERYTHROPOIETIN.........................................................80, 236

ERYTHROPOIETINS.........................................................81, 236

ESBIOTHRIN.............................................................140, 173

ESCITALOPRAM..............................................................81

ESFENVALERATE.........................................................140, 173

ESMOLOL..................................................................81

ESOMEPRAZOLE...........................................................50, 81

ESTRAMUSTINE..............................................................81

ESTROPIPATE...............................................................81

ETACONAZOLE...........................................................200, 280

ETAFEDRINE................................................................38

ETANERCEPT................................................................81

ETHACRYNIC ACID............................................................81

ETHAMBUTOL...............................................................81

ETHAMETSULFURON-METHYL...................................................230

ETHAMIVAN................................................................81

ETHANOLAMINE.................................................81, 140, 173, 243, 266

ETHCHLORVYNOL............................................................81

ETHEPHON.................................................................173

ETHER......................................................38, 81, 140, 173, 243, 266

ETHINAMATE...............................................................81

ETHINYLOESTRADIOL.........................................................81

ETHIOFENCARB.............................................................173

ETHION...................................................................200

ETHIONAMIDE...............................................................81

ETHISTERONE...............................................................81

ETHOATE-METHYL...........................................................173

ETHOFUMESATE.............................................................140

ETHOGLUCID................................................................81

ETHOHEPTAZINE.............................................................81

ETHOPABATE...............................................................230

ETHOPROPAZINE.............................................................81

ETHOPROPHOS...........................................................173, 201

ETHOSUXIMIDE..............................................................81

ETHOTOIN..................................................................81

ETHOXYETHYLMERCURIC CHLORIDE..............................................266

ETHOXYQUIN...............................................................140

ETHOXYSULFURON..........................................................140

ETHOXZOLAMIDE............................................................81

ETHYL ACETATE............................................................230

ETHYL ALCOHOL............................................................230

ETHYL BROMIDE......................................................173, 243, 266

ETHYL BUTYRATE...........................................................230

ETHYL CHLORIDE............................................................81

Ethyl formate................................................................173

ETHYL LACTATE............................................................230

ETHYL METHACRYLATE....................................................141, 266

ETHYLAMPHETAMINE.........................................................208

ETHYLBUTYLACETYL-........................................................230

ETHYLDIENOLONE............................................................81

ETHYLENE CHLOROHYDRIN....................................................173, 266

ETHYLENE DIBROMIDE.....................................................201, 280

ETHYLENE DICHLORIDE.......................................................173

ETHYLENE GLYCOL.................................................141, 173, 218, 244

Ethylene glycol monoalkyl ethers....................................................174, 244, 266

ETHYLENE OXIDE...................................................201, 244, 266, 280

ETHYLHEXANEDIOL........................................................81, 218

ETHYLMERCURIC CHLORIDE....................................................266

ETHYLMETHYLTHIAMBUTENE...................................................212

ETHYLMORPHINE.......................................................38, 81, 208, 282

ETHYLOESTRENOL............................................................82

ETHYNODIOL...............................................................82

ETICYCLIDINE..............................................................212

ETIDOCAINE................................................................82

ETIDRONIC ACID.............................................................82

ETILEFRIN..................................................................82

ETIPROSTON................................................................82

ETODOLAC.................................................................82

ETOFENAMATE............................................................38, 82

ETONITAZENE..............................................................212

ETONOGESTREL..............................................................82

ETOPOSIDE.................................................................82

ETORICOXIB................................................................82

ETORPHINE................................................................212

ETOXAZOLE................................................................230

ETOXERIDINE..............................................................212

ETRAVIRINE................................................................82

ETRETINATE.......................................................82, 235, 266, 286

ETRIDIAZOLE...............................................................141

ETRIMFOS.................................................................174

EUBACTERIUM sp. strain DSM11798.................................................230

EUCALYPTUS OIL.........................................................174, 244

EUGENOL........................................................141, 174, 244, 266

EUPATORIUM CANNABINUM....................................................218

EVEROLIMUS................................................................82

EXEMESTANE...............................................................82

EXENATIDE.................................................................82

EXPLOSIVES...............................................................222

EXTRACT OF LEMON EUCALYPTUS................................................141

EZETIMIBE.................................................................82

F

FAMCICLOVIR.............................................................50, 82

FAMOTIDINE...........................................................38, 82, 266

FAMPHUR..............................................................175, 201

FARFUGIUM JAPONICUM ......................................................218

FEBANTEL.................................................................175

FEBUXOSTAT...............................................................82

FELBINAC................................................................38, 82

FELODIPINE.................................................................82

FELYPRESSIN...............................................................82

FENAMIPHOS............................................................175, 201

FENARIMOL................................................................141

FENAZAFLOR...............................................................175

FENBENDAZOLE.............................................................141

FENBUCONAZOLE............................................................141

FENBUFEN.................................................................82

FENBUTATIN OXIDE..........................................................175

FENCAMFAMIN..............................................................82

FENCHLORAZOLE-ETHYL......................................................141

FENCHLORPHOS.............................................................175

FENCLOFENAC..............................................................82

FENETYLLINE..............................................................212

FENFLURAMINE..............................................................82, 282

FENFURAM................................................................230

FENHEXAMID...............................................................230

FENITROTHION.............................................................175

FENOFIBRATE...............................................................82

FENOLDOPAM...............................................................83

FENOPROFEN................................................................83

FENOPROP.................................................................141

FENOTEROL................................................................83

FENOXACRIM............................................................175, 201

FENOXAPROP-ETHYL.........................................................141

FENOXAPROP-P-ETHYL........................................................141

FENOXYCARB..............................................................230

FENPIPRAMIDE..............................................................83

FENPIPRANE................................................................83

FENPROPOREX...............................................................83

FENPROSTALENE.............................................................83

FENPYROXIMATE............................................................175

FENSON...................................................................141

FENSULFOTHION............................................................201

FENTANYL.................................................................208

FENTEROL.................................................................266

FENTHION...........................................................141, 175, 201

FENTHION-ETHYL............................................................201

FENVALERATE..............................................................175

FEXOFENADINE............................................................38, 83

FIBRINOLYSIN...............................................................83

FIDAXOMICIN...............................................................83

FILGRASTIM................................................................83

FINASTERIDE................................................................83

FINGOLIMOD.............................................................83, 286

FIPRONIL...............................................................141, 175

FIROCOXIB.................................................................83

FLAMPROP-METHYL..........................................................141

FLAMPROP-M-METHYL........................................................141

FLAVOXATE................................................................50

FLAZASULFURON............................................................141

FLECAINIDE................................................................83

FLEROXACIN................................................................83

FLOCOUMAFEN..........................................................175, 201

FLOCTAFENINE..............................................................83

FLONICAMID...............................................................175

FLORASULAM..............................................................141

FLORFENICOL...............................................................83

FLUANISONE................................................................83

FLUAZIFOP-BUTYL...........................................................175

FLUAZIFOP-P-BUTYL..........................................................175

FLUAZINAM................................................................175

FLUAZURON...............................................................141

FLUBENDAZOLE.............................................................141

FLUBENDIAMIDE............................................................141

FLUCHLORALIN.............................................................142

FLUCLOROLONE.............................................................83

FLUCLOXACILLIN............................................................83

FLUCOFURON............................................................175, 201

FLUCONAZOLE......................................................50, 83, 266, 277

FLUCYTHRINATE............................................................201

FLUCYTOSINE...............................................................83

FLUDARABINE...............................................................83

FLUDIOXONIL..............................................................142

FLUDROCORTISONE...........................................................83

fluensulfone.................................................................176

FLUFENAMIC ACID............................................................84

FLUFENOXURON............................................................230

FLUMAZENIL................................................................84

FLUMETHASONE.............................................................84

FLUMETHIAZIDE.............................................................84

FLUMETHRIN............................................................142, 176

FLUMETSULAM.............................................................230

flumiclorac pentyl.............................................................142

FLUMIOXAZIN...........................................................176, 201

FLUNISOLIDE...............................................................84

Flunitrazepam................................................................282

FLUNITRAZEPAM............................................................208

FLUNIXIN MEGLUMINE.........................................................84

FLUOCINOLONE..............................................................84

FLUOCINONIDE..............................................................84

FLUOCORTIN................................................................84

FLUOCORTOLONE............................................................84

FLUOMETURON.............................................................230

FLUORESCEIN...............................................................84

FLUORIDES......................................................39, 50, 84, 142, 176, 244, 266

FLUOROACETAMIDE..........................................................201

FLUOROACETIC ACID......................................................201, 280

FLUOROMETHOLONE..........................................................84

FLUOROURACIL..............................................................84

FLUOXETINE................................................................84

FLUOXYMESTERONE..........................................................84

FLUPENTHIXOL..............................................................84, 283

FLUPHENAZINE..............................................................84, 283

FLUPROPANATE.............................................................176

FLUPROSTENOL..............................................................84

FLUQUINCONAZOLE..........................................................176

FLURALANER...............................................................142

FLURANDRENOLONE..........................................................84

FLURAZEPAM...............................................................84, 283

FLURBIPROFEN............................................................39, 84

FLUROACETAMIDE...........................................................280

FLUROXENE................................................................84

FLUROXYPYR..............................................................230

FLUSILAZOL...............................................................176

FLUSPIRILENE...............................................................84

FLUTAMIDE.................................................................84

FLUTICASONE.............................................................39, 84

FLUTOLANIL...............................................................230

FLUTRIAFOL...............................................................176

FLUVALINATE...........................................................142, 176

FLUVASTATIN...............................................................84

FLUVOXAMINE..............................................................84

FLUXAPYROXAD............................................................142

FOLIC ACID...............................................................39, 84

FOLINIC ACID.............................................................39, 84

FOLLICLE-STIMULATING HORMONE.............................................85, 276

FOLLISTATIN.............................................................85, 236

FOLLITROPIN ALPHA.......................................................85, 235

FOLLITROPIN BETA........................................................85, 235

FOLPET................................................................201, 280

FOMIVIRSEN................................................................85

FONDAPARINUX.............................................................85

FOOD....................................................................222

FORAMSULFURON...........................................................142

FORCHLORFENURON.........................................................230

FORMALDEHYDE.................................................39, 176, 218, 244, 266

FORMALDEHYDE CONDENSATION PRODUCT.........................................181

FORMEBOLONE..............................................................85

FORMESTANE...............................................................85

FORMETANATE.............................................................201

FORMIC ACID.........................................................142, 244, 266

FORMOTHION..............................................................176

FOSAMPRENAVIR.............................................................85

FOSAPREPITANT.............................................................85

FOSCARNET................................................................85

FOSFESTROL................................................................85

FOSINOPRIL.................................................................85

FOSPHENYTOIN..............................................................85

FOSPIRATE.............................................................142, 176

FOSTHIAZATE..............................................................201

FOTEMUSTINE...............................................................85

FRAMYCETIN...............................................................85

FRITTED GLAZING OR ENAMELLING PREPARATIONS...................................222

FULLERS EARTH.............................................................230

FULVESTRANT...............................................................85

FUMAGILLIN...............................................................176

FUNGAL PROTEASE derived from..................................................230

FURALAXYL...............................................................142

FURALTADONE..............................................................85

FURATHIOCARB..........................................................142, 201

FURAZABOL................................................................85

FURAZOLIDONE..............................................................85

FURETHIDINE...............................................................212

FURFURAL...........................................................176, 244, 266

FUROSEMIDE................................................................85

FUSIDIC ACID...............................................................85

G

GABAPENTIN................................................................85, 283

GALANTAMINE..............................................................85

GALANTHUS spp..............................................................85

GALLAMINE................................................................85

GALSULFASE................................................................85

GAMMA HYDROXYBUTYRATE...................................................212

GAMMA-CYHALOTHRIN....................................................142, 201

GANCICLOVIR...............................................................85

GANIRELIX.................................................................85

GATIFLOXACIN..............................................................85

GEFITINIB..................................................................86

GELSEMIUM SEMPERVIRENS..................................................40, 276

GEMCITABINE...............................................................86, 283

GEMEPROST................................................................86

GEMFIBROZIL...............................................................86

GEMIFLOXACIN..............................................................86

GEMTUZUMAB OZOGAMICIN....................................................86

GENTAMICIN................................................................86

GERANIUM OIL..............................................................230

GESTODENE................................................................86

GESTONORONE..............................................................86

GESTRINONE................................................................86

GHRH INJECTABLE PLASMID.....................................................86

GIBBERELLIC ACID...........................................................230

GITALIN...................................................................86

GLASS....................................................................222

GLATIRAMER ACETATE........................................................86

GLAZED POTTERY...........................................................222

GLIBENCLAMIDE.............................................................86

GLIBORNURIDE..............................................................86

GLICLAZIDE................................................................86

GLIMEPIRIDE................................................................86

GLIPIZIDE..................................................................86

GLISOXEPIDE...............................................................86

GLUCAGON..............................................................50, 276

-GLUCANASE derived from Aspergillus niger...........................................230

GLUFOSINATE-AMMONIUM.....................................................142

GLUTARALDEHYDE...............................................40, 142, 176, 244, 266

GLUTATHIONE...............................................................86

GLUTETHIMIDE...........................................................86, 236, 283

GLYCERYL THIOGLYCOLLATE...................................................177

GLYCERYL TRINITRATE...................................................50, 86, 276

GLYCOLIC ACID.......................................................177, 244, 266

GLYCOPYRRONIUM.........................................................50, 86

GLYMIDINE.................................................................86

GLYPHOSATE...............................................................142

GnRH VACCINE..............................................................86

GOLIMUMAB................................................................86

GONADORELIN..............................................................86

GONADOTROPHIC HORMONES....................................................86

GOSERELIN.................................................................86

GRAMICIDIN................................................................86

GRANISETRON...............................................................87

GREPAFLOXACIN.............................................................87

GRISEOFULVIN..............................................................87

GROWTH HORMONE..........................................................276

GUAIPHENESIN............................................................40, 87

GUANABENZ................................................................87

GUANACLINE...............................................................87

GUANETHIDINE..............................................................87

GUANIDINE...........................................................87, 177, 244

GUAZATINE................................................................177

H

HACHIMYCIN...............................................................87

HAEMATIN.................................................................87

HAEMOPHILUS INFLUENZAE VACCINE..............................................87

HALAUXIFEN METHYL........................................................230

HALCINONIDE...............................................................87

HALOFANTRINE..............................................................87

HALOFENATE...............................................................87

HALOFUGINONE.......................................................87, 201, 281

HALOGENATED DIBENZODIOXINS AND DIBENZOFURANS.............................201, 281

HALOPERIDOL............................................................87, 276, 283

HALOSULFURON-METHYL......................................................142

HALOTHANE................................................................87

HALOXON.................................................................177

HALOXYFOP...............................................................177

HARMALA ALKALOIDS........................................................212

HCB..................................................................201, 281

HELIOTROPIUM spp...........................................................218

HEMEROCALLIS..............................................................87

HEPARINS..................................................................87

HEPATITIS A VACCINE.........................................................87

HEPATITIS B VACCINE.........................................................87

HEPTACHLOR...............................................................177

HEROIN...................................................................212

HETACILLIN................................................................87

HEXACHLOROPHANE...............................................40, 87, 177, 244, 267

HEXACONAZOLE............................................................142

HEXAFLURON..............................................................230

HEXAMETHONIUM............................................................88

HEXAZINONE............................................................142, 177

HEXETIDINE................................................................88

HEXLOXYETHANOL..........................................................267

HEXOBENDINE..............................................................88

HEXOCYCLIUM..............................................................88

HEXOPRENALINE.............................................................88

HEXYL ACETATE............................................................230

HEXYLOXYETHANOL......................................................177, 244

HEXYTHIAZOX..............................................................230

HISTAMINE.................................................................88

HMG-CoA REDUCTASE INHIBITORS................................................88

HOMATROPINE..............................................................88

HUMAN BLOOD PRODUCTS.....................................................222

HUMAN CHORIONIC GONADATROPHIN..............................................88

HUMAN OSTEOGENIC PROTEIN-1 (OP-1).............................................230

HUMAN PAPILLOMAVIRUS VACCINE...............................................88

HYALURONIC ACID AND ITS POLYMERS.............................................88

HYDRALAZINE..............................................................88

HYDRAMETHYLNON.......................................................142, 177

HYDRARGAPHEN.............................................................88

HYDRAZINE..........................................................177, 244, 267

HYDROCARBONS............................................................244

HYDROCARBONS LIQUID AROMATIC..............................................201

HYDROCARBONS, LIQUID......................................................143

HYDROCHLORIC ACID...................................................143, 177, 244, 267

HYDROCHLOROTHIAZIDE.......................................................88

HYDROCODONE.............................................................208, 283

HYDROCORTISONE.................................................40, 50, 88, 267, 277

HYDROCORTISONE ACETATE..................................................40, 50

HYDROCYANIC ACID.................................................88, 202, 267, 276

HYDROCYANIC ACID AND CYANIDES..............................................281

HYDROFLUMETHIAZIDE........................................................88

HYDROFLUORIC ACID................................................143, 177, 202, 281

HYDROGEN PEROXIDE............................................143, 177, 218, 245, 267

HYDROGEN SULFIDE..........................................................202

HYDROMORPHINOL..........................................................208

HYDROMORPHONE...........................................................208, 283

HYDROPRENE..............................................................230

HYDROQUINONE..................................................40, 88, 178, 245, 267

HYDROSILICOFLUORIC ACID........................................143, 178, 202, 245, 267

HYDROXYCHLOROQUINE.......................................................88

HYDROXYEPHEDRINE.........................................................88

HYDROXYPETHIDINE.........................................................212

HYDROXYPHENAMATE.........................................................89

HYDROXYPROGESTERONE......................................................89

HYDROXYPROPYL CELLULOSE..................................................230

HYDROXYSTENOZOL..........................................................89

HYDROXYUREA..............................................................89

HYDROXYZINE..............................................................89, 283

HYGROMYCIN...............................................................89

HYOSCINE............................................................40, 89, 276

HYOSCINE BUTYLBROMIDE.....................................................40

HYOSCYAMINE...........................................................41, 276

HYOSCYAMUS NIGER.......................................................41, 276

HYPOTHALAMIC RELEASING FACTORS..........................................89, 276

HYPROMELLOSE.............................................................89

I

IBAFLOXACIN...............................................................89

IBANDRONIC ACID............................................................89

IBOGAINE..................................................................89

IBRITUMOMAB..............................................................89

IBUFENAC..................................................................89

IBUPROFEN.........................................................41, 51, 89, 268

IBUTEROL..................................................................89

IBUTILIDE..................................................................89

ICATIBANT.................................................................89

ICODEXTRIN...............................................................230

IDARUBICIN................................................................89

IDOXURIDINE...............................................................89

IDURSULFASE...............................................................89

IFOSFAMIDE................................................................89

ILOPROST..................................................................89

IMATINIB..................................................................89

IMAZALIL.................................................................143

IMAZAMOX................................................................143

IMAZAPIC.................................................................143

IMAZAPYR.................................................................143

IMAZETHAPYR..............................................................143

IMEPITOIN..................................................................90

IMIDACLOPRID...........................................................143, 178

IMIDAPRIL.................................................................90

IMIDOCARB................................................................178

IMIGLUCERASE..............................................................90

iminoctadine trialbesilate.........................................................178

IMIPENIM..................................................................90

IMIPRAMINE................................................................90, 283

IMIPROTHRIN............................................................143, 178

IMIQUIMOD.................................................................90

IMMUNOGLOBULINS..........................................................90

IN VITRO DIAGNOSTIC AND ANALYTICAL PREPARATIONS...............................223

INDACATEROL...............................................................90

INDANAZOLINE..............................................................41

INDAPAMIDE................................................................90

INDAZIFLAM...............................................................178

INDINAVIR.................................................................90

INDOLE-3-ACETIC ACID........................................................230

INDOMETHACIN........................................................41, 90, 276

INDOPROFEN................................................................90

INDORAMIN................................................................90

INDOXACARB............................................................144, 178

INFLIXIMAB................................................................90

INFLUENZA AND CORYZA VACCINES...............................................90

INGENOL MEBUTATE..........................................................90

INOSITOL NICOTINATE.........................................................51

INSULIN GLARGINE...........................................................90

INSULIN-LIKE GROWTH FACTOR I.................................................90

INSULIN-LIKE GROWTH FACTORS..............................................90, 236

INSULINS..................................................................90

INTERFERONS...............................................................90

INTERLEUKINS..............................................................90

INTRAOCULAR VISCOELASTIC PRODUCTS...........................................223

IODINE...........................................................41, 178, 245, 268

IODOMETHANE..........................................................202, 281

IODOPHORS.............................................................178, 245

IODOSULFURON-METHYL-SODIUM................................................144

IODOTHIOURACIL............................................................90

IOXYNIL..................................................................178

IPCONAZOLE............................................................144, 178

IPILIMUMAB................................................................90

IPRATROPIUM.............................................................42, 90

IPRATROPIUM BROMIDE.......................................................268

IPRIFLAVONE...............................................................90

IPRINDOLE.................................................................90

IPRODIONE................................................................230

IPRONIAZID.................................................................90

IRBESARTAN................................................................91

IRINOTECAN................................................................91

IRON COMPOUNDS....................................................42, 91, 144, 178

ISOAMINILE................................................................91

ISOAMYL NITRITE............................................................91

ISOBUTYL NITRITE............................................................91

ISOCARBOPHOS.............................................................202

ISOCARBOXAZID.............................................................91

ISOCONAZOLE.......................................................42, 51, 91, 179

ISOCYANATES........................................................179, 245, 268

ISOETARINE................................................................91

ISOEUGENOL............................................................144, 179

ISOFENPHOS...............................................................202

ISOFLURANE................................................................91

ISOMETHADONE.............................................................212

ISOMETHEPTENE.............................................................91

ISONIAZID..................................................................91

ISOPHORONE............................................................144, 245

ISOPRENALINE............................................................91, 268

ISOPRENE ALCOHOL..........................................................230

ISOPRINOSINE...............................................................91

ISOPROPAMIDE............................................................42, 91

ISOPROTURON..............................................................202

ISOSORBIDE DINITRATE......................................................51, 91

ISOSORBIDE MONONITRATE.....................................................91

ISOSTEARYL ALCOHOL ETHOXYLATE.............................................230

ISOTRETINOIN......................................................91, 235, 268, 286

ISOXABEN.................................................................144

ISOXAFLUTOLE.............................................................144

ISOXICAM..................................................................91

ISOXSUPRINE...............................................................91

ISRADIPINE.................................................................91

ITRACONAZOLE..............................................................91

IVABRADINE................................................................91

IVACAFTOR.................................................................91

IVERMECTIN..........................................................91, 144, 202

IXABEPILONE...............................................................91

J

JAPANESE ENCEPHALITIS VACCINE................................................91

JUNIPERUS SABINE...........................................................219

K

KANAMYCIN................................................................91

KAOLIN...................................................................230

KEROSENE.................................................................245

KETAMINE.................................................................208

KETANSERIN................................................................92

KETAZOLAM................................................................92

KETOBEMIDONE.............................................................212

KETOCONAZOLE...........................................................42, 92

KETOPROFEN.............................................................51, 92

KETOROLAC................................................................92

KETOTIFEN...............................................................42, 92

KHELLIN...................................................................92

KITASAMYCIN............................................................92, 144

KRESOXIM-METHYL..........................................................230

KUNZEA OIL...............................................................230

L

LABETALOL................................................................92

LACIDIPINE.................................................................92

LACOSAMIDE...............................................................92

LAMBDA-CYHALOTHRIN.................................................144, 179, 202

LAMIVUDINE................................................................92

Lamotrigine.................................................................283

LAMOTRIGINE...............................................................92

LANATOSIDES...............................................................92

LANREOTIDE................................................................92

LANSOPRAZOLE...........................................................51, 92

LANTHANUM................................................................92

LAPATINIB.................................................................92

LARONIDASE................................................................92

LAROPIPRANT...............................................................92

LASALOCID................................................................179

LATAMOXEF................................................................92

LATANOPROST..............................................................92

LAUDEXIUM................................................................93

LAURETH CARBOXYLIC ACIDS................................................179, 245

LAURIC ACID...............................................................230

LAUROMACROGOLS...........................................................93

LAURYL ALCOHOL (1-DODECANOL)...............................................230

LAURYL ISOQUINOLINIUM BROMIDE...........................................179, 245

LAVANDIN OIL..............................................................230

LAVENDER OIL..............................................................230

LEAD.....................................................................93

LEAD COMPOUNDS............................................145, 179, 219, 245, 266, 268

LEAD METALLIC.............................................................231

LEFETAMINE................................................................93

LEFLUNOMIDE.........................................................93, 268, 286

LEMON OIL..........................................................145, 245, 268

LEMONGRASS OIL...........................................................231

LENALIDOMIDE.....................................................93, 235, 268, 286

LENOGRASTIM..............................................................93

LEPIDOPTEROUS SEX PHEROMONES...............................................231

LEPIRUDIN.................................................................93

LEPTAZOL..................................................................93

LEPTOPHOS................................................................202

Leptospermum scoparium oil.......................................................245

LEPTOSPERMUM SCOPARIUM OIL.................................................180

LERCANIDIPINE..............................................................93

LETROZOLE.................................................................93

LEUPRORELIN...............................................................93

LEVALLORPHAN.............................................................93

LEVAMISOLE..........................................................93, 145, 180

LEVAMPHETAMINE...........................................................208

LEVETIRACETAM.............................................................93, 283

LEVOBUNOLOL..............................................................93

LEVOBUPIVACAINE...........................................................93

LEVOCABASTINE.....................................................42, 93, 268, 286, 283

LEVODOPA.................................................................93

LEVOMEPROMAZINE..........................................................93

LEVOMETHAMPHETAMINE.....................................................208

LEVOMETHORPHAN..........................................................212

LEVOMORAMIDE............................................................208

LEVONORGESTREL.........................................................51, 93

LEVOPHENACYLMORPHAN.....................................................212

LEVORPHANOL.............................................................208

LEVOSIMENDAN.............................................................93

LIDOFLAZINE...............................................................93

LIGNOCAINE...........................................................42, 93, 145

LIGULARIA DENTATA.........................................................219

LIME OIL............................................................145, 245, 268

LIMONENE.................................................................231

LINAGLIPTIN................................................................94

LINCOMYCIN................................................................94

LINDANE..........................................................42, 94, 145, 180

LINEZOLID.................................................................94

LINOLEIC ACID..............................................................231

LINSEED FATTY ACIDS........................................................231

LINURON..................................................................231

LIOTHYRONINE..............................................................94

LIQUORICE, DEGLYCYRRHISINISED...............................................231

LIRAGLUTIDE...............................................................94

LISDEXAMFETAMINE.........................................................208

LISINOPRIL.................................................................94

LISURIDE..................................................................94

LITHIUM.................................................................42, 94

LITHIUM PERFLUOROOCTANE SULFONATE..........................................202

LIXISENATIDE...............................................................94

LOBELIA INFLATA............................................................43

LOBELINE..................................................................43

LODOXAMIDE.............................................................43, 94

LOFEXIDINE................................................................94

LOGIPARIN.................................................................94

LOMEFLOXACIN.............................................................94

LOMUSTINE.................................................................94

LOPERAMIDE..........................................................43, 94, 268

LOPINAVIR.................................................................94

LOPRAZOLAM...............................................................94

LORACARBEF...............................................................94

LORATADINE.............................................................43, 94

LORAZEPAM................................................................95, 283

LORMETAZEPAM.............................................................95

LOSARTAN.................................................................95

LOTEPREDNOL..............................................................95

LOXAPINE..................................................................95

LUBRICANTS...............................................................223

LUFENURON...............................................................145

LUMEFANTRINE..............................................................95

LUMIRACOXIB...............................................................95

LURASIDONE.............................................................95, 283

LUTEINISING HORMONE.....................................................95, 235

LYMECYCLINE..............................................................95

LYSERGIC ACID.............................................................212

LYSERGIDE................................................................212

M

MACITENTAN.........................................................95, 236, 286

MACROGOLS..............................................................43, 51

MADURAMICIN.......................................................145, 202, 281

MAFENIDE..............................................................95, 180

MAGNESIUM CHLORATE.................................................145, 245, 268

MAGNESIUM SULFATE.........................................................51

MALACHITE GREEN.......................................................145, 202

MALATHION...............................................................51, 146, 180, 245

MALEIC HYDRAZIDE..........................................................231

MANCOZEB................................................................146

MANDIPROPAMID............................................................146

MANDRAGORA OFFICINARUM....................................................95

MANGANESE DIOXIDE........................................................231

MANNITYL HEXANITRATE......................................................51

MANNOMUSTINE.............................................................95

MAPROTILINE...............................................................95

MARAVIROC................................................................95

MARBOFLOXACIN............................................................95

MARJORAM OIL..........................................................146, 246

MAROPITANT...............................................................95

MATCHES.................................................................223

MAVACOXIB................................................................95

MAZIDOX.................................................................202

MAZINDOL.................................................................95, 283

MCPA.................................................................146, 180

MCPB....................................................................146

MEASLES VACCINE...........................................................95

MEBANAZINE...............................................................95

MEBENDAZOLE........................................................43, 146, 181

MEBEVERINE................................................................95

MEBHYDROLIN..............................................................95, 283

MEBOLAZINE...............................................................95

MEBUTAMATE...............................................................95

MECAMYLAMINE.............................................................95

MECARBAM................................................................202

MECASERMIN...............................................................96

MECILLINAM................................................................96

MECLOCYCLINE.............................................................96

MECLOFENAMATE............................................................96

MECLOFENAMIC ACID........................................................146

MECLOFENOXATE............................................................96

MECLOQUALONE............................................................212

MECLOZINE..............................................................43, 96, 283

MECOPROP.............................................................146, 181

MECOPROP-P...............................................................181

MEDAZEPAM................................................................96, 283

MEDETOMIDINE..............................................................96

MEDICAL AND VETERINARY ADHESIVES, GLUES AND CEMENTS...........................223

MEDICAL DEVICES...........................................................223

MEDIGOXIN.................................................................96

MEDROXYPROGESTERONE......................................................96

MEDRYSONE................................................................96

MEFENAMIC ACID.......................................................43, 96, 268

MEFENOREX................................................................96

MEFENPYR-DIETHYL..........................................................146

MEFLOQUINE...............................................................96

MEFLUIDIDE...............................................................181

MEFRUSIDE.................................................................96

MEGASPHAERA ELSDENII strain 41125...............................................231

MEGESTROL................................................................96

MELAGATRAN...............................................................96

MELALEUCA OIL.........................................................181, 246

MELATONIN................................................................96

MELENGESTROL.............................................................96

MELENGESTROL ACETATE.....................................................181

MELIA AZEDARACH..........................................................219

MELOXICAM................................................................96

MELPHALAN................................................................96

MEMANTINE................................................................96

MENAZON.................................................................181

MENINGOCOCCAL VACCINE.....................................................96

MENOTROPHIN..............................................................96

MEPACRINE.................................................................96

MEPENZOLATE..............................................................96

MEPHENESIN................................................................96

MEPHENTERMINE............................................................96

MEPINDOLOL...............................................................96

MEPIQUAT.................................................................146

MEPITIOSTANE..............................................................96

MEPIVACAINE...............................................................97

Meprobamate................................................................283

MEPROBAMATE..............................................................97

MEPTAZINOL................................................................97

Mepyramine.................................................................283

MEPYRAMINE...........................................................43, 51, 97

MEQUITAZINE...............................................................97

MERCAPTOMERIN............................................................97

MERCAPTOPURINE............................................................97

MERCURIC CHLORIDE.........................................................202

MERCURIC IODIDE...........................................................246

MERCURIC NIRATE...........................................................246

MERCURIC OXIDE.........................................................181, 246

MERCURIC POTASSIUM IODIDE..................................................246

MERCURIC THIOCYANATE...................................................246, 268

MERCUROCHROME...................................................43, 97, 181, 246

MERCUROUS CHLORIDE.......................................................246

MERCURY.......................................................43, 97, 202, 276, 281

MERCURY metallic............................................................246

MERCURY, organic compounds.....................................................246

MEROPENEM................................................................97

MERSALYL.................................................................97

MERURIC CHLORIDE..........................................................246

MESABOLONE...............................................................97

MESALAZINE................................................................97

MESNA....................................................................97

MESOLSULFURON-METHYL.....................................................231

MESOTRIONE...............................................................146

MESTANOLONE..............................................................97

MESTEROLONE..............................................................97

MESTRANOL................................................................97

METACRESOLSULPHONIC ACID..................................................181, 268

METAFLUMIZONE............................................................146

METALAXYL............................................................146, 181

METALDEHYDE.......................................................146, 181, 246

METANDIENONE.............................................................97

METARAMINOL..............................................................97

METARHIZIUM ANISOPLIAE......................................................231

METAZOCINE...............................................................212

METENOLONE...............................................................97

METERGOLINE...............................................................97

METFORMIN................................................................97

METHABENZTHIAZURON.......................................................146

METHACHOLINE.............................................................97

METHACRIFOS........................................................181, 203, 281

METHACYCLINE.............................................................97

METHADONE...............................................................208, 283

METHALLENOESTRIL..........................................................97

METHAM..................................................................181

METHAMIDOPHOS...........................................................203

METHANDRIOL..............................................................97

METHANOL.......................................................146, 181, 246, 269

METHANTHELINIUM...........................................................97

METHAPYRILENE............................................................203

METHAQUALONE............................................................212

METHAZOLAMIDE............................................................97

METHAZOLE...............................................................203

METHCATHINONE............................................................212

METHDILAZINE............................................................51, 98, 283

METHENOLONE..............................................................98

METHICILLIN................................................................98

METHIDATHION.............................................................203

METHIMAZOLE..............................................................98

METHIOCARB.........................................................146, 182, 203

METHISAZONE...............................................................98

METHIXENE................................................................98

METHOCARBAMOL...........................................................98, 283

METHOFLUTHRIN............................................................147

METHOHEXITONE............................................................98

METHOIN..................................................................98

METHOMYL.............................................................182, 203

METHOPRENE..............................................................231

METHOTREXATE.............................................................98

METHOXAMINE.........................................................43, 98, 269

METHOXSALEN..............................................................98

METHOXYCHLOR............................................................147

METHOXYETHYLMERCURIC ACETATE..........................................203, 281

METHOXYETHYLMERCURIC CHLORIDE............................................203

METHOXYFENOZIDE..........................................................231

METHOXYFLURANE...........................................................98

METHOXYPHENAMINE.........................................................43

METHSUXIMIDE..............................................................98

METHYCLOTHIAZIDE..........................................................98

METHYL (2S, 4aR, 6aR, 7R, 9S, 10aS, 10bR)-9-ACETOXY-6a,10b-DIMETHYL-4,10-DIOXO-DODECAHYDRO-2-(3-FURYL)-2H-NAPHTHO[2,1-c]PYRAN-7-CARBOXYLATE              213

METHYL ACETATE...........................................................231

METHYL AMINOLEVULINATE....................................................98

METHYL BENZOQUATE........................................................231

METHYL BROMIDE........................................................203, 281

METHYL CHLORIDE..........................................................269

METHYL ETHYL KETONE.................................................147, 246, 269

METHYL ETHYL KETONE OXIME...........................................182, 246, 269

METHYL ETHYL KETONE PEROXIDE.........................................147, 246, 269

METHYL ISOAMYL KETONE..................................................147, 246

METHYL ISOBUTYL KETONE.................................................147, 246

METHYL ISOTHIOCYANATE.....................................................182

METHYL MERCURY...........................................................98

Methyl methacrylate............................................................269

METHYL METHACRYLATE...................................................182, 219

METHYL NEODECANAMIDE.....................................................182

METHYL p-HYDROXYBENZOATE.................................................231

METHYL SALICYLATE...................................................98, 147, 182

Methyl salicylate liquid..........................................................247

METHYLAMPHETAMINE.......................................................208

METHYLANDROSTANOLONE.....................................................98

METHYLATED SPIRIT.........................................................246

METHYLATED SPIRIT(S).......................................................147

METHYLCLOSTEBOL..........................................................98

Methylcyclopentadienyl Manganese Tricarbonyl........................................182, 203

METHYLDESORPHINE.........................................................213

METHYLDIBROMO GLUTARONITRILE........................................182, 219, 269

METHYLDIHYDROMORPHINE....................................................208

METHYLDOPA...............................................................98

METHYLENE BISTHIOCYANATE...............................................182, 269

METHYLENE BLUE......................................................98, 147, 203

METHYLEPHEDRINE...........................................................43

METHYLERGOMETRINE........................................................98

METHYLEUGENOL.....................................................182, 246, 269

METHYLMERCURY...........................................................276

METHYLNALTREXONE.........................................................98

METHYLNORBORNYLPYRIDINE..................................................182

METHYLPENTYNOL...........................................................98

METHYLPHENIDATE..........................................................208

METHYLPHENOBARBITONE.....................................................98

METHYLPREDNISOLONE........................................................98

METHYLTESTOSTERONE........................................................98

METHYLTHIOURACIL..........................................................99

METHYLTRIENOLONE..........................................................99

METHYPRYLONE.............................................................99

METHYSERGIDE..............................................................99

METIRAM.................................................................147

METOCLOPRAMIDE.........................................................51, 99

METOFLUTHRIN.............................................................182

METOLACHLOR.............................................................147

METOLAZONE...............................................................99

METOPON.................................................................213

METOPROLOL...............................................................99

METOSULAM...............................................................182

METRAFENONE..........................................................147, 182

METRIBOLONE..............................................................99

METRIBUZIN...............................................................183

METRIFONATE...............................................................99

METRONIDAZOLE............................................................99

METSULFURONMETHYL.......................................................231

METYRAPONE...............................................................99

MEVINPHOS................................................................203

MEXILETINE................................................................99

MEZLOCILLIN...............................................................99

MIANSERIN.................................................................99, 283

MIBEFRADIL................................................................99

MIBOLERONE...............................................................99

MICAFUNGIN................................................................99

MICONAZOLE..................................................43, 51, 99, 183, 269, 277

MIDAZOLAM................................................................99

MIDODRINE.................................................................99

MIFEPRISTONE..............................................................99

MIGLITOL..................................................................99

MIGLUSTAT.................................................................99

MILBEMECTIN...........................................................147, 183

MILBEMYCIN OXIME.......................................................99, 147

MILRINONE.................................................................99

MINOCYCLINE...............................................................99

MINOXIDIL...............................................................43, 99

MIPAFOX..................................................................203

MIRABEGRON...............................................................99

MIREX.................................................................203, 281

MIRTAZAPINE..............................................................100, 283

MISOPROSTOL........................................................100, 269, 286

MITOBRONITOL.............................................................100

MITOMYCIN................................................................100

MITOTANE.................................................................100

MITOXANTRONE............................................................100

MITRAGYNA SPECIOSA........................................................213

MITRAGYNINE..............................................................213

MITRATAPIDE..............................................................100

MIVACURIUM CHLORIDE.......................................................100

MOCLOBEMIDE.............................................................100

MODAFINIL................................................................100

MOLGRAMOSTIM............................................................100

MOLINATE..............................................................203, 281

MOLINDONE...............................................................100

MOMETASONE............................................................43, 100

MONENSIN...........................................................100, 147, 183

MONEPANTEL..............................................................147

MONOBENZONE.............................................................100

MONOCLONAL ANTIBODIES....................................................100

MONOCROTOPHOS...........................................................203

MONTELUKAST.............................................................100

MOPERONE................................................................100

MORANTEL.............................................................147, 183

MORAZONE................................................................100

MORICIZINE................................................................100

MORPHERIDINE.............................................................213

MORPHINE.................................................................208, 283

MORPHINE METHOBROMIDE....................................................208

MORPHINE-N-OXIDE..........................................................208

MOTOR, HEATING or FURNACE FUELS..............................................223

MOTRAZEPAM..............................................................100

MOTRETINIDE..............................................................100

MOXIDECTIN......................................................100, 147, 183, 203

MOXIFLOXACIN.............................................................100

MOXONIDINE...............................................................100

MSMA.................................................................183, 203

MUMPS VACCINE............................................................101

MUPIROCIN................................................................101

MURAGLITAZAR.............................................................101

MUROMONAB..............................................................101

MUSCIMOL................................................................213

MUSTINE..................................................................101

MYCLOBUTANIL.............................................................148

MYCOPHENOLIC ACID.........................................................101

MYRISTIC ACID.............................................................231

MYROPHINE................................................................213

N

N- α -[METHYL-3,4-(METHYLENEDIOXY)PHENETHYL]HYDROXYLAMINE......................213

N-(N-DODECYL)-2-PYRROLIDONE..............................................140, 172, 243

N-(N-OCTYL)-2-PYRROLIDONE................................................148, 184, 247

N, α -DIMETHYL-3,4-(METHYLENEDIOXY)PHENYLETHYLAMINE............................211

N,N-BIS(PHENYLMETHYLENE)-BICYCLO-(2.2.1)HEPTANE-2,5-DIMETHANAMINE.................162, 248, 271

N,N-BIS(PHENYLMETHYLENE)-BICYCLO-(2.2.1)HEPTANE-2,6-DIMETHANAMINE.................162, 248, 271

N,N-DIALLYLDICHLOROACETAMIDE..............................................138

N,N-DIETHYLTRYPTAMINE.....................................................211

N,N-DIMETHYLAMPHETAMINE...................................................211

N,N-DIMETHYLTRYPTAMINE....................................................211

NAA.....................................................................148

NABILONE.................................................................208

NABIXIMOLS.........................................................208, 235, 283

NABUMETONE..............................................................101

NADOLOL.................................................................101

NADROPARIN...............................................................101

NAFARELIN................................................................101

NAFTIDROFURYL............................................................101

NALBUPHINE...............................................................101, 283

NALED................................................................148, 183

NALIDIXIC ACID.............................................................101

NALMEFENE...............................................................101

NALORPHINE...............................................................101

NALOXONE................................................................101

NALTREXONE..............................................................101

NANDROLONE..............................................................101

NAPHAZOLINE............................................................43, 269

NAPHTHALENE.....................................................183, 247, 269, 276

NAPHTHALOPHOS.........................................................183, 203

NAPHTHOYLINDOLES.........................................................213

NAPHTHOYLPYRROLES........................................................213

NAPHTHYLMETHYLINDENES....................................................213

NAPHTHYLMETHYLINDOLES....................................................213

NAPROPAMIDE..............................................................231

NAPROXEN.........................................................43, 51, 101, 269

NAPTALAM................................................................148

NAPTHALEN-1-YL-(1-BUTYLINDOL-3-YL)METHANONE..................................214

NAPTHYL ACETAMIDE........................................................231

NARASIN...............................................................101, 183

NARATRIPTAN..............................................................101

NATALIZUMAB.............................................................101

NATAMYCIN...............................................................101

NATEGLINIDE..............................................................101

n-BUTYL BUTYRATE..........................................................229

n-BUTYL LACTATE...........................................................229

N-COCO-1,3-DIAMINOPROPANE..................................................168

N-cyclohexyldiazeniumdioxy-potassium................................................169

NEBACUMAB...............................................................101

NEBIVOLOL................................................................101

NEDOCROMIL..............................................................101

NEFAZODONE..............................................................101

NEFOPAM.................................................................102

NELFINAVIR...............................................................102

NEOMYCIN................................................................102

NEOSTIGMINE..............................................................102

NEPAFENAC................................................................102

NERIUM OLEANDER.......................................................102, 276

NEROLI OIL................................................................231

NESIRITIDE................................................................102

N-ETHYL-α-METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE..........................212

NETILMICIN................................................................102

NETOBIMIN.............................................................148, 183

NEVIRAPINE...............................................................102

NIALAMIDE................................................................102

NICARBAZIN...............................................................231

NICARDIPINE...............................................................102

NICERGOLINE..............................................................102

NICKEL SULFATE............................................................183

NICLOSAMIDE...............................................................43

NICOCODINE...............................................................214

NICODICODINE..............................................................214

NICOFURANOSE.............................................................102

NICOMORPHINE.............................................................214

NICORANDIL...............................................................102

NICOTINE.....................................................102, 183, 203, 269, 281

NICOTINIC ACID...........................................................51, 102

NICOTINYL ALCOHOL..........................................................52

NICOUMALONE.............................................................102

NIFEDIPINE................................................................102

NIFENAZONE...............................................................102

NIKETHAMIDE..............................................................102

NILOTINIB.................................................................102

NILUTAMIDE...............................................................102

NIMESULIDE...............................................................102

NIMIDANE..............................................................183, 203

NIMODIPINE................................................................102

NIMORAZOLE...............................................................102

NIRIDAZOLE...............................................................102

NISIN....................................................................231

NISOLDIPINE................................................................103

NITENPYRAM...............................................................183

NITISINONE................................................................103

NITRAZEPAM...............................................................103, 283

NITRENDIPINE..............................................................103

NITRIC ACID......................................................148, 183, 247, 269

NITRIC OXIDE..............................................................103

NITROBENZENE.......................................................183, 247, 270

NITROFEN..............................................................203, 281

NITROFURANTOIN...........................................................103

NITROFURAZONE............................................................103

NITROPHENOLS.............................................................184, 247, 270

NITROPRUSSIDES...................................................184, 204, 247, 270

NITROSCANATE.............................................................148

NITROUS OXIDE.............................................................103

NITROXOLINE..............................................................103

NITROXYNIL...............................................................184

NIZATIDINE...........................................................43, 103, 270

N-METHYL-1-(3,4-METHYLENEDIOXYPHENYL)-2-BUTANAMINE............................213

N-METHYL-2-PYRROLIDONE..............................................147, 182, 246

N-OCTYL BICYCLOHEPTENE DICARBOXIMIDE........................................148

N-OLEYL-1,3-DIAMINOPROPANE..................................................184

NOMEGESTROL.............................................................103

NOMIFENSINE..............................................................103

NONOXINOL 9........................................................148, 184, 247

NORACYMETHADOL..........................................................214

NORADRENALINE.........................................................103, 270

NORANDROSTENOLONE.......................................................103

NORBOLETHONE............................................................103

NORBORMIDE..............................................................148

NORCLOSTEBOL.............................................................103

NORCODEINE...............................................................208

NORELGESTROMIN...........................................................103

NORETHANDROLONE.........................................................103

NORETHISTERONE...........................................................103

NORFLOXACIN..............................................................103

NORFLURAZON.............................................................231

NORGESTREL...............................................................103

NORIBOGAINE..............................................................103

NORLEVORPHANOL..........................................................214

NORMAL HUMAN IMMUNOGLOBULIN..............................................103

NORMETHADONE............................................................209, 283

NORMETHANDRONE..........................................................103

NORMORPHINE.............................................................214

NORPIPANONE..............................................................214

NORTRIPTYLINE.............................................................103, 283

NOSCAPINE.................................................................44

NOVALURON...............................................................231

NOVOBIOCIN...............................................................103

NOXIPTYLINE..............................................................103

N-PHENETHYL-4-PIPERIDONE....................................................214

N-TALLOW ALKYL-1,3-PROPANEDIAMINE DIACETATE..................................192

NUTMEG OIL...............................................................148

NUTRITION REPLACEMENT PREPARATIONS FOR PARENTERAL ADMINISTRATION...............223

NYSTATIN.......................................................44, 52, 103, 270, 277

O

OCLACITNIB...............................................................104

OCRIPLASMIN..............................................................104

OCTAMYLAMINE............................................................104

OCTATROPINE..............................................................104

OCTHILINONE..............................................................184

OCTREOTIDE...............................................................104

OCTYL ALCOHOLS...........................................................231

OCTYL NITRITE.............................................................104

OESTRADIOL.........................................................104, 149, 276

OESTRIOL.................................................................104

OESTROGENS...............................................................104

OESTRONE..............................................................104, 276

OFATUMUMAB..............................................................104

OFLOXACIN................................................................104

Olanzapine..................................................................283

OLANZAPINE...............................................................104

OLAQUINDOX..............................................................184

OLEANDOMYCIN.........................................................104, 149

OLEANDRIN................................................................104

OLEIC ACID................................................................231

OLMESARTAN..............................................................104

OLODATEROL..............................................................104

OLOPATADINE..............................................................104

OLSALAZINE...............................................................104

OMALIZUMAB..............................................................104

OMEGA-3-ACID ETHYL ESTERS...................................................104

OMEPRAZOLE............................................................52, 104

OMETHOATE.........................................................149, 184, 204

ONDANSETRON.............................................................104

OPIPRAMOL................................................................104

Opium....................................................................283

OPIUM....................................................................209

ORANGE OIL...............................................................247

ORANGE OIL (BITTER).........................................................149

ORANGE OIL, SWEET..........................................................231

ORBIFLOXACIN.............................................................104

ORCIPRENALINE..........................................................104, 270

ORGANOPHOSPHORUS COMPOUNDS...............................................104

ORLISTAT...............................................................52, 105

ORNIDAZOLE...............................................................105

ORNIPRESSIN...............................................................105

ORPHENADRINE.............................................................105

ortho-DICHLOROBENZENE......................................................263

ortho-PHENYLPHENOL......................................................248, 271

ortho-PHTHALADEHYDE........................................................271

ortho-PHTHALALDEHYDE.......................................................248

ORTHOPTERIN..............................................................105

ORTHO-TOLIDINE............................................................281

OSELTAMIVIR..............................................................105

OUABAIN..................................................................105

OVANDROTONE.............................................................105

OXABETRINIL..............................................................231

OXABOLONE...............................................................105

OXACILLIN................................................................105

OXADIARGYL..............................................................149

OXADIAZON...............................................................184

OXADIXYL.................................................................149

OXALATES.................................................................270

OXALIC ACID.........................................................184, 247, 270

OXALIPLATIN..............................................................105

OXAMYL..................................................................204

OXANDROLONE.............................................................105

OXANTEL EMBONATE.........................................................149

OXAPROZIN................................................................105

OXAZEPAM................................................................105, 283

OXCARBAZEPINE............................................................105

OXEDRINE.................................................................105

OXETACAINE.............................................................44, 105

OXFENDAZOLE.............................................................149

OXIBENDAZOLE.............................................................149

OXICONAZOLE.........................................................44, 52, 105

OXITROPIUM...............................................................105

OXOLAMINE...............................................................105

OXOLINIC ACID.............................................................105

OXPENTIFYLLINE............................................................105

OXPRENOLOL..............................................................105

OXYBUPROCAINE............................................................105

OXYBUTYNIN..............................................................105

OXYCARBOXIN.............................................................149

OXYCLOZANIDE.............................................................184

Oxycodone..................................................................283

OXYCODONE...............................................................209

OXYDEMETON METHYL.......................................................204

OXYFLUORFEN.............................................................231

OXYMESTERONE............................................................105

OXYMETAZOLINE.........................................................44, 270

OXYMETHOLONE............................................................106

OXYMORPHONE.............................................................209

OXYPHENBUTAZONE.........................................................106

OXYPHENCYCLIMINE.........................................................106

OXYPHENISATIN............................................................219

OXYPHENONIUM............................................................106

OXYTETRACYCLINE.......................................................106, 149

OXYTHIOQUINOX............................................................149

OXYTOCIN..............................................................106, 276

P

PACLITAXEL...............................................................106

PACLOBUTRAZOL............................................................149

PAECILOMYCES LILACINUS Strain 251..............................................184

PAINT....................................................................270

PALIFERMIN...............................................................106

PALIPERIDONE..............................................................106, 283

PALIVIZUMAB..............................................................106

PALMAROSA OIL............................................................231

PALMITIC ACID.............................................................231

PALONOSETRON.............................................................106

PAMAQUIN................................................................106

PAMIDRONIC ACID...........................................................106

PANCREATIC ENZYMES........................................................106

PANCURONIUM.............................................................106

PANITUMUMAB.............................................................106

PANTOPRAZOLE...........................................................52, 106

Papaveretum.................................................................283

PAPAVERINE.............................................................44, 106

PAPER....................................................................223

PARACETAMOL......................................................44, 52, 106, 270

para-DICHLOROBENZENE.......................................................263

PARA-FLUOROFENTANYL......................................................214

PARAFORMALDEHYDE................................................44, 184, 219, 247

PARALDEHYDE.............................................................106

PARAMETHADIONE...........................................................106

PARAMETHASONE...........................................................107

PARAQUAT................................................................204

PARATHION................................................................204

PARATHION-METHYL......................................................185, 204

PARBENDAZOLE.............................................................185

PARECOXIB................................................................107

PARICALCITOL..............................................................107

PAROMOMYCIN.............................................................107

PAROXETINE...............................................................107

PASIREOTIDE...............................................................107

PATCHOULI OIL.............................................................231

PAZOPANIB................................................................107

PEBULATE.................................................................185

PECAZINE.................................................................107

PECTINASE derived from Aspergillus niger..............................................231

PEFLOXACIN...............................................................107

PEGAPTANIB...............................................................107

PEGFILGRASTIM.............................................................107

PEGINTERFERON............................................................107

PEGVISOMANT..............................................................107

PEHNOLS..................................................................247

PEMETREXED...............................................................107

PEMOLINE.................................................................107

PEMPIDINE................................................................107

PENBUTOLOL...............................................................107

PENCICLOVIR............................................................44, 107

PENCONAZOLE..............................................................149

PENCYCURON..............................................................231

PENDIMETHALIN............................................................149

PENETHAMATE.............................................................107

PENFLUFEN................................................................149

PENICILLAMINE.............................................................107

PENNYROYAL OIL........................................................185, 247

PENTACHLOROPEHNOL........................................................270

PENTACHLOROPHENOL.....................................................185, 204

PENTADECANOIC ACID........................................................231

PENTAERYTHRITYL TETRANITRATE...............................................107

PENTAGASTRIN.............................................................107

PENTAMETHONIUM..........................................................107

PENTAMIDINE..............................................................107

PENTAZOCINE..............................................................209, 283

PENTHIENATE..............................................................107

PENTHIOPYRAD.............................................................149

PENTOBARBITONE........................................................107, 209, 283

PENTOLINIUM..............................................................107

PENTOSAN POLYSULFATE SODIUM................................................107

PEPPERMINT OIL............................................................231

PERACETIC ACID...................................................149, 185, 247, 270

PERAMPANEL.........................................................107, 236, 283

PERFLUIDONE..............................................................185

PERGOLIDE................................................................107

PERHEXILINE...............................................................108

PERICYAZINE...............................................................108, 283

PERINDOPRIL...............................................................108

PERMANGANATES........................................................185, 270

PERMETHRIN.........................................................108, 149, 185

PERPHENAZINE.............................................................108, 283

PERTUSSIS ANTIGEN..........................................................108

PERTUZUMAB..............................................................108

PETASITES spp..............................................................219

PETHIDINE.................................................................209, 283

PETROL................................................................150, 247

PHEDRAZINE................................................................44

PHENACEMIDE..............................................................108

PHENACETIN...............................................................108

PHENADOXONE.............................................................214

PHENAGLYCODOL...........................................................108

PHENAMPROMIDE...........................................................214

PHENAZOCINE..............................................................214

PHENAZONE..........................................................44, 108, 150

PHENAZOPYRIDINE...........................................................108

PHENCYCLIDINE.............................................................214

PHENDIMETRAZINE..........................................................209

PHENELZINE...............................................................108, 283

PHENETICILLIN.............................................................108

PHENFORMIN...............................................................108

PHENGLUTARIMIDE..........................................................108

PHENINDIONE..............................................................108

PHENIRAMINE..........................................................44, 52, 108, 283

PHENISATIN................................................................108

PHENISOPHAM..............................................................150

PHENMEDIPHAM............................................................231

PHENMETRAZINE............................................................209

PHENOBARBITONE...........................................................108, 283

PHENOL.......................................................45, 108, 150, 185, 270

PHENOLPHTHALEIN..........................................................108

PHENOLS...............................................................247, 270

PHENOMORPHAN............................................................214

PHENOPERIDINE.............................................................209, 283

PHENOTHIAZINE.............................................................186

PHENOXYBENZAMINE.........................................................108

PHENOXYMETHYLPENICILLIN...................................................108

PHENSUXIMIDE.............................................................108

PHENTERMINE...........................................................108, 236

PHENTHIMENTONIUM.........................................................108

PHENTOLAMINE.............................................................108

PHENYL METHYL KETONE...................................................150, 248

PHENYLACETYLINDOLES......................................................214

PHENYLBUTAZONE...........................................................108

PHENYLENEDIAMINES.....................................................186, 219, 248, 270

PHENYLEPHRINE.......................................................45, 108, 270

PHENYLMERCURIC ACETATE.................................................204, 281

PHENYLPHENOL.............................................................150

PHENYLPROPANOLAMINE......................................................109

PHENYLTOLOXAMINE.........................................................109, 283

PHENYTOIN.............................................................109, 271

PHOLCODINE..........................................................45, 109, 209, 283

PHORATE..................................................................204

PHOSALONE................................................................186

PHOSFOLAN................................................................204

PHOSMET.................................................................186

PHOSPHIDE................................................................281

PHOSPHIDES, METALLIC.......................................................204

PHOSPHINE.............................................................204, 281

PHOSPHODIESTERASE TYPE 5 INHIBITORS...........................................109

PHOSPHONIC...............................................................150

PHOSPHONIC ACID........................................................248, 271

PHOSPHORIC ACID..................................................150, 186, 248, 271

PHOSPHORUS............................................................271, 276

PHOSPHORUS,..............................................................248

PHOSPHORUS, YELLOW........................................................204

PHOTOGRAPHIC PAPER or FILM..................................................223

PHOXIM...................................................................186

PHTHALALDEHYDE.......................................................150, 186

PHTHALYLSULFATHIAZOLE....................................................109

PHYSOSTIGMINE............................................................109

PHYTASE..................................................................232

PICARIDIN.................................................................150

PICLORAM.................................................................232

PICOLINAFEN...............................................................232

PICRIC ACID.............................................................248, 271

PICROTOXIN...............................................................109

PIGMENTS.................................................................223

PILOCARPINE...............................................................109

PIMECROLIMUS.............................................................109

PIMELIC ACID..............................................................232

PIMINODINE................................................................214

PIMOBENDAN..............................................................109

PIMOZIDE.................................................................109, 283

PINACIDIL.................................................................109

PINDOLOL.................................................................109

PINDONE..................................................................186

PINE OILS.................................................................150, 186

PINOXADEN.............................................................150, 187

PIOGLITAZONE..............................................................109

PIPECURONIUM.............................................................109

PIPEMIDIC ACID.............................................................109

PIPENZOLATE..............................................................109

PIPER METHYSTICUM.........................................................109

PIPERACILLIN..............................................................110

PIPERAZINE..............................................................45, 150

PIPERIDINE................................................................110

PIPERIDOLATE..............................................................110

PIPERONYL BUTOXIDE........................................................232

PIPEROPHOS...............................................................187

PIPOBROMAN...............................................................110

PIPOTHIAZINE..............................................................110

PIPRADROL................................................................110

PIRACETAM................................................................110

PIRBUTEROL...............................................................110

PIRENOXINE...............................................................110

PIRENZEPINE...............................................................110

PIRETANIDE................................................................110

PIRIMICARB.............................................................150, 187

PIRIMIPHOS-ETHYL...........................................................187

PIRIMIPHOS-METHYL.........................................................187

PIRITRAMIDE...............................................................209

PIROXICAM................................................................110

PIRPROFEN................................................................110

PITAVASTATIN..............................................................110

PITUITARY HORMONES........................................................110

PIVAMPICILLIN.............................................................110

PIZOTIFEN.................................................................110, 283

PLERIXAFOR...............................................................110

PLICAMYCIN...............................................................110

PNEUMOCOCCAL VACCINE.....................................................110

PODOPHYLLIN..............................................................271

PODOPHYLLOTOXIN..................................................45, 52, 110, 271

PODOPHYLLUM EMODI...................................................45, 52, 110

PODOPHYLLUM PELTATUM................................................45, 52, 111

PODOPHYLLUM RESIN........................................................276

POLIDEXIDE................................................................111

POLIHEXANIDE..........................................................150, 271

POLIOMYELITIS VACCINE......................................................111

POLIXETONIUM SALTS.....................................................150, 187

POLOXALENE...............................................................232

POLY (GNRF) OVALBUMIN......................................................232

POLY DIALLYL DIMETHYL AMMONIUM............................................232

POLY(OXY-1,2-ETHANEDIYL), α -[2-[(2-HYDROXYETHYL)AMINO]-2-OXOETHYL]- α -HYDROXY-,MONO-C13-15-ALKYL ETHERS              150, 248

POLYACRYLAMIDE...........................................................111

POLYCAPROLACTONE.........................................................111

POLYESTRADIOL............................................................111

POLYETHANOXY (15) TALLOW AMINE.............................................150, 248

POLYHEDROSIS VIRUS of.......................................................232

POLYLACTIC ACID...........................................................111

POLYMYXIN...............................................................111

POLYSORBATE 20............................................................232

POLYSULFATED GLYCOSAMINOGLYCANS..........................................111

POLYTHIAZIDE..............................................................111

PORACTANT...............................................................111

PORCELAIN................................................................223

PORCINE SOMATOTROPHIN.....................................................232

POSACONAZOLE.............................................................111

POTASIUM BROMATE.........................................................248

POTASIUM CHLORATE........................................................248

POTASSIUM AZELOYL DIGLYCINATE..............................................187

POTASSIUM BICARBONATE.....................................................232

POTASSIUM BROMATE........................................................187

POTASSIUM BROMIDE.........................................................111

POTASSIUM CHLORATE.....................................................45, 150

POTASSIUM CHLORIDE........................................................111

POTASSIUM CYANATE.....................................................187, 248

POTASSIUM HYDROXIDE...........................................150, 187, 219, 248, 272

POTASSIUM METABISULPHITE................................................151, 272

POTASSIUM NITRITE..............................................151, 187, 204, 248, 272

POTASSIUM PERCHLORATE.....................................................112

POTASSIUM PEROXOMONOSULFATE TRIPLE SALT..................................151, 187

POTASSIUM PERSULFATE................................................188, 249, 272

potassium sorbate..............................................................232

POTASSIUM SULFIDE...................................................151, 249, 272

PRACTOLOL................................................................112

PRADOFLOXACIN............................................................112

PRALATREXATE.............................................................112

PRALIDOXIME..............................................................112

PRALLETHRIN...........................................................151, 188

PRAMIPEXOLE..............................................................112

PRAMOCAINE...............................................................112

PRAMPINE.................................................................112

PRASTERONE...............................................................112

PRASUGREL................................................................112

PRAVASTATIN..............................................................112

PRAZEPAM................................................................112, 283

PRAZIQUANTEL.............................................................112

PRAZOSIN.................................................................112

PREDNISOLONE.............................................................112

PREDNISONE...............................................................112

PREGABALIN...............................................................112, 283

PREGNENOLONE.............................................................112

PRENALTEROL..............................................................112

PRENYLAMINE..............................................................112

PRILOCAINE.............................................................45, 112

PRIMAQUINE...............................................................112

PRIMIDONE................................................................112

PRINTING INKS or INK ADDITIVES.................................................223

PROBENECID...............................................................112

PROBUCOL................................................................112

PROCAINAMIDE.............................................................112

PROCAINE.................................................................112

PROCAINE PENICILLIN........................................................112

PROCARBAZINE.............................................................112

PROCHLORAZ..............................................................188

Prochlorperazine..............................................................283

PROCHLORPERAZINE.......................................................52, 112

PROCYCLIDINE...........................................................45, 113

PROCYMIDONE.............................................................204

PROFENOFOS...............................................................188

PROFOXYDIM...............................................................151

PROGESTERONE.......................................................113, 151, 276

PROGESTOGENS.............................................................113

PROGLUMIDE...............................................................113

PROGUANIL................................................................113

PROHEPTAZINE.............................................................214

PROHEXADIONE CALCIUM.....................................................151

PROLINTANE...............................................................113

PROMACYL................................................................188

PROMAZINE................................................................113, 283

PROMETHAZINE........................................................45, 52, 113, 283

PROMETRYN...............................................................151

PROMOXOLANE.............................................................113

PROPACHLOR...............................................................188

PROPAFENONE..............................................................113

PROPAMIDINE............................................................46, 113

PROPAMOCARB.............................................................151

PROPANIDID...............................................................113

PROPANIL.................................................................151

PROPANTHELINE............................................................113

PROPAQUIZAFOP............................................................151

PROPARGITE...............................................................188

PROPENTOFYLLINE...........................................................113

PROPERIDINE...............................................................214

PROPETAMPHOS.............................................................188

PROPETANDROL.............................................................113

PROPICONAZOLE.........................................................151, 188

PROPINEB.................................................................188

PROPIONIBACTERIUM ACNES...................................................113

PROPIONIC ACID....................................................151, 188, 249, 272

PROPIRAM.................................................................209

PROPOFOL.................................................................113

PROPOXUR.............................................................151, 188

PROPRANOLOL...........................................................113, 276

PROPYL ACETATES...........................................................232

PROPYLENE................................................................204

PROPYLENE GLYCOL.........................................................232

PROPYLENE OXIDE...........................................................281

PROPYLHEXEDRINE..........................................................113

PROPYLTHIOURACIL..........................................................113

PROPYPHENAZONE...........................................................113

PROPYZAMIDE..............................................................152

PROQUAZONE..............................................................113

PROQUINAZID..............................................................188

PROSCILLARIDIN............................................................113

PROSTAGLANDINS...........................................................113

PROSTIANOL...............................................................113

PROSULFOCARB.............................................................188

PROSULFURON..............................................................188

PROTAMINE................................................................113

PROTHIOCONAZOLE..........................................................232

PROTHIOCONAZOLE-DESCHLORO................................................152

PROTHIOCONAZOLE-TRIAZOLIDINETHIONE.........................................152

PROTHIOFOS...............................................................188

PROTHIONAMIDE............................................................113

PROTHIPENDYL.............................................................113

PROTIRELIN................................................................113

PROTOVERATRINES..........................................................113

Protriptyline.................................................................283

PROTRIPTYLINE.............................................................114

PROXYMETACAINE...........................................................114

PRUCALOPRIDE.............................................................114

PSEUDOEPHEDRINE........................................................52, 114

PSEUDOMONAS FLUORESCENS...................................................232

PSILOCYBINE...............................................................214

PTERIDIUM spp..............................................................219

PULMONARIA spp............................................................219

PYMETROZINE..............................................................152

PYRACLOFOS...............................................................188

PYRACLOSTROBIN...........................................................152

PYRAFLUFEN-ETHYL.........................................................152

PYRANTEL.................................................................46

PYRASULFOTOLE............................................................152

PYRAZINAMIDE.............................................................114

PYRAZOPHOS...............................................................188

PYRETHRINS.............................................................46, 152

PYRIDABEN.............................................................152, 188

Pyridalyl...................................................................188

PYRIDATE.................................................................188

PYRIDINOLCARBAMATE.......................................................114

PYRIDOSTIGMINE............................................................114

PYRIDOXAL................................................................114

PYRIDOXAMINE.............................................................114

PYRIDOXINE...............................................................114

PYRIFENOX................................................................152

PYRIMETHAMINE............................................................114

PYRIMETHANIL.............................................................232

PYRINURON.............................................................204, 281

PYRIOFENONE..............................................................189

PYRIPROLE................................................................188

PYRIPROXYFEN.............................................................232

PYRITHIOBAC SODIUM........................................................152

pyrithione copper..............................................................188

PYRITHIONE ZINC...................................................46, 152, 188, 249

PYROVALERONE............................................................114

PYROXASULFONE............................................................189

PYROXSULAM..............................................................189

PYRVINIUM................................................................114

Q

QUASSIA..................................................................232

QUATERNARY AMMONIUM COMPOUNDS........................................152, 189

QUAZEPAM................................................................114

QUETIAPINE................................................................114, 284

QUINAGOLIDE..............................................................114

QUINALBARBITONE..........................................................209, 284

QUINAPRIL................................................................114

QUINBOLONE...............................................................114

QUINCLORAC...............................................................152

QUINETHAZONE.............................................................114

QUINIDINE.................................................................114

QUININE............................................................114, 152, 204

QUINISOCAINE..............................................................114

QUINOXYFEN...............................................................232

QUINTOZENE...............................................................152

QUINUPRISTIN..............................................................114

QUIZALOFOP ETHYL..........................................................189

QUIZALOFOP-P-ETHYL.....................................................153, 189

QUIZALOFOP-P-TEFURYL.......................................................189

R

RABEPRAZOLE............................................................52, 114

RABIES VACCINE............................................................114

RACEMETHORPHAN..........................................................214

RACEMORAMIDE............................................................209

RACEMORPHAN.............................................................214

RACTOPAMINE...........................................................114, 153

RADIOGRAPHIC CONTRAST MEDIA................................................224

RADIOISOTOPES.............................................................224

RALOXIFENE...............................................................114

RALTEGRAVIR..............................................................114

RALTITREXED..............................................................115

RAMIPRIL.................................................................115

RANIBIZUMAB..............................................................115

RANITIDINE...........................................................46, 115, 272

RAPACURONIUM............................................................115

RASAGILINE...............................................................115

RASBURICASE..............................................................115

RAUWOLFIA SERPENTINA......................................................115

RAUWOLFIA VOMITORIA.......................................................115

RAZOXANE................................................................115

REBOXETINE...............................................................115

RED YEAST RICE.............................................................115

REGORAFENIB..............................................................115

REMIFENTANIL.............................................................209

REMOXIPRIDE..............................................................115

REPAGLINIDE...............................................................115

RESERPINE................................................................115

RESMETHRIN............................................................153, 189

RETAPAMULIN..............................................................115

RETEPLASE................................................................115

RETIGABINE.............................................................115, 284

RIBAVIRIN.................................................................115

RIDAFOROLIMUS............................................................115

RIFABUTIN................................................................115

RIFAMPICIN................................................................115

RIFAMYCIN................................................................115

RIFAPENTINE...............................................................115

RIFAXIMIN.................................................................115

RILPIVIRINE................................................................115

RILUZOLE.................................................................116

RIMEXOLONE...............................................................116

RIMITEROL................................................................116

RIMONABANT..............................................................116

RIMSULFURON..............................................................153

RIOCIGUAT..........................................................116, 235, 286

RISEDRONIC ACID...........................................................116

RISPERIDONE...............................................................116, 284

RITODRINE................................................................116

RITONAVIR................................................................116

RITUXIMAB................................................................116

RIVAROXABAN.............................................................116

RIVASTIGMINE..............................................................116

RIZATRIPTAN...............................................................116

ROBENACOXIB..............................................................116

ROBENIDINE...............................................................153

ROFECOXIB................................................................116

ROFLUMILAST..............................................................116

ROLICYCLIDINE.............................................................214

ROLITETRACYCLINE..........................................................116

romidepsin..................................................................116

ROMIFIDINE................................................................116

ROMIPLOSTIM..............................................................116

RONIDAZOLE...............................................................116

ROPINIROLE................................................................116

ROPIVACAINE..............................................................116

ROSEMARY OIL.............................................................232

ROSIGLITAZONE.............................................................116

ROSOXACIN................................................................116

ROSUVASTATIN.............................................................116

ROTENONE................................................................189

ROTIGOTINE...............................................................116, 284

ROXIBOLONE...............................................................116

ROXITHROMYCIN............................................................116

RUBELLA VACCINE...........................................................117

RUBOXISTAURIN............................................................117

RUPATADINE............................................................117, 284

RUXOLITINIB...............................................................117

S

SAFLUFENACIL..........................................................153, 204

SAFROLE............................................................189, 219, 272

SAGE OIL...............................................................189, 249

SAGE OIL (Spanish)............................................................232

SALBUTAMOL.........................................................52, 117, 272

SALCATONIN...............................................................117

SALFROLE.................................................................249

SALICYLAMIDE........................................................46, 117, 272

SALICYLANILIDE............................................................153

SALICYLIC ACID.............................................................53

SALINOMYCIN...........................................................117, 190

SALMETEROL...............................................................117

SALVIA DIVINORUM...........................................................214

SANDALWOOD OIL...........................................................232

SANTONIN..................................................................53

SAPROPTERIN..............................................................117

SAQUINAVIR...............................................................117

SASSAFRAS OIL.......................................................190, 249, 272

SAXAGLIPTIN...............................................................117

SCHOENOCAULON OFFICINALE..................................................117

SCHRADAN................................................................204

SCOPOLIA CARNIOLICA........................................................117

SEAWEED & UNFRACTIONED....................................................232

SECBUTOBARBITONE.........................................................209, 284

SEDAXANE................................................................153

SEEDS....................................................................224

SELAMECTIN...............................................................153

SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARM)............................117, 236

SELEGILINE................................................................117

SELENIUM......................................................46, 117, 190, 204, 276

SELENIUM COMPOUNDS....................................................249, 272

SEMDURAMICIN..........................................................190, 205

SENECIO spp................................................................220

SERELAXIN................................................................117

SERMORELIN...............................................................117

SERTINDOLE...............................................................117

SERTRALINE...............................................................118

SETHOXYDIM...............................................................153

SEVELAMER...............................................................118

SEVOFLURANE..............................................................118

SEX HORMONES.............................................................118

SIBUTRAMINE..............................................................118

SIDURON..................................................................153

SILANDRONE...............................................................118

SILDENAFIL................................................................118

SILICOFLUORIDES........................................................153, 190

SILICONES..............................................................118, 220, 272

SILVER....................................................................46

SILVER NITRATE............................................................190

SILVER SALTS..............................................................249

SILVER SULFADIAZINE........................................................118

SIMAZINE.................................................................232

SIMEPREVIR................................................................118

SIMVASTATIN..............................................................118

SINBIOALLETHRIN........................................................153, 190

SINGLE-USE TUBES...........................................................224

SIROLIMUS................................................................118

SISOMICIN.................................................................118

SITAGLIPTIN...............................................................118

SITAXENTAN......................................................118, 236, 272, 286

SLIMICIDES................................................................222

SODIUM ALUMINATE...................................................191, 249, 272

SODIUM BICARBONATE........................................................232

SODIUM BROMATE........................................................191, 249

SODIUM BROMIDE...........................................................118

SODIUM CELLULOSE PHOSPHATE.................................................118

SODIUM CHLORATE....................................................153, 249, 272

SODIUM CROMOGLYCATE...................................................46, 118

SODIUM DIACETATE.......................................................153, 249

SODIUM DICHLOROISOCYANURATE...............................................249

Sodium dodecylbenzene sulfonate....................................................273

SODIUM DODECYLBENZENE SULFONATE........................................153, 249

SODIUM FLUORIDE...........................................................273

SODIUM HYDROGEN SULFATE................................................153, 250, 273

SODIUM HYDROSULFITE.......................................................153, 273

SODIUM HYDROXIDE.............................................153, 191, 220, 250, 273

SODIUM LAURETH-6 CARBOXYLATE..............................................153, 250, 273

SODIUM LAURYL SULFATE.....................................................250

SODIUM METABISULPHITE...............................................153, 250, 273

SODIUM MORRHUATE.........................................................118

SODIUM NITRITE..............................................46, 153, 191, 205, 250, 273

SODIUM NITROPRUSSIDE.......................................................118

SODIUM OXYBATE........................................................209, 235

SODIUM PERCARBONATE...................................................154, 191

SODIUM PERSULFATE...................................................192, 250, 273

SODIUM PHOSPHATE.......................................................53, 118

SODIUM PICOSULFATE.........................................................53

SODIUM POLYSTYRENE SULPHONATE..........................................118, 154

SODIUM PRECARBONATE......................................................250

sodium propionate.............................................................232

SODIUM SALICYLATE.........................................................118

SODIUM STANNATE.......................................................154, 250

SODIUM SULFIDE...................................................154, 192, 250, 273

SODIUM TETRADECYLSULFATE..................................................118

SODIUM TRICHLOROACETATE...................................................250

SODIUMHYDROSULFITE.......................................................250

SOFOSBUVIR...............................................................118

SOLASODINE...............................................................118

SOLIFENACIN...............................................................118

SOMATOSTATIN.............................................................118

SOMATOTROPIN EQUINE.......................................................118

SOMATROPIN............................................................119, 236

SONTOQUINE...............................................................119

SORAFENIB................................................................119

SOTALOL..................................................................119

SPARFLOXACIN.............................................................119

SPARTEINE................................................................119

SPECTINOMYCIN............................................................119

SPINETORAM...............................................................154

SPINOSAD.................................................................154

SPIRAMYCIN...............................................................119

SPIRAPRIL.................................................................119

SPIRONOLACTONE...........................................................119

SPIROTETRAMAT............................................................192

SPIROXAMINE..............................................................192

SQUILL....................................................................46

STANOLONE...............................................................119

STANOZOLOL...............................................................119

STAR ANISE OIL.............................................................154

STAVUDINE................................................................119

STENBOLONE...............................................................119

STERIC ACID...............................................................232

STEROID HORMONES.........................................................119

STILBOESTROL..............................................................119

STRCHNINE................................................................250

STREPTODORNASE...........................................................119

STREPTOKINASE............................................................119

STREPTOMYCIN.............................................................119

STRONTIUM RANELATE.......................................................119

STROPHANTHINS............................................................119

STROPHANTHUS spp...........................................................119, 276

STRYCHNINE......................................................119, 205, 276, 281

STRYCHNOS spp..............................................................119

STYRAMATE...............................................................119

STYRENE............................................................154, 250, 273

SUCCIMER.................................................................119

SUCRALFATE...............................................................232

SUFENTANIL...............................................................209

SUGAMMADEX..............................................................119

SULBACTAM...............................................................119

SULCOFURON......................................................192, 205, 250, 281

SULCONAZOLE...........................................................46, 119

SULESOMAB...............................................................232

SULFACETAMIDE.......................................................53, 119, 154

SULFADIAZINE...........................................................120, 154

SULFADIMETHOXINE.........................................................120

SULFADIMIDINE..........................................................120, 154

SULFADOXINE..............................................................120

SULFAFURAZOLE............................................................120

SULFAGUANIDINE...........................................................120

SULFAMERAZINE.........................................................120, 154

SULFAMETHIZOLE...........................................................120

SULFAMETHOXAZOLE........................................................120

SULFAMETHOXYDIAZINE......................................................120

SULFAMETHOXYPYRIDAZINE...................................................120

SULFAMETROLE.............................................................120

SULFAMIC ACID....................................................154, 192, 250, 273

SULFAMONOMETHOXINE......................................................120

SULFAMOXOLE.............................................................120

SULFAPHENAZOLE...........................................................120

SULFAPYRIDINE.............................................................120

SULFAQUINOXALINE.........................................................120

SULFASALAZINE............................................................120

SULFATHIAZOLE.........................................................120, 154

SULFATROXAZOLE...........................................................120

SULFENTRAZONE............................................................205

SULFINPYRAZONE...........................................................120

SULFLURAMID..............................................................192

SULFOMETURON-METHYL......................................................154

SULFOMYXIN...............................................................120

SULFONAMIDES.............................................................120

SULFONMETHANE...........................................................120

SULFOSULFURON............................................................232

SULFOTEP.................................................................205

SULFOXAFLOR...........................................................154, 192

SULFURIC ACID.......................................................192, 250, 273

SULFURYL FLUORIDE.........................................................192

SULINDAC.................................................................120

SULPHATED POLYSACCHARIDES.................................................232

SULPROFOS................................................................192

SULTAMICILLIN.............................................................120

SULTHIAME................................................................120

SUMATRIPTAN..............................................................121

SUNITINIB.................................................................121

SUPROFEN.................................................................121

SUTILAINS.................................................................121

suvorexant..................................................................284

SUVOREXANT..............................................................121

SUXAMETHONIUM...........................................................121

SUXETHONIUM.............................................................121

SYMPHYTUM spp.............................................................154, 220, 273

SYNTHETIC CANNABINOMIMETICS................................................214

T

TACRINE..................................................................121

TACROLIMUS...............................................................121

TADALAFIL................................................................121

TAFLUPROST...............................................................121

TALIGLUCERASE ALFA........................................................121

TALLOW ALKYLAMINE ACETATES................................................192

TAMOXIFEN................................................................121

TAMSULOSIN...............................................................121

TANACETUM VULGARE........................................................121

TANNIC ACID...............................................................232

TANNIC ACID/BENZYL ALCOHOL.................................................232

TAPENTADOL............................................................209, 284

TAR ACIDS.................................................................192

TASONERMIN...............................................................121

TAZAROTENE............................................................121, 273

TAZOBACTAM..............................................................121

T-CELL RECEPTOR ANTIBODY...................................................121

TCMTB...................................................................192

TDE......................................................................192

TDE (1,1-dichloro-2,2-bis[4-chlorophenyl]ethane)..........................................154

TEBUCONAZOLE.............................................................155

TEBUFENOZIDE.............................................................155

TEBUFENPYRAD.............................................................192

TEBUTHIURON..............................................................192

TEFLUTHRIN............................................................155, 205

TEGAFUR..................................................................121

TEGASEROD................................................................121

TEICOPLANIN...............................................................121

TELAPREVIR...............................................................121

TELBIVUDINE..............................................................121

TELITHROMYCIN............................................................121

TELMISARTAN..............................................................121

TEMAZEPAM...............................................................121, 284

TEMEPHOS..............................................................155, 192

TEMOZOLOMIDE............................................................121

TEMSIROLIMUS.............................................................121

TENECTEPLASE.............................................................121

TENIPOSIDE................................................................122

TENOCYCLIDINE............................................................214

TENOFOVIR................................................................122

TENOXICAM...............................................................122

TEPOXALIN................................................................122

TEPP.....................................................................205

TEPRALOXYDIM.............................................................155

TERAZOSIN................................................................122

TERBACIL.................................................................232

TERBINAFINE............................................................46, 122

TERBUFOS.................................................................205

TERBUTALINE.........................................................53, 122, 273

TERBUTHYLAZINE...........................................................192

TERBUTRYN...............................................................155

TERFENADINE...........................................................122, 273

TERIFLUNOMIDE.........................................................122, 273

TERIFLUOMIDE.............................................................287

TERIPARATIDE...........................................................122, 235

TERLIPRESSIN..............................................................122

TERMITE BARRIERS..........................................................224

TERODILINE................................................................122

TEROPTERIN...............................................................122

TERPENES..............................................................250, 273

TERPENES, CHLORINATED......................................................192

TESTOLACTONE.............................................................122

TESTOSTERONE.......................................................122, 192, 276

TETANUS ANTITOXIN.........................................................122

TETANUS TOXOID............................................................122

TETRABENAZINE............................................................122

TETRACHLOROETHANE...............................................205, 250, 273, 281

TETRACHLOROETHYLENE..........................................46, 155, 192, 250, 273

TETRACHLORVINPHOS........................................................155

TETRACONAZOLE.........................................................155, 193

TETRACOSACTRIN...........................................................122

TETRACYCLINE..........................................................122, 155

TETRADIFON...............................................................193

TETRAETHYLAMMONIUM......................................................122

TETRAHYDROCANNABINOLS....................................................214

TETRAHYDROZOLINE.......................................................46, 273

TETRAMETHRIN.............................................................155

TETRAMISOLE..............................................................193

TETROXOPRIM..............................................................122

THALIDOMIDE.....................................................122, 235, 274, 287

THALLIUM..............................................................205, 281

THAUMATIN...............................................................232

THEBACON................................................................209

THEBAINE.................................................................209

THENYLDIAMINE............................................................122, 284

THEOPHYLLINE...........................................................53, 122

THEVETIA PERUVIANA........................................................122

THEVETIN.................................................................122

THIABENDAZOLE..........................................................46, 155

THIACETARSAMIDE..........................................................122

THIACLOPRID..............................................................193

THIAMBUTOSINE............................................................123

THIAMETHOXAM.........................................................155, 193

THIAZAFLURON.............................................................193

THIAZOPYR................................................................155

THIAZOSULFONE............................................................123

THIDIAZURON..............................................................232

THIETHYLPERAZINE..........................................................123, 284

THIFENSULFURON...........................................................155

THIOACETAZONE............................................................123

THIOBENCARB..............................................................155

THIOCARLIDE..............................................................123

THIODICARB............................................................155, 193

THIOFANOX................................................................205

THIOFENTANYL.............................................................215

THIOGUANINE..............................................................123

THIOMESTERONE............................................................123

THIOMETON................................................................193

THIOPENTONE..............................................................123

THIOPHANATE-METHYL....................................................155, 193

THIOPROPAZATE............................................................123, 284

THIOPROPERAZINE...........................................................123

THIORIDAZINE..............................................................123, 284

THIOSTREPTON.............................................................123

THIOTEPA.................................................................123

THIOTHIXENE..............................................................123, 284

THIOURACIL...............................................................123

THIOUREA...........................................................123, 250, 274

THIOUREA AND ALKYL THIOUREAS...............................................193

THIRAM...................................................................193

THUJONE...............................................................193, 250

THYME OIL.............................................................156, 250

THYMOL..................................................................193

THYMOXAMINE.............................................................123

THYROID..................................................................123

THYROTROPHIN.............................................................123

THYROXINE.............................................................123, 276

TIAGABINE................................................................123

TIAMULIN.................................................................123

TIAPROFENIC ACID...........................................................123

TIARAMIDE................................................................123

TIBOLONE.................................................................123

TICAGRELOR...............................................................123

TICARCILLIN...............................................................123

TICLOPIDINE...............................................................123

TIEMONIUM................................................................123

TIENILIC ACID..............................................................123

TIGECYCLINE...............................................................124

TIGLOIDINE................................................................124

TILDIPIROSIN...............................................................124

TILETAMINE...............................................................124

TILIDINE..................................................................209

TILMICOSIN................................................................124

TILUDRONIC ACID...........................................................124

TIMBER or WALLBOARD.......................................................224

TIMOLOL..................................................................124

TIN ORGANIC COMPOUNDS.....................................................205

TINIDAZOLE...............................................................124

TINZAPARIN...............................................................124

TIOCARBAZIL..............................................................156

TIOCONAZOLE.........................................................46, 53, 124

TIOTROPIUM...............................................................124

TIPEPIDINE................................................................124

TIPRANAVIR...............................................................124

TIRILAZAD................................................................124

TIROFIBAN................................................................124

TOBRAMYCIN..............................................................124

TOCAINIDE................................................................124

TOCERANIB................................................................124

TOCILIZUMAB..............................................................124

TOLAZAMIDE...............................................................124

TOLAZOLINE...............................................................124

TOLBUTAMIDE..............................................................124

TOLCAPONE................................................................124

TOLCLOFOS-METHYL.........................................................156

TOLFENAMIC ACID...........................................................124

TOLIDINE..............................................................206, 251

TOLMETIN.................................................................124

TOLONIUM................................................................124

TOLPROPAMINE.............................................................124

TOLRESTAT................................................................124

TOLTERODINE..............................................................125

TOLTRAZURIL..............................................................156

TOLUENE............................................................193, 251, 274

TOLUENEDIAMINE..................................................193, 220, 251, 274

TOLVAPTAN...............................................................125

TOLYLFLUANID.............................................................194

TOPIRAMATE...............................................................125

TOPOTECAN................................................................125

TORASEMIDE...............................................................125

TOREMIFENE...............................................................125

TOXOIDS..................................................................125

TRALKOXYDIM.............................................................156

TRAMADOL................................................................125, 284

TRAMAZOLINE...........................................................46, 274

trametinib dimethyl sulfoxide.......................................................125

TRANDOLAPRIL.............................................................125

TRANEXAMIC ACID..........................................................125

TRANSFLUTHRIN............................................................194

TRANYLCYPROMINE..........................................................125, 284

TRASTUZUMAB.............................................................125

Trastuzumab emtansine..........................................................125

TRAVOPROST...............................................................125

TRAZODONE...............................................................125

TRENBOLONE............................................................125, 156

TREOSULPHAN..............................................................125

TREPROSTINIL..............................................................125

TRESTOLONE...............................................................125

TRETAMINE................................................................125

TRETINOIN........................................................125, 236, 274, 287

TRIACETYLOLEANDOMYCIN....................................................125

TRIADIMEFON...........................................................156, 194

TRIADIMENOL..............................................................156

TRI-ALLATE................................................................156

TRIAMCINOLONE.....................................................47, 53, 125, 274

TRIAMIPHOS...............................................................206

TRIAMTERENE..............................................................125

TRIASULFURON.............................................................233

TRIAZBUTIL................................................................206

TRIAZIQUONE..............................................................125

TRIAZOLAM................................................................125

TRIBENURON-METHYL........................................................156

TRIBUFOS.................................................................206

TRICHLORFON..............................................................194

TRICHLORMETHIAZIDE........................................................125

TRICHLOROACETIC ACID...........................................125, 156, 194, 251, 274

Trichloroacetic acid alkali salts......................................................251

TRICHLOROETHYLENE...............................................126, 194, 251, 274

TRICHLOROISOCYANURIC ACID...............................................251, 281

TRICHLOROPHENOL.......................................................194, 274

TRICHODERMA HARZIANUM....................................................233

TRICHODESMA AFRICANA......................................................220

TRICLABENDAZOLE..........................................................194

TRICLOFOS................................................................126

TRICLOPYR................................................................194

TRICLOSAN................................................................194

TRICYCLAMOL..............................................................126

TRIDEMORPH...............................................................194

TRIDIHEXETHYL.............................................................126

TRIDIPHANE...............................................................156

TRIETAZINE................................................................157

TRIETHANOLAMINE.................................................126, 157, 251, 274

TRIETHYL PHOSPHATE.....................................................194, 251

TRIETHYLENE GLYCOL........................................................233

TRIFLOXYSTROBIN...........................................................157

TRIFLOXYSULFURON.........................................................233

TRIFLUMIZOLE..............................................................157

TRIFLUMURON..............................................................157

TRIFLUOPERAZINE...........................................................126, 284

TRIFLUOROMETHANESULFONIC ACID..........................................194, 251, 274

TRIFLUPERIDOL.............................................................126

TRIFLUPROMAZINE...........................................................126

TRIFLURALIN...............................................................233

TRIFORINE.................................................................233

TRIISOPROPANOLAMINE LAURYL ETHER SULFATE.................................157, 251, 274

TRILOSTANE...............................................................126

Trimeprazine................................................................284

TRIMEPRAZINE.........................................................47, 53, 126, 284

TRIMETAPHAN..............................................................126

TRIMETHOPRIM.............................................................126

TRIMIPRAMINE.............................................................126, 284

TRIMUSTINE...............................................................126

TRINEXAPAC-ETHYL..........................................................157

TRINITROPHENOL.........................................................126, 194

TRIOXYSALEN..............................................................126

TRIPARANOL...............................................................220

TRIPELENNAMINE...........................................................126

TRIPLE ANTIGEN VACCINE.....................................................126

TRIPROLIDINE..........................................................47, 53, 126, 284

TRIPTORELIN...............................................................126

TRISODIUM NITRILOTRIACETATE.................................................194

TRITICONAZOLE.............................................................157

TROGLITAZONE.............................................................126

TROMETAMOL..............................................................126

TROPICAMIDE..............................................................126

TROPISETRON..............................................................126

TROVAFLOXACIN............................................................126

TROXIDONE................................................................126

TRYPTOPHAN...............................................................126

TUAMINOHEPTANE...........................................................47

TUBERCULIN...............................................................126

TUBOCURARINE.............................................................126

TULATHROMYCIN...........................................................126

TULOBUTEROL..............................................................127

TURPENTINE...............................................................251

TURPENTINE OIL.........................................................157, 251

TUSSILAGO FARFARA.........................................................220

TYLOSIN..................................................................127

TYMAZOLINE............................................................47, 274

TYPHOID VACCINE...........................................................127

U

Ulocladium oudemansii..........................................................233

UMECLIDINIUM.............................................................127

UNOPROSTONE.............................................................127

URACIL...................................................................127

URAPIDIL.................................................................127

UREA....................................................................233

URETHANE................................................................127

UROFOLLITROPIN.........................................................127, 235

UROKINASE................................................................127

URSODEOXYCHOLIC ACID......................................................127

USTEKINUMAB..............................................................127

V

VACCINES.................................................................127

VACCINIA VIRUS VACCINE.....................................................127

VALACICLOVIR.............................................................127

VALDECOXIB...............................................................127

VALGANCICLOVIR...........................................................127

VALNOCTAMIDE............................................................127

VALPROIC ACID.............................................................127

VALSARTAN...............................................................127

VAMIDOTHION..............................................................194

VANCOMYCIN..............................................................127

VANDETANIB...............................................................127

VARDENAFIL...............................................................127

VARENICLINE..............................................................127

VARICELLA VACCINE.........................................................127

VASOPRESSIN..............................................................127

VECURONIUM..............................................................128

VEDAPROFEN...............................................................128

vEDOLIZUMAB..............................................................128

VELAGLUCERASE ALFA.......................................................128

VEMURAFENIB..............................................................128

VENLAFAXINE..............................................................128

VERAPAMIL................................................................128

VERATRUM................................................................128

VERNAKALANT.............................................................128

VERNOLATE...............................................................157

VERTEPORFIN..............................................................128

VETIVER OIL...............................................................233

VIDARABINE...............................................................128

VIGABATRIN...............................................................128

VILANTEROL...............................................................128

VILDAGLIPTIN..............................................................128

VILOXAZINE...............................................................128

VINBLASTINE...............................................................128

VINCAMINE................................................................128

VINCLOZOLIN...........................................................206, 274

VINCRISTINE...............................................................128

VINDESINE................................................................128

VINFLUNINE...............................................................128

VINORELBINE..............................................................128

VINYL CHLORIDE.........................................................206, 281

VINYL ETHER............................................................128, 233

VIRGINIAMYCIN..........................................................128, 157

VISMODEGIB...............................................................128

VISNADINE................................................................128

VITAMIN A.................................................................128

VITAMIN D..............................................................53, 129

VITAMIN K.................................................................233

VITREOUS ENAMELS..........................................................224

VORICONAZOLE.............................................................129

VORINOSTAT...............................................................129

VORTIOXETINE.............................................................129

W

WARFARIN...........................................................129, 157, 194

WHITE SPIRIT...............................................................251

WRITING CORRECTION PENS....................................................224

X

XAMOTEROL...............................................................129

XANTHINOL NICOTINATE......................................................129

XANTHOPHYLL.............................................................233

XIMELAGATRAN............................................................129

XIPAMIDE.................................................................129

XYLANASE derived from Aspergillus niger..............................................233

XYLAZINE.................................................................129

XYLENE.............................................................194, 251, 274

XYLENOLS.................................................................251

XYLOMETAZOLINE........................................................47, 274

Y

YLANG YLANG OIL...........................................................233

YOHIMBINE................................................................129

Z

ZAFIRLUKAST..............................................................129

ZALCITABINE...............................................................129

ZALEPLON.................................................................129

ZANAMIVIR................................................................129

ZERANOL..............................................................129, 195

ZETA-CYPERMETHRIN......................................................195, 206

ZIDOVUDINE...............................................................129

ZILPATEROL...............................................................129

ZIMELDINE................................................................129

ZINC BORATE...............................................................195

ZINC CHLORIDE...........................................................47, 251

ZINC COMPOUNDS...........................................................129

ZINC NAPHTHENATE..........................................................233

ZINC para-PHENOLSULFONATE...................................................195

ZINC SULFATE........................................................195, 251, 275

ZINEB....................................................................157

ZIPRASIDONE...............................................................129, 284

ZIRAM.................................................................195, 206

ZOLAZEPAM...............................................................129

ZOLEDRONIC ACID...........................................................129

ZOLMITRIPTAN.............................................................129

ZOLPIDEM.................................................................129, 284

Zonisamide.................................................................284

ZONISAMIDE...............................................................130

ZOPICLONE................................................................130, 284

ZOXAZOLAMINE.............................................................130

ZUCLOPENTHIXOL...........................................................130


 

1

1,1,1-TRICHLOROETHANE

 See also DESIGNATED SOLVENT

1,1-DICHLORO-2,2-BIS[4-CHLOROPHENYL]ETHANE

 See TDE

1-DODECANOL

 See LAURYL ALCOHOL

2

2-[(4-AMINOPHENYL)AZO]-1,3-DIMETHYL-1H-IMIDAZOLIUM CHLORIDE

 See BASIC ORANGE 31

2-[THIOCYANOMETHYLTHIO]BENZOTHIAZOLE

 See TCMTB

2C-I

 See 2,5-DIMETHOXY-4-IODOPHENETHYLAMINE

2C-T-2

 See 2,5-DIMETHOXY-4-ETHYLTHIOPHENETHYLAMINE

2C-T-7

 See 2,5-DIMETHOXY-4-(N)-PROPYLTHIOPHENETHYLAMINE

2-(dimethylamino)ethanol

     See DMEA, DIMETHYL MEA, DEANOL

2-furancarboxaldehyde

     see furfural

3

3,4-METHYLENEDIOXY-N-α-DIMETHYLPHENYLETHYLAMINE

 See N,A-DIMETHYL-3,4-(METHYLENEDIOXYL)PHENYLETHYLAMINE

4

4-CHLOROTESTOSTERONE

 See CLOSTEBOL

4-FLUORO-N-METHAMPHETAMINE

 See 4-FLUORO-N-METHYLAMPHETAMINE

4-METHYLHEXANE-2-AMINE

See 1,3-DIMETHYLAMYLAMINE 

5

5-MeO-AMT

 See 5-METHOXY--METHYLTRYPTAMINE

8

8-HYDROXYQUINOLINE

 See also CLIOQUINOL

A

Acetone

 See also DESIGNATED SOLVENT

ALBUMIN

 See HUMAN BLOOD PRODUCTS

ALKYL ACETANILIDES

 See ACETANILIDE

ALKYL SULFONALS

 See SULFONMETHANE

ALKYL THIOUREAS

 See THIOUREA AND ALKYL THIOUREAS

ALKYLATED PHENYLENEDIAMINES

 See PHENYLENEDIAMINES

ALUMINIUM PHOSPHIDE

 See PHOSPHIDES, METALLIC

ALPHA-CHLORALOSE

 See CHLORALOSE

AM-694

 See 1-(5-FLUOROPENTYL)-3-(2-IODOBENZOYL)INDOLE

AMFEBUTAMONE

 See BUPROPION

AMIDOPYRINE

 See AMINOPHENAZONE

2-[(4-AMINOPHENYL)AZO]-1,3-DIMETHYL-1H-IMIDAZOLIUM CHLORIDE

 See BASIC ORANGE 31

Ammonia

 See also CHROMATES

AMMONIUM BIFLUORIDE

 See BIFLUORIDES

AMMONIUM CHROMATE

 See CHROMATES

 See CHROMIUM

AMMONIUM hydroxide

 See AMMONIA

 See AMMONIA/AMMONIUM HYDROXIDE

AMMONIUM SALTS

 See BIFLUORIDES

ANALYTICAL PREPARATIONS

 See IN VITRO DIAGNOSTIC AND ANALYTICAL PREPARATIONS

ANDROSTALONE

 See MESTANOLONE

ANDROSTERONE

 See ANABOLIC STEROIDAL AGENTS

ANTIBIOTIC SUBSTANCES

 See also BACTERIAL CULTURE MEDIA

ANTICOAGULANT MEDICAL DEVICES

 See MEDICAL DEVICES

ANTICOAGULATION COMPLEX

 See HUMAN BLOOD PRODUCTS

ANTIMONY

 See also ANTIMONY COMPOUNDS

ANTIMONY CHLORIDE

 See also ANTIMONY COMPOUNDS

ANTIMONY COMPOUNDS

 See also ANTIMONY

ANTIMONY TITANATE

 See ANTIMONY COMPOUNDS

 See ANTIMONY

ARBUTIN

 See HYDROQUINONE

ARISTOLOCHIC ACID

 See also bragantia

 See also ASARUM spp

AROMATIC EXTRACT OILS

 See also HYDROCARBONS LIQUID AROMATIC

ARSENIC

 See also CACODYLIC ACID

 See also TERMITE BARRIERS

ARSENIC  TRIOXIDE

 See ARSENIC

ARTIFICIAL TEARS

 See MEDICAL DEVICES

ASPERGILLUS NIGER

 See -AMYLASE

 See CELLULASE

 See FUNGAL PROTEASE

 See -GLUCANASE

 See PECTINASE

 See XYLANASE

ASPIDOSPERMA QUEBRACHO

 See YOHIMBINE

ASPIRIN

 See also DIHYDROCODEINE (+ aspirin)

 See also PARACETAMOL (+ aspirin)

 See also SALICYLAMIDE (+ aspirin)

ASTEMIZOLE

 See also Antihistamines

ATROPINE METHONITRATE

 See also ATROPINE

ATROPINE SULFATE

 See DIFENOXIN (+ atropine sulfate)

 See DIPHENOXYLATE (+ atropine sulfate)

AZELASTINE

 See also ANTIHISTAMINES

B

BARIUM

 See BARIUM SALTS

BARIUM CHROMATE

  See CHROMATES

  See CHROMIUM

BARIUM metaborate

 See BARIUM SALTS

BARIUM salts

BARIUM SELENATE

 See SELENIUM

BARIUM SILICOFLUORIDE

 See also SILICOFLUORIDES

BARIUM SULFATE

 See BARIUM SALTS

BATTERIES

 See ELECTRICAL ACCUMULATORS, BATTERIES, COMPONENTS OR LAMPS

BDMPEA

 See 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE

BEECHWOOD

 See CREOSOTE

BELLADONNA

 See ATROPA BELLADONNA

BENZALKONIUM CHLORIDE

 See also QUATERNARY AMMONIUM COMPOUNDS

BENZATHINE PENICILLIN

BENZATROPINE

 See BENZTROPINE

Benzene

 See also HYDROCARBONS, LIQUID

BENZOYL METRONIDAZOLE

 See METRONIDAZOLE

BISMUTH CITRATE

 See BISMUTH COMPOUNDS

BISMUTH FORMIC IODIDE

 See BISMUTH COMPOUNDS

BISMUTH OXYCHLORIDE

 See BISMUTH COMPOUNDS

BISMUTH SUBIODIDE

 See BISMUTH COMPOUNDS

BIS(TROBUTYLTINOXIDE)

 See TRIBUTYL TIN OXIDE

BLEACHES

 See CHLORINATING AGENTS

BLOOD

 See also BLOOD COMPONENTS

 See also DEXTRANS, GELATIN SUCCINYLATED & ETHERIFIED STARCHES

 See also HUMAN BLOOD PRODUCTS

Borage

 See BORAGO OFFICINALIS

BORATES

 See BORON

BORAX

 See also BORON

BORIC ACID

 See also BORON

BORON

 See also BORIC ACID

BORON COMPOUNDS

 See BORON

BORON TRIFLUORIDE

 See also BORON

BROMO-DRAGONFLY

 See 1-(8-BROMOBENZO[1,2-B;4,5-B]DIFURAN-4-YL)-2-AMINOPROPANE

BROMOCHLORODIMETHYLHYDANTOIN

 See CHLORINATING COMPOUNDS

BUTYPHENONES

 See HALOPERIDOL

BZP

 See BENZYLPIPERAZINE

C

C1 ESTERASE INHIBITORS

 See HUMAN BLOOD PRODUCTS

CADMIUM

 See also CADMIUM COMPOUNDS

CADMIUM ACETATE

 See CADMIUM COMPOUNDS

CADMIUM CHLORIDE

 See CADMIUM COMPOUNDS

CADMIUM COMPOUNDS

 See also CADMIUM

CADMIUM NITRATE

 See CADMIUM COMPOUNDS

CAFFEINE

 See ASPIRIN (+ caffeine)

 See SALICYLAMIDE (+ caffeine)

calamus

 See ACORUS CALAMUS

CALCIUM FOLINATE

 See FOLINIC ACID

CALCIUM HYPOCHLORITE

 See CHLORINATING COMPOUNDS

CALOMEL

 See MERCURIC CHLORIDE

CAMPHOR

 See also ESSENTIAL OILS

CAMPHOR OIL (white)

 See CINEOLE

CANNABICHROMENE

 See NABIXIMOLS

CANNABICYCLOHEXANOL

 See 2-[(1R,3S)-3-HYDROXYCYCLOHEXYL]-5-(2-METHYLNONAN-2-YL)PHENOL

CANNABIDIOL

 See NABIXIMOLS

CANNABIDIOLIC ACID

 See NABIXIMOLS

CANNABIDIVAROL

 See NABIXIMOLS

CANNABIGEROL

 See NABIXIMOLS

CANNABINOIDS

 See NABIXIMOLS

CANNABINOL

 See NABIXIMOLS

CANNABIS SATIVA

 See HEMP SEED OIL

 See NABIXIMOLS

CARDIAC GLYCOSIDES

 See UNDER INDIVIDUAL ENTRIES

CATALIN

 See PIRENOXINE

CATECHOL
     See 1,2-BENZENEDIOL

CEPHACETRILE

 See CEFACETRILE

CEPHALORIDINE

 See CEFALORIDINE

CEPHAMANDOLE

 See CEFAMANDOLE

CEPHAPIRIN

 See CEFAPIRIN

CEPHAZOLIN

 See CEFAZOLIN

CETYL TRANEXAMATE

 See TRANEXAMIC ACID

CHILD-RESISTANT CLOSURE

 See also NON-ACCESS PACKAGING

CHILD-RESISTANT PACKAGING

 See also NON-ACCESS PACKAGING

CHLORINATED TERPENES

 See TERPENES, CHLORINATED

chlorine

 See also CHLORINATING COMPOUNDS

 See also DICHLOROISOCYANURATES

 See also DICHLOROISOCYANURIC ACID

CHLOROMESTERONE

 See DEHYDROCHLOROMETHYLTESTOSTERONE

4-CHLOROTESTOSTERONE

 See CLOSTEBOL

CHLORQUINALDOL

 See also CLIOQUINOL

CHOLECALCIFEROL

 See COLECALCIFEROL

CHOLINE SALICYLATE

 See SALICYLIC ACID

Chromates

 See also CHROMIUM

CHROMIC ACID

 See CHROMIUM TRIOXIDE

CHROMIUM

  See also CHROMATES

chrysanthemic ACID ESTERS

 See PYRETHRINS

2C-I

 See 2,5-DIMETHOXY-4-IODOPHENETHYLAMINE

CINEROLONE

 See PYRETHRINS

CLOTTING FACTORS

 See HUMAN BLOOD PRODUCTS

COLECALCIFEROL

 See also VITAMIN D

COLESTYRAMINE

 See CHOLESTYRAMINE

COLLAGEN

 See also MEDICAL DEVICES

COLTSFOOT

 See TUSSILAGO

COMFREY

 See SYMPHYTUM spp.

coniine

 See CONIUM MACULATUM

CONTAINERS

 See also  IMMEDIATE CONTAINER

 See also SELECTED CONTAINER

CONTRAST MEDIA, RADIOGRAPHIC (RADIOPAQUES)

 See RADIOGRAPHIC CONTRAST MEDIA

COPPER CHLORIDE

 See COPPER NITRATE

COPPER-CHROME-ARSENIC

 See CHROMATES, AND ARSENIC

COPPER SALICYLATE

 See DIMETHYL SULFOXIDE

COPPER

 See COPPER COMPOUNDS

CORROSIVE SUBLIMATE

 See MERCUROUS CHLORIDE

CORYMBIA CITRIODORA

 See EXTRACT OF LEMON EUCALYPTUS

CP 47,497 C8 HOMOLOGUE

 See 2-[(1R,3S)-3-HYDROXYCYCLOHEXYL]-5-(2-METHYLNONAN-2-YL)PHENOL

CP 47,497

 See 2-[(1R,3S)-3-HYDROXYCYCLOHEXYL]-5-(2-METHYLOCTAN-2-YL)PHENOL

CREOSOTE

 See also PHENOL

CROTON OIL

 See CROTON TIGLIUM

CRYOPRECIPITATE

 See HUMAN BLOOD PRODUCTS

CRYSTAL WARE

 See GLASS

2C-T-2

 See 2,5-DIMETHOXY-4-ETHYLTHIOPHENETHYLAMINE

2C-T-7

 See 2,5-DIMETHOXY-4-(N)-PROPYLTHIOPHENETHYLAMINE

CUBE

See ROTENONE

curing agents FOR EPOXY RESINS

 See AMINES FOR USE AS CURING AGENTS FOR EPOXY RESIN

 See Anhydrides, organic acid FOR USE AS CURING AGENTS FOR EPOXY RESINS

 See EPOXY RESINS

Cyanides

 See also HYDROCYANIC ACID AND CYANIDES

CYPERMETHRIN

 See also ZETA-CYPERMETHRIN, ALPHA-CYPERMETHRIN AND BETA-CYPERMETHRIN

D

DALMATIAN

 See SAGE OIL

D.D.A.V.P.

 See DESMOPRESSIN

DDT

 See DICOPHANE

DEANOL
     See 2-(DIMETHYLAMINO)ETHANOL, DMEA, DIMETHYL MEA

DEET

 See DIETHYLTOLUAMIDE

DEHYDROEPIANDROSTERONE

 See PRASTERONE

DEHYDROISOANDROSTERONE

 See PRASTERONE

DEHYDROTESTOSTERONE

 See BOLDENONE

DELAVIRDINE MESYLATE

 See DELAVIRDINE

DELTA-9-TETRAHYDROCANNABINOL

 See DRONABINOL

DENATONIUM BENZOATE

 See BENDIOCARB

 See DIETHYLENE GLYCOL

 See ETHYLENE GLYCOL

 See METHOMYL

 See METHYLATED SPIRIT(S)

DESLORATADINE

 See also ANTIHISTAMINES

DET

 See N,N-DIETHYLTRYPTAMINE

DIALKYL and DIALKOYL QUATERNARY AMMONIUM COMPOUNDS

 See QUATERNARY AMMONIUM COMPOUNDS

dialkyl TIN COMPOUNDS

 See TIN ORGANIC COMPOUNDS

DIBENZODIOXINS, HALOGENATED

 See HALOGENATED DIBENZODIOXINS

DIBENZOFURANS, HALOGENATED

 See HALOGENATED DIBENZODIOXINS AND DIBENZOFURANS

DIBUTYL TIN COMPOUNDS

 See TIN ORGANIC COMPOUNDS

1,1-DICHLORO-2,2-BIS[4-CHLOROPHENYL]ETHANE

 See TDE

4,5-DICHLORO-2-N-OCTYL-3(2H)-ISOTHIAZOLONE

DICHLOROETHYL ETHER

 See also CHLORINATING COMPOUNDS

DICHROMATES

 See also CHROMATES

DICOBALT EDETATE

 See COBALT

 See EDETIC ACID

DIESEL (DISTILLATE)

 See also HYDROCARBONS, LIQUID

DIETHYL TIN COMPOUNDS

 See TIN ORGANIC COMPOUNDS

DIETHYL-PARA-PHENYLENEDIAMINE

 See PHENYLENEDIAMINES

DIETHYLSTILBOESTROL

 See STILBOESTROL

DIETHYLSTILBOESTROL DIPHOSPHATE

 See FOSFESTROL

DI-IODOHYDROXYQUINOLINE (iodoquinol)

DIMETAMFETAMINE

 See  N,N-DIMETHYLAMPHETAMINE

DIMETHISOQUIN

 See QUINISOCAINE

DIMETHYL MEA
     See 2-(DIMETHYLAMINO)ETHANOL, DEANOL, DMEA

DIMETHYL SULFONE

 See METHYLSULFONYLMETHANE

DIMETHYL TIN DICHLORIDE

 See TIN ORGANIC COMPOUNDS

DIMETHYL TIN COMPOUNDS

 See TIN ORGANIC COMPOUNDS

DIMETHYLFORMAMIDE

 See also DESIGNATED SOLVENT

DIMETHYL-PARA-PHENYLENEDIAMINE

 See PHENYLENEDIAMINES

DI-N-PROPYL ISOCINCHOMERONATE

DIOCTYL SODIUM SULFOSUCCINATE

 See DOCUSATE SODIUM

DIOXINS

 See HALOGENATED DIBENZODIOXINS

DIPENTENE

 See LIMONENE

DIPROPYL TIN COMPOUNDS

 See TIN ORGANIC COMPOUNDS

DISODIUM ETIDRONATE

 See ETIDRONIC ACID

DISODIUM PAMIDRONATE

 See PAMIDRONIC ACID

DISODIUM TILUDRONATE

 See TILUDRONIC ACID

DISTILLATE (DIESEL)

 See Diesel

See also HYDROCARBONS, LIQUID

DITHIOCARBAMATES

 See UNDER INDIVIDUAL ENTRIES

DMA

 See 2,5-DIMETHOXYAMPHETAMINE

DMAA

 See 1,3-DIMETHYLAMYLAMINE

DMEA

     See 2-(DIMETHYLAMINO)ETHANOL, DEANOL, DIMETHYL MEA

DMHP

 See 3-(1,2-DIMETHYLHEPTYL)-1-HYDROXY-7,8,9,10-TETRAHYDRO-6,6,9- TRIMETHYL-6H-DIBENZO (b,d) PYRAN

DMT

 See N,N-DIMETHYLTRYPTAMINE

DOB

 See 2,5-DIMETHOXY-4-BROMOAMPHETAMINE

1-DODECANOL

 See LAURYL ALCOHOL

DOET

 See 2,5-DIMETHOXY-4-ETHYL-a-AMPHETAMINE

DOM

 See 2-AMINO-1-(2,5-DIMETHOXY-4-METHYL)PHENYLPROPANE

DRONABINOL (delta-9-TETRAHYDROCANNABINOL)

 See also NABIXIMOLS

DRY CLEANING FLUID

 See LIQUID HYDROCARBONS

 See HYDROCARBONS, LIQUID

E

ECOTHIOPATE IODIDE

 See ECOTHIOPATE

EMETINE

 See also CEPHAELIS ACUMINATA

ENAMELLING PREPARATIONS

 See FRITTED GLAZING OR ENAMELLING PREPARATIONS

ENDOTOXIN

 See BACILLUS THURINGIENSIS

ENILCONAZOLE

 See IMAZALIL

EPHEDRINE

  See also EPHEDRA

EQUINE ANTI-HUMAN THYMOCYTE IMMUNOGLOBULIN

 See IMMUNOGLOBULINS

ERGOCACIFEROL

 See VITAMIN D

ESSENTIAL OILS

 See also CAMPHOR

ETHANEDINITRILE

 See CYANOGEN

ETHANOL

 See METHYLATED SPIRIT(S)

 See also ETHYL ALCOHOL

ETHOXYETHYLMERCURIC CHLORIDE

 See also MERCURY

ETHOXYQUIN

 See also MERCURY

ETHYL ALCOHOL

 See also ETHANOL

F

FAMPRIDINE

 See 4-AMINOPYRIDINE

FENBUTATIN OXIDE

 See also TIN ORGANIC COMPOUNDS

FERRICYANIDES

 See CYANIDES

FERROCYANIDES

 See CYANIDES

FEXOFENADINE

 See also Antihistamines

FIBRINOGEN

 See HUMAN BLOOD PRODUCTS

FILM OR PAPER, PHOTOGRAPHIC

 See PHOTOGRAPHIC PAPER or FILM

FLAVOPHOSPHOLIPOL

 See BAMBERMYCIN

FLUORESCEIN

 See also METHYLATED SPIRIT(S)

FLUORIDES

 See also SILICOFLUORIDES

4-FLUORO-N-METHAMPHETAMINE

 See 4-FLUORO-N-METHYLAMPHETAMINE

FLUOROSILICATES

 See SILICOFLUORIDES

FLUOROSILICIC ACID

 See HYDROSILICOFLUORIC ACID

FOLLICLE STIMULANT, RECOMBINANT

 See CORIFOLLITROPIN ALFA

FOLLICLE-STIMULATING HORMONE, HUMAN

 See UROFOLLITROPIN

FOLLICLE-STIMULATING HORMONE, RECOMBINANT HUMAN

 See FOLLITROPIN ALPHA

 See FOLLITROPIN BETA

FORMALDEHYDE

 See also METACRESOLSULPHONIC ACID AND FORMALDEHYDE CONDENSATION PRODUCT

 See also FREE FORMALDEHYDE

FORMOTEROL

 See EFORMOTEROL

FREE FORMALDEHYDE

 See also FORMALDEHYDE

 See also PARAFORMALDEHYDE

FRUSEMIDE

 See FUROSEMIDE

FUELS

 See MOTOR, HEATING or FURNACE FUELS

FUELS, HOBBY

 See MOTOR, HEATING or FURNACE FUELS

FUELS, TOY

 See MOTOR, HEATING or FURNACE FUELS

G

GAMMA HYDROXYBUTYRATE (GHB)

 See 4-HYDROXYBUTANOIC ACID

GENTIAN VIOLET

 See CRYSTAL VIOLET

GHB (GAMMA HYDROXYBUTYRATE)

 See 4-HYDROXYBUTANOIC ACID

GLYCOSYLATED HYDROQUINONE

See HYDROQUINONE

GUAIPHENESIN

 See also PARACETAMOL (+ guaiphenesin)

H

H5N1 INFLUENZA VIRUS HAEMAGGLUTININ

 See INFLUENZA AND CORYZA VACCINES

HALQUINOL

 See CLIOQUINOL

HELICO ZEA OCCLUSION BODIES

 See POLYHEDROSIS VIRUS

HELICOVERPA ARMIGERA

 See NUCLEAR POLYHEDROSIS VIRUS

HEMP AGRIMONY

 See EUPATORIUM CANNABINUM

HEMP

 See CANNABIS

HEMP SEED OIL

  See also TETRAHYDROCANNABINOLS

HEXACHLOROPHANE

 See also HCB

HEXAFLUOROSILICATES

 See SILICOFLUORIDES

HEXAFLUOROSILIC ACID

 See HYDROSILICOFLUORIC ACID

HEXAMETHYLMELAMINE

 See ALTRETAMINE

HOBBY FUELS

 See MOTOR, HEATING or FURNACE FUELS

HORMONE, FOLLICLE-STIMULATING

 See also FOLLICLE-STIMULATING HORMONE

HORMONE, GROWTH

 See GROWTH HORMONE

HORMONE, HUMAN FOLLICLE-STIMULATING

 See UROFOLLITROPIN

HORMONE, HUMAN GROWTH

 See SOMATROPIN

HORMONE, RECOMBINANT HUMAN FOLLICLE-STIMULATING

 See FOLLITROPIN ALPHA

 See FOLLITROPIN BETA

HUMAN BLOOD PRODUCTS

 See also BLOOD

HUMAN FOLLICLE-STIMULATING HORMONE

 See UROFOLLITROPIN

human growth hormone

 See SOMATROPIN

HYDROCARBONS, LIQUID

 See also DESIGNATED SOLVENT

 See also NAPHTHALENE

 See also LIQUID HYDROCARBONS

 HYDROCHLORIC ACID

HYDROCARBONS LIQUID AROMATIC

 See also HYDROCARBONS, LIQUID

HYDROFLUOSILICIC ACID

 See HYDROSILICOFLUORIC ACID

HYDROGEN FLUORIDE

 See HYDROFLUORIC ACID

HYDROQUINONE

 See also MONOBENZONE

8-HYDROXYQUINOLINE

 See also CLIOQUINOL

HYOSCINE BUTYLBROMIDE

 See also HYOSCINE

I

IBUPROFEN

 See also PARACETAMOL (+ ibuprofen)

IMMUNOSERA

 See ANTISERA

INJECTABLE TISSUE RECONSTRUCTIVE, AUGMENTATION AND RESTORATION MATERIALS

 See MEDICAL DEVICES

INK ADDITIVES

 See PRINTING INKS OR INK ADDITIVES

INTRA-ARTICULAR FLUIDS

 See MEDICAL DEVICES

Iodine

 See also IODOPHORS

3-IODO-2-PROPYNYL BUTYL CARBAMATE (iodocarb)

Iodocarb

 See 3-IODO-2-PROPYNYL BUTYL CARBAMATE

IODOPHORS

 See also IODINE

iodoquinol

 See DI-IODOHYDROXYQUINOLINE

IPECACUANHA

 See CEPHAELIS IPECACUANHA

 See CEPHAELIS ACUMINATA

IRON OXIDES

 See IRON COMPOUNDS

J

JASMOLONE

 See PYRETHRINS

JEQUIRITY

 See ABRUS PRECATORIUS

JWH-018

 See 1-PENTYL-3-(1-NAPHTHOYL)INDOLE

JWH-073

 See NAPTHALEN-1-YL-(1-BUTYLINDOL-3-YL)METHANONE

JWH-122

 See 1-PENTYL-3-(4-METHYL-1-NAPTHOYL)INDOLE

JWH-200

 See 1-(2-MORPHOLIN-4-YLETHYL)INDOL-3-YL)-NAPTHALEN-1-YLMETHANONE

JWH-250

 See 2-(2-METHOXYPHENYL)-1-(1-PENTYLINDOL-3-YL)ETHANONE

K

KAVA

 See PIPER METHYSTICUM

KAVALACTONES

 See PIPER METHYSTICUM

KEROSENE

 See also LIQUID HYDROCARBONS

 See also HYDROCARBONS, LIQUID

 See also MOTOR, HEATING or FURNACE FUELS

K-HDO

 See N-CYCLOHEXYLDIAZENIUMDIOXY-POTASSIUM

L

LABELS

 See also DISPENSING LABEL

 See also MAIN LABEL

LAMP OIL

 See LIQUID HYDROCARBONS

 See HYDROCARBONS, LIQUID

LAMPS

 See ELECTRICAL ACCUMULATORS, BATTERIES, COMPONENTS OR LAMPS

LAURETH-9

 See LAUROMACROGOL

LAVANDIN OIL

 See also CAMPHOR

LEAD & LEAD COMPOUNDS

 See also PRINTING INKS or INK ADDITIVES

 See also SELENIUM

 See also GLAZING PREPARATIONS

LEMON EUCALYPTUS OIL

 See EXTRACT OF LEMON EUCALYPTUS

LEVOCETIRIZINE

 See CETIRIZINE

LIDOCAINE

 See LIGNOCAINE

LIGHT MINERAL OILS

 See HYDROCARBONS, LIQUID

LINDANE

 See also BHC

LINSEED OIL

 See ETHOPROPHOS

LIPASE

 See PANCREATIC ENZYMES

LIQUID AROMATIC HYDROCARBONS

 See HYDROCARBONS, LIQUID

LIQUID Hydrocarbons

 See also HYDROCARBONS, LIQUID

 See also NAPHTHALENE

LORATADINE

 See also ANTIHISTAMINES

LUTEIN

 See XANTHOPHYLL

LYE WATER

 See ALKALINE SALTS, SODIUM HYDROXIDE OR POTASSIUM HYDROXIDE

M

MAGNESIUM FLUOSILICATE

 See FLUORIDES

MAGNESIUM PHOSPHIDE

 See PHOSPHIDES, METALLIC

MAGNETIC RESONANCE IMAGING ENHANCING AGENTS

 See ENHANCING AGENTS

Malathion

 See also ORGANOPHOSPHORUS COMPOUNDS

MALDISON

 See MALATHION

MANCOZEB

 See also DITHIOCARBAMATES

MANUKA oil

 See LEPTOSPERMUM SCOPARIUM OIL

MBDB

 See N-METHYL-1-(3,4-METHYLENEDIOXYPHENYL)-2-BUTANAMINE

MDA

 See 3,4-METHYLENEDIOXYAMPHETAMINE

MDMA

 See N,-DIMETHYL-3,4-(METHYLENEDIOXY)PHENYLETHYLAMINE

MDPV

 See 3,4-METHYLENEDIOXYPYROVALERONE

MELANOCYTE STIMULATING HORMONE

 See AFAMELANOTIDE

5-MeO-AMT

 See 5-METHOXY--METHYLTRYPTAMINE

MEPHEDRONE

 See 4-METHYLMETHCATHINONE

MERCURY

 See also PHENYLMERCURIC ACETATE

MESCALINE

 See 3,4,5-TRIMETHOXYPHENETHYLAMINE

METHADONE INTERMEDIATE

 See 4-CYANO-2-DIMETHYLAMINO-4,4-DIPHENYLBUTANE

METHAM SODIUM

 See METHAM

METHAMPHETAMINE

 See METHYLAMPHETAMINE

METHANOL

  See also MOTOR, HEATING or FURNACE FUELS

METHOTRIMEPRAZINE

 See LEVOMEPROMAZINE

METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA

 See EPOETINS

METHOXYPHENAMINE

 See also 3,4,5-TRIMETHOXYPHENETHYLAMINE (MESCALINE)

METHOXY-PHENYLETHYLAMINE

 See 3,4,5-TRIMETHOXYPHENETHYLAMINE

METHYL CHAVICOL

 See BASIL OIL

METHYL ETHYL KETONE

 See also DESIGNATED SOLVENT

METHYL ISOAMYL KETONE

 See also DESIGNATED SOLVENT

METHYL ISOBUTYL KETONE

 See also DESIGNATED SOLVENT

 See also METHYLATED SPIRIT(S)

METHYL SALICYLATE

 See also DIMETHYL SULFOXIDE

METHYLDIGOXIN

 See MEDIGOXIN

METHYLENE chloride

 See DICHLOROMETHANE

METHYLENE dianiline

 See 4,4-DIAMINODIPHENYLMETHANE

METHYLENE GLYCOL

 See FREE FORMALDEHYDE

 See FORMALEDHYDE

3,4-METHYLENEDIOXY-N-α-DIMETHYLPHENYLETHYLAMINE

 See N,A-DIMETHYL-3,4-(METHYLENEDIOXYL)PHENYLETHYLAMINE

4-METHYLHEXANE-2-AMINE

 See 1,3-DIMETHYLAMYLAMINE

METHYLPHENOBARBITONE

 See also BARBITURATE METHYLPREDNISOLONE

METHYLSULFONYLMETHANE

 See DIMETHYL SULFONE

METRIFONATE (trichlorfon)

 See also TRICHLORFON

MINERAL OILS

 See HYDROCARBONS, LIQUID

MINERAL OILS, LIGHT

 See HYDROCARBONS, LIQUID

MINERAL TURPENTINE

 See LIQUID HYDROCARBONS

 See HYDROCARBONS, LIQUID

MMDA

 See 5-METHOXY-3,4-METHYLENEDIOXYAMPHETAMINE

MOCA

 See 4-DIMETHYLAMINOAZOBENZENE

MONOBENZONE

 See also HYDROQUINONE

MORAMIDE

 See DEXTROMORAMIDE

MORAMIDE INTERMEDIATE

 See 2-METHYL-3-MORPHOLINO-1, 1-DIPHENYLPROPANE CARBOXYLIC ACIDMPPP

 See 1-METHYL-4-PHENYL-4-PIPERIDINOL PROPIONATE

MYCOPHENOLATE MOFETIL

 See MYCOPHENOLIC ACID

N

N-(N-DODECYL)-2-PYRROLIDONE

 See also DESIGNATED SOLVENT

 See also N-(N-OCTYL)-2-PYRROLIDONE

 See also N-METHYL-2-PYRROLIDONE

N-(N-octyl)-2- PYRROLIDONE

 See also DESIGNATED SOLVENT

 See also N-(N-DODECYL)-2-PYRROLIDONE

 See also N-METHYL-2-PYRROLIDONE

N,N-BIS(PHENYLMETHYLENE)-BICYCLO-(2.2.1)HEPTANE-2,5-DIMETHANAMINE

 See also N,N-BIS(PHENYLMETHYLENE)-BICYCLO-(2.2.1)HEPTANE-2,6-DIMETHANAMINE

N,N-bIS(PHENYLMETHYLENE)-BICYCLO-(2.2.1)HEPTANE-2,6-DIMETHANAMINE

 See also N,N-BIS(PHENYLMETHYLENE)-BICYCLO-(2.2.1)HEPTANE-2,5-DIMETHANAMINE

N,N-DIMETHYL-4-[PHENYLAZO]-BENZENAMINE

 See 4-DIMETHYLAMINOAZOBENZENE

NAPTHALENEACETIC ACID

 See NAA

NEEM

 See DEBITTERISED NEEM SEED OIL

 See Azadirachta indica

NEFAZODONE

N-ETHYL MDA

 See N-ETHYL--METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE

N-HYDROXY MDA

 See N--[METHYL-3,4-(METHYLENEDIOXY)PHENETHYL]HYDROXYLAMINE

NICOTINAMIDE

 See NICOTINIC ACID

NISIN

 See also ANTIBIOTIC SUBSTANCES

nitrogen mustard

 See MUSTINE

N-METHYL-2-PYRROLIDONE

 See also DESIGNATED SOLVENT

 See also N-(N-DODECYL)-2-PYRROLIDONE

 See also N-(N-OCTYL)-2-PYRROLIDONE

N-METHYLMETHANAMINE

 See 1,2-ETHANEDIAMINE POLYMER WITH (CHLOROMETHYL)OXIRANE and N-METHYLMETHANAMINE

NON-ACCESS PACKAGING

 See also CHILD-RESISTANT CLOSURE

 See also CHILD-RESISTANT PACKAGING

NOSCAPINE

 See also OPIUM

NUX VOMICA

 See STRYCHNINE

O

OCITHILINONE

 See 2-OCTYL-4-ISOTHIAZOLIN-3-ONE

OIL OF LEMON EUCALYPTUS (Corymbia citriodora)

 See EXTRACT OF LEMON EUCALYPTUS

OIL OF TANSY

 See TANACETUM VULGARE

ORGANO TIN-COMPOUNDS

 See TIN ORGANIC COMPOUNDS

OXALONITRILE

 See CYANOGEN

OXETHAZAINE

 See OXETACAINE

P

PACKAGING

 See LABELS  & CONTAINERS

 See also PRIMARY PACK

 See also MEASURE PACK

PAPAVERINE

 See also OPIUM

PAPER

 See also PHOTOGRAPHIC PAPER or FILM

Paracetamol

 See also ASPIRIN (+ paracetamol)

 See also METOCLOPRAMIDE (+ paracetamol)

 See also SALICYLAMIDE (+ paracetamol)

PARAFFIN OILS

 See HYDROCARBONS, LIQUIDPARAHEXYL

 See 3-HEXYL-1-HYDROXY-7,8,9,10-TETRAHYDRO-6,6,9-TRIMETHYL-6H-DIBENZO (b,d) PYRAN

PCBS

 See POLYCHLORINATED BIPHENYLS

PCE

 See ETICYCLIDINE

PCP

 See PHENCYCLIDINE

PCPY

 See ROLICYCLIDINE

PDB

 See PARA-Dichlorobenzene

PENTACHLORONITROBENZENE

 See QUINTOZENE

PENTOXIFYLLINE

 See OXPENTIFYLLINE

PEPAP

 See 1-PHENYLETHYL-4-PHENYL-4-PIPERIDINOL ACETATE

PETHIDINE INTERMEDIATE A

 See 4-CYANO-1-METHYL-4-PHENYLPIPERIDINE

PETHIDINE INTERMEDIATE B

 See 4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID ETHYL ESTER

PETHIDINE INTERMEDIATE C

 See 1-METHYL-4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID

Petrol

 See also BENZENE

 See also MOTOR, HEATING or FURNACE FUELS

PETROLEUM OILS

 See HYDROCARBONS, LIQUID

PHENOLS

 See also CREOSOTE

PHENYL MERCURIC CHLORIDE

 See MERCURY

PHENYL METHYL KETONE

 See also DESIGNATED SOLVENT

Phenylephrine

 See also CODEINE (+ phenylephrine)

 See also PARACETAMOL (+ phenylephrine)

 See also IBUPROFEN (+ phenylephrine)

PHOSPHOURUS ACID

 See PHOSPHONIC ACID

PHP

 See ROLICYCLIDINE

PHYTOMENADIONE

See VITAMIN K

PIMARCIN

 See NATAMYCIN

PIPERAZINE OESTRONE SULFATE

 See ESTROPIPATE

PLASMA

 See BLOOD COMPONENTS

 See HUMAN BLOOD PRODUCTS

PLASMA SUBSTITUTES

 See DEXTRANS, GELATIN SUCCINYLATED & ETHERIFIED STARCHES

PLASMA-DERIVED THERAPEUTIC PROTEINS

 See HUMAN BLOOD PRODUCTS

PLATELETS

 See BLOOD COMPONENTS

 See HUMAN BLOOD PRODUCTS

PMA

 See 4-METHOXY--METHYLPHENYLETHYLAMINE

PODOPHYLLIN

 See also PODOPHYLLUM EMODI

 See also PODOPHYLLUM PELTATUM

 See also PODOPHYLLUM RESIN

POLYDADMAC

 See POLY DIALLYL DIMETHYL AMMONIUM CHLORIDE

POLYSILICONE-15

 See DIMETHICODIETHYLBENZALMALONATE

POTASSIUM CARBONATE

 See ALKALINE SALTS

POTASSIUM CHROMATE

 See CHROMATES

 See CHROMIUM

POTASSIUM PERMANGANATE

 see PERMANGANATES

POTASSIUM PHOSPHATE

 See ALKALINE SALTS

POTASSIUM SALTS

 See ALKALINE SALTS

 See BIFLUORIDES

POTASSIUM SILICATE

See ALKALINE SALTS

propineb

 See also DITHIOCARBAMATES

PROTEIN C

 See HUMAN BLOOD PRODUCTS

PROTHROMBIN COMPLEX CONCENTRATE (PCC)

 See HUMAN BLOOD PRODUCTS

PSILOCINE

 See 3-(2-DIMETHYLAMINOETHYL)-4-HYDROXYINDOLE

PSILOTSIN

 See 3-(2-DIMETHYLAMINOETHYL)-4-HYDROXYINDOLE

PYRETHRIC ACIDS

 See PYRETHRINS

PYRETHROLONE

 See PYRETHRINS

Q

QUIZALOFOP ETHYL (D + ISOMER)

 See QUIZALOFOP ETHYL

R

RADIOPAQUES

 See RADIOGRAPHIC CONTRAST MEDIA

RASML

 See REQUIRED ADVISORY STATEMENTS FOR MEDICINE LABELS

RECOMBINANT FOLLICLE STIMULANT

 See CORIFOLLITROPIN ALFA

RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE

 See FOLLITROPIN ALPHA

 See FOLLITROPIN BETA

RED CELLS

 See BLOOD COMPONENTS

 See HUMAN BLOOD PRODUCTS

REDUCERS

 See HYDROCARBONS, LIQUID

 See LIQUID HYDROCARBONS

ROSEMARY OIL

 See also CAMPHOR

 See also CINEOLE

S

s,s,s-TRIBUTYLPHOSPHOROTRITHIOATE

 See TRIBUFOS

SABADILLA

 See SCHOENOCAULON OFFICINALE

Safrole

 See also SASSAFRAS OIL

SAGE OIL (Spanish)

 See also CAMPHOR

Salicylamide

 See also ASPIRIN (+ salicylamide)

 See also PARACETAMOL (+ salicylamide)

SALVINORIN A

 See METHYL (2S, 4aR, 6aR, 7R, 9S, 10aS, 10bR)-9-ACETOXY-6a,10b-DIMETHYL-4,10-DIOXO-DODECAHYDRO-2-(3-FURYL)-2H-NAPHTHO[2,1-c]PYRAN-7-CARBOXYLATE

SARM

 See SELECTIVE ANDROGEN RECEPTOR MODULATORS

SAVIN(E)

 See JUNIPERUS SABINE

SECOBARBITAL

See QUINALBARBITONE

SELENIUM ARSENIDE

 See ARSENIC

 See SELENIUM

SELENIUM SULFIDE

 See SELENIUM

SHUI OIL

 See CAMPHOR

SILICOFLUORIC ACID

See HYDROSILICOFLUORIC ACID

SILICOFLUORIDES

 See also FLUORIDES

SILVER SALTS

 See also SILVER NITRATE

SODIUM CARBONATE

 See ALKALINE SALTS

SODIUM CHROMATE

 See CHROMATES

 See CHROMIUM

SODIUM CLODRONATE

 See CLODRONIC ACID

SODIUM DICHLOROISOCYANURATE

 See also DICHLOROISOCYANURATES

SODIUM 2,2-DICHLOROPROPIONATE

 See 2,2-DPA

SODIUM HYPOCHLORITE

 See CHLORINATING COMPOUNDS

SODIUM OXYBATE

 See 4-HYDROXYBUTANOIC ACID

SODIUM SALTS

 See ALKALINE SALTS

 See BIFLUORIDES

SODIUM SILICATE(S)

 See ALKALINE SALTS

STABAXOL

 See 2,2',6'6'-TETRAISOPROPYL-DIPHENYL-CARBODIIMIDE

STAPHISAGRIA

 See DELPHINIUM STAPHISAGRIA

STATINS

 See HMG-CoA REDUCTASE INHIBITORS

STEM CELLS

 See BLOOD COMPONENTS

 See also HUMAN BLOOD PRODUCTS

STEROIDAL AGENTS

 See ANABOLIC STEROIDAL AGENTS

 See ANDROGENIC STEROIDAL AGENTS

STP

 See 2-AMINO-1-(2,5-DIMETHOXY-4-METHYL)PHENYLPROPANE

STRAMONIUM

 See DATURA STRAMONIUM

 See DATURA TATULA

STRONTIUM CHROMATE

 See CHROMATES

 See CHROMIUM

Styrene

 See also DESIGNATED SOLVENT

SULFACETAMIDE

 See also SULFONAMIDES

SULFONAL

 See SULFONMETHANE

SULPHANILAMIDE

 See SULFONAMIDES

SYNEPHRINE

 See OXEDRINE

T

TANSY OIL

 See TANACETUM VULGARE

TAPENTADOL

TAR

See PHENOL

TBTO

 See TRI-ALKYL TIN COMPOUNDS/SALTS

TCP

 See TENOCYCLIDINE

TDE (1,1-dichloro-2,2-bis[4-chlorophenyl]ethane)

TEA TREE OIL

 See MELALEUCA OIL

TERBUCONAZOLE

 See TEBUCONAZOLE

TERFENADINE

  See also ANTIHISTAMINES

TETRACAINE

 See AMETHOCAINE

Tetrachloroethylene

  See also DESIGNATED SOLVENT

TETRAHYDROCANNABINOLIC ACID

 See NABIXIMOLS

TETRAHYDROCANNABINOLS

  See also NABIXIMOLS

TETRAHYDROCANNABIVAROL

 See NABIXIMOLS

TETRAPION

 See FLUPROPANATE

TFMPP

 See 1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE

Thallium

THALLIUM SULFATE

 See THALLIUM

THIACETARSAMIDE

 See also ARSENIC

THIAMAZOLE

 See METHIMAZOLE

THINNERS

 See HYDROCARBONS, LIQUID

 See LIQUID HYDROCARBONS

2-[THIOCYANOMETHYLTHIO]BENZOTHIAZOLE

 See TCMTB

thiram

 See also DITHIOCARBAMATES

THROMBIN

 See HUMAN BLOOD PRODUCTS

Thujone

  See also SAGE OIL

TIOMESTERONE

 See THIOMESTERONE

TISSUE RECONSTRUCTIVE, AUGMENTATION AND RESTORATION MATERIALS INJECTABLE

 See MEDICAL DEVICES

TMA

 See 3,4,5-TRIMETHOXY--METHYLPHENYLETHYLAMINE

TOLUENE

 See also HYDROCARBONS, LIQUID

 See also XYLENE

TOY

TOY FUELS

 See MOTOR, HEATING or FURNACE FUELS

TRIALKYL TIN COMPOUNDS

 See TIN ORGANIC COMPOUNDS

TRIBUTYL TIN COMPOUNDS

 See TIN ORGANIC COMPOUNDS

TRICHLORFON

  See also METRIFONATE

1,1,1-TRICHLOROETHANE

 See also DESIGNATED SOLVENT

TRICHLOROETHENE

 See TRICHLOROETHYLENE

TRICHLOROISOCYANURIC ACID

  See also CHLORINATING COMPOUNDS

TRICOSENE

 See (Z)-9-TRICOSENE

TRIENBOLONE

 See TRENBOLONE

TRIENOLONE

 See TRENBOLONE

TRIETHYL TIN COMPOUNDS

 See TIN ORGANIC COMPOUNDS

TRIETHYLENE THIOPHOSPHORAMIDE

 See THIOTEPA

TRIIODOTHYRONINE

 See LIOTHYRONINE SODIUM

TRIMETHYL TIN COMPOUNDS

 See TIN ORGANIC COMPOUNDS

TRIPHENYL TIN COMPOUNDS

 See TIN ORGANIC COMPOUNDS

TRIPROPYL TIN COMPOUNDS

 See TIN ORGANIC COMPOUNDS

TSH

 See THYROTROPHIN

TURPENTINE OIL

 See also OIL OF TURPENTINE

U

ULTRASONIC AND MAGNETIC RESONANCE IMAGING ENHANCING AGENTS

 See ENHANCING AGENTS

UNICONAZOLE-P

 See (E)-(S)-1-(4-CHLOROPHENYL)-4,4-DIMETHYL-2-(1H-1,2,4-TRIAZOL-1-YL)PENT-1-EN-3-OL

URINARY CATHETERS

 See MEDICAL DEVICES

V

VINCA ALKALOIDS

 See UNDER INDIVIDUAL ENTRIES

VIPRYNIUMA

 See PYRVINIUM

W

WALLBOARD

 See TIMBER

WHITE CELLS

 See BLOOD COMPONENTS

 See HUMAN BLOOD PRODUCTS

WHITE LEAD

 See BASIC LEAD CARBONATE

WHITE MINERAL OILS

 See HYDROCARBONS, LIQUID

WHITE PETROLEUM SPIRIT

 See LIQUID HYDROCARBONS

 See HYDROCARBONS, LIQUID

WHITE SPIRIT

 See also HYDROCARBONS, LIQUID

WHOLE BLOOD

 See HUMAN BLOOD PRODUCTS

WOOD

 See CREOSOTE

X

Xylene

  See also HYDROCARBONS, LIQUID

  See also TOLUENE

XYLENOLS

 See also PHENOL

Y

YELLOW PHOSPHORUS

 See PHOSPHORUS, YELLOW

Z

ZINC CHROMATE

 See CHROMATES

 See CHROMIUM

ZINC PHOSPHIDE

 See PHOSPHIDES METALLIC

zineb

 See also DITHIOCARBAMATES